Details of Disease

General Information of Disease (ID: DISTR26C)

Disease Name Lung carcinoma
Synonyms lung cancer, NOS; lung cancer; cancer of lung; cancer of the lung; lung carcinoma; carcinoma of lung; carcinoma of the lung
Definition A carcinoma that arises from epithelial cells of the lung
Disease Hierarchy
DISH9F1N: Carcinoma
DISCM4YA: Lung cancer
DISTR26C: Lung carcinoma
Disease Identifiers
MONDO ID
MONDO_0005138
UMLS CUI
C0684249
MedGen ID
195765

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 990 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCC3 TTVLG21 Limited Altered Expression [1]
ACKR3 TTRQJTC Limited Biomarker [2]
ALDH2 TTFLN4T Limited Biomarker [3]
ANPEP TTPHMWB Limited Altered Expression [4]
ARAF TT5TURO Limited Biomarker [5]
ATP1A1 TTWK8D0 Limited Biomarker [6]
AZGP1 TTUPYLV Limited Altered Expression [7]
BCL2L2 TTQ79W8 Limited Biomarker [8]
BIRC2 TTQ5LRD Limited Biomarker [9]
BMX TTN2I9E Limited Biomarker [10]
BPHL TTTZ3EU Limited Biomarker [11]
CAMKK2 TTV298Y Limited Biomarker [12]
CAMP TTULOB6 Limited Biomarker [13]
CCL20 TT2XAZY Limited Biomarker [14]
CCL21 TTLZK1U Limited Biomarker [15]
CCN1 TTPK79J Limited Biomarker [16]
CCR2 TTFZYTO Limited Altered Expression [17]
CD38 TTPURFN Limited Altered Expression [18]
CDK12 TTJ21A9 Limited Biomarker [19]
CFH TTUW6OP Limited Altered Expression [20]
CHRNB4 TTTVAFQ Limited Genetic Variation [21]
CMA1 TT8VUE0 Limited Genetic Variation [22]
CRYZ TTP6UO8 Limited Genetic Variation [23]
CSK TTX6F0Q Limited Genetic Variation [24]
CTSG TTQAJF1 Limited Biomarker [25]
CXCR6 TT2BVUA Limited Biomarker [2]
CYP19A1 TTSZLWK Limited Biomarker [26]
CYP21A2 TTP4GLG Limited Genetic Variation [24]
CYP2B6 TTMH124 Limited Genetic Variation [27]
CYP3A5 TTHS0OK Limited Genetic Variation [28]
DAPK3 TTERVQN Limited Altered Expression [29]
DEPDC1 TT8S9CM Limited Biomarker [30]
DLL3 TT1C9K6 Limited Altered Expression [31]
DLL4 TTV23LH Limited Altered Expression [32]
DNAJB1 TTPXAWS Limited Altered Expression [33]
DNMT3A TTJUALD Limited Biomarker [34]
DPP4 TTDIGC1 Limited Biomarker [35]
E2F3 TTWIJYH Limited Altered Expression [36]
EGLN1 TT9ISBX Limited Genetic Variation [37]
EGLN2 TTMHFRY Limited Genetic Variation [38]
EIF2AK3 TT79U1M Limited Altered Expression [39]
ELAVL1 TTPC9D0 Limited Biomarker [40]
EPCAM TTZ8WH4 Limited Biomarker [41]
EPHA5 TTV9KOD Limited Biomarker [42]
EPHB1 TT8MDAC Limited Biomarker [43]
EPOR TTAUX24 Limited Biomarker [44]
EREG TTYSB89 Limited Altered Expression [45]
F3 TT38MDJ Limited Altered Expression [46]
FGL2 TTYBS89 Limited Biomarker [47]
FN1 TTPJ921 Limited Biomarker [48]
FOXQ1 TTEJZOL Limited Biomarker [49]
G3BP1 TTG0R8Z Limited Altered Expression [50]
GADD45B TTMDW9L Limited Genetic Variation [51]
GDF2 TTAP4T1 Limited Biomarker [52]
GLIPR1 TTEQF1O Limited Biomarker [53]
GRB2 TTEYRJ9 Limited Biomarker [54]
GSN TTUH7OM Limited Biomarker [55]
HAL TTXQOZW Limited Biomarker [56]
HDAC10 TTYHPU6 Limited Biomarker [57]
HNRNPA1 TTPJ9XK Limited Biomarker [58]
HNRNPA2B1 TT8UPW6 Limited Altered Expression [59]
HSPA5 TTW26OG Limited Biomarker [60]
IFNW1 TTS2TGF Limited Genetic Variation [61]
IL1RL1 TT4GZA4 Limited Biomarker [62]
IL22 TTLDX4N Limited Biomarker [63]
IRF1 TT4TU3L Limited Altered Expression [64]
IRF8 TTHUBNK Limited Biomarker [65]
KDM4C TTV8CRH Limited Biomarker [66]
KHDRBS1 TTAT6C7 Limited Altered Expression [67]
MAGEA2 TTOZT28 Limited Altered Expression [68]
MAGEC1 TT9M6NA Limited Altered Expression [69]
MALT1 TTCI81G Limited Genetic Variation [70]
MAP3K2 TTIX0ZU Limited Biomarker [71]
MARK2 TTAJ45Y Limited Biomarker [72]
MCM7 TT1RM3F Limited Altered Expression [73]
MMP12 TTXZ0KQ Limited Biomarker [74]
MMP15 TTNSTO3 Limited Altered Expression [75]
NFKB1 TTUIZKC Limited Genetic Variation [76]
PAK4 TT7Y3BZ Limited Biomarker [77]
PARG TT39J16 Limited Biomarker [11]
PBK TTMY6BZ Limited Altered Expression [78]
PCSK9 TTNIZ2B Limited Biomarker [79]
PDCD1LG2 TTW14O3 Limited Biomarker [80]
PDCD2 TTYOVWN Limited Biomarker [81]
PDE10A TTJW4LU Limited Altered Expression [82]
PDE5A TTJ0IQB Limited Biomarker [83]
PDPK1 TTYMGWX Limited Altered Expression [84]
PLA2G4A TTT1JVS Limited Altered Expression [85]
PLCG1 TT6T4JI Limited Biomarker [86]
PLG TTP86E2 Limited Biomarker [87]
PLK1 TTH4IP0 Limited Biomarker [88]
PLOD2 TT8MEUD Limited Altered Expression [89]
PPIA TTL2ADK Limited Biomarker [90]
PPP1CA TTFLH0E Limited Biomarker [91]
PRKDC TTK3PY9 Limited Altered Expression [92]
PRTN3 TT5MLC4 Limited Biomarker [93]
PTBP1 TTWMX0U Limited Biomarker [94]
RAB22A TTAJ746 Limited Biomarker [95]
RABL3 TTYGK57 Limited Biomarker [96]
RENBP TTZCG0Q Limited Genetic Variation [97]
RNASEL TT7V0K4 Limited Biomarker [98]
RRM1 TTWP0NS Limited Genetic Variation [99]
RSF1 TTMP86V Limited Altered Expression [100]
SCG3 TTY5R9H Limited Biomarker [101]
SERPINF1 TTR59S1 Limited Biomarker [102]
SERPINH1 TTPSWQG Limited Altered Expression [103]
SIK2 TTCUGZR Limited Biomarker [104]
SKP2 TT5B2EO Limited Biomarker [105]
SLC16A1 TTN1J82 Limited Genetic Variation [22]
SLC27A4 TT20AYF Limited Biomarker [106]
SLC38A4 TTJE54U Limited Genetic Variation [99]
SLC44A4 TT0NYDG Limited Genetic Variation [24]
SLC6A2 TTAWNKZ Limited Biomarker [43]
SMAD1 TT9GR53 Limited Altered Expression [107]
SORT1 TTRX9AV Limited Altered Expression [108]
SOX5 TTXHSZK Limited Altered Expression [109]
SREBF1 TTER0UB Limited Biomarker [110]
SSTR2 TTZ6T9E Limited Altered Expression [111]
STS TTHM0R1 Limited Biomarker [112]
TNFRSF10B TTW20TU Limited Altered Expression [113]
TPT1 TT3PTB6 Limited Altered Expression [114]
TRPM8 TTXDKTO Limited Biomarker [115]
USP10 TT5IH09 Limited Biomarker [116]
USP14 TTVSYP9 Limited Biomarker [117]
VEGFB TTPJQHE Limited Biomarker [118]
VEGFC TT0QUFV Limited Altered Expression [119]
WNT5A TTKG7F8 Limited Altered Expression [120]
ABCC1 TTOI92F Disputed Altered Expression [121]
AQP3 TTLDNMQ Disputed Biomarker [122]
CDK4 TT0PG8F Disputed Altered Expression [123]
CHUK TT1F8OQ Disputed Biomarker [124]
DAAM2 TTN0Z6H Disputed Genetic Variation [125]
DKK1 TTE3RAC Disputed Biomarker [126]
DNMT3B TT6VZ78 Disputed Biomarker [127]
FGF2 TTGKIED Disputed Biomarker [128]
HPGDS TTCYE56 Disputed Altered Expression [129]
KRT19 TT3JF9E Disputed Biomarker [130]
LARP1 TTSN1YP Disputed Biomarker [131]
LRRC32 TT0FAYT Disputed Altered Expression [132]
MDM4 TT9OUDQ Disputed Altered Expression [121]
PTGER4 TT79WV3 Disputed Posttranslational Modification [133]
PTN TTA9EJK Disputed Altered Expression [134]
RUNX3 TTKCVO7 Disputed Biomarker [135]
SIRT1 TTUF2HO Disputed Biomarker [136]
SLIT2 TTDWK85 Disputed Altered Expression [137]
TACSTD2 TTP2HE5 Disputed Biomarker [138]
TUSC2 TTJ8O14 Disputed Biomarker [139]
VDR TTK59TV Disputed Genetic Variation [140]
XPA TTGT87E Disputed Genetic Variation [141]
ADAM9 TTTYQNS moderate Biomarker [142]
ADORA3 TTJFY5U moderate Biomarker [143]
AKR1C3 TT5ZWB6 moderate Biomarker [144]
ALCAM TT2AFT6 moderate Biomarker [145]
AMOT TTI48OS moderate Altered Expression [146]
ANGPT2 TTKLQTJ moderate Altered Expression [147]
ANXA1 TTUCK4B moderate Altered Expression [148]
ASRGL1 TT4WT91 moderate Biomarker [126]
AURKB TT9RTBL moderate Biomarker [149]
AVP TTJ8EWH moderate Altered Expression [150]
BMP4 TTD3BSX moderate Altered Expression [151]
BRAF TT0EOB8 moderate Genetic Variation [152]
BRSK1 TTV6WMQ moderate Biomarker [153]
BRSK2 TTHZN4X moderate Biomarker [153]
CA9 TT2LVK8 moderate Altered Expression [154]
CARM1 TTIZQFJ moderate Biomarker [155]
CASP2 TT12VNG moderate Biomarker [156]
CASP5 TTWR48J moderate Genetic Variation [157]
CBR1 TTVG0SN moderate Biomarker [158]
CCNB1 TT9P6OW moderate Altered Expression [159]
CD276 TT6CQUM moderate Altered Expression [160]
CD33 TTJVYO3 moderate Biomarker [161]
CD40LG TTIJP3Q moderate Biomarker [162]
CD9 TTZEIBV moderate Biomarker [163]
CDK5 TTL4Q97 moderate Biomarker [164]
CFLAR TTJZQYH moderate Biomarker [165]
CHAT TTKYFSB moderate Altered Expression [166]
CHRNA7 TTLA931 moderate Biomarker [167]
COL18A1 TT63DI9 moderate Biomarker [168]
COMT TTKWFB8 moderate Genetic Variation [169]
CR1 TTEA8OW moderate Genetic Variation [170]
CRTC1 TT4GO0F moderate Altered Expression [171]
CSF1R TT7MRDV moderate Altered Expression [172]
CXCL1 TTLK1RW moderate Biomarker [173]
CYP17A1 TTRA5BZ moderate Altered Expression [174]
CYP3A4 TTWP7HQ moderate Genetic Variation [28]
DCN TTB3XAN moderate Biomarker [175]
DDR2 TTU98HG moderate Genetic Variation [176]
DLK1 TTF4AVB moderate Biomarker [177]
DNM2 TTVRA5G moderate Genetic Variation [178]
DRD1 TTZFYLI moderate Genetic Variation [179]
DYRK1B TTYGQ8A moderate Altered Expression [180]
EBP TT4VQZX moderate Biomarker [181]
ENTPD1 TTYM8DJ moderate Biomarker [182]
EPAS1 TTWPA54 moderate Altered Expression [183]
EPHA1 TTLFZVU moderate Biomarker [184]
EPHB4 TTI4ZX2 moderate Biomarker [185]
ERBB4 TTWALCO moderate Biomarker [186]
ETS1 TTTGPSD moderate Altered Expression [175]
F2R TTL935N moderate Altered Expression [187]
FAT1 TTGUJYV moderate Biomarker [188]
FDFT1 TTFQEO5 moderate Altered Expression [189]
FGFR3 TTST7KB moderate Biomarker [190]
FGFR4 TT1KX2S moderate Biomarker [191]
FKBP10 TT4P8O2 moderate Biomarker [192]
FLT4 TTDCBX5 moderate Biomarker [193]
FOSL1 TTY8LZG moderate Altered Expression [194]
GAST TT4LRVO moderate Altered Expression [195]
GDF15 TT4MXVG moderate Genetic Variation [196]
GGT1 TTZVT7O moderate Biomarker [197]
GRPR TTC1MVT moderate Biomarker [198]
HKDC1 TTVUI8G moderate Biomarker [199]
HMGB2 TTA78JQ moderate Genetic Variation [200]
HSP90AB1 TTH5YN2 moderate Biomarker [201]
HSPA9 TTMTPG3 moderate Biomarker [202]
IGFBP1 TTCJTWF moderate Altered Expression [203]
IGFBP5 TTDWEA8 moderate Altered Expression [204]
IGFBP7 TTUQ01B moderate Biomarker [205]
IL12A TTRTK6Y moderate Genetic Variation [206]
IL13RA2 TTMPZ7V moderate Biomarker [207]
IL16 TTW4R0B moderate Genetic Variation [208]
IL7 TT8FRMO moderate Biomarker [209]
ITGAM TTB69FJ moderate Biomarker [161]
KDM1A TTNR0UQ moderate Biomarker [210]
KDM2A TT8XTY2 moderate Biomarker [211]
KLK1 TT5T3P6 moderate Altered Expression [212]
KLK4 TT4319X moderate Altered Expression [212]
KLK5 TTULSEW moderate Altered Expression [212]
KLK7 TTE6GTB moderate Altered Expression [212]
LATS2 TTML7FG moderate Altered Expression [213]
LDHA TTW76JE moderate Altered Expression [214]
LGALS3 TTFPQV7 moderate Biomarker [215]
MAP3K3 TTJZNIG moderate Biomarker [216]
MAPK7 TTU6FSC moderate Biomarker [217]
MARCKS TTHRM39 moderate Biomarker [218]
MIA TT5HNVS moderate Biomarker [219]
MSLN TT4RXME moderate Biomarker [220]
MTNR1A TT0WAIE moderate Genetic Variation [221]
MYCN TT9JBY5 moderate Biomarker [222]
NCOA3 TT124R0 moderate Biomarker [223]
NES TTHZ752 moderate Biomarker [224]
NPR1 TTM9IYA moderate Altered Expression [225]
NRP1 TTIPJCB moderate Biomarker [226]
NRP2 TTRXUVC moderate Biomarker [227]
OPRM1 TTKWM86 moderate Biomarker [228]
PDE4A TTZ97H5 moderate Biomarker [229]
PDE4D TTSKMI8 moderate Altered Expression [229]
PDGFA TTSM78N moderate Altered Expression [230]
PECAM1 TT4EZB2 moderate Genetic Variation [231]
PGR TTUV8G9 moderate Biomarker [232]
PIM1 TTTN5QW moderate Biomarker [233]
PIN1 TTJNTSI moderate Altered Expression [234]
PINX1 TT4FJ3A moderate Altered Expression [235]
PKM TT4LOT8 moderate Biomarker [236]
PLA2G2A TTO8QRU moderate Altered Expression [237]
POSTN TT8ALTZ moderate Altered Expression [238]
PPIF TTRFQTB moderate Biomarker [239]
PPME1 TTXQ54R moderate Biomarker [240]
PRKCZ TTBSN0L moderate Biomarker [241]
RARA TTW38KT moderate Biomarker [242]
RPS6KA2 TT0ZW9O moderate Biomarker [243]
RPS6KA3 TTUM2ZR moderate Biomarker [244]
S100A12 TTQ4ESF moderate Biomarker [245]
S100A3 TTCDFR1 moderate Biomarker [242]
SFTPD TTGLMU7 moderate Genetic Variation [246]
SIRT6 TTUXYWF moderate Biomarker [247]
SLC22A16 TTITAVR moderate Altered Expression [248]
SMAD7 TT0J32Z moderate Biomarker [249]
SPHK1 TTOHFIY moderate Biomarker [250]
SPHK2 TTCN0M9 moderate Biomarker [251]
TAP1 TT7JZI8 moderate Altered Expression [252]
TDO2 TTXNCBV moderate Altered Expression [253]
TDP1 TT64IHJ moderate Biomarker [254]
TENT4A TT0XZ4Q moderate Altered Expression [255]
THBD TTAPV67 moderate Biomarker [256]
TIE1 TTT4236 moderate Genetic Variation [257]
TLR9 TTSHG0T moderate Biomarker [258]
TNFRSF1B TT63WSF moderate Genetic Variation [259]
TNFSF13 TTOI1RM moderate Biomarker [260]
TRIM28 TTQ2BKV moderate Biomarker [261]
USP8 TT1J07C moderate Biomarker [262]
WEE1 TTJFOAL moderate Biomarker [263]
ABCA4 TTLB52K Strong Altered Expression [264]
ABCB4 TTJUXV6 Strong Posttranslational Modification [265]
ABCC2 TTFLHJV Strong Altered Expression [1]
ABCC4 TTUEAFL Strong Altered Expression [266]
ABCG1 TTMWDGU Strong Altered Expression [267]
ACAT1 TTK3C21 Strong Biomarker [268]
ACE2 TTUI5H7 Strong Genetic Variation [269]
ACLY TT0Z6Y2 Strong Biomarker [270]
ACR TTAHE2N Strong Biomarker [271]
ACVR1B TTPKHTZ Strong Genetic Variation [272]
ADA TTLP57V Strong Biomarker [273]
ADAM17 TT6AZXG Strong Biomarker [274]
ADAM8 TTQWYMD Strong Altered Expression [275]
ADAMTS1 TTS2TEI Strong Biomarker [276]
ADAMTS5 TTXSU2Y Strong Altered Expression [277]
ADCY1 TTV1ZSQ Strong Genetic Variation [278]
ADCYAP1 TTW4LYC Strong Biomarker [279]
ADCYAP1R1 TT5OREU Strong Biomarker [279]
ADRA1A TTNGILX Strong Biomarker [2]
ADRA2B TTWM4TY Strong Biomarker [2]
AGR2 TT9K86S Strong Biomarker [280]
AGTR2 TTQVOEI Strong Biomarker [281]
AICDA TTKRTP6 Strong Genetic Variation [282]
AIMP2 TTXWHGF Strong Altered Expression [283]
AKR1B1 TTFBNVI Strong Biomarker [284]
AKT3 TTO6SGY Strong Biomarker [285]
ALOX12B TTQ4QQH Strong Genetic Variation [286]
ALOX15 TTN9T81 Strong Altered Expression [287]
ALPI TTHYMUV Strong Biomarker [288]
ANGPT1 TTWNQ1T Strong Biomarker [289]
ANGPTL4 TTWALY5 Strong Biomarker [290]
ANK1 TTKFPMH Strong Posttranslational Modification [291]
ANO1 TTOJI4S Strong Altered Expression [292]
ANXA10 TT0NL6U Strong Biomarker [293]
ANXA2 TT4YANI Strong Altered Expression [294]
ANXA5 TT2Z83I Strong Biomarker [295]
APCS TTB7VAT Strong Biomarker [296]
APEH TTYWEDQ Strong Genetic Variation [297]
APLN TT87D3J Strong Altered Expression [298]
APOC3 TTXOZQ1 Strong Biomarker [299]
AQP1 TTSF1KH Strong Biomarker [300]
AREG TT76B3W Strong Biomarker [194]
ARRB1 TTMVD4A Strong Altered Expression [301]
ARSA TTYQANR Strong Genetic Variation [302]
ASAP3 TTB4ZEN Strong Altered Expression [303]
ATAT1 TTWUHQ1 Strong Altered Expression [304]
ATF3 TTCE793 Strong Altered Expression [305]
ATF4 TTQCKWT Strong Biomarker [306]
ATG7 TTLVB9Z Strong Altered Expression [307]
ATP2A2 TTE6THL Strong Genetic Variation [308]
ATP4A TTF1QVM Strong Biomarker [309]
ATP7B TTOPO51 Strong Genetic Variation [310]
ATR TT8ZYBQ Strong Biomarker [311]
ATXN2 TTPQJ7P Strong Genetic Variation [312]
ATXN3 TT6A17J Strong Biomarker [313]
AXL TTZPY6J Strong Biomarker [314]
BACE1 TTJUNZF Strong Biomarker [315]
BACH1 TT2ME4S Strong Biomarker [316]
BAK1 TTFM7V0 Strong Altered Expression [317]
BBC3 TT7JUKC Strong Biomarker [318]
BCAT1 TTES57P Strong Biomarker [319]
BCL2A1 TTGT9C7 Strong Biomarker [320]
BIRC3 TTAIWZN Strong Genetic Variation [321]
BMI1 TTIPNSR Strong Biomarker [322]
BMP1 TT0L58T Strong Altered Expression [323]
BMP2 TTP3IGX Strong Biomarker [324]
BMP6 TT07RIB Strong Biomarker [325]
BRD2 TTDP48B Strong Biomarker [326]
BRD9 TTR7L5Y Strong Genetic Variation [125]
BRDT TT7CPI5 Strong Biomarker [327]
BRS3 TTKYEPM Strong Biomarker [2]
BSG TT5UJWD Strong Altered Expression [328]
C1QBP TTWTD7F Strong Altered Expression [329]
C5AR1 TTHXFA1 Strong Biomarker [330]
CA12 TTSYM0R Strong Biomarker [331]
CACNA2D2 TTU8P3M Strong Biomarker [332]
CAD TT2YT1K Strong Biomarker [333]
CALCA TTVSFJW Strong Biomarker [334]
CALCR TTLWS2O Strong Biomarker [335]
CAMKK1 TTGLQWZ Strong Genetic Variation [336]
CASP4 TT6KIOT Strong Genetic Variation [337]
CASP7 TTM7Y45 Strong Altered Expression [338]
CASR TTBUYHA Strong Altered Expression [339]
CBS TTVZJ7G Strong Genetic Variation [340]
CCL22 TTBTWI1 Strong Altered Expression [341]
CCND3 TT1JXNR Strong Biomarker [342]
CCR1 TTC24WT Strong Altered Expression [17]
CCR3 TTD3XFU Strong Altered Expression [17]
CCR4 TT7HQD0 Strong Biomarker [343]
CCR6 TTFDB30 Strong Altered Expression [344]
CD163 TTTZ9DE Strong Biomarker [345]
CD200 TT0BE68 Strong Altered Expression [18]
CD22 TTM6QSK Strong Altered Expression [346]
CD24 TTCTYNP Strong Biomarker [347]
CD27 TTDO1MV Strong Biomarker [348]
CD44 TTWFBT7 Strong Biomarker [349]
CD47 TT28S46 Strong Biomarker [350]
CD55 TT5Z9WY Strong Genetic Variation [351]
CD59 TTBGTEJ Strong Altered Expression [352]
CD69 TTPQE9F Strong Altered Expression [353]
CD70 TTNCIE0 Strong Biomarker [354]
CD74 TTCMYP9 Strong Altered Expression [355]
CD80 TT89Z17 Strong Biomarker [356]
CDC20 TTBKFDV Strong Biomarker [357]
CDC25A TTLZS4Q Strong Biomarker [358]
CDC25B TTR0SWN Strong Altered Expression [359]
CDC25C TTESBNC Strong Biomarker [360]
CDCA8 TT04YCM Strong Altered Expression [361]
CDH11 TTRGWZC Strong Altered Expression [362]
CDH2 TT1WS0T Strong Biomarker [363]
CDH5 TTXLCFO Strong Altered Expression [364]
CDH6 TT9QHUK Strong Biomarker [365]
CDK1 TTH6V3D Strong Biomarker [366]
CDK3 TTMYWL7 Strong Altered Expression [367]
CDK5R1 TTBYM6V Strong Altered Expression [368]
CDK7 TTQYF7G Strong Biomarker [369]
CDKN1C TTBSUAR Strong Altered Expression [370]
CEACAM6 TTIGH2W Strong Biomarker [371]
CEBPA TT5LWG1 Strong Altered Expression [372]
CFI TT6ATLX Strong Altered Expression [373]
CGA TTFC29G Strong Genetic Variation [374]
CHEK1 TTTU902 Strong Biomarker [375]
CHEK2 TT9ABMF Strong Biomarker [376]
CHKA TT10AWB Strong Biomarker [166]
CHM TTOA18V Strong Altered Expression [377]
CHRNA1 TT54JVQ Strong Genetic Variation [378]
CHRNA4 TT4H1MQ Strong Genetic Variation [379]
CHRNA9 TTQACP9 Strong Genetic Variation [380]
CLDN4 TTMTS9H Strong Biomarker [381]
CNTN1 TTPR8FK Strong Altered Expression [382]
COL6A3 TT5WCAH Strong Biomarker [383]
COPS5 TTSTNJR Strong Biomarker [384]
CPB2 TTP18AY Strong Altered Expression [385]
CRTC2 TTFWETR Strong Biomarker [386]
CRY1 TT5MLZR Strong Biomarker [387]
CRY2 TTAO58M Strong Biomarker [387]
CSE1L TTTRULD Strong Genetic Variation [388]
CSNK1E TTA8PLI Strong Biomarker [387]
CTAG1A TTE5ITK Strong Biomarker [389]
CTCFL TTY0RZT Strong Biomarker [390]
CTSB TTF2LRI Strong Biomarker [391]
CTSD TTPT2QI Strong Altered Expression [392]
CTSK TTDZN01 Strong Altered Expression [393]
CTSL TT36ETB Strong Biomarker [394]
CTSS TTUMQVO Strong Biomarker [395]
CUBN TT9YLCR Strong Biomarker [396]
CX3CL1 TT1OFBQ Strong Biomarker [397]
CXCL11 TTWG0RE Strong Altered Expression [398]
CXCL12 TT4UGTF Strong Altered Expression [399]
CXCR1 TTMWT8Z Strong Biomarker [400]
CXCR2 TT30C9G Strong Genetic Variation [401]
CXCR4 TTBID49 Strong Biomarker [402]
CYP26A1 TTD7Q0R Strong Altered Expression [403]
CYP2C19 TTZ58XG Strong Genetic Variation [404]
CYSLTR1 TTGKOY9 Strong Biomarker [405]
CYTH2 TTOM97J Strong Altered Expression [406]
DBH TTYIP79 Strong Biomarker [407]
DCK TTJOCE4 Strong Biomarker [408]
DCLK1 TTOHTCY Strong Posttranslational Modification [409]
DDIT4 TTVEOY6 Strong Biomarker [410]
DDX5 TTZKPVC Strong Altered Expression [411]
DEK TT1NMGV Strong Altered Expression [412]
DHCR24 TTTK0NH Strong Biomarker [413]
DIABLO TTN74LE Strong Biomarker [414]
DKK2 TTST5KX Strong Genetic Variation [415]
DLL1 TT9CFQD Strong Altered Expression [416]
DNASE1 TTYWGOJ Strong Genetic Variation [417]
DNMT1 TT6S2FE Strong Biomarker [127]
DOT1L TTSZ8T1 Strong Altered Expression [418]
DPYSL2 TTZCW3T Strong Altered Expression [419]
DSG3 TTEO4P8 Strong Biomarker [420]
DUSP1 TTG8HIM Strong Altered Expression [421]
DUSP5 TTZN92A Strong Altered Expression [422]
DUT TTH6MBO Strong Altered Expression [423]
DYRK1A TTSBVFO Strong Altered Expression [424]
E2F2 TT5FYX0 Strong Altered Expression [425]
EBI3 TTJF68X Strong Biomarker [426]
ECE1 TTQ9RYT Strong Biomarker [427]
EDNRB TT3ZTGU Strong Biomarker [428]
EGR1 TTE8LGD Strong Altered Expression [429]
ENAH TTY36UA Strong Biomarker [430]
ENG TTB30LE Strong Biomarker [431]
ENOX2 TTUJZRL Strong Biomarker [432]
ENPP1 TTZTIWS Strong Biomarker [433]
EPHA4 TTG84D3 Strong Biomarker [434]
EPHA7 TTAHTVG Strong Biomarker [435]
EPHB6 TTZEMUY Strong Biomarker [436]
EPHX2 TT7WVHI Strong Genetic Variation [437]
ERF TTGXULC Strong Biomarker [438]
ESRRA TTPNQAC Strong Altered Expression [439]
ETS2 TT9AH0M Strong Altered Expression [440]
EYA2 TTUY9C6 Strong Biomarker [441]
EZH2 TT9MZCQ Strong Biomarker [442]
EZR TTE47YC Strong Biomarker [443]
F11R TT3C8EG Strong Altered Expression [444]
F13A1 TTXI2RA Strong Altered Expression [445]
F13B TTAXGIP Strong Altered Expression [445]
F2RL1 TTQR74A Strong Biomarker [2]
FABP4 TTHWMFZ Strong Biomarker [446]
FAM83B TT1Q347 Strong Biomarker [447]
FDXR TT3W4IX Strong Biomarker [284]
FER TTRA9G0 Strong Altered Expression [448]
FES TTLBY21 Strong Biomarker [449]
FGF1 TTMY81X Strong Biomarker [450]
FGF10 TTNPEFX Strong Biomarker [451]
FGF18 TT6ICRA Strong Altered Expression [452]
FGR TTPOGS1 Strong Altered Expression [453]
FOLH1 TT9G4N0 Strong Biomarker [454]
FOLR1 TTVC37M Strong Altered Expression [455]
FOLR2 TTT54CI Strong Biomarker [456]
FOXC2 TTLBAP1 Strong Altered Expression [457]
FOXP3 TT1X3QF Strong Biomarker [458]
FPR2 TTOJ1NF Strong Altered Expression [459]
FSCN1 TTTRS9B Strong Biomarker [460]
FTO TTFW3BT Strong Biomarker [461]
FUT3 TTUPAD7 Strong Biomarker [462]
FUT4 TTNV1KZ Strong Biomarker [463]
FYN TT2B9KF Strong Biomarker [300]
G6PD TTKN8W0 Strong Biomarker [464]
GABRA3 TT37EDJ Strong Altered Expression [465]
GABRQ TTXDUR9 Strong Genetic Variation [466]
GALC TT5IZRB Strong Posttranslational Modification [467]
GAS6 TT69QD2 Strong Biomarker [468]
GATA3 TT45KOB Strong Biomarker [469]
GATA4 TT1VDN2 Strong Biomarker [470]
GCK TTDLNGZ Strong Biomarker [471]
GCLM TTNFESW Strong Altered Expression [472]
GHR TTHJWYD Strong Genetic Variation [473]
GHSR TTWDC17 Strong Biomarker [474]
GJB1 TTSJIRP Strong Biomarker [475]
GJB2 TTRGZX3 Strong Biomarker [476]
GJB4 TTBRDFI Strong Altered Expression [477]
GLB1 TTNGJPH Strong Biomarker [478]
GLI1 TTJOMH6 Strong Biomarker [479]
GPC3 TTJTSX4 Strong Biomarker [220]
GPI TT19JIZ Strong Biomarker [480]
GPRC5D TTHRAPJ Strong Altered Expression [481]
GRHL2 TTUGH4C Strong Altered Expression [482]
GRIA2 TTWM461 Strong Biomarker [483]
GSS TTVEWR4 Strong Genetic Variation [484]
GSTA1 TT4P8DE Strong Altered Expression [485]
GSTA2 TTNLFBE Strong Genetic Variation [486]
GUSB TTHS7CM Strong Altered Expression [487]
HBEGF TT15SL0 Strong Biomarker [488]
HDAC2 TTSHTOI Strong Biomarker [489]
HDAC5 TTUELN5 Strong Biomarker [490]
HDAC7 TTMUEK1 Strong Biomarker [491]
HDAC9 TT8M4E1 Strong Genetic Variation [492]
HDGF TTKGV26 Strong Altered Expression [493]
HGFAC TTD96RW Strong Biomarker [87]
HK2 TTK02H8 Strong Altered Expression [494]
HLA-A TTHONFT Strong Genetic Variation [495]
HLA-B TTGS10J Strong Altered Expression [496]
HOXA11 TTEX4ZA Strong Biomarker [497]
HOXA13 TTN26OM Strong Altered Expression [498]
HOXA5 TTXSVQP Strong Biomarker [499]
HPD TT8DSFC Strong Altered Expression [500]
HPSE TTR7GJO Strong Biomarker [501]
HSD11B2 TT9H85R Strong Genetic Variation [502]
HSD17B1 TTIWB6L Strong Altered Expression [503]
HSF1 TTN6STZ Strong Biomarker [504]
HSP90B1 TTFPKXQ Strong Biomarker [505]
HSPA12B TTAI9ZQ Strong Biomarker [506]
HSPA8 TTMQL3K Strong Genetic Variation [507]
HSPB3 TTLH8WG Strong Biomarker [410]
HTATIP2 TTC6IX5 Strong Biomarker [508]
IAPP TTHN8EM Strong Biomarker [288]
ID1 TTBXVDE Strong Altered Expression [509]
IFNAR1 TTSYFMA Strong Biomarker [510]
IFNB1 TT4TZ8J Strong Biomarker [511]
IGF2 TTE8WGO Strong Biomarker [512]
IGF2R TTPNE41 Strong Genetic Variation [513]
IGFBP2 TTU4QSN Strong Altered Expression [514]
IGFBP6 TTLAYV8 Strong Biomarker [515]
IKBKB TTJ3E9X Strong Biomarker [516]
IL13 TT0GVCH Strong Altered Expression [517]
IL15 TTJFA35 Strong Genetic Variation [518]
IL24 TT1EPXZ Strong Biomarker [479]
IL25 TTVMO5W Strong Biomarker [519]
IL2RB TT9721Y Strong Biomarker [520]
IL31 TT1RJXK Strong Genetic Variation [521]
IL31RA TT9HPX0 Strong Genetic Variation [522]
IL32 TTD4G7L Strong Biomarker [523]
IL33 TT5MD4P Strong Genetic Variation [520]
IL37 TTQTX98 Strong Biomarker [524]
IL4R TTDWHC3 Strong Genetic Variation [525]
IL7R TTAWI51 Strong Biomarker [209]
IL9 TT0JTFD Strong Biomarker [526]
ILK TT7ALZG Strong Biomarker [527]
INPP5D TTTP2Z1 Strong Biomarker [528]
IRAK3 TTBPJOK Strong Altered Expression [529]
IRS1 TTAJSQ0 Strong Biomarker [530]
IRS2 TTF95B8 Strong Altered Expression [531]
ISG15 TTVOH3T Strong Altered Expression [532]
ITCH TT5SEWD Strong Biomarker [533]
ITGA11 TTANXZ7 Strong Altered Expression [534]
ITGA2 TTSJ542 Strong Biomarker [535]
ITGA5 TTHIZP9 Strong Biomarker [536]
ITGAV TTT1R2L Strong Genetic Variation [537]
ITGB1 TTBVIQC Strong Altered Expression [538]
ITGB3 TTJA1ZO Strong Altered Expression [539]
ITGB6 TTKQSXZ Strong Genetic Variation [537]
ITGB8 TTIF29E Strong Biomarker [540]
JAK1 TT6DM01 Strong Biomarker [541]
KCNJ5 TTEO25X Strong Altered Expression [542]
KCNK3 TTGR91N Strong Biomarker [543]
KDM3A TTKXS4A Strong Altered Expression [544]
KDM4A TTZHPB8 Strong Biomarker [545]
KDM5B TTCLI75 Strong Biomarker [546]
KIR2DS1 TTVWAGF Strong Biomarker [547]
KIR3DL2 TTQH3N0 Strong Biomarker [547]
KLK2 TTJLNAW Strong Genetic Variation [286]
KLK3 TTS78AZ Strong Biomarker [548]
KLK8 TTH5MRS Strong Biomarker [549]
KLKB1 TTN0PCX Strong Biomarker [550]
KLRK1 TTLRN4A Strong Altered Expression [551]
KRT17 TTKV0EC Strong Altered Expression [552]
L1CAM TTC9D3K Strong Altered Expression [553]
LAMB3 TT2WOUQ Strong Biomarker [554]
LANCL1 TTZW8NS Strong Biomarker [526]
LAPTM4B TTEJQT0 Strong Biomarker [555]
LASP1 TTZJA87 Strong Biomarker [556]
LGR4 TTY6C71 Strong Biomarker [557]
LIF TTGZ5WN Strong Biomarker [558]
LILRB1 TTC0QRJ Strong Altered Expression [559]
LIMK1 TTWL9TY Strong Biomarker [560]
LIN28A TTO50LN Strong Biomarker [561]
LNPEP TTY2KP7 Strong Biomarker [562]
LONP1 TTM1VPZ Strong Biomarker [563]
LOX TTQHNAM Strong Biomarker [564]
LOXL2 TTFSUHX Strong Biomarker [565]
LPAR1 TTQ6S1K Strong Biomarker [566]
LPAR2 TTB7Y8I Strong Biomarker [2]
LSM1 TT2KHSC Strong Altered Expression [567]
LTB TTHQ6US Strong Biomarker [453]
LY6K TT5GKHN Strong Biomarker [568]
LYN TT1RWNJ Strong Altered Expression [569]
LYVE1 TTG8DNU Strong Biomarker [570]
MAD1L1 TTNE9U7 Strong Genetic Variation [571]
MAGEA3 TTWSKHD Strong Biomarker [572]
MAGEA4 TT9EQUY Strong Altered Expression [573]
MAGEC2 TTKGUEB Strong Altered Expression [574]
MAP2K2 TT8H9GB Strong Genetic Variation [575]
MAP2K7 TT6QY3J Strong Biomarker [576]
MAP3K1 TTW8TJI Strong Altered Expression [577]
MAP3K20 TTTUZ3O Strong Genetic Variation [578]
MAP3K5 TTOQCD8 Strong Biomarker [579]
MAP3K8 TTGECUM Strong Altered Expression [580]
MAP4K3 TTI0AHJ Strong Biomarker [471]
MAPK12 TTYT93M Strong Altered Expression [581]
MAPK8 TT0K6EO Strong Biomarker [582]
MAPK9 TT3IVG2 Strong Biomarker [583]
MAPKAPK2 TTMUG9D Strong Biomarker [584]
MBL2 TTMQDZ5 Strong Altered Expression [585]
MBNL2 TTH9OLG Strong Altered Expression [586]
MCAM TTHRE05 Strong Biomarker [587]
MDK TTV8UE7 Strong Biomarker [588]
MELK TTBZOTY Strong Biomarker [104]
MERTK TTO7LKR Strong Biomarker [589]
MGLL TTZ963I Strong Altered Expression [590]
MLH1 TTISG27 Strong Posttranslational Modification [591]
MMP10 TTXLEG7 Strong Biomarker [592]
MMP11 TTZW4MV Strong Genetic Variation [593]
MMP14 TTJ4QE7 Strong Altered Expression [594]
MPL TTIHYA4 Strong Altered Expression [595]
MSH2 TTCAWRT Strong Altered Expression [116]
MSI1 TTSM4BA Strong Genetic Variation [596]
MSI2 TTTXQF6 Strong Altered Expression [597]
MSMB TTYH1ZK Strong Posttranslational Modification [598]
MSR1 TT2TDH9 Strong Biomarker [599]
MST1R TTBQ3OC Strong Biomarker [600]
MSTN TTM8I2X Strong Biomarker [601]
MTA1 TTO4HUS Strong Altered Expression [602]
MTAP TTDBX7N Strong Biomarker [603]
MTDH TTH6SA5 Strong Altered Expression [604]
MTR TTUTO39 Strong Genetic Variation [605]
MUC17 TTVO0JU Strong Altered Expression [606]
MUC5AC TTEL90S Strong Biomarker [607]
MUTYH TTNB0ZK Strong Biomarker [608]
MYD88 TTB6Q2O Strong Biomarker [609]
MYLK TT18ETS Strong Altered Expression [610]
NCK1 TTMA3VF Strong Genetic Variation [611]
NCL TTK1V5Q Strong Biomarker [612]
NECTIN4 TTPO9EG Strong Biomarker [613]
NEDD4 TT1QU6G Strong Biomarker [391]
NEDD8 TTNDC4K Strong Altered Expression [614]
NEDD9 TT1UREA Strong Biomarker [615]
NEK2 TT3VZ24 Strong Biomarker [616]
NEK8 TT8AH9I Strong Biomarker [617]
NELL1 TT7H4BF Strong Biomarker [618]
NFKB2 TTKLNRV Strong Altered Expression [619]
NISCH TT789FN Strong Genetic Variation [620]
NME1 TTDY8JH Strong Biomarker [621]
NOD1 TTYSRXM Strong Genetic Variation [622]
NOD2 TTYPUHA Strong Biomarker [622]
NOP2 TTBLG3H Strong Altered Expression [623]
NOTCH3 TTVX7IA Strong Genetic Variation [624]
NPEPPS TT371QC Strong Biomarker [548]
NR0B2 TT25A9Q Strong Biomarker [625]
NR1D1 TTAD1O8 Strong Biomarker [387]
NR1H2 TTXA6PH Strong Genetic Variation [626]
NR1I2 TT7LCTF Strong Biomarker [627]
NR1I3 TTRANFM Strong Altered Expression [339]
NR4A1 TTMXE2Q Strong Biomarker [628]
NR4A2 TT9HKN3 Strong Biomarker [629]
NR4A3 TTJQB49 Strong Altered Expression [630]
NR5A2 TTAU3SY Strong Altered Expression [631]
NT5E TTK0O6Y Strong Biomarker [632]
NTN1 TT0AH4L Strong Biomarker [633]
NTRK1 TTTDVOJ Strong Biomarker [634]
NTSR1 TTTUMEP Strong Biomarker [635]
NUF2 TTIXBFP Strong Biomarker [568]
OAT TTTSCQ2 Strong Altered Expression [636]
ODC1 TTUMGNO Strong Biomarker [637]
OGFR TT6IEYX Strong Altered Expression [638]
ORAI1 TTE76YK Strong Biomarker [639]
OXTR TTSCIUP Strong Altered Expression [640]
P2RX1 TTJW7B3 Strong Genetic Variation [641]
P2RX3 TT2THBD Strong Genetic Variation [641]
P2RX4 TT1NLOA Strong Genetic Variation [641]
P2RY1 TTA93TL Strong Genetic Variation [641]
P2RY2 TTOZHQC Strong Genetic Variation [641]
PABPC1 TTHC8EF Strong Altered Expression [642]
PADI4 TTQHAXM Strong Biomarker [643]
PAH TTGSVH2 Strong Genetic Variation [644]
PAK1 TTFN95D Strong Altered Expression [645]
PAM TTF4ZPC Strong Biomarker [646]
PARP1 TTVDSZ0 Strong Genetic Variation [647]
PCNA TTLG1PD Strong Biomarker [648]
PDCD1 TTNBFWK Strong Biomarker [649]
PDE7A TT1BC3A Strong Altered Expression [650]
PDGFB TTQA6SX Strong Biomarker [651]
PDK1 TTCZOF2 Strong Biomarker [652]
PDK2 TTJGCKM Strong Altered Expression [653]
PDXP TT9UYG4 Strong Biomarker [654]
PEBP1 TT1BGU8 Strong Biomarker [655]
PFKFB3 TTTHMQJ Strong Altered Expression [656]
PGD TTZ3IFB Strong Altered Expression [657]
PGF TT48I1Y Strong Biomarker [658]
PGRMC1 TTY3LAZ Strong Biomarker [659]
PHB TT6U071 Strong Altered Expression [660]
PHF8 TT81PFE Strong Biomarker [661]
PHGDH TT8DRCK Strong Biomarker [662]
PIM2 TT69J2Z Strong Altered Expression [663]
PKD2L1 TTAHD89 Strong Biomarker [193]
PLA2G1B TT9V5JH Strong Biomarker [237]
PLAC1 TTM18HX Strong Altered Expression [664]
PLAUR TTNOSTX Strong Biomarker [665]
PLK4 TTGPNZQ Strong Biomarker [373]
PMEL TT8MK59 Strong Altered Expression [619]
PML TTLH9NY Strong Biomarker [666]
PMS1 TTX1ISF Strong Genetic Variation [667]
POLB TTA0XPV Strong Genetic Variation [668]
POR TTOQ9GZ Strong Biomarker [669]
PORCN TTNFBTO Strong Biomarker [670]
PPARD TT2JWF6 Strong Genetic Variation [671]
PPM1D TTENJAB Strong Genetic Variation [672]
PRDX5 TTLPJWH Strong Biomarker [673]
PRKCA TTFJ8Q1 Strong Biomarker [674]
PRKCD TT7A1BO Strong Biomarker [675]
PRKCI TTWJTHX Strong Biomarker [676]
PRMT1 TTVOJAI Strong Altered Expression [650]
PROM1 TTXMZ81 Strong Altered Expression [677]
PSIP1 TTH9LDP Strong Biomarker [678]
PSMB6 TT8EPLT Strong Biomarker [679]
PTGES TTYLQ8V Strong Biomarker [680]
PTK7 TTXH2ZN Strong Biomarker [681]
PTP4A1 TTA8GFO Strong Biomarker [682]
PTP4A2 TT1MHKD Strong Biomarker [683]
PTP4A3 TT7YM8D Strong Biomarker [684]
PTPN13 TT405FP Strong Biomarker [685]
PTPRB TT64I9Q Strong Biomarker [686]
PTPRJ TTWMKXP Strong Genetic Variation [687]
RAC1 TT2M9CG Strong Biomarker [688]
RACK1 TTJ10AL Strong Altered Expression [689]
RAD51 TTC0G1L Strong Genetic Variation [690]
RALBP1 TTVSRUA Strong Altered Expression [691]
RAPGEF3 TTOE7I0 Strong Biomarker [692]
RECK TTRZBW7 Strong Altered Expression [693]
REG3A TTL4H8N Strong Biomarker [694]
REG4 TTVZEHU Strong Biomarker [695]
RICTOR TT143WL Strong Biomarker [696]
ROBO1 TTND1YP Strong Altered Expression [697]
ROCK1 TTZN7RP Strong Biomarker [698]
ROR1 TTDEJAU Strong Biomarker [699]
ROR2 TTUDPCI Strong Biomarker [700]
RORA TT1TYN7 Strong Biomarker [387]
RPS6KA1 TTIXKA4 Strong Biomarker [243]
RSPO1 TTI9HL4 Strong Biomarker [701]
RSPO3 TT7HJTF Strong Biomarker [701]
RTN4 TT7GXMU Strong Altered Expression [702]
RUNX2 TTD6SZ8 Strong Altered Expression [703]
RXRA TT6PEUO Strong Biomarker [704]
S100A4 TTPR5SX Strong Altered Expression [705]
S100A6 TT716MY Strong Biomarker [706]
S100A8 TT4AF6N Strong Biomarker [707]
S100A9 TT0TMQG Strong Biomarker [708]
S1PR3 TTDYP7I Strong Biomarker [709]
SAA1 TTY0DN9 Strong Biomarker [710]
SATB1 TTLFRIC Strong Biomarker [711]
SCD TT6RIOV Strong Biomarker [712]
SCGB1A1 TTONPVW Strong Biomarker [713]
SCGB1D2 TT5D314 Strong Biomarker [714]
SCT TTOBVIN Strong Posttranslational Modification [715]
SDC1 TTYDSVG Strong Biomarker [716]
SDC2 TT5H2F0 Strong Altered Expression [717]
SEMA4D TT5UT28 Strong Altered Expression [718]
SENP1 TTW9HY5 Strong Biomarker [719]
SENP8 TTMBUHI Strong Biomarker [720]
SERPINB3 TT6QLPX Strong Biomarker [721]
SERPINB5 TT1KW50 Strong Altered Expression [722]
SETD2 TTPC3H4 Strong Biomarker [723]
SETD7 TTJ0FSU Strong Biomarker [724]
SFRP4 TTX8I1Y Strong Genetic Variation [725]
SGO1 TTBPKGD Strong Biomarker [726]
SH2B3 TT36N7Z Strong Genetic Variation [312]
SHCBP1 TTZ9WGL Strong Biomarker [727]
SIK1 TT1H6LC Strong Biomarker [728]
SIK3 TTW6L4V Strong Biomarker [728]
SIRT2 TTLKF5M Strong Biomarker [729]
SIRT5 TTH0IOD Strong Biomarker [730]
SLC14A1 TTWVJU1 Strong Biomarker [731]
SLC18A2 TTNZRI3 Strong Biomarker [732]
SLC19A1 TT09I7D Strong Genetic Variation [733]
SLC1A5 TTF7WRM Strong Biomarker [734]
SLC1A7 TTK41DM Strong Genetic Variation [735]
SLC25A1 TTTD730 Strong Altered Expression [736]
SLC33A1 TTL69WB Strong Biomarker [737]
SLC34A2 TTQPZTM Strong Altered Expression [738]
SLC38A1 TT1YE9Z Strong Altered Expression [739]
SLC3A2 TT5CZSM Strong Biomarker [740]
SLC46A1 TTY8Z2E Strong Altered Expression [650]
SLC52A2 TT6TKEN Strong Altered Expression [741]
SLC5A2 TTF8JAT Strong Altered Expression [742]
SLC5A5 TTW7HI9 Strong Biomarker [743]
SLC6A8 TTYUHB5 Strong Biomarker [335]
SLC7A11 TTBZMIO Strong Altered Expression [744]
SLC7A5 TTPH2JB Strong Biomarker [745]
SLCO1B1 TTFGXEB Strong Biomarker [746]
SLCO1B3 TTU86P0 Strong Altered Expression [747]
SLCO2A1 TTKVTQO Strong Biomarker [748]
SMAD6 TTON5JB Strong Biomarker [107]
SNCG TT5TQNZ Strong Altered Expression [749]
SOCS1 TT8COJM Strong Biomarker [750]
SOCS3 TTI0ME6 Strong Biomarker [751]
SPDEF TT2ZUPY Strong Biomarker [707]
SPN TTOZAX0 Strong Altered Expression [752]
SQLE TTE14XG Strong Biomarker [753]
SQSTM1 TTOT2RY Strong Altered Expression [67]
SRC TT6PKBN Strong Altered Expression [754]
SRGN TTCHB06 Strong Biomarker [755]
SSTR1 TTIND6G Strong Altered Expression [756]
SSTR3 TTJX3UE Strong Biomarker [757]
SSTR4 TTAE1BR Strong Biomarker [2]
SSTR5 TT2BC4G Strong Biomarker [757]
ST14 TTPRO7W Strong Biomarker [758]
ST8SIA4 TTDP8YM Strong Genetic Variation [759]
STAT6 TTWOE1T Strong Altered Expression [760]
STC1 TTDLUER Strong Biomarker [761]
STC2 TT4EFTR Strong Altered Expression [762]
STK33 TTP34DQ Strong Altered Expression [763]
STK38 TT27XFN Strong Biomarker [577]
STMN1 TT7W5OT Strong Altered Expression [764]
STOML2 TTOI329 Strong Altered Expression [765]
STYK1 TTRMCYJ Strong Altered Expression [766]
SUCNR1 TT4FX9Y Strong Altered Expression [767]
SUV39H1 TTUWQTK Strong Altered Expression [591]
SYK TT2HUPM Strong Biomarker [768]
TACC3 TTQ4UFD Strong Altered Expression [769]
TAGLN TTDRZ9H Strong Genetic Variation [770]
TARDBP TT9RZ03 Strong Biomarker [771]
TBK1 TTMP03S Strong Biomarker [772]
TBL1XR1 TTYXT16 Strong Altered Expression [773]
TBXA2R TT2O84V Strong Altered Expression [774]
TDP2 TTYF26D Strong Biomarker [775]
TEK TT9VGXW Strong Biomarker [147]
TEP1 TTQGAVX Strong Biomarker [776]
TERF1 TT1Y6J2 Strong Genetic Variation [777]
TERF2 TT5XSLT Strong Genetic Variation [778]
TF TT8WXAV Strong Biomarker [779]
TFAP2A TTDY4BS Strong Altered Expression [780]
TFPI TT068JH Strong Biomarker [781]
TGM1 TT7A949 Strong Altered Expression [445]
TGM2 TT2F4OL Strong Biomarker [782]
THBS1 TTKI0H1 Strong Altered Expression [102]
THPO TTCG5PE Strong Biomarker [783]
TIAM1 TTNU6I5 Strong Biomarker [784]
TK1 TTP3QRF Strong Biomarker [785]
TLR5 TTCXP8J Strong Altered Expression [786]
TMEM219 TTY078U Strong Biomarker [787]
TMEM97 TT9NXW4 Strong Biomarker [788]
TMSB4X TTMVAIU Strong Altered Expression [789]
TNC TTUCPMY Strong Biomarker [790]
TNFAIP3 TT5W0IO Strong Biomarker [791]
TNFRSF12A TTKPS7V Strong Biomarker [792]
TNFRSF1A TTG043C Strong Biomarker [793]
TNFRSF8 TT2GM5R Strong Altered Expression [794]
TNFSF11 TT9E8HR Strong Biomarker [795]
TNFSF15 TTEST6I Strong Genetic Variation [796]
TNKS2 TTFQI4H Strong Biomarker [797]
TNS4 TT1K65C Strong Altered Expression [798]
TOP1 TTGTQHC Strong Biomarker [799]
TOP2A TTCGY2K Strong Biomarker [678]
TOP2B TT4NVEM Strong Altered Expression [800]
TPBG TT70MLA Strong Altered Expression [801]
TPP1 TTOVYPT Strong Biomarker [802]
TPX2 TT0PHL4 Strong Altered Expression [619]
TRAF6 TTCDR6M Strong Biomarker [803]
TREM1 TTHZQP0 Strong Biomarker [804]
TRIM27 TTTO3QN Strong Altered Expression [459]
TRIM59 TT613U4 Strong Altered Expression [805]
TRPA1 TTELV3W Strong Biomarker [806]
TRPM2 TTEBMN7 Strong Biomarker [807]
TRPM7 TTFPVZO Strong Biomarker [808]
TRPV3 TT946IA Strong Biomarker [809]
TSG101 TTHU7JA Strong Altered Expression [810]
TSPO TTPTXIN Strong Altered Expression [811]
TTK TTP7EGM Strong Altered Expression [812]
TTR TTPOYU7 Strong Biomarker [813]
TWIST1 TTX1MY7 Strong Biomarker [814]
TXNIP TTTLDZK Strong Biomarker [815]
TXNRD1 TTR7UJ3 Strong Biomarker [816]
TYRO3 TTIEMFN Strong Altered Expression [817]
UBE2E2 TTXJEOF Strong Biomarker [532]
UCP2 TTSC2YM Strong Altered Expression [818]
UGT1A1 TT34ZAF Strong Genetic Variation [819]
ULK1 TT4D7MJ Strong Genetic Variation [820]
USP1 TTG9MT5 Strong Biomarker [821]
USP13 TTVJIO2 Strong Altered Expression [822]
USP33 TT4E85Q Strong Biomarker [823]
USP44 TTJLTNM Strong Altered Expression [824]
USP7 TTXU3EQ Strong Altered Expression [461]
UTRN TTNO1VA Strong Altered Expression [825]
VDAC1 TTAMKGB Strong Altered Expression [826]
VDAC2 TTM1I7L Strong Biomarker [827]
VEGFD TTOM5H4 Strong Biomarker [828]
VHL TTEMWSD Strong Biomarker [829]
VIP TTGTWLF Strong Biomarker [830]
VIPR1 TTCL30I Strong Biomarker [831]
VIPR2 TT4O5P0 Strong Biomarker [831]
VTCN1 TTCK85E Strong Biomarker [832]
WDR5 TT7OFWB Strong Altered Expression [833]
WNK1 TTJ9UMX Strong Biomarker [834]
WNT7A TT8NARC Strong Altered Expression [835]
WWP2 TT6TU05 Strong Altered Expression [760]
XPO1 TTCJUR4 Strong Biomarker [836]
YES1 TT0SQ8J Strong Biomarker [837]
ZWINT TTWY768 Strong Biomarker [838]
AGER TTMO9HF Definitive Biomarker [839]
AMACR TTLN1AP Definitive Genetic Variation [840]
AURKA TTPS3C0 Definitive Biomarker [841]
CASP9 TTB6T7O Definitive Altered Expression [842]
CCK TT90CMU Definitive Biomarker [843]
CCR8 TTE836A Definitive Altered Expression [844]
CLDN18 TT6PKBX Definitive Altered Expression [845]
CLDN6 TTKSV48 Definitive Altered Expression [845]
CLU TTRL76H Definitive Biomarker [846]
CSNK2A1 TTER6YH Definitive Biomarker [847]
CSNK2A2 TT7GR5W Definitive Genetic Variation [848]
CYP24A1 TT82UI1 Definitive Genetic Variation [849]
DKK3 TTY2ZV6 Definitive Altered Expression [850]
DRD4 TTE0A2F Definitive Genetic Variation [851]
E2F1 TTASI04 Definitive Biomarker [852]
EEF2K TT1QFLA Definitive Biomarker [853]
EIF5A2 TTH53G9 Definitive Genetic Variation [854]
EML4 TT92GY4 Definitive Genetic Variation [855]
EPHA2 TTRJB2G Definitive Biomarker [856]
EPHA3 TTHS2LR Definitive Biomarker [857]
EPHB2 TTKPV6O Definitive Biomarker [858]
ESR1 TTZAYWL Definitive Biomarker [859]
FOXM1 TTD3KOX Definitive Altered Expression [860]
FOXO1 TTLRVIA Definitive Biomarker [861]
FPR1 TT5Y4EM Definitive Altered Expression [862]
FST TTDNM9W Definitive Altered Expression [863]
GALNS TTT9YPO Definitive Biomarker [864]
HLA-DQA1 TTU2I3J Definitive Genetic Variation [495]
HSP90AA1 TT78R5H Definitive Biomarker [865]
IDO1 TTZJYKH Definitive Altered Expression [866]
IGFBP3 TTZHNQA Definitive Biomarker [867]
JAK2 TTRMX3V Definitive Biomarker [868]
KAT2B TTVK7SB Definitive Biomarker [869]
KCNH1 TT9XKUC Definitive Altered Expression [870]
KEAP1 TT3Z6Y9 Definitive Genetic Variation [871]
KLF4 TTTI53X Definitive Altered Expression [872]
LGALS1 TTO3NYT Definitive Biomarker [873]
LTF TTSZDQU Definitive Posttranslational Modification [874]
MAGEA1 TT63M7Q Definitive Biomarker [875]
MAPK14 TTQBR95 Definitive Biomarker [876]
MAPK3 TT1MG9E Definitive Biomarker [877]
MCL1 TTL53M6 Definitive Posttranslational Modification [878]
MUC1 TTBHFYQ Definitive Altered Expression [879]
NTRK2 TTKN7QR Definitive Biomarker [880]
NTRK3 TTXABCW Definitive Biomarker [881]
PPM1A TTLA7IX Definitive Biomarker [823]
PRDX4 TTPBL9I Definitive Altered Expression [882]
PRMT5 TTR1D7X Definitive Biomarker [883]
RORB TTGB2LZ Definitive Biomarker [387]
RORC TTGV6LY Definitive Genetic Variation [387]
RXFP1 TTMAHD1 Definitive Altered Expression [884]
SERPINC1 TT4QPUL Definitive Biomarker [313]
SMARCA4 TTVQEZS Definitive Biomarker [885]
SOX2 TTCNOT6 Definitive Posttranslational Modification [886]
SPARC TTBQFM7 Definitive Biomarker [431]
SSRP1 TTETDKQ Definitive Biomarker [887]
SULF2 TTLQTHB Definitive Biomarker [888]
TCF7L2 TT80QAL Definitive Altered Expression [889]
TNKS TTVUSO7 Definitive Altered Expression [890]
TRIM24 TT9Q7AE Definitive Biomarker [891]
TRIM37 TTAMCSL Definitive Biomarker [892]
------------------------------------------------------------------------------------
⏷ Show the Full List of 990 DTT(s)
This Disease Is Related to 22 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC17A4 DTHE530 Limited Genetic Variation [24]
SLC25A3 DTCRIWV Limited Biomarker [893]
SLC26A1 DTJ785O moderate Altered Expression [894]
SLC30A1 DT1BO38 moderate Altered Expression [895]
ABCA3 DT2T6VQ Strong Biomarker [896]
ABCC10 DTPS120 Strong Genetic Variation [897]
ABCC11 DTWN7FC Strong Biomarker [898]
ABCC5 DTYVM24 Strong Biomarker [899]
ATP12A DT5NLZA Strong Biomarker [309]
SLC18A1 DTM953D Strong Altered Expression [732]
SLC25A37 DTLBGTZ Strong Biomarker [900]
SLC27A2 DTXK9WA Strong Biomarker [901]
SLC27A3 DTEW95J Strong Biomarker [902]
SLC28A1 DT0EQPW Strong Genetic Variation [903]
SLC2A10 DT3BI6S Strong Biomarker [904]
SLC2A3 DT9SQ3L Strong Biomarker [905]
SLC31A1 DTP8L4F Strong Biomarker [906]
SLC39A4 DTEZCUM Strong Biomarker [907]
SLC44A1 DT3I2SU Strong Altered Expression [908]
SLC4A9 DTSQY0W Strong Biomarker [909]
SLC52A1 DT7NOKR Strong Biomarker [910]
SLC5A8 DTE3TAW Strong Biomarker [911]
------------------------------------------------------------------------------------
⏷ Show the Full List of 22 DTP(s)
This Disease Is Related to 60 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ALDH1A1 DE2JP1Y Limited Biomarker [912]
APRT DE2MV1R Limited Altered Expression [913]
AS3MT DE9KJP3 Limited Genetic Variation [914]
ASNS DEXISVQ Limited Biomarker [915]
CYP27B1 DE3FYEM Limited Genetic Variation [916]
HK1 DEDMAGE Limited Biomarker [917]
MARS1 DE0K52I Limited Altered Expression [918]
PARK7 DEPOVCH Limited Biomarker [919]
UGDH DE48Q2Z Limited Posttranslational Modification [920]
PCYT1A DEQYXD4 Disputed Biomarker [921]
CYP2A13 DEXZA9U moderate Biomarker [922]
CYP3A7 DERD86B moderate Genetic Variation [923]
FUT10 DEP8X02 moderate Biomarker [924]
FUT11 DERG61P moderate Biomarker [924]
GPT DER5HFI moderate Biomarker [925]
NT5C2 DE1DOKJ moderate Biomarker [926]
SULT1A1 DEYWLRK moderate Genetic Variation [927]
ABO DESIA7R Strong Altered Expression [928]
ACP5 DESITDW Strong Biomarker [929]
ADH1C DEM1HNL Strong Altered Expression [150]
ADH5 DEIOH6A Strong Biomarker [930]
AK2 DEY1FJO Strong Biomarker [931]
AKR1A1 DED2FW3 Strong Genetic Variation [932]
AKR1C1 DE7P2FB Strong Biomarker [933]
CHKB DEHWR6V Strong Altered Expression [934]
CPA4 DEXKD7J Strong Biomarker [935]
CRMP1 DE0EUXB Strong Altered Expression [825]
CYP27A1 DEBS639 Strong Altered Expression [916]
CYP2C18 DEZMWRE Strong Altered Expression [936]
CYP4B1 DEMF740 Strong Genetic Variation [937]
CYP4F3 DEFCMPI Strong Genetic Variation [938]
DIO3 DET89OV Strong Biomarker [177]
DTYMK DEOTVYU Strong Biomarker [939]
EGLN3 DEMQTKH Strong Biomarker [940]
FMO3 DEP76YL Strong Biomarker [941]
GCLC DESYL1F Strong Biomarker [942]
GGCT DEKW6PB Strong Altered Expression [943]
GLDC DEIN8FB Strong Biomarker [944]
GLS DE3E0VT Strong Posttranslational Modification [945]
GSTA4 DEH7XYP Strong Genetic Variation [946]
GSTM4 DERQ52Z Strong Genetic Variation [947]
HPGD DEHKSC6 Strong Altered Expression [948]
HPRT1 DEVXTP5 Strong Genetic Variation [949]
ME1 DE97WM8 Strong Biomarker [950]
MT1A DE5ME8A Strong Genetic Variation [221]
MTRR DE6NIY9 Strong Genetic Variation [605]
NAT1 DE7OAB3 Strong Genetic Variation [951]
NAT10 DEZV4AP Strong Biomarker [126]
NDUFS2 DEKX5CD Strong Altered Expression [705]
P4HA2 DE5EGK0 Strong Posttranslational Modification [952]
PSAT1 DEBS17P Strong Biomarker [548]
PTGR1 DE4Q2OE Strong Biomarker [953]
SAT1 DEMWO83 Strong Altered Expression [894]
SULT1E1 DESTKG6 Strong Biomarker [954]
THOP1 DE95LJC Strong Genetic Variation [387]
UCK2 DETN1O0 Strong Biomarker [955]
UGT1A6 DESD26P Strong Genetic Variation [956]
UGT1A7 DEZO4N3 Strong Genetic Variation [957]
PER1 DE9HF0I Definitive Biomarker [387]
VKORC1L1 DERQV72 Definitive Genetic Variation [958]
------------------------------------------------------------------------------------
⏷ Show the Full List of 60 DME(s)
This Disease Is Related to 1765 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
AATK OTVHAX5N Limited Biomarker [959]
ABCB10 OT1C44F9 Limited Genetic Variation [960]
ACAD8 OT3JI5GB Limited Genetic Variation [961]
ACOT7 OT7C68YV Limited Altered Expression [962]
ACSL1 OTB06ESI Limited Altered Expression [963]
ACSL4 OTI71MUJ Limited Altered Expression [963]
ACTA2 OTEDLG8E Limited Genetic Variation [964]
ACYP2 OTRB4S6X Limited Genetic Variation [965]
ADAMTS7 OTVKZ1DV Limited Genetic Variation [24]
AGO1 OTD3R434 Limited Biomarker [966]
AK5 OTTGXLOT Limited Genetic Variation [24]
ALDOA OTWRFTIB Limited Biomarker [967]
ALKBH3 OTS1CD9Z Limited Biomarker [968]
AP4B1 OTGJUIRA Limited Altered Expression [1]
APOM OTI3FQQC Limited Genetic Variation [24]
ARHGAP10 OT84ATF5 Limited Biomarker [969]
ARMC3 OTF6M9MM Limited Altered Expression [970]
ATG4A OTDHXAPG Limited Genetic Variation [971]
ATG4B OTQ4RNRM Limited Altered Expression [106]
ATL1 OTR2788Y Limited Biomarker [972]
ATN1 OTNZFLKY Limited Biomarker [973]
ATP2A3 OTFYDEES Limited Altered Expression [974]
BAZ1B OTD5KR2J Limited Biomarker [975]
BEND4 OT7Z1422 Limited Biomarker [976]
BHLHE23 OTLSVD17 Limited Altered Expression [1]
BTN2A1 OTUYPMZJ Limited Genetic Variation [24]
BTN3A1 OTGZADIX Limited Genetic Variation [24]
CA11 OT8RX3AJ Limited Biomarker [81]
CA8 OT9Y8GA8 Limited Biomarker [81]
CADM1 OTRWG9QS Limited Altered Expression [977]
CAP1 OTYM8A2N Limited Altered Expression [978]
CARMIL1 OT1A5IX5 Limited Genetic Variation [24]
CCDC54 OTW5WCX9 Limited Biomarker [979]
CCNG2 OTII38K2 Limited Biomarker [980]
CCT2 OTW1VV4E Limited Altered Expression [981]
CCT6A OTCYWL5F Limited Biomarker [982]
CD151 OTF3UZS7 Limited Biomarker [983]
CD164 OTZ7FIU8 Limited Altered Expression [984]
CD1D OT3ROU4J Limited Biomarker [985]
CD99 OTPUZ5DE Limited Genetic Variation [986]
CDC16 OTB914M7 Limited Biomarker [987]
CDH4 OT8LH3HN Limited Biomarker [988]
CDK20 OTOLNN68 Limited Biomarker [989]
CDX2 OTCG4TSY Limited Biomarker [469]
CENPW OTZL05QN Limited Biomarker [990]
CEP170 OTNTK4Q6 Limited Genetic Variation [24]
CHN1 OTM196M3 Limited Biomarker [991]
CISD2 OTVS7S2H Limited Biomarker [992]
CITED4 OTR6NHI2 Limited Biomarker [993]
CLDN2 OTRF3D6Y Limited Biomarker [994]
CLDN5 OTUX60YO Limited Biomarker [995]
CORO1C OTXDF9T3 Limited Biomarker [996]
COX5A OTP0961M Limited Genetic Variation [38]
CPOX OTIAY121 Limited Genetic Variation [38]
CPSF1 OTAU1KOM Limited Altered Expression [997]
CRISPLD2 OTVSFHTL Limited Biomarker [998]
CROT OTWK68MM Limited Genetic Variation [24]
CRTAC1 OT4PGEVE Limited Genetic Variation [24]
CTDP1 OTHHFW17 Limited Altered Expression [999]
CTDSPL OTZJ0CZK Limited Genetic Variation [1000]
DCTN4 OTM7C943 Limited Altered Expression [67]
DDA1 OTAZIAIH Limited Altered Expression [1001]
DHX33 OTREUESJ Limited Altered Expression [1002]
DLGAP5 OTWCN39U Limited Biomarker [1003]
DUOX2 OTU14HCN Limited Posttranslational Modification [1004]
DUOXA1 OTNG3HH4 Limited Altered Expression [1004]
DUOXA2 OT7AZBZJ Limited Altered Expression [1004]
DUSP4 OT6WAO12 Limited Biomarker [1005]
ECH1 OTA0UNHM Limited Biomarker [1006]
EIF4G2 OTEO98CR Limited Biomarker [1007]
EMP1 OTSZHUHQ Limited Biomarker [1008]
EMP2 OTPS2H0L Limited Biomarker [1009]
EMSY OTBQ3KQE Limited Biomarker [1010]
ENO1 OTB1KWJS Limited Altered Expression [1011]
EPS8 OTZ6ES6V Limited Biomarker [1012]
ERCC6 OT2QZKSF Limited Genetic Variation [1013]
ERGIC3 OT8RWHN3 Limited Altered Expression [1014]
ERP44 OT7ZI7AG Limited Biomarker [1015]
ETAA1 OTHFX32I Limited Genetic Variation [24]
ETHE1 OTP9A2BQ Limited Biomarker [1016]
EXTL3 OT2BRUBN Limited Biomarker [1017]
FAM133A OTO75ZO4 Limited Biomarker [1018]
FBLN5 OTLVNZ8U Limited Posttranslational Modification [1019]
FBXO4 OT6VYX67 Limited Biomarker [1020]
FCGBP OT63T6XQ Limited Genetic Variation [1021]
FGA OTMIHY80 Limited Genetic Variation [1022]
FGF16 OT6BHWZP Limited Biomarker [1023]
FMNL2 OT9OVWCV Limited Altered Expression [1024]
FOXA2 OTJOCVOY Limited Biomarker [1025]
FRY OT74IAG2 Limited Genetic Variation [24]
FTHL17 OTIWALXH Limited Altered Expression [1026]
FUT1 OTODG57A Limited Biomarker [1027]
GALK2 OTHR35JF Limited Genetic Variation [24]
GAS7 OT0M5TNY Limited Biomarker [1028]
GASK1B OT2HPHEI Limited Altered Expression [1029]
GDF10 OTEVXGJ7 Limited Genetic Variation [1030]
GEMIN4 OTX7402E Limited Genetic Variation [1031]
GFM1 OTUN4V3N Limited Biomarker [488]
GIPC2 OT68YFO1 Limited Genetic Variation [24]
GIT2 OTQ2EQJ1 Limited Biomarker [1032]
GOLT1A OTY8H2OF Limited Altered Expression [1033]
GPR135 OTXOY5NW Limited Biomarker [976]
GPR180 OT2P0XNK Limited Biomarker [1034]
GPR78 OT8TKE6F Limited Biomarker [1035]
GPRC5A OTPOCWR7 Limited Altered Expression [120]
GPX3 OT6PK94R Limited Biomarker [1036]
GSTM2 OTG4WT05 Limited Genetic Variation [1037]
GTF2H4 OTPD1DIU Limited Genetic Variation [1038]
GTSE1 OTPP742Z Limited Biomarker [1039]
H2AC6 OTF3YK7V Limited Genetic Variation [24]
H2AX OT18UX57 Limited Genetic Variation [1040]
H3C1 OTGBGOZW Limited Altered Expression [1041]
HAS2 OTTD3PAL Limited Altered Expression [1042]
HAT1 OT307KEN Limited Altered Expression [1043]
HAVCR1 OT184CRZ Limited Altered Expression [1044]
HCP5 OTV0YRI8 Limited Genetic Variation [24]
HELLS OTVVV668 Limited Biomarker [1045]
HHLA2 OTYBTVQS Limited Biomarker [1046]
HLA-DOA OTZE5Q7R Limited Biomarker [1047]
HLA-DOB OTKADDUB Limited Genetic Variation [24]
HLA-DQA2 OT1DH0N9 Limited Genetic Variation [24]
HOXB9 OTMVHQOU Limited Biomarker [1048]
HOXC10 OT5WF17M Limited Biomarker [1049]
HOXC9 OT60K4M0 Limited Altered Expression [1050]
HSF4 OT1UX9SK Limited Biomarker [1051]
HYKK OTBK1QPN Limited Genetic Variation [1052]
ING3 OTDIJXFP Limited Altered Expression [1053]
INPP4B OTLROA7G Limited Biomarker [1054]
INVS OT8KPESR Limited Biomarker [1055]
IPO7 OTDFMQ00 Limited Altered Expression [1056]
IQGAP1 OTZRWTGA Limited Biomarker [471]
IRS4 OTTOL40K Limited Altered Expression [1057]
JARID2 OT14UM8H Limited Biomarker [1058]
KDM6A OTZM3MJJ Limited Altered Expression [1059]
KLF12 OTVH4KD4 Limited Altered Expression [1060]
KLHL25 OTPG0G97 Limited Altered Expression [270]
KMT2C OTC59BCO Limited Biomarker [1061]
KRR1 OTCMJ3K3 Limited Biomarker [1062]
LAMTOR3 OTG93MCO Limited Biomarker [1063]
LINGO2 OT3N88Q1 Limited Genetic Variation [61]
LMO1 OTB59SKB Limited Altered Expression [812]
LNPK OTOBNX6G Limited Altered Expression [1064]
LRP1B OT4YZG2N Limited Biomarker [1065]
MALRD1 OTCAAPVO Limited Genetic Variation [1066]
MAP3K12 OT5HODDD Limited Altered Expression [29]
MAPK6 OTDDNF3Q Limited Altered Expression [1067]
MARK4 OT6Z2TGV Limited Altered Expression [1068]
MCAT OTH07FIW Limited Genetic Variation [22]
MCCC2 OTQDHSMI Limited Biomarker [1069]
MCTS1 OT7SAOJP Limited Genetic Variation [22]
MED1 OTOO24C4 Limited Biomarker [1070]
MEST OT8Q4U8Y Limited Biomarker [1071]
MFAP1 OTZN4FT3 Limited Altered Expression [913]
MIP OTEBLU3E Limited Biomarker [659]
MKLN1 OTHMIMH6 Limited Genetic Variation [24]
MORF4L1 OTEA6FYJ Limited Genetic Variation [24]
MPZL2 OTKFNDUI Limited Genetic Variation [24]
MRTFA OTCVXASM Limited Altered Expression [1072]
MS4A2 OTMCAS2D Limited Biomarker [1073]
MT3 OTVCZ7HI Limited Biomarker [1074]
MTO1 OT7HCZ1D Limited Biomarker [960]
MYBL2 OTZ3JX8Q Limited Altered Expression [1075]
MYEOV OTDC7UHL Limited Altered Expression [1076]
NAA40 OTFLRVQO Limited Biomarker [1077]
NABP2 OTQU8081 Limited Biomarker [1078]
NANOS2 OTFM2IDJ Limited Genetic Variation [1079]
NBN OT73B5MD Limited Genetic Variation [1080]
NCBP2 OTQNZTE4 Limited Genetic Variation [1081]
NFATC2 OTK5T6HZ Limited Biomarker [1082]
NFIB OTX94PD0 Limited Biomarker [1083]
NINJ1 OTLRZ1EU Limited Biomarker [1084]
NUMBL OTWMTMMH Limited Genetic Variation [24]
NUP62 OTMN63DH Limited Altered Expression [67]
OLA1 OTAPOTTG Limited Altered Expression [1085]
OLIG2 OTMCN6D3 Limited Biomarker [1086]
PAXIP1 OTRHTKG3 Limited Biomarker [1087]
PBX2 OTEBYCAW Limited Biomarker [1088]
PCBP1 OTHN0TD7 Limited Biomarker [1089]
PCDHGB6 OT1Y20JS Limited Posttranslational Modification [1090]
PDLIM5 OTLQVV22 Limited Biomarker [1091]
PDRG1 OT8ZMFZE Limited Biomarker [1092]
PDS5B OT3U3X8Z Limited Genetic Variation [24]
PEAK1 OTVVM637 Limited Altered Expression [1093]
PEBP4 OTKDCVC6 Limited Biomarker [1094]
PFDN1 OT9837QM Limited Biomarker [1095]
PHB2 OTCAX3AW Limited Altered Expression [1096]
PHF20 OTCBVH5P Limited Biomarker [1097]
PHF5A OTS94JFM Limited Biomarker [1098]
PHIP OTZY806Z Limited Biomarker [1099]
PIWIL4 OTDA9MY0 Limited Biomarker [1100]
PKP3 OTPL1HRB Limited Biomarker [1101]
PLAG1 OTT9AJQY Limited Biomarker [548]
PLIN3 OT9ZA7MR Limited Genetic Variation [24]
PLPP5 OTHT51D6 Limited Biomarker [1102]
PMAIP1 OTXEE550 Limited Biomarker [1103]
PNPLA2 OTR3ERMR Limited Biomarker [102]
PODXL OTPNQXF3 Limited Altered Expression [1104]
PPP1R18 OT0JVGOZ Limited Genetic Variation [24]
PPP1R9B OTDCTHTT Limited Biomarker [91]
PRDX2 OTLWCY9T Limited Biomarker [1105]
PTPRU OTHDO0QG Limited Biomarker [893]
PVR OT3N91T7 Limited Altered Expression [1106]
PXN OTVMMUOF Limited Altered Expression [1107]
RAB1A OTKPHRD0 Limited Biomarker [1108]
RAB35 OTRH1E2T Limited Altered Expression [1032]
RAB3D OTGKRR3C Limited Genetic Variation [820]
RAB5A OTFR2KM4 Limited Altered Expression [1109]
RANBP9 OTM8COM5 Limited Biomarker [1110]
RASSF5 OT6Q41I2 Limited Altered Expression [1111]
RBFOX3 OTL0F3D6 Limited Altered Expression [1112]
RBM47 OT6W67VM Limited Altered Expression [1113]
REEP6 OTY4FPO8 Limited Biomarker [400]
RGS17 OT5RVUDS Limited Biomarker [1114]
RMC1 OT7K8MTJ Limited Biomarker [1115]
RP1 OTDDT69Y Limited Genetic Variation [24]
RPL14 OTZZW7TK Limited Genetic Variation [1116]
RRAS OTBBF28C Limited Biomarker [1117]
RRN3 OTKGOZ49 Limited Biomarker [1118]
RTKN OTSS8XR6 Limited Biomarker [1119]
RUSC2 OT0EKMVR Limited Biomarker [1032]
SAA2 OTYAVJWG Limited Biomarker [1120]
SAV1 OTSAEV92 Limited Altered Expression [1121]
SCGB3A2 OTB63PHR Limited Biomarker [1122]
SCGN OTGD7SKH Limited Genetic Variation [24]
SDCBP OTS3NCC5 Limited Altered Expression [1123]
SDHC OTC8G2MX Limited Genetic Variation [1124]
SDR9C7 OTQY8SJ3 Limited Genetic Variation [1066]
SECISBP2L OTMSOLZU Limited Genetic Variation [24]
SELENBP1 OT3NZNTR Limited Biomarker [1125]
SEMA3F OTQFMS8S Limited Altered Expression [1126]
SEMA6D OTU0UAZS Limited Genetic Variation [24]
SETD1A OTVVWRIC Limited Posttranslational Modification [1127]
SFTPB OTOHS07E Limited Biomarker [352]
SHOX2 OTLCZZJW Limited Biomarker [1128]
SKAP2 OTSF44KP Limited Biomarker [1129]
SKP1 OT5BPAZ4 Limited Biomarker [1130]
SMARCA2 OTSGJ8SV Limited Biomarker [885]
SNAI1 OTDPYAMC Limited Biomarker [1131]
SNRPD3 OTZXBQ45 Limited Posttranslational Modification [1132]
SOCS2 OTBPNKJQ Limited Biomarker [1133]
SOX12 OT93P8C9 Limited Altered Expression [1134]
SPA17 OT8J7T7U Limited Biomarker [979]
SPAG5 OTCLJ56M Limited Biomarker [1135]
SPANXA1 OTMK3QIS Limited Biomarker [1136]
SRSF1 OTF61HOV Limited Biomarker [1137]
SSBP1 OTH2PZWH Limited Biomarker [1078]
STAMBPL1 OTI4CYTF Limited Genetic Variation [964]
STAT5B OTZVPEBT Limited Biomarker [1138]
STXBP6 OTUEKTIP Limited Posttranslational Modification [1139]
TAB3 OT1ECMDL Limited Biomarker [1140]
TBC1D9 OTSSCTB5 Limited Genetic Variation [1141]
TCERG1L OTSBSCLF Limited Genetic Variation [24]
TCF4 OTB9ASTK Limited Altered Expression [889]
TCHP OTVDMHSY Limited Biomarker [1142]
TCP1 OT1MGUX9 Limited Biomarker [982]
TENM4 OT91K3FC Limited Genetic Variation [24]
THBS2 OTXET551 Limited Biomarker [1143]
TMEM132C OT3297S6 Limited Genetic Variation [24]
TMEM205 OTGV8KK4 Limited Biomarker [1144]
TMEM237 OTQEVL7L Limited Genetic Variation [24]
TMEM45B OTVQCO8N Limited Biomarker [1145]
TMEM8B OTJZWPS6 Limited Altered Expression [443]
TNFAIP8L1 OTVVKOTV Limited Biomarker [1146]
TNXB OTVBWAV5 Limited Genetic Variation [24]
TOPORS OT1ERFFQ Limited Biomarker [1147]
TRAT1 OTMPUNPD Limited Altered Expression [1148]
TRIM11 OTMD6IM2 Limited Biomarker [1149]
TRIM25 OT35SG1R Limited Biomarker [1150]
TRIM26 OTS0DJIP Limited Genetic Variation [24]
TRIM62 OT15YO6N Limited Altered Expression [1151]
TRIP13 OTFM3TI9 Limited Altered Expression [1152]
TSC1 OTFF4YZ7 Limited Biomarker [1153]
TSC22D1 OTN4GFWD Limited Biomarker [963]
TSPYL5 OT7QEI2X Limited Biomarker [1154]
TTLL12 OTJQ8RF4 Limited Biomarker [1155]
AHNAK OT6KH1WG Disputed Biomarker [1156]
ANLN OTXJY54C Disputed Biomarker [1157]
ASCL1 OTI4X44G Disputed Altered Expression [1158]
BAD OT63ERYM Disputed Biomarker [1159]
BANP OT1JMTBD Disputed Biomarker [131]
BNC2 OTU22H9Z Disputed Altered Expression [1160]
CD109 OTDADBM4 Disputed Biomarker [1161]
CD82 OTH8MC64 Disputed Altered Expression [1162]
CNGB1 OTA5DE38 Disputed Altered Expression [132]
CRYBG3 OTHXQCX7 Disputed Altered Expression [1163]
CTNND1 OTUMPSHR Disputed Altered Expression [1164]
DUS2 OTVBE313 Disputed Altered Expression [1165]
EFEMP2 OT0I2B4J Disputed Altered Expression [1166]
ETV4 OT8C98UZ Disputed Biomarker [1167]
FBN2 OT3KYJQL Disputed Posttranslational Modification [1168]
GOLPH3 OTDLGYM3 Disputed Altered Expression [1169]
H3-4 OTY6ITYF Disputed Biomarker [1170]
HIVEP1 OT7CAG4A Disputed Altered Expression [1166]
HSD17B6 OTSB55D2 Disputed Genetic Variation [1171]
LPXN OTUNV3CK Disputed Altered Expression [1172]
MSH3 OTD3YPVL Disputed Altered Expression [121]
RASSF10 OTGB7EBG Disputed Altered Expression [1173]
RGN OTD04KB1 Disputed Altered Expression [1174]
RLIM OTEBRNHJ Disputed Biomarker [1175]
SELENOP OT02B8IR Disputed Biomarker [1176]
SIX3 OTP5E3VU Disputed Biomarker [1177]
SRCIN1 OTQZNQQ5 Disputed Biomarker [1178]
TANK OTZSGFIK Disputed Biomarker [1179]
TRAIP OTMPT9Y2 Disputed Biomarker [1179]
TRIB2 OTHSX3MX Disputed Altered Expression [1180]
AADAC OT8VACT2 moderate Biomarker [1181]
ADAM11 OTPTVW5W moderate Biomarker [1182]
ADAM28 OT3GBVHL moderate Biomarker [1183]
ADIPOR1 OT65ZFZN moderate Altered Expression [1184]
ALG1 OTVXPA9E moderate Genetic Variation [221]
AP2A1 OTEFZB21 moderate Altered Expression [1185]
ARFGEF3 OTGQV0CU moderate Biomarker [1186]
ARHGDIB OT9PD6CS moderate Biomarker [1187]
ASH1L OTUT5NLJ moderate Biomarker [368]
ASS1 OT4ZMG0Q moderate Biomarker [1188]
ATP2C1 OTQN51T3 moderate Biomarker [457]
AXIN1 OTRGZGZ5 moderate Genetic Variation [1189]
AXIN2 OTRMGQNU moderate Altered Expression [1190]
BANF1 OTP7Z38L moderate Biomarker [1191]
BPIFB1 OTOZYJMO moderate Genetic Variation [1192]
BTG2 OTZF6K1H moderate Biomarker [1193]
BTRC OT2EZDGR moderate Altered Expression [1194]
CABYR OTKYMT99 moderate Biomarker [1195]
CANX OTYP1F6J moderate Biomarker [1196]
CCNA1 OTX4HD45 moderate Biomarker [1197]
CCNG1 OT17IA9L moderate Biomarker [1198]
CCNY OTK1KG5W moderate Biomarker [1199]
CCP110 OTNOVXA2 moderate Biomarker [1200]
CEMP1 OTUEH5X5 moderate Altered Expression [1201]
CETN1 OTGQ8JOZ moderate Biomarker [1202]
CFAP100 OTHHFM2Z moderate Biomarker [1203]
CLDN1 OT27KV99 moderate Altered Expression [1204]
CLIC4 OT6KTPKD moderate Biomarker [1205]
CLPTM1 OT14QP7N moderate Genetic Variation [97]
CLSPN OTZZXNDK moderate Biomarker [1206]
CRKL OTOYSD1R moderate Genetic Variation [1207]
CTCF OT8ZB70U moderate Biomarker [390]
CTNND2 OTYKE30Y moderate Biomarker [1208]
CXCL14 OTM189TA moderate Biomarker [1209]
DAB2 OTRMQTMZ moderate Biomarker [1210]
DACH1 OTMKNAGG moderate Posttranslational Modification [1211]
DAP OT5YLL7E moderate Biomarker [1212]
DDX53 OTHK3EGZ moderate Biomarker [1213]
DEF6 OTIRBYVK moderate Genetic Variation [1214]
DENND11 OTC0IJ87 moderate Genetic Variation [1215]
DGKH OTYNPJ4B moderate Biomarker [1216]
DLEU7 OTVKX1YP moderate Altered Expression [1217]
DUOX1 OTQ2AEW0 moderate Biomarker [1218]
DVL3 OTPRROHJ moderate Biomarker [1219]
EEF1A1 OT00THXS moderate Biomarker [1220]
EFEMP1 OTZVUOOB moderate Biomarker [1221]
EI24 OTD4NOYS moderate Altered Expression [1222]
EIF4G1 OT2CF1E6 moderate Biomarker [1223]
ENTPD5 OTFH05B9 moderate Biomarker [1224]
EPC1 OT3Q25ND moderate Biomarker [1225]
ERCC4 OTFIOPG1 moderate Genetic Variation [1226]
ERRFI1 OT7VZ2IZ moderate Biomarker [1227]
FAM168A OTDXQCS5 moderate Altered Expression [1228]
FAM3C OTBR6U9G moderate Biomarker [1229]
FANCD2 OTVEB5LF moderate Biomarker [1230]
FBXO32 OTUE978R moderate Biomarker [1231]
FBXW4 OTEGSZOX moderate Biomarker [1181]
FKBPL OTR9ND6K moderate Genetic Variation [1192]
FOSB OTW6C05J moderate Biomarker [1232]
FOXD3 OTXYV6GO moderate Biomarker [833]
FOXF1 OT2CJZ5K moderate Biomarker [1233]
FSTL1 OT6KEZUD moderate Altered Expression [1234]
FUT5 OTOPGL9M moderate Biomarker [924]
FUT7 OTJF6BSN moderate Biomarker [924]
FUT9 OTLIJBQY moderate Biomarker [924]
GATA2 OTBP2QQ2 moderate Posttranslational Modification [1235]
GCAT OT6WZPWV moderate Genetic Variation [1236]
GINS1 OTVQZMMQ moderate Biomarker [252]
GKN1 OT7ZYFQ9 moderate Genetic Variation [1237]
GLUD1 OTXKOCUH moderate Biomarker [12]
GNL3 OTILGYO4 moderate Biomarker [1238]
HBP1 OTDPGGDV moderate Biomarker [1239]
HMG20B OTY94WRA moderate Genetic Variation [1240]
HNF4G OTTSIHJP moderate Biomarker [1241]
HNRNPA0 OTCP792K moderate Biomarker [1242]
HOXD13 OTWSC8TF moderate Biomarker [1243]
HPR OTXSC9UB moderate Biomarker [902]
HTRA3 OTXJ0H4X moderate Biomarker [1244]
HUWE1 OTFH6BJS moderate Biomarker [1245]
IL27 OTIS3OF8 moderate Biomarker [1246]
IMMT OTBDSLE7 moderate Altered Expression [1247]
IQGAP3 OT4RZV2M moderate Biomarker [1248]
ISG20 OTCWRJJW moderate Biomarker [1249]
ITGA7 OTTBTAYW moderate Genetic Variation [1250]
ITGA9 OTHN1IKA moderate Biomarker [1251]
JUNB OTG2JXV5 moderate Biomarker [1232]
JUND OTNKACJD moderate Biomarker [1232]
KIF2A OT2WQ6QD moderate Altered Expression [1252]
KIF2C OTJ8G3NP moderate Altered Expression [1252]
KIF4A OT3UWL7D moderate Biomarker [1253]
KLF9 OTBFEJRQ moderate Biomarker [1254]
KRT7 OTLT3JFN moderate Altered Expression [1255]
LRRC42 OTZ02075 moderate Biomarker [1256]
LRRFIP1 OTN7XAUD moderate Biomarker [963]
LSP1 OTSPSIFO moderate Genetic Variation [1257]
MAD2L1 OTXNGZCG moderate Altered Expression [1258]
MAK16 OTD546E5 moderate Biomarker [1259]
MAP2K4 OTZPZX11 moderate Biomarker [1175]
MARCHF8 OTH7PNN2 moderate Altered Expression [1260]
MARVELD1 OT5CPOJE moderate Biomarker [1261]
MAST1 OTEYFN5O moderate Biomarker [1262]
MDC1 OTEUQH4J moderate Genetic Variation [1263]
MED19 OTT9RT5N moderate Biomarker [1264]
MEN1 OTN6U6V0 moderate Altered Expression [1265]
MEOX1 OTJEMT2D moderate Biomarker [1266]
MLXIP OT30UNI7 moderate Altered Expression [1260]
MMP26 OT9O89KU moderate Biomarker [1267]
MOAP1 OTVF3LUG moderate Biomarker [1268]
MSN OTZJ4J6G moderate Biomarker [202]
MST1 OTOC4UNG moderate Genetic Variation [1269]
MT1B OTUA4FFH moderate Genetic Variation [221]
MT1E OTXJKU4Y moderate Genetic Variation [221]
MT1F OTZVUYG1 moderate Genetic Variation [221]
MT1H OT0MVBM6 moderate Genetic Variation [221]
MT1M OTVT8PLU moderate Genetic Variation [221]
MTFMT OT1OIVJL moderate Biomarker [1270]
MXI1 OTUQ9E0D moderate Altered Expression [1271]
MYCL OT1MFQ5U moderate Genetic Variation [1272]
MYDGF OT9HRPL6 moderate Biomarker [1246]
MYH6 OT3YNCH1 moderate Biomarker [1273]
MYLIP OTL0PFGV moderate Altered Expression [1260]
MYO6 OTJQYRC7 moderate Altered Expression [1273]
MYO9B OTQ94R5K moderate Biomarker [1274]
MYOD1 OTV2S79X moderate Biomarker [1275]
NLN OTFRITPU moderate Genetic Variation [1276]
NLRP2 OTJA81JU moderate Genetic Variation [1080]
NMI OTYVG3NM moderate Biomarker [1277]
NPTX1 OTKVHCV0 moderate Posttranslational Modification [1278]
OPN1LW OTFNUZ7O moderate Biomarker [1279]
OPN4 OT1LZ7TS moderate Genetic Variation [1276]
PAEP OTQA0NV4 moderate Biomarker [1280]
PAG1 OTFOJUIQ moderate Biomarker [1279]
PEG10 OTWD2278 moderate Altered Expression [1281]
PLA2G10 OTRZ2L5A moderate Altered Expression [237]
PLA2G6 OT5FL0WU moderate Biomarker [1204]
PLAGL2 OT6AP4V2 moderate Altered Expression [1282]
PLCE1 OTJISZOX moderate Altered Expression [1283]
PLEKHO1 OTMVUQ9W moderate Altered Expression [1284]
POLK OTKZ38JH moderate Altered Expression [255]
POLL OTZ24QGM moderate Altered Expression [255]
POU3F1 OTYARA94 moderate Altered Expression [248]
PRB2 OTAD4JZ0 moderate Genetic Variation [1285]
PRDX6 OTS8KC8A moderate Biomarker [1286]
PRKN OTJBN41W moderate Biomarker [1287]
PRRC2A OTBX6FM5 moderate Genetic Variation [1192]
PSMA4 OTAD2XXI moderate Biomarker [1288]
PTBP2 OTF4S7NE moderate Biomarker [1289]
PTTG1 OTIMYS4W moderate Biomarker [1290]
RAB37 OTRL8IUO moderate Biomarker [1291]
RAN OT2TER5M moderate Altered Expression [1292]
RAP2B OTD2NDQP moderate Biomarker [1293]
RASD2 OTETA815 moderate Altered Expression [1294]
RBM4 OT5SFQA3 moderate Biomarker [1295]
RGS5 OTUY0Q2I moderate Altered Expression [1296]
RND3 OTXMXPIH moderate Altered Expression [1297]
RPA1 OT76POLP moderate Altered Expression [1298]
RPL36A OT1LYV85 moderate Biomarker [1227]
RPL39 OTL8TZHQ moderate Biomarker [1299]
SALL4 OTC08PR5 moderate Biomarker [1300]
SCIN OT6U09OL moderate Biomarker [1301]
SCN7A OTK05PXY moderate Biomarker [1302]
SCRIB OTW4N3FV moderate Biomarker [1303]
SDF4 OTQ7WFYW moderate Biomarker [1202]
SEL1L OTC0FB7T moderate Altered Expression [1304]
SEMA6A OTDQ7QAW moderate Biomarker [1305]
SEPTIN9 OT1VMRFQ moderate Posttranslational Modification [1306]
SESN2 OT889IXY moderate Biomarker [1307]
SLPI OTUNFUU8 moderate Biomarker [126]
SOX15 OTTB37I1 moderate Biomarker [1308]
SPRY4 OT2VK9N0 moderate Biomarker [815]
SRA1 OTYOGMTG moderate Biomarker [1309]
SRRM2 OTSIMMC9 moderate Biomarker [1259]
SRSF2 OTVDHO6U moderate Biomarker [1310]
TAS2R38 OTX5MM36 moderate Altered Expression [1261]
TCF21 OT393IMA moderate Posttranslational Modification [1311]
TCIM OTARUXQF moderate Biomarker [1312]
TET1 OTZDHT1D moderate Biomarker [1313]
TFAP2C OTUDIW05 moderate Altered Expression [1314]
THOC1 OTVABJ4Z moderate Biomarker [1315]
TIMELESS OTD8DCBJ moderate Altered Expression [1044]
TIMP2 OT8S1RRP moderate Altered Expression [1316]
TIMP3 OTDGQAD1 moderate Biomarker [1317]
TJP1 OTBDCUPK moderate Altered Expression [1318]
TLE1 OT50MRZ1 moderate Biomarker [1319]
TOPBP1 OT6UPZPD moderate Biomarker [1206]
TOX4 OTSOXQFN moderate Altered Expression [1320]
TPST1 OTDPQKEA moderate Biomarker [1321]
TSGA13 OT81V4LS moderate Altered Expression [1322]
TSPAN2 OTTDPQF1 moderate Biomarker [1323]
AAMP OTZXBSS4 Strong Biomarker [1324]
AATF OT1QOKLD Strong Biomarker [1325]
ABI2 OT8GIIS5 Strong Genetic Variation [321]
ABI3 OTQTDSHP Strong Biomarker [1326]
ACACA OT5CQPZY Strong Posttranslational Modification [1327]
ACP1 OTJ9CKLU Strong Biomarker [686]
ACSBG1 OTM040MW Strong Altered Expression [1328]
ACSL3 OT3MWER1 Strong Biomarker [1329]
ACTN4 OTCNZAJ5 Strong Altered Expression [1330]
ACTR3 OT05LJSH Strong Biomarker [678]
ACTRT1 OTHFKSIZ Strong Genetic Variation [321]
ADAMTS12 OTG7HEA2 Strong Altered Expression [1331]
ADAMTS18 OTRMFI04 Strong Biomarker [1332]
ADAMTS8 OT2KFY1S Strong Altered Expression [1333]
ADAR OTQNOHR8 Strong Genetic Variation [24]
ADARB1 OTGKSZEV Strong Biomarker [1334]
ADD1 OTTF68DC Strong Biomarker [1335]
ADGRE2 OTUYJVYG Strong Altered Expression [425]
ADSS1 OTF6FE38 Strong Genetic Variation [1336]
AFAP1 OTR473H8 Strong Altered Expression [1337]
AGO2 OT4JY32Q Strong Biomarker [1338]
AIFM1 OTKPWB7Q Strong Biomarker [827]
AIMP1 OTTA5C3U Strong Biomarker [1339]
AK4 OTA0T02Q Strong Altered Expression [1340]
AKAP12 OTCVRDDX Strong Posttranslational Modification [1341]
AKAP3 OT42QOFG Strong Altered Expression [1342]
AKAP8 OTK3EQAI Strong Altered Expression [692]
AKT1S1 OT4JHN4Y Strong Biomarker [1343]
ALDH1A3 OT1C9NKQ Strong Biomarker [1344]
ALDH1L1 OT15HOJX Strong Altered Expression [1345]
ALDH3A1 OTAYZZE6 Strong Biomarker [1346]
ALKBH1 OTADGU5D Strong Altered Expression [1347]
ALOX15B OTWQQ08W Strong Altered Expression [1348]
ALPK1 OTBW6SGD Strong Altered Expression [1349]
ALPP OTZU4G9W Strong Biomarker [126]
ALX4 OTNS9A29 Strong Altered Expression [1350]
AMFR OTQRX7LC Strong Altered Expression [1351]
AMMECR1 OTWMQ67T Strong Biomarker [1352]
AMPD1 OTU17BCI Strong Genetic Variation [1353]
AMPH OTWPGWZX Strong Biomarker [1354]
ANGPTL1 OTXIN6V5 Strong Biomarker [1355]
ANKRD18A OTHLBM3Z Strong Posttranslational Modification [1356]
ANKRD36B OT3MW415 Strong Altered Expression [1357]
ANP32B OT3SQMLU Strong Biomarker [260]
ANTXR1 OT5W1GPC Strong Altered Expression [1358]
ANXA3 OTDD8OI7 Strong Biomarker [1359]
ANXA4 OTUCRYXL Strong Biomarker [1360]
APAF1 OTJWIVY0 Strong Altered Expression [1361]
APOBEC3A OTYO6F5P Strong Genetic Variation [1362]
APOBEC3B OTHLNI51 Strong Biomarker [1363]
APOBEC3H OTXIH4X4 Strong Genetic Variation [1364]
APPBP2 OTLNFV4J Strong Biomarker [1365]
AQP5 OT77GBY8 Strong Biomarker [1366]
AQP8 OT99JKME Strong Altered Expression [1367]
ARF6 OTVV7KJO Strong Altered Expression [303]
ARHGAP1 OT0H2ZBZ Strong Altered Expression [1368]
ARHGAP15 OT9CKHDC Strong Biomarker [1369]
ARHGAP25 OTYW7ED8 Strong Altered Expression [1370]
ARHGAP5 OTOQELUN Strong Biomarker [1371]
ARHGAP6 OTNVXXFX Strong Biomarker [1368]
ARHGEF11 OTDOMEH6 Strong Genetic Variation [1372]
ARHGEF19 OTKD9XY9 Strong Altered Expression [1373]
ARHGEF2 OTBQTFRT Strong Biomarker [526]
ARHGEF28 OT3F32IU Strong Genetic Variation [1372]
ARHGEF5 OTUVGFT9 Strong Altered Expression [1044]
ARHGEF7 OT9BPJCL Strong Biomarker [1374]
ARL11 OTF6UDDB Strong Altered Expression [1375]
ARL4C OTQ3QNNU Strong Altered Expression [1376]
ARL6IP1 OT536XAV Strong Genetic Variation [321]
ARMC8 OTNAXGM7 Strong Altered Expression [1377]
ARMCX3 OTMG7RWW Strong Altered Expression [1378]
ARMH1 OTTJC0D6 Strong Biomarker [526]
ARPP21 OTWXZN5I Strong Altered Expression [1379]
ARR3 OTRZ00CH Strong Altered Expression [339]
ARTN OTWIWGL6 Strong Biomarker [1380]
ASAH1 OT1DNGXL Strong Biomarker [1381]
ASCC2 OT3B204T Strong Altered Expression [619]
ASL OTI2NGQR Strong Biomarker [1382]
ASXL1 OTX931AW Strong Genetic Variation [1383]
ATF1 OT251CI0 Strong Posttranslational Modification [1384]
ATF2 OTNIZPEA Strong Altered Expression [1385]
ATG10 OTVRPC5X Strong Altered Expression [1386]
ATG16L1 OTEOYC5D Strong Genetic Variation [1387]
ATG3 OT28VBVK Strong Biomarker [1388]
ATOH1 OTBZYG2R Strong Altered Expression [1389]
ATOX1 OT05LF59 Strong Biomarker [1390]
ATP6AP2 OT0IABVV Strong Biomarker [1391]
ATP6V1E1 OT76J5R9 Strong Biomarker [1392]
ATRNL1 OTY5JUX2 Strong Biomarker [126]
B3GAT1 OTXFP98E Strong Altered Expression [1393]
B4GALT1 OTBCXEK7 Strong Biomarker [1394]
BABAM1 OTCFPER6 Strong Genetic Variation [312]
BAG1 OTRQNIA4 Strong Altered Expression [1395]
BAG6 OT4Z0S2U Strong Genetic Variation [1052]
BAIAP2L2 OTQDY90J Strong Biomarker [1396]
BAMBI OTCEJ8W5 Strong Altered Expression [1397]
BATF2 OT4XBZC9 Strong Biomarker [1398]
BCAR1 OTKT2C2N Strong Biomarker [1399]
BCL11B OT8KKCVJ Strong Biomarker [1400]
BCL2L12 OTS6IFZY Strong Altered Expression [910]
BCL9 OTRBIPR4 Strong Biomarker [1401]
BHLHE22 OTZUQY5L Strong Altered Expression [1402]
BHLHE40 OTITX14U Strong Altered Expression [1403]
BID OTOSHSHU Strong Altered Expression [1404]
BMS1 OTEGQ8ZO Strong Biomarker [1405]
BNIP3 OT4SO7J4 Strong Altered Expression [1406]
BPIFA1 OTQFD2J5 Strong Altered Expression [1407]
BRD8 OTIKS3PC Strong Altered Expression [623]
BRF2 OT2C6TH2 Strong Biomarker [1408]
BRINP1 OTEUVSCP Strong Biomarker [1409]
BRK1 OTTUB5KS Strong Biomarker [1410]
BRMS1 OTV5A6LL Strong Biomarker [1411]
BST1 OTAV5SE7 Strong Biomarker [1412]
BTBD7 OTNUV6MQ Strong Biomarker [1413]
BTG3 OT9ANHVT Strong Biomarker [1414]
BUB1B OT8KME51 Strong Altered Expression [1415]
BZW1 OT4GUFIG Strong Altered Expression [1416]
C1D OTI9PMN1 Strong Biomarker [1417]
C2 OTHMF4YM Strong Biomarker [1418]
C4orf3 OT6TFN1O Strong Biomarker [407]
C5AR2 OTP1Q82J Strong Biomarker [1419]
CABLES1 OTMN4XSX Strong Altered Expression [1420]
CACUL1 OT6P1ZVP Strong Biomarker [1421]
CALB2 OTSNMCG9 Strong Biomarker [1422]
CALU OTSYQN71 Strong Biomarker [1423]
CAMSAP3 OTQGT916 Strong Biomarker [1424]
CAND1 OTGB6NU0 Strong Biomarker [1425]
CAPNS1 OT95EBBD Strong Altered Expression [1426]
CAPRIN2 OTDYKD95 Strong Genetic Variation [1427]
CARD10 OT2RPM4I Strong Altered Expression [1428]
CARD9 OTJ81AWD Strong Biomarker [1429]
CARTPT OTTE4V9S Strong Genetic Variation [1430]
CASS4 OTGPIPUS Strong Biomarker [1399]
CASTOR1 OTYIH7WK Strong Biomarker [1431]
CASZ1 OTWJ2OR8 Strong Biomarker [1432]
CAVIN2 OTFHHDRU Strong Altered Expression [1433]
CAVIN3 OTOLBK79 Strong Altered Expression [1434]
CBFA2T2 OTNOIB23 Strong Biomarker [1374]
CBLIF OTNE20WU Strong Altered Expression [1435]
CBLL2 OTB4AD3V Strong Altered Expression [1436]
CBX4 OT4XVRRF Strong Biomarker [322]
CBX5 OT8VYY84 Strong Biomarker [1437]
CCDC106 OTWUTA1W Strong Biomarker [1438]
CCDC116 OTYMNP3C Strong Biomarker [1219]
CCDC6 OTXRQDYG Strong Genetic Variation [1439]
CCDC8 OTO295IH Strong Biomarker [1440]
CCDC85B OTKEQLNK Strong Biomarker [1441]
CCDC88A OT3SSYYC Strong Biomarker [1442]
CCL13 OTNX0JD0 Strong Genetic Variation [518]
CCL18 OT7JYSK9 Strong Biomarker [1443]
CCL19 OTQ2UJMH Strong Altered Expression [1444]
CCL25 OTLWJ8CJ Strong Biomarker [1445]
CCL27 OTUZYC61 Strong Biomarker [126]
CCL28 OTY6XNQ7 Strong Posttranslational Modification [1446]
CCL4 OT6B8P25 Strong Altered Expression [1447]
CCL4L2 OTDBSXOU Strong Altered Expression [1447]
CCL7 OTDIS99H Strong Altered Expression [17]
CCN4 OT69BER9 Strong Biomarker [1448]
CCNB2 OTIEXTDK Strong Altered Expression [1449]
CCRL2 OT5PX0RX Strong Biomarker [1450]
CCT4 OT5D452X Strong Biomarker [1451]
CD2AP OTC76KQM Strong Genetic Variation [1452]
CD68 OTOYEY3J Strong Biomarker [402]
CD79A OTOJC8DV Strong Altered Expression [1453]
CDC34 OTNBK390 Strong Altered Expression [1454]
CDC42 OT5QBC5M Strong Biomarker [1455]
CDC42EP3 OTUZ3U9Z Strong Biomarker [1456]
CDC45 OT6NNLOD Strong Biomarker [1457]
CDC6 OTX93FE7 Strong Biomarker [1458]
CDCA5 OTZLCQ5U Strong Altered Expression [368]
CDCP1 OTD7RRWK Strong Genetic Variation [1459]
CDK16 OTUBXIIT Strong Altered Expression [1460]
CDK2AP2 OTR99SJ8 Strong Posttranslational Modification [1461]
CDKN2B OTAG24N1 Strong Biomarker [1462]
CDKN2D OT2TTZPZ Strong Posttranslational Modification [1463]
CDKN3 OTBE3H07 Strong Biomarker [261]
CEP55 OTGSG2PA Strong Biomarker [1363]
CERS6 OTOP4GV1 Strong Biomarker [1464]
CFL1 OTT6D5MH Strong Biomarker [1465]
CGN OTBCQ8AQ Strong Altered Expression [1466]
CHCHD5 OTVESFOA Strong Altered Expression [1467]
CHD5 OTS5EVHH Strong Altered Expression [1468]
CHL1 OT6E6E8P Strong Biomarker [1469]
CHMP4C OT5X8A3O Strong Biomarker [1470]
CHODL OTVCNOUQ Strong Altered Expression [1471]
CHPT1 OT4FJ0K3 Strong Biomarker [1472]
CHRNA3 OTCZQY1U Strong Genetic Variation [379]
CHRNA6 OTT6W86V Strong Genetic Variation [1473]
CHRNB3 OTE5XENW Strong Genetic Variation [1474]
CHST7 OT9HCUST Strong Biomarker [1475]
CIB1 OT4BVCRU Strong Altered Expression [1476]
CIB2 OT9ZJX1I Strong Altered Expression [370]
CILK1 OTWOYEYP Strong Altered Expression [1477]
CIR1 OTKP5JKH Strong Genetic Variation [99]
CIZ1 OT3UKHPI Strong Biomarker [1478]
CKS1B OTNUPLUJ Strong Altered Expression [1479]
CLDN12 OTO55YZI Strong Altered Expression [1480]
CLDN16 OTTHAIKR Strong Genetic Variation [1481]
CLDN3 OT71MN9S Strong Biomarker [1482]
CLEC2D OTVRLKPM Strong Altered Expression [1483]
CLYBL OTXZLTST Strong Altered Expression [1484]
CNN1 OTVPG39Z Strong Genetic Variation [770]
CNOT3 OT4D5Z9L Strong Biomarker [1485]
COL11A2 OT3BQUBH Strong Genetic Variation [647]
COL4A2 OTJK1LKN Strong Biomarker [1486]
COL4A5 OTHG60RE Strong Biomarker [904]
COPE OTBKHBT7 Strong Genetic Variation [1487]
COPS3 OTZWPJ24 Strong Altered Expression [1488]
COX7A1 OTHV25GG Strong Biomarker [1489]
COX8A OTU0NR39 Strong Genetic Variation [38]
CPD OT2CS64Y Strong Altered Expression [1490]
CPNE1 OTH5YKSL Strong Biomarker [1491]
CPNE3 OTCR3WG2 Strong Biomarker [1492]
CPQ OTTNZNLD Strong Posttranslational Modification [1493]
CPSF4 OT53UK5L Strong Biomarker [1494]
CRABP2 OTY01V9G Strong Altered Expression [1495]
CRISP2 OT8HLTV5 Strong Biomarker [1496]
CRLS1 OT7XNL0K Strong Altered Expression [1497]
CRTAP OT53H5U6 Strong Genetic Variation [157]
CRYGD OTW29JC4 Strong Genetic Variation [1276]
CSH1 OT33HTRR Strong Genetic Variation [1013]
CSH2 OTW8JVAN Strong Genetic Variation [1013]
CSMD3 OTAT75SW Strong Genetic Variation [1498]
CSNK2A3 OTZP4KZK Strong Genetic Variation [848]
CSNK2B OT2WW7R1 Strong Genetic Variation [578]
CSTA OT1K68KE Strong Altered Expression [1499]
CSTB OT3U0JF8 Strong Altered Expression [1500]
CSTF2 OTR6G4II Strong Altered Expression [1501]
CT45A1 OT80VTZO Strong Altered Expression [1502]
CT47A11 OTQHGP0S Strong Altered Expression [1503]
CT83 OTQEGHAB Strong Altered Expression [1504]
CTAG1B OTIQGW6U Strong Biomarker [389]
CTNNA1 OTFC725Z Strong Biomarker [1505]
CTNNBIP1 OTX9SBJG Strong Altered Expression [1506]
CTTN OTJRG4ES Strong Biomarker [1507]
CUL4A OTTBV70J Strong Biomarker [293]
CUL4B OT2QX4DO Strong Biomarker [1508]
CUL5 OTMTZD47 Strong Biomarker [1509]
CUX1 OTU1LCNJ Strong Altered Expression [619]
CXADR OT9ZP02A Strong Altered Expression [339]
CXCL16 OTD49T9R Strong Biomarker [1510]
CXCL17 OTRCEVIZ Strong Altered Expression [1511]
CXCL6 OTFTCQ4O Strong Biomarker [1512]
CYGB OTX153DQ Strong Biomarker [1513]
CYLD OT37FKH0 Strong Altered Expression [1074]
CYP20A1 OTIUZ6CF Strong Genetic Variation [1514]
CYP2D7 OTYJTL3S Strong Genetic Variation [1515]
CYTIP OTRJ3ZC5 Strong Genetic Variation [157]
DAAM1 OT0VHIYZ Strong Altered Expression [1516]
DAB2IP OTF456VC Strong Biomarker [1517]
DACT2 OTNLCC0K Strong Posttranslational Modification [1518]
DAND5 OTWNWQDJ Strong Genetic Variation [1519]
DAPK1 OTNCNUCO Strong Biomarker [1520]
DAPK2 OTWODUQG Strong Altered Expression [825]
DAXX OTX6O7PL Strong Biomarker [1521]
DCAF12 OT24XM7T Strong Biomarker [1522]
DCAF4 OTQU0EUO Strong Genetic Variation [522]
DCBLD1 OTA702JK Strong Genetic Variation [1523]
DCD OTV5PBGJ Strong Biomarker [708]
DCDC2 OTSUFH1H Strong Altered Expression [1524]
DCTN6 OTI8PIN9 Strong Altered Expression [809]
DDB2 OTO8HVVB Strong Genetic Variation [1525]
DDIAS OTTGG2PM Strong Biomarker [1526]
DDIT3 OTI8YKKE Strong Biomarker [1527]
DDOST OT39PDMS Strong Biomarker [1528]
DDX3X OTDO4TRX Strong Altered Expression [1529]
DDX43 OTK1RYSK Strong Altered Expression [1530]
DDX59 OTHJANS0 Strong Biomarker [1531]
DECR1 OTCDIR6X Strong Altered Expression [1532]
DEFB1 OT5SV0E4 Strong Altered Expression [1533]
DENND2D OTXEFJWM Strong Altered Expression [1534]
DENR OTXP9HOY Strong Altered Expression [825]
DERL1 OTJUS74N Strong Altered Expression [1535]
DERL2 OTI3TUUZ Strong Biomarker [1536]
DESI2 OTHUOKOC Strong Genetic Variation [1537]
DHDDS OTVLYBUS Strong Biomarker [1472]
DHX9 OT5AAOQI Strong Altered Expression [1538]
DIAPH3 OTPOT23F Strong Biomarker [577]
DIRAS3 OT3XHLQA Strong Altered Expression [1539]
DIXDC1 OT87DXEG Strong Altered Expression [1540]
DKC1 OTX7DJR6 Strong Altered Expression [1541]
DKK4 OTWCCVF6 Strong Genetic Variation [1542]
DLC1 OTP8LMCR Strong Biomarker [1543]
DLD OT378CU9 Strong Biomarker [1544]
DLX5 OTEEFBEU Strong Altered Expression [120]
DMP1 OTBWBWW7 Strong Biomarker [1545]
DNAH11 OT6IYFVV Strong Genetic Variation [1546]
DNAJB4 OTUD01BK Strong Genetic Variation [24]
DNTTIP1 OTAP29SS Strong Altered Expression [1547]
DOCK8 OTNQLL21 Strong Altered Expression [1548]
DOK2 OTIJ38UF Strong Altered Expression [1549]
DOK7 OTR2V7HO Strong Altered Expression [1550]
DPYSL3 OTINJV20 Strong Altered Expression [1551]
DRG1 OTIFYMI3 Strong Biomarker [1552]
DROSHA OTCE68KZ Strong Biomarker [1553]
DSC2 OTODVH8K Strong Biomarker [1554]
DSC3 OTYG47F8 Strong Altered Expression [1555]
DSPP OT1TYNDN Strong Biomarker [1556]
DSTN OTMXO4YB Strong Biomarker [55]
DTX1 OTYX91DX Strong Biomarker [1557]
DUSP2 OTH54FMR Strong Posttranslational Modification [1558]
DUSP22 OTEZ3U85 Strong Biomarker [11]
DUSP6 OT4H6RKW Strong Genetic Variation [1559]
DVL1 OTD67RF1 Strong Altered Expression [1560]
DYNLRB1 OTWVKOFB Strong Altered Expression [1561]
E2F8 OTQKZGFP Strong Biomarker [1562]
EBAG9 OTTQLQCP Strong Altered Expression [1563]
EBNA1BP2 OTBRVMZH Strong Biomarker [526]
EDIL3 OTDVVNS0 Strong Genetic Variation [1564]
EEF1A2 OT9Z23K5 Strong Genetic Variation [1565]
EEF1B2 OTW64NPU Strong Biomarker [1565]
EEF1E1 OTRA6XOB Strong Biomarker [1565]
EEF1G OTW7DH2F Strong Biomarker [1565]
EEF2 OTZ7SZ39 Strong Biomarker [1565]
EFNA1 OTU2NUA2 Strong Biomarker [1566]
EFNA3 OTJGOUMZ Strong Altered Expression [1567]
EHD1 OTDMEKLV Strong Altered Expression [1568]
EIF2B5 OTV3R4RB Strong Biomarker [1569]
EIF3A OTFABY9G Strong Biomarker [1570]
EIF3E OTI0WG98 Strong Altered Expression [1571]
EIF3J OTJ4TAWK Strong Genetic Variation [1572]
EIF4A2 OT08H03R Strong Biomarker [1573]
EIF6 OTEXMUED Strong Biomarker [1574]
ELF3 OTUTLEQO Strong Biomarker [1575]
ELK1 OTH9MXD6 Strong Posttranslational Modification [1576]
ELMO3 OTQHO9VM Strong Altered Expression [1577]
ELOVL6 OTB26UJJ Strong Altered Expression [1578]
ELP1 OTYEWBF7 Strong Genetic Variation [259]
EMP3 OTODMJ1D Strong Altered Expression [1579]
EMX2 OT0V8OYK Strong Biomarker [1580]
ENO3 OT3HYKYI Strong Biomarker [1581]
ERAS OT528IZO Strong Biomarker [1582]
ERCC3 OTVAW3P1 Strong Biomarker [1583]
ERLEC1 OTQO3Z0R Strong Altered Expression [1584]
ERVW-1 OTWV8DXJ Strong Biomarker [1585]
ESRP1 OTNCS4SL Strong Altered Expression [1586]
ETFA OTXX61VZ Strong Biomarker [1587]
ETV5 OTE2OBM4 Strong Biomarker [1588]
EXO1 OTI87RS5 Strong Genetic Variation [1589]
EXOC1 OTX1CC39 Strong Biomarker [1590]
FAIM2 OT6QINVO Strong Biomarker [1591]
FAM107A OTBG61YZ Strong Altered Expression [1592]
FAM111B OT9IQ9NV Strong Altered Expression [1593]
FAM13A OTZ6GN0Q Strong Altered Expression [1594]
FAM3B OTC2S91N Strong Altered Expression [1595]
FAM98A OTBLMZXO Strong Biomarker [1596]
FAT4 OT7QONNV Strong Altered Expression [1597]
FBLN2 OTEHR7N7 Strong Biomarker [1598]
FBRS OTUVH446 Strong Biomarker [1599]
FBXO22 OTEJ5MO0 Strong Altered Expression [1600]
FBXO6 OT58MKP3 Strong Altered Expression [1601]
FBXO8 OTZNGJGW Strong Biomarker [1599]
FBXW2 OTCHPUCP Strong Biomarker [1602]
FCN2 OTTHJBKZ Strong Altered Expression [368]
FERMT1 OT626PBA Strong Altered Expression [1603]
FEV OTYEC4IR Strong Genetic Variation [1604]
FEZ1 OTWCXPRE Strong Biomarker [1605]
FGF13 OTHNNVSG Strong Altered Expression [1606]
FGF3 OT9PK2SI Strong Altered Expression [1607]
FGF9 OT2SKDGM Strong Altered Expression [1608]
FLNB OTPCOYL6 Strong Biomarker [1609]
FLOT2 OTZ0QR5L Strong Altered Expression [1610]
FNDC3A OTUX3S2I Strong Biomarker [1611]
FOXA1 OTEBY0TD Strong Biomarker [1025]
FOXA3 OTRGT2OT Strong Biomarker [1025]
FOXD1 OT80PRHS Strong Biomarker [1612]
FOXD4L5 OTROMIG7 Strong Biomarker [1613]
FOXE1 OT5IR5IT Strong Biomarker [1614]
FOXK1 OTLZGS7J Strong Altered Expression [1615]
FOXN2 OTBPLTCM Strong Biomarker [244]
FRAT1 OT1PS84E Strong Biomarker [1616]
FRK OTEKV1SC Strong Biomarker [1617]
FRMD5 OTC73XJK Strong Biomarker [1618]
FRMPD1 OTCC9A0E Strong Altered Expression [1619]
FSD1 OT8P6PT3 Strong Biomarker [1620]
FSD1L OTBQ48RF Strong Biomarker [1620]
FSIP1 OTYLL6GM Strong Biomarker [1621]
FUT2 OTLXM6WI Strong Biomarker [1622]
FUT8 OTJJCVG1 Strong Biomarker [1623]
FXYD3 OT9PPRHE Strong Altered Expression [1624]
FXYD5 OT81DIOD Strong Biomarker [1625]
FZD1 OTZATHVS Strong Altered Expression [1626]
FZD8 OTZ9IRFL Strong Altered Expression [1627]
G0S2 OT8FL49L Strong Biomarker [1628]
GAB1 OTQKE6V4 Strong Genetic Variation [1629]
GAB2 OTBFN705 Strong Altered Expression [1630]
GADD45A OTDRV63V Strong Altered Expression [1631]
GADD45G OT8V1J4M Strong Biomarker [1632]
GATA5 OTO81B63 Strong Biomarker [1633]
GATA6 OTO2BC0F Strong Genetic Variation [1634]
GATAD2B OTJL128N Strong Altered Expression [1635]
GBE1 OTK2N05B Strong Biomarker [723]
GCHFR OTEOT8GI Strong Altered Expression [368]
GCNT1 OTF6OC66 Strong Altered Expression [1636]
GDE1 OTU6FSBF Strong Biomarker [1637]
GDF1 OTZ1VRBH Strong Genetic Variation [1638]
GDI2 OTGLY3I7 Strong Altered Expression [1639]
GFI1 OT9HB9H8 Strong Biomarker [1640]
GHRH OT94U6MO Strong Genetic Variation [1641]
GINS4 OTCVOO3S Strong Biomarker [1045]
GIPC1 OTXLVCPJ Strong Altered Expression [1642]
GK5 OT65U8L1 Strong Biomarker [1643]
GLCE OTPRSHX5 Strong Altered Expression [1644]
GLRX3 OTUPAU1N Strong Altered Expression [1645]
GNAI2 OTTLGRGH Strong Altered Expression [1646]
GOLGA2 OT5S9KYM Strong Altered Expression [1647]
GOLM1 OTOZSV6O Strong Biomarker [1648]
GOPC OTRBGH71 Strong Genetic Variation [1649]
GORASP1 OTQS91S7 Strong Altered Expression [75]
GPC5 OT8NR7GC Strong Biomarker [1650]
GPR19 OTR7MUS5 Strong Altered Expression [481]
GPR4 OTIBF32I Strong Altered Expression [481]
GPR42 OTEB0ROY Strong Biomarker [2]
GPRC5C OT45AJT3 Strong Altered Expression [481]
GPX2 OTXI2NTI Strong Biomarker [144]
GPX4 OTRAFFX2 Strong Altered Expression [766]
GREB1 OTU6ZA26 Strong Biomarker [1651]
GSDME OT1ZWY32 Strong Altered Expression [1652]
GSPT1 OT18H1B0 Strong Biomarker [1430]
GTF2H1 OTCRXC6B Strong Altered Expression [67]
GTF2IRD1 OTEG9KU1 Strong Biomarker [1653]
GYPA OTABU4YV Strong Biomarker [1654]
GYPB OTESHUIX Strong Biomarker [1654]
GYPE OTBHAG6A Strong Biomarker [1654]
GZMA OT43R33L Strong Altered Expression [1655]
H4C1 OTB71W46 Strong Biomarker [1077]
HADHA OTO557N2 Strong Biomarker [1656]
HAP1 OT6SG0JQ Strong Genetic Variation [1657]
HBE1 OTJPKMX4 Strong Biomarker [1658]
HDGFL3 OTNN7WYH Strong Biomarker [1659]
HERC4 OTU4DSDE Strong Biomarker [1660]
HERC5 OTZ5PR39 Strong Biomarker [1661]
HES3 OTJ1J42N Strong Biomarker [1662]
HEY1 OTJQL0I3 Strong Altered Expression [1663]
HHIP OT77RQYS Strong Biomarker [1664]
HIC1 OTI9TWY4 Strong Biomarker [1665]
HJURP OTWMV16B Strong Altered Expression [1333]
HLA-DRB4 OTNXIHQU Strong Genetic Variation [1666]
HLTF OTRX2OSF Strong Altered Expression [1667]
HM13 OTGEO1LP Strong Altered Expression [1668]
HMGB3 OTCJ2EZY Strong Biomarker [74]
HMGN5 OTUUAHVQ Strong Altered Expression [1669]
HNF1B OTSYIC3T Strong Genetic Variation [312]
HNRNPK OTNPRM8U Strong Biomarker [1670]
HNRNPU OTLQN1E2 Strong Altered Expression [623]
HOOK1 OTTTKV7V Strong Altered Expression [1671]
HOPX OTBSR6C9 Strong Biomarker [1672]
HORMAD2 OTL2ENWI Strong Genetic Variation [1673]
HOXA1 OTMSOJ7D Strong Biomarker [1674]
HOXA4 OTNVTQDT Strong Altered Expression [1675]
HOXA9 OTKNK5H0 Strong Biomarker [1676]
HOXB7 OTC7WYU8 Strong Altered Expression [1677]
HOXC8 OTJUYU8J Strong Altered Expression [1678]
HOXD3 OTBUZ35T Strong Biomarker [1187]
HOXD8 OTJ5H7AT Strong Biomarker [1679]
HRG OTPLUFOG Strong Biomarker [1680]
HS3ST2 OTWFA0GJ Strong Altered Expression [1681]
HSD11B1L OTZ6KH9M Strong Altered Expression [1682]
HSPA1A OTKGIE76 Strong Altered Expression [33]
HSPA1L OTC2V1K6 Strong Genetic Variation [1683]
HSPA2 OTSDET7B Strong Biomarker [1684]
HSPA4 OT5HR0AR Strong Altered Expression [283]
HSPB2 OTS01646 Strong Biomarker [410]
HYAL2 OTTVINXW Strong Biomarker [1685]
ICAM2 OT3E070F Strong Biomarker [18]
ICAM3 OTTZ5A5D Strong Biomarker [1686]
ID4 OTPMJ39I Strong Biomarker [1687]
IFI27 OTI2XGIT Strong Altered Expression [809]
IFIT2 OTI4EOAR Strong Biomarker [1688]
IFITM1 OTECO1G8 Strong Biomarker [1689]
IFNA1 OTPMKY0L Strong Biomarker [1690]
IFNA8 OTW0PCKU Strong Biomarker [1691]
IFNL2 OT4BMJF7 Strong Biomarker [1692]
IFNLR1 OTWWWK45 Strong Altered Expression [1693]
IFRD1 OT4SQMLQ Strong Biomarker [1694]
IGF2BP1 OT9G360P Strong Altered Expression [1695]
IGF2BP3 OTB97VIK Strong Altered Expression [1696]
IGFBP4 OT2HZRBD Strong Biomarker [1697]
IGSF1 OT3XD6U2 Strong Altered Expression [623]
IGSF10 OTB9QOGO Strong Altered Expression [1698]
IKZF1 OTCW1FKL Strong Posttranslational Modification [1699]
IL17B OTS86H50 Strong Biomarker [1700]
IL17C OTKXIVNQ Strong Biomarker [1700]
IL17RB OT0KDNSF Strong Altered Expression [1701]
IL18R1 OT83XMPQ Strong Biomarker [426]
IL34 OTZ15VVK Strong Altered Expression [1702]
IL6R OTCQL07Z Strong Biomarker [1703]
IL6ST OT1N9C70 Strong Biomarker [366]
IL9R OTILCLXA Strong Biomarker [1704]
ILF3 OTKMZ5K5 Strong Biomarker [1705]
ILRUN OTE8FHQD Strong Altered Expression [1706]
IMMP1L OTA6LOLR Strong Altered Expression [1668]
IMPA1 OTBUVW1Z Strong Altered Expression [1707]
IMPACT OTQ923OB Strong Biomarker [1708]
ING1 OTEZBRKW Strong Biomarker [1709]
ING2 OT6H0EWF Strong Altered Expression [1710]
ING4 OT0VVG4V Strong Biomarker [1711]
ING5 OTRNNSFM Strong Altered Expression [1712]
INO80B OTSHV8JF Strong Biomarker [1713]
INS-IGF2 OTZR74BO Strong Biomarker [512]
INSL4 OTK9F0LX Strong Biomarker [1714]
INSM1 OTG8RV8E Strong Biomarker [1158]
INSRR OT3F75WA Strong Genetic Variation [1715]
INTS1 OT7TY1M1 Strong Biomarker [1716]
IPO8 OTBHGNKT Strong Biomarker [1717]
IREB2 OT747D24 Strong Altered Expression [1718]
IRF5 OT8SIIAP Strong Biomarker [852]
IRF6 OTKJ44EV Strong Altered Expression [1719]
IRF7 OTC1A2PQ Strong Biomarker [1720]
IST1 OTSFEZ2O Strong Altered Expression [1721]
ISYNA1 OT49ONSE Strong Biomarker [1722]
ITGAX OTOGIMHE Strong Biomarker [1723]
ITGB4 OT28UK84 Strong Altered Expression [1724]
ITIH1 OTSXJGQF Strong Genetic Variation [1725]
ITIH5 OTP46PZM Strong Posttranslational Modification [1726]
ITPKA OTX5ERUD Strong Biomarker [1727]
ITSN1 OT8YF3S5 Strong Biomarker [1012]
JAG1 OT3LGT6K Strong Genetic Variation [1728]
JTB OT314JB6 Strong Biomarker [1729]
KARS1 OT0EU4SV Strong Genetic Variation [1730]
KAT5 OTL7257A Strong Biomarker [264]
KAT8 OT5LPQTR Strong Biomarker [1731]
KATNA1 OTISKGMK Strong Genetic Variation [1732]
KCTD11 OT64DFBU Strong Biomarker [1733]
KDM4B OT5P1UPY Strong Biomarker [1734]
KHSRP OTDHZARB Strong Biomarker [1690]
KIDINS220 OTLBH2MA Strong Genetic Variation [1735]
KIF13A OTSSZGBQ Strong Genetic Variation [1736]
KIF20A OTXOQHE0 Strong Biomarker [582]
KIF22 OTY6X6BL Strong Biomarker [1737]
KIF23 OTY850JC Strong Biomarker [1738]
KIF3A OTMUBSSK Strong Biomarker [1739]
KIF5B OTT34MT8 Strong Altered Expression [1740]
KL OTD4VWU6 Strong Biomarker [1741]
KLC4 OTACUFB2 Strong Biomarker [1742]
KLF11 OTKVQDJD Strong Altered Expression [1743]
KLF17 OT5NWVP7 Strong Biomarker [1744]
KLF2 OTIP1UFX Strong Biomarker [1745]
KLF3 OTIIAC18 Strong Biomarker [1746]
KLF5 OT1ABI9N Strong Altered Expression [1747]
KLF6 OTQY9S7F Strong Altered Expression [1748]
KLF8 OTUC5CDB Strong Biomarker [1749]
KLHL1 OTAX6SAD Strong Altered Expression [1]
KLK11 OT5PKX7Y Strong Altered Expression [1750]
KLK12 OTNYK59J Strong Biomarker [1751]
KLK13 OT8LOD2U Strong Biomarker [1752]
KLRB1 OTQ2959Y Strong Altered Expression [1483]
KPNA2 OTU7FOE6 Strong Altered Expression [1753]
KPNA4 OTP0EX18 Strong Altered Expression [1754]
KRT14 OTUVZ1DW Strong Biomarker [1755]
KRT5 OTVGI9HT Strong Biomarker [1756]
KRT8 OTTM4X11 Strong Posttranslational Modification [1009]
LAMTOR2 OTHEDISB Strong Posttranslational Modification [1461]
LARP6 OTUQ9QS9 Strong Biomarker [1757]
LARS1 OT4557NF Strong Altered Expression [1758]
LATS1 OTOOCG4R Strong Biomarker [1759]
LAYN OT9A9Q1X Strong Biomarker [1760]
LDHB OT9B1CT3 Strong Altered Expression [1761]
LDOC1 OTWZH4O9 Strong Biomarker [1762]
LECT2 OTSFZ9JD Strong Biomarker [973]
LETM1 OT8N4MRU Strong Altered Expression [1763]
LGALS3BP OT9AGQKH Strong Biomarker [1764]
LGALS8 OT71LJ8T Strong Biomarker [1765]
LGI3 OT0CZ85H Strong Altered Expression [1766]
LGSN OTQG5Z82 Strong Genetic Variation [1767]
LHX6 OT47UQZ5 Strong Altered Expression [1091]
LIMCH1 OTYPC4XA Strong Biomarker [1245]
LIMD1 OTN1CG6R Strong Biomarker [1768]
LIN28B OTVWP0FN Strong Biomarker [1305]
LMLN OTQF0JPY Strong Posttranslational Modification [598]
LMNB1 OT100T3P Strong Biomarker [1769]
LMO7 OTDLY6TC Strong Biomarker [1770]
LNX1 OTZWFMAZ Strong Biomarker [1762]
LOXL4 OT6XY2JL Strong Biomarker [1771]
LPCAT1 OTCV7AGV Strong Genetic Variation [1772]
LPIN1 OTQ75KF2 Strong Biomarker [1773]
LPP OT6TU8SE Strong Genetic Variation [1774]
LRFN2 OTI2QPM2 Strong Genetic Variation [1546]
LRPAP1 OT6DVD2Q Strong Biomarker [1775]
LRPPRC OTXSK5LP Strong Biomarker [366]
LUM OTSRC874 Strong Biomarker [1776]
LYNX1 OTK4103B Strong Biomarker [1777]
LYPD4 OTYNO8BS Strong Biomarker [1778]
LZTS1 OTXXL864 Strong Biomarker [1779]
LZTS2 OTQFSQEE Strong Biomarker [1780]
MACC1 OTV3DLX0 Strong Altered Expression [1781]
MACROH2A2 OTAKSVYV Strong Biomarker [1782]
MAD2L2 OT24ZO59 Strong Biomarker [1783]
MAFG OTBQFUZH Strong Genetic Variation [1784]
MAGED1 OT6EOLFC Strong Biomarker [1785]
MAGI1 OTMV4ASV Strong Genetic Variation [1786]
MAGI2 OTXDDKZS Strong Genetic Variation [321]
MAGT1 OTQSAV5C Strong Biomarker [288]
MAML2 OT1TSVAR Strong Altered Expression [1787]
MAP1B OTVXW089 Strong Biomarker [1670]
MAP2K3 OTI2OREX Strong Biomarker [1788]
MAP2K6 OTK13JKC Strong Altered Expression [1789]
MAPK15 OT8SW0L7 Strong Biomarker [1790]
MAPK1IP1L OTG5B19W Strong Biomarker [1791]
MAPRE1 OTCVQD60 Strong Biomarker [1792]
MARCKSL1 OT13J2FM Strong Altered Expression [1793]
MARVELD3 OTFTPOJ4 Strong Biomarker [1794]
MATK OTVOJJLJ Strong Genetic Variation [1795]
MAX OTKZ0YKM Strong Biomarker [1796]
MB OTYWYL2D Strong Biomarker [1275]
MBD1 OTD19VO6 Strong Genetic Variation [1797]
MBD2 OTUQPP0R Strong Biomarker [1798]
MBD3 OTRL76H5 Strong Biomarker [1256]
MBD4 OTWR9YXE Strong Genetic Variation [667]
MCM10 OTV0O3JN Strong Biomarker [1799]
MCM2 OTGGORIQ Strong Altered Expression [1800]
MCM5 OTAHLB62 Strong Biomarker [1801]
MCRS1 OT8K2X8P Strong Altered Expression [1802]
MED12 OTQZ4D2X Strong Biomarker [1803]
MED23 OTKZQT0R Strong Altered Expression [1576]
MED8 OTSIZ1I7 Strong Altered Expression [1803]
MEF2D OT7CEIG0 Strong Altered Expression [1804]
MEIOB OTTX5TF0 Strong Altered Expression [1805]
MEOX2 OTKZCJCB Strong Biomarker [1806]
MESP1 OTY5QDBN Strong Biomarker [1807]
METTL3 OTSXP1M3 Strong Altered Expression [1808]
MFSD2A OTVG1VG0 Strong Genetic Variation [1809]
MICA OTPEIEAR Strong Biomarker [1810]
MID1 OTWN1PGU Strong Biomarker [1811]
MIEF1 OTFSP3FS Strong Biomarker [842]
MINDY3 OT6YZPWC Strong Altered Expression [1812]
MINDY4 OTBZ2SZB Strong Biomarker [1813]
MIPEP OTB2IHCT Strong Genetic Variation [1814]
MKS1 OT83W5PB Strong Biomarker [950]
MLKL OTDSLC81 Strong Biomarker [1815]
MMD OTB5I4OC Strong Biomarker [1816]
MMP19 OTLSTT2B Strong Altered Expression [1817]
MMP28 OTHQZXM1 Strong Biomarker [1818]
MMRN1 OT7ZNYHT Strong Biomarker [1819]
MMUT OTBBBV70 Strong Biomarker [1820]
MNAT1 OTXLOYCB Strong Altered Expression [368]
MOB1A OTSPBZ4Z Strong Biomarker [1821]
MOGS OT99MBGB Strong Biomarker [472]
MOK OTQK7M9V Strong Genetic Variation [1822]
MOS OTNMQPFJ Strong Biomarker [1823]
MPG OTAHW80B Strong Biomarker [1824]
MPRIP OT5FV5NS Strong Biomarker [1825]
MRE11 OTGU8TZM Strong Genetic Variation [667]
MRPL17 OTBPCPVW Strong Biomarker [1826]
MRPL58 OTPTWLZY Strong Biomarker [1827]
MSC OTBRPZL5 Strong Biomarker [1828]
MT1G OTAV1OCR Strong Genetic Variation [221]
MT1X OT9AKFVS Strong Biomarker [1829]
MTA2 OTCCYIQJ Strong Genetic Variation [1830]
MTG1 OTC9U1LI Strong Altered Expression [303]
MTHFD1 OTMKHVWC Strong Altered Expression [1831]
MTMR3 OTBIT23O Strong Genetic Variation [1814]
MTURN OTEBJNVG Strong Altered Expression [1796]
MTUS1 OTBPALMU Strong Altered Expression [1832]
MTX1 OTLSDNZO Strong Genetic Variation [312]
MUC3A OTI4XUDY Strong Altered Expression [606]
MUC4 OTLT11V1 Strong Biomarker [1833]
MUC6 OTPVL723 Strong Altered Expression [607]
MUL1 OT2JC9YR Strong Altered Expression [1436]
MXD1 OTS5CTHX Strong Genetic Variation [1353]
MXRA5 OTXZBWCU Strong Genetic Variation [1834]
MYH9 OT94Z706 Strong Biomarker [1492]
MYL12B OTXMLQOT Strong Altered Expression [1835]
MYL9 OT6B22JB Strong Altered Expression [610]
MYO18B OTGYY4NK Strong Genetic Variation [1613]
MYO7A OTBZSPEL Strong Biomarker [1836]
MZB1 OT071TET Strong Biomarker [279]
NAA10 OTYB9R6I Strong Biomarker [1837]
NAA25 OTS3QVF1 Strong Altered Expression [623]
NAB2 OTG4BDF3 Strong Posttranslational Modification [1838]
NAIF1 OT0B3H72 Strong Biomarker [1839]
NANOG OTUEY1FM Strong Biomarker [1840]
NANOS3 OTGX9IQU Strong Altered Expression [1841]
NAPSA OT6F8IAL Strong Biomarker [469]
NCBP1 OTYBR927 Strong Biomarker [1842]
NCOA2 OTMQFPBB Strong Altered Expression [453]
NDC80 OTS7D306 Strong Biomarker [1064]
NDUFA4L2 OTK0PG7R Strong Biomarker [1843]
NDUFS1 OTTIZDFR Strong Biomarker [1844]
NDUFS8 OTMEAWKO Strong Biomarker [1844]
NECTIN1 OTTE5ZR6 Strong Biomarker [613]
NECTIN2 OTIE0W6O Strong Biomarker [613]
NEDD4L OT1B19RU Strong Altered Expression [1845]
NEIL2 OTV6JEON Strong Altered Expression [1846]
NEK10 OTN0JAYL Strong Genetic Variation [312]
NEK4 OTOB8366 Strong Biomarker [1847]
NEMF OT9DK06P Strong Altered Expression [1848]
NEU1 OTH9BY8Y Strong Biomarker [1849]
NEURL1 OT2C4P70 Strong Biomarker [1849]
NFASC OTBDUXZT Strong Biomarker [1850]
NFATC1 OT4TMERS Strong Altered Expression [1851]
NFIL3 OTQH9HM3 Strong Biomarker [1852]
NFYA OTWFFOVH Strong Altered Expression [1853]
NFYB OTXSE7KW Strong Biomarker [1854]
NHLH1 OTXN5B9R Strong Biomarker [1855]
NIBAN2 OTVDQSPI Strong Biomarker [1856]
NID2 OTHC33FF Strong Posttranslational Modification [1857]
NINL OTWIK6HT Strong Biomarker [1858]
NIPBL OTF6OOLU Strong Biomarker [1859]
NIT1 OT1KHPKJ Strong Biomarker [1860]
NKD1 OTY3MO97 Strong Altered Expression [1861]
NKX2-8 OT6Q3DJ0 Strong Biomarker [1862]
NLK OT2LETFS Strong Altered Expression [1863]
NLRP6 OTEREN4W Strong Biomarker [1864]
NLRP7 OTE9BI32 Strong Biomarker [617]
NMB OT4NLN6H Strong Biomarker [1865]
NMBR OTBJEGPN Strong Altered Expression [1866]
NME2 OTCYGLHV Strong Altered Expression [1867]
NMU OTW9X7BQ Strong Biomarker [1868]
NOCT OTVSYP2D Strong Genetic Variation [1869]
NOG OTGRHHPG Strong Biomarker [1870]
NOL10 OTC4R5O7 Strong Altered Expression [1586]
NOXO1 OTW29FB4 Strong Biomarker [1871]
NPAS2 OTMRT2TS Strong Biomarker [387]
NPC1 OTRIPICX Strong Biomarker [1872]
NPRL2 OTOB10MO Strong Genetic Variation [1000]
NPTN OTAQKSAU Strong Biomarker [707]
NR1D2 OT9CVF41 Strong Biomarker [387]
NR2C2 OTDZWVOJ Strong Biomarker [1873]
NR2F2 OTJFS67N Strong Genetic Variation [1874]
NR5A1 OTOULYR4 Strong Biomarker [504]
NSD2 OTQ6SW4R Strong Biomarker [1875]
NSD3 OT3677ZG Strong Biomarker [1876]
NSG1 OTRIMA50 Strong Genetic Variation [1877]
NSUN5 OTBN7RS8 Strong Altered Expression [623]
NTHL1 OTPQXPT1 Strong Genetic Variation [1878]
NTMT1 OTLRH78U Strong Genetic Variation [1879]
NTS OTPGDNQS Strong Biomarker [1880]
NUCB2 OTHO6JWN Strong Altered Expression [1881]
NUDCD1 OT8DS3CX Strong Biomarker [1882]
NUDT1 OTZSES3W Strong Altered Expression [1883]
NUMB OTMB586Q Strong Biomarker [1884]
NUP205 OTJKHCY6 Strong Biomarker [1885]
NUP58 OTMLLWJW Strong Genetic Variation [1886]
NUP98 OTNT12G2 Strong Altered Expression [1887]
NUSAP1 OT85HIJ5 Strong Biomarker [74]
NUTM1 OTONYC08 Strong Altered Expression [1888]
NXF1 OTEFHXG6 Strong Biomarker [1609]
OAS3 OT6E5FYS Strong Altered Expression [619]
OASL OTZ05YRP Strong Biomarker [1889]
OBP2A OTBIJ5TI Strong Biomarker [1737]
OCLN OTSUTVWL Strong Biomarker [1890]
OGA OT7ZBWT1 Strong Biomarker [1891]
ONECUT1 OTK1QUQT Strong Biomarker [1892]
OPRPN OT6K1ZD6 Strong Biomarker [682]
OR2AG1 OTEITRP4 Strong Genetic Variation [1893]
ORM1 OTZKSBRE Strong Biomarker [1894]
OSR1 OTB19LEQ Strong Biomarker [1895]
OTUD3 OTHUWQHP Strong Biomarker [1896]
OTUD7B OTMVM8R7 Strong Altered Expression [1897]
OVCA2 OT5LSKCS Strong Altered Expression [1898]
OXA1L OTS0BFRD Strong Biomarker [1899]
P2RX2 OT0LF34A Strong Genetic Variation [641]
P2RX5 OTLBR20R Strong Genetic Variation [641]
P2RX6 OT1FNTXA Strong Genetic Variation [641]
P3H3 OTRC8QCM Strong Altered Expression [1900]
PADI2 OTT40K94 Strong Biomarker [1901]
PAF1 OTDDGUBQ Strong Biomarker [1902]
PAFAH1B1 OT9T2TCJ Strong Genetic Variation [1903]
PAK5 OT32WQGL Strong Biomarker [1904]
PAPLN OTCJD85N Strong Biomarker [670]
PAPPA OTTTG9PG Strong Biomarker [1905]
PAQR7 OTIWX5AM Strong Biomarker [1906]
PAX8 OTRPD9MI Strong Biomarker [469]
PCDH10 OT2GIT0E Strong Altered Expression [1907]
PCDH7 OTP091X8 Strong Biomarker [1908]
PCK2 OTJ8LX4N Strong Biomarker [1909]
PCLAF OTMVIOUU Strong Biomarker [1910]
PDCD4 OTZ6NXUX Strong Altered Expression [1911]
PDCD5 OT6T2DDL Strong Biomarker [1912]
PDCD6 OT2YA5M8 Strong Genetic Variation [1913]
PDCD6IP OTS8T6A7 Strong Genetic Variation [321]
PDIK1L OTISF4KG Strong Biomarker [1914]
PDK4 OTCMHMBZ Strong Altered Expression [1915]
PDLIM2 OTEURRPD Strong Biomarker [1916]
PDLIM3 OTVXQC81 Strong Biomarker [126]
PDPN OTBUV19I Strong Altered Expression [1917]
PDSS2 OTEOQBMX Strong Altered Expression [1918]
PDZK1IP1 OTWA6M5K Strong Biomarker [1919]
PEA15 OTKCKTSX Strong Altered Expression [1920]
PELI1 OTMLBCLC Strong Biomarker [1921]
PER2 OTU2B1DJ Strong Biomarker [387]
PERP OTP0YL53 Strong Biomarker [1922]
PFN2 OT5SSSA7 Strong Biomarker [1923]
PGK1 OT6V1ICH Strong Biomarker [1924]
PHF14 OTZT3GV1 Strong Biomarker [1925]
PHLPP1 OTIFXW8D Strong Altered Expression [1926]
PHPT1 OTFYWNFX Strong Biomarker [1927]
PIAS3 OT3TWH9R Strong Biomarker [1928]
PIAS4 OTB7SVMZ Strong Biomarker [1929]
PIK3R1 OT5BZ1J9 Strong Biomarker [1930]
PIK3R2 OTZSUQK5 Strong Biomarker [1374]
PIK3R3 OTXGJ8N1 Strong Biomarker [1931]
PINK1 OT50NR57 Strong Biomarker [1932]
PITX1 OTA0UN4C Strong Altered Expression [1933]
PIWIL1 OT7CRGZ3 Strong Biomarker [1100]
PKD1 OT5ALRZ5 Strong Biomarker [115]
PKP1 OT9HSQ8F Strong Altered Expression [1934]
PLAA OTZ7NJGA Strong Biomarker [562]
PLAAT4 OTI66SAJ Strong Altered Expression [1935]
PLB1 OTZ6TTYV Strong Biomarker [237]
PLCD1 OT6WFVXZ Strong Genetic Variation [1936]
PLEC OTU4XDEG Strong Biomarker [1937]
PLK3 OT19CT2Z Strong Biomarker [1938]
PLOD3 OTT00T7Q Strong Biomarker [1939]
PLPP4 OTH5EXZC Strong Biomarker [1940]
PLRG1 OTIVZ5LL Strong Biomarker [682]
PMEPA1 OTY8Z9UF Strong Biomarker [1941]
PNO1 OT010GIS Strong Biomarker [1942]
POLA2 OTTWQ73N Strong Biomarker [1943]
POLD1 OTWO4UCJ Strong Genetic Variation [1944]
POLE OTFM3MMU Strong Genetic Variation [1944]
POLI OTBA4DCE Strong Biomarker [1945]
POLM OT0SRIP4 Strong Biomarker [1945]
POLQ OTBHK0E6 Strong Altered Expression [1946]
POLR3B OT3FS9MB Strong Biomarker [1947]
POT1 OTNBXJCQ Strong Genetic Variation [778]
POTEF OTV3WXYE Strong Altered Expression [1948]
PPA1 OTHZK1QB Strong Altered Expression [1949]
PPBP OT1FHGQS Strong Biomarker [1950]
PPP1R11 OTSHYPPW Strong Altered Expression [579]
PPP1R12C OT9Q86JO Strong Biomarker [1374]
PPP1R13B OTC88VQO Strong Biomarker [1374]
PPP1R1A OTGTAGCV Strong Genetic Variation [1951]
PPP2R1A OTYA3GB4 Strong Genetic Variation [1952]
PPP2R2B OTSFVC82 Strong Genetic Variation [1953]
PPP2R2C OTXK0SDM Strong Genetic Variation [1954]
PPP2R5C OTF7CGO2 Strong Genetic Variation [1955]
PPP2R5E OT8GPFT5 Strong Biomarker [1956]
PRAP1 OT48QD82 Strong Biomarker [1957]
PRCC OTJ0KRYX Strong Altered Expression [1958]
PRDM1 OTQLSVBS Strong Biomarker [1959]
PRDM16 OT0BGA27 Strong Altered Expression [1960]
PRDM2 OT8L7CGX Strong Genetic Variation [1961]
PRDM5 OTU1GB68 Strong Biomarker [1962]
PRDX1 OTZ3BEC4 Strong Biomarker [1963]
PRG2 OT0BCPQG Strong Biomarker [1964]
PRIMA1 OT9ITT3P Strong Biomarker [1965]
PRKAA1 OT7TNF0L Strong Altered Expression [1966]
PRKAA2 OTU1KZPV Strong Altered Expression [1966]
PRKAB1 OT1OG4QZ Strong Altered Expression [1966]
PRMT6 OT5V3XIN Strong Biomarker [1967]
PROCR OTRHED17 Strong Biomarker [1968]
PROS1 OTXQWNOI Strong Biomarker [548]
PRPF31 OTSJ0Z1Y Strong Genetic Variation [1219]
PRR11 OT2JJ08Z Strong Biomarker [1969]
PRR14 OTZMIMOK Strong Altered Expression [1970]
PRSS55 OTXXWI5Y Strong Biomarker [1496]
PSD OTUZIXUZ Strong Biomarker [1971]
PSMA6 OTJ6RPX5 Strong Biomarker [1972]
PSMD2 OT6HZHN7 Strong Biomarker [1973]
PSMD7 OT7PZZ4K Strong Biomarker [526]
PSMD8 OTY6X27P Strong Biomarker [1392]
PSMD9 OT6Y5CC3 Strong Altered Expression [809]
PSME3 OTSTC4YY Strong Biomarker [249]
PSMG1 OTZ5I6UM Strong Altered Expression [1974]
PSPH OTV1PVAX Strong Biomarker [1975]
PSRC1 OT7MDJMN Strong Altered Expression [1976]
PTGFRN OTBG4SA2 Strong Altered Expression [1977]
PTPA OTRGFOI7 Strong Biomarker [1978]
PTPMT1 OT9WVC6N Strong Biomarker [1979]
PTPN3 OTSLZBVY Strong Biomarker [1516]
PTPRD OTZPJ3GX Strong Biomarker [1980]
PTPRG OT9N2WOF Strong Biomarker [1981]
PTPRH OTDUHQGF Strong Altered Expression [1982]
PTRH2 OTBU39Q1 Strong Biomarker [1319]
PXDN OTFGGM9R Strong Biomarker [1983]
PYCR1 OTQHB52T Strong Biomarker [1984]
QKI OTTAUGLB Strong Biomarker [1985]
QRSL1 OTJDU2UG Strong Genetic Variation [1986]
QTRT1 OTC33MCV Strong Biomarker [1987]
RAB15 OTU0GGR3 Strong Biomarker [1791]
RAB23 OTBAKFBR Strong Altered Expression [1988]
RAB25 OTW0W6NP Strong Biomarker [1989]
RAB26 OTHMPRJK Strong Biomarker [1990]
RAB40B OTCA9ZF5 Strong Biomarker [1991]
RABEP2 OTO61X27 Strong Biomarker [1992]
RABEPK OTCZSREH Strong Biomarker [526]
RAC2 OTAOHFNH Strong Biomarker [1993]
RACGAP1 OTQE8IEH Strong Biomarker [1994]
RAD17 OT1I93DT Strong Biomarker [1995]
RAD23A OTBPAWHX Strong Biomarker [814]
RAD23B OT0PGOG3 Strong Genetic Variation [1996]
RAD50 OTYMU9G1 Strong Biomarker [591]
RAD51AP1 OTXM7UTD Strong Altered Expression [1997]
RAD51B OTCJVRMY Strong Genetic Variation [312]
RAD52 OT0OTDHI Strong Biomarker [1066]
RAD9A OTJ3AJQU Strong Altered Expression [1998]
RAG1 OTV131E4 Strong Biomarker [1704]
RALGPS2 OTOYS0SD Strong Biomarker [1999]
RALY OT78NNWY Strong Genetic Variation [312]
RAMP2 OTGQXLH5 Strong Biomarker [884]
RAP1A OT5RH6TI Strong Biomarker [2000]
RASA2 OTL06RG2 Strong Biomarker [2001]
RASEF OTGSAM2E Strong Biomarker [2002]
RASSF2 OT2JHDO4 Strong Biomarker [2003]
RASSF4 OT7YLOFH Strong Altered Expression [2004]
RASSF7 OT0V4EIZ Strong Altered Expression [2005]
RASSF8 OTXKGIB3 Strong Biomarker [2006]
RBBP6 OTTVG4HU Strong Genetic Variation [2007]
RBFOX2 OTXY1WVH Strong Altered Expression [2008]
RBL1 OTDEBFYC Strong Altered Expression [2009]
RBM10 OTES2MES Strong Biomarker [2010]
RBM39 OTCMPTF9 Strong Biomarker [2011]
RBM6 OTI99KAZ Strong Genetic Variation [1884]
RBMS3 OTFSC9MR Strong Biomarker [1259]
RCC2 OTUJVTLS Strong Altered Expression [2012]
RCCD1 OT60N06L Strong Biomarker [2013]
RCOR1 OTREADPC Strong Biomarker [2014]
RDM1 OTBSJEAG Strong Altered Expression [2015]
RDX OTNSYUN6 Strong Biomarker [2016]
RECQL OTPCH3JH Strong Biomarker [2017]
RECQL4 OT59LSW7 Strong Biomarker [2018]
REEP5 OTZU4TJI Strong Biomarker [400]
REG1A OTMHUH1D Strong Biomarker [694]
REG1B OTSC2133 Strong Biomarker [694]
REG3G OTLIUY8Z Strong Altered Expression [694]
REST OTLL92LQ Strong Biomarker [2014]
RETN OTW5Z1NH Strong Biomarker [2019]
RETREG2 OT5CJTMK Strong Biomarker [2020]
REV1 OTHIKICX Strong Biomarker [2021]
REV3L OT0OP8EJ Strong Biomarker [2022]
RGCC OTYJMLWM Strong Biomarker [2023]
RGL1 OTY6ZHVA Strong Biomarker [2024]
RGS11 OTIAZ36F Strong Altered Expression [2025]
RHOV OTW4N3QN Strong Altered Expression [2026]
RING1 OTCWTAX0 Strong Altered Expression [2027]
RIOK1 OT1OS3H3 Strong Biomarker [2028]
RIOX1 OTN41QXP Strong Altered Expression [2029]
RIOX2 OT2YFPI2 Strong Biomarker [2030]
RIPK3 OTL1D484 Strong Biomarker [1825]
RNASE1 OTKZ7CO9 Strong Biomarker [2031]
RNASE3 OTVE2XD1 Strong Biomarker [2032]
RNF111 OTO3QT6Q Strong Biomarker [2033]
RNF146 OTE4CO7E Strong Altered Expression [2034]
RNF2 OTFPLOIN Strong Genetic Variation [1786]
RNF38 OTRLV4WZ Strong Biomarker [2035]
RNH1 OT6EC79B Strong Genetic Variation [1638]
ROM1 OTE7H0YV Strong Biomarker [2036]
ROMO1 OTIEYVBW Strong Altered Expression [2037]
RPL17 OTTYMPS6 Strong Biomarker [2038]
RPL22 OTVCN8K0 Strong Altered Expression [2039]
RPL29 OTUFIBJL Strong Altered Expression [2040]
RPN2 OTJ1SKOA Strong Biomarker [2041]
RPP14 OT4OYFSK Strong Posttranslational Modification [1461]
RPRM OTNNBAS1 Strong Altered Expression [2042]
RPS15A OT0BUA12 Strong Altered Expression [2043]
RRAD OTW2O4GD Strong Altered Expression [2044]
RSL1D1 OT3CL4R3 Strong Biomarker [2045]
RSPO2 OT3HHXU0 Strong Biomarker [701]
RTEL1 OTI3PJCT Strong Genetic Variation [2046]
RTN1 OTCX1SMK Strong Altered Expression [702]
RTRAF OTJ6NVMW Strong Biomarker [1569]
RUFY3 OTMA4YA4 Strong Altered Expression [2047]
RUNDC3B OT8ZPQLC Strong Altered Expression [2048]
RUVBL1 OTWV19L7 Strong Biomarker [2049]
RYBP OTZZ4P2Z Strong Altered Expression [2050]
S100A11 OTI57KDN Strong Altered Expression [2051]
S100A13 OT582SUS Strong Altered Expression [2052]
S100A2 OTTGHJ1H Strong Altered Expression [2053]
S100A7 OTJFVJRF Strong Biomarker [2054]
SAGE1 OT4H6FFA Strong Altered Expression [1530]
SAMHD1 OTBCIBC7 Strong Altered Expression [2055]
SAMSN1 OT7N88T1 Strong Genetic Variation [2056]
SARDH OTQ49Q27 Strong Biomarker [627]
SARNP OTE0OVK5 Strong Biomarker [2011]
SARS1 OTFKXQ1O Strong Biomarker [1730]
SARS2 OTU4T99W Strong Biomarker [1730]
SART3 OTC1AM7S Strong Altered Expression [619]
SASH1 OTQA8BD4 Strong Biomarker [2057]
SATB2 OT2W80XC Strong Biomarker [2058]
SBSN OT89RKJH Strong Altered Expression [2059]
SCAF1 OT16TM3N Strong Biomarker [2060]
SCARA3 OT46I38Y Strong Genetic Variation [2061]
SCG5 OTXSJMT1 Strong Genetic Variation [2062]
SCML1 OT7V5DAR Strong Altered Expression [1586]
SCNN1A OTE2KVZV Strong Altered Expression [2063]
SDHAF2 OT0UG9H5 Strong Altered Expression [2064]
SEC14L3 OTGQ8GWM Strong Altered Expression [2065]
SELENOF OT2JFB3S Strong Genetic Variation [2066]
SEMA3B OTCZCPMS Strong Genetic Variation [2067]
SEMA4B OT1Y3YZD Strong Biomarker [2068]
SEMA4G OT7BCPU7 Strong Genetic Variation [2069]
SEMA5A OTUOIOJV Strong Biomarker [2070]
SERPINA4 OTBK0GG7 Strong Biomarker [2071]
SERPINB4 OT88LHZ8 Strong Biomarker [721]
SESN3 OTJRY1Y5 Strong Biomarker [2072]
SET OTGYYQJO Strong Biomarker [2073]
SETDB1 OTWVUA1B Strong Biomarker [2074]
SEZ6L OT5Z9CUA Strong Genetic Variation [2075]
SF3B6 OTPRKS6S Strong Posttranslational Modification [1461]
SFN OTLJCZ1U Strong Posttranslational Modification [2076]
SFRP1 OT0U9G41 Strong Altered Expression [2077]
SFTPA2 OT6SFOMU Strong Genetic Variation [2078]
SFTPC OTIZJD09 Strong Altered Expression [2079]
SGSM3 OTIB1P8A Strong Biomarker [2080]
SH2B1 OTJZO2CI Strong Biomarker [2081]
SH3RF1 OT7MYGYO Strong Genetic Variation [2082]
SHARPIN OTU1J2KH Strong Biomarker [2083]
SHC1 OT1J5IRN Strong Altered Expression [2084]
SHC3 OT305NPA Strong Genetic Variation [1638]
SHISA3 OTE8TPCP Strong Biomarker [2085]
SHMT1 OTIINA3J Strong Biomarker [2086]
SHMT2 OT5NCAZN Strong Genetic Variation [2087]
SHOC2 OTUNQ2CT Strong Genetic Variation [2088]
SIAH2 OTKED2XN Strong Biomarker [2089]
SINHCAF OTHMZZ0A Strong Altered Expression [2090]
SIPA1 OTXY5RXC Strong Genetic Variation [2091]
SIRT4 OT5S0J23 Strong Biomarker [2092]
SIX1 OT70YYWM Strong Altered Expression [2093]
SIX2 OTYOVGSC Strong Altered Expression [2094]
SKA2 OTVYF4XT Strong Biomarker [1969]
SLAMF1 OTBTT3ZQ Strong Altered Expression [2095]
SLC22A18 OT9C3KR4 Strong Genetic Variation [2096]
SLC2A4RG OTW3LX8D Strong Biomarker [2097]
SLFN5 OTT1AESL Strong Altered Expression [2098]
SLIT3 OTU8MKEU Strong Biomarker [2099]
SMAD2 OTC6VB4K Strong Genetic Variation [2100]
SMAGP OT57BZII Strong Altered Expression [2101]
SMARCA1 OT0Y6PTU Strong Genetic Variation [2102]
SMARCD1 OTHFFT6G Strong Biomarker [2103]
SMARCE1 OTAX4ITH Strong Altered Expression [2104]
SMR3B OTL5HNM8 Strong Biomarker [2105]
SMUG1 OT2YIOCQ Strong Biomarker [2106]
SMURF1 OT5UIZR8 Strong Biomarker [2107]
SMURF2 OT3TRVL7 Strong Biomarker [2108]
SNAI2 OT7Y8EJ2 Strong Altered Expression [1929]
SND1 OTT734JN Strong Altered Expression [619]
SNIP1 OTL3RA91 Strong Biomarker [2109]
SNU13 OTH56TIH Strong Biomarker [2110]
SNX1 OTXQSJ1J Strong Posttranslational Modification [2111]
SNX2 OT889MQA Strong Biomarker [2112]
SOAT1 OTB4Y5RJ Strong Biomarker [511]
SOSTDC1 OTAKDNSM Strong Genetic Variation [1964]
SOX1 OTVI1RAR Strong Posttranslational Modification [2113]
SOX17 OT9H4WWE Strong Altered Expression [2114]
SOX18 OTPUMHWA Strong Altered Expression [2115]
SOX30 OTGT38E3 Strong Biomarker [2116]
SOX4 OTSS40SS Strong Altered Expression [2117]
SOX6 OTT0W0LE Strong Biomarker [2118]
SOX7 OTOZOFAG Strong Altered Expression [2119]
SOX9 OTVDJFGN Strong Altered Expression [2120]
SPAAR OTWXG2R8 Strong Biomarker [2121]
SPAG9 OT45AHMB Strong Altered Expression [2122]
SPATA2 OTOA45GL Strong Biomarker [2038]
SPATC1L OTED6WB8 Strong Genetic Variation [1481]
SPC24 OT1HVYV4 Strong Altered Expression [2123]
SPC25 OTCAS0OH Strong Altered Expression [2124]
SPECC1 OTPEML48 Strong Altered Expression [702]
SPG7 OT8OY9ST Strong Altered Expression [339]
SPINK7 OTK3VOI3 Strong Biomarker [2125]
SPINT2 OTQV7BKQ Strong Altered Expression [87]
SPNS2 OTPODAPU Strong Biomarker [2126]
SPON2 OTE7JLNM Strong Altered Expression [2127]
SPOP OTP0107S Strong Altered Expression [2128]
SPZ1 OTQH8HJ5 Strong Biomarker [1496]
SRF OTW18FQN Strong Altered Expression [1695]
SRL OT7IEBWZ Strong Biomarker [627]
SRRM4 OTALUISN Strong Biomarker [2129]
SRSF5 OTC5WP98 Strong Altered Expression [2130]
SRSF7 OTRS4W4S Strong Biomarker [2131]
SRY OT516T6D Strong Altered Expression [1081]
ST13 OTNML6UP Strong Biomarker [2132]
ST6GAL1 OT7US3NO Strong Genetic Variation [2133]
STAT2 OTO9G2RZ Strong Altered Expression [306]
STAT5A OTBSJGN3 Strong Biomarker [1138]
STATH OTQHBHM9 Strong Altered Expression [2134]
STIP1 OT7TXLOX Strong Biomarker [254]
STPG4 OT5K4UFL Strong Genetic Variation [2135]
STUB1 OTSUYI9A Strong Biomarker [2132]
SUGP1 OT7W0EB8 Strong Biomarker [2136]
SULF1 OTJCNCO0 Strong Altered Expression [2137]
SUMO1 OTJFD4P5 Strong Biomarker [2138]
SUN2 OT2IQJUC Strong Biomarker [153]
SUSD2 OTSJTAZP Strong Biomarker [2139]
SUV39H2 OTU0F4LL Strong Altered Expression [2140]
SYCE1L OTXU44F3 Strong Altered Expression [1]
SYCP3 OTKOF54H Strong Altered Expression [2141]
SYNE1 OTSBSLUH Strong Biomarker [2024]
SYNGR2 OTJX84RI Strong Genetic Variation [272]
SYNJ2 OTLRHXP1 Strong Altered Expression [2142]
SYNM OTOI8TRJ Strong Biomarker [2143]
SYT1 OTVTPOI6 Strong Altered Expression [75]
SYT7 OTBWAOWY Strong Biomarker [2144]
SYTL2 OTUIOWKL Strong Altered Expression [765]
TAP2 OTWSYFI7 Strong Altered Expression [2065]
TAPBP OTL81AVZ Strong Altered Expression [2145]
TARBP2 OT1QQ8H3 Strong Biomarker [2146]
TBKBP1 OTXTU37H Strong Biomarker [2147]
TBX1 OTQLBPRA Strong Genetic Variation [374]
TC2N OT6482WN Strong Altered Expression [2148]
TCEAL1 OTAPG2L5 Strong Genetic Variation [1877]
TCN1 OTW6A49Y Strong Biomarker [2149]
TENM1 OTSKSU4V Strong Biomarker [2150]
TES OTL8PP6V Strong Biomarker [2151]
TESC OTI8C76M Strong Biomarker [2152]
TESMIN OTZ5UILU Strong Biomarker [2153]
TFAM OTXXV5V7 Strong Altered Expression [2154]
TFAP2B OTR1T8E9 Strong Biomarker [2155]
TFDP1 OT6RZ7VT Strong Biomarker [2156]
TFDP3 OTI4K6MN Strong Altered Expression [2157]
TFF2 OTRXB19X Strong Altered Expression [2158]
TFF3 OTJJDRTU Strong Altered Expression [2158]
TFPI2 OTZCRWOR Strong Altered Expression [2159]
TGFBI OTR443C5 Strong Altered Expression [458]
TGFBR3 OTQOOUC4 Strong Biomarker [2160]
THEM4 OTSIZU8Y Strong Biomarker [2161]
THY1 OTVONVTB Strong Biomarker [2162]
TIAM2 OTPYIPT6 Strong Biomarker [2163]
TICAM2 OTK7GIJ5 Strong Altered Expression [809]
TIGAR OTR7NMRJ Strong Altered Expression [2164]
TIMD4 OTGGC20G Strong Biomarker [2165]
TIMMDC1 OTIK4I5R Strong Biomarker [2166]
TLCD3A OTVZUR1Z Strong Altered Expression [2167]
TM4SF1 OTY0ECQN Strong Altered Expression [2168]
TM4SF4 OTRI8EHN Strong Altered Expression [2169]
TM7SF2 OTILU5S7 Strong Biomarker [1458]
TMED7 OTONO8E6 Strong Altered Expression [809]
TMEFF2 OT1WZ2QO Strong Biomarker [2170]
TMEM100 OTRJ6OHY Strong Biomarker [2171]
TMEM106B OTUWA6NW Strong Biomarker [2172]
TMEM125 OTWF8MC1 Strong Biomarker [18]
TMEM17 OTEU00OH Strong Altered Expression [2173]
TMEM176A OTOZDWXX Strong Altered Expression [2174]
TMEM196 OTPFLB1R Strong Posttranslational Modification [2175]
TMEM209 OTH9U9U1 Strong Altered Expression [1885]
TMEM74 OT3IZBM0 Strong Biomarker [2176]
TMEM88 OTA96YEL Strong Biomarker [2177]
TMPRSS13 OTMAOAP3 Strong Posttranslational Modification [598]
TMPRSS4 OTCCGY2K Strong Biomarker [2178]
TNFAIP8 OT1G9297 Strong Biomarker [1759]
TNFAIP8L2 OTII0RM0 Strong Biomarker [2179]
TNFAIP8L3 OTHSBS1B Strong Biomarker [2180]
TNFRSF19 OTTVT4MB Strong Biomarker [2181]
TNFSF8 OTDYGDJ3 Strong Genetic Variation [2182]
TNFSF9 OTV9L89D Strong Altered Expression [2183]
TOB1 OTNW949D Strong Altered Expression [2184]
TOMM34 OTH6MITE Strong Altered Expression [1901]
TOP1MT OT2H77ID Strong Altered Expression [2185]
TOX OTE8BL5Z Strong Altered Expression [2186]
TOX3 OTC9NR4W Strong Altered Expression [2186]
TP53AIP1 OT1XVNDP Strong Altered Expression [2187]
TP53BP2 OTOWJ2Y4 Strong Biomarker [2188]
TPI1 OT14KP4B Strong Biomarker [2189]
TPM4 OTN4YLYR Strong Biomarker [2190]
TRAF1 OTTLM5RU Strong Biomarker [2191]
TRAF2 OT1MEZZN Strong Biomarker [707]
TRAF4 OTJLRVMC Strong Biomarker [2192]
TRAP1 OTNG0L8J Strong Biomarker [2193]
TRARG1 OTQ1R3JD Strong Altered Expression [2194]
TREH OTJE0NOY Strong Altered Expression [2195]
TRIB3 OTG5OS7X Strong Biomarker [2196]
TRIM13 OTQIUACB Strong Altered Expression [339]
TRIM15 OTNYAKP6 Strong Biomarker [2197]
TRIM21 OTA4UJCF Strong Biomarker [2198]
TRIM32 OTJOV0PG Strong Biomarker [868]
TRIM45 OTFDQT4E Strong Altered Expression [2199]
TRIM52 OTKTKCT1 Strong Biomarker [2200]
TRIM58 OT7OIIRH Strong Posttranslational Modification [2201]
TRIM65 OTSQTK3A Strong Biomarker [2202]
TRIT1 OTCU9FS5 Strong Biomarker [2203]
TRO OTRZQMU8 Strong Altered Expression [2204]
TROAP OTC8CE0R Strong Altered Expression [2205]
TRPS1 OT7XPPEL Strong Altered Expression [2206]
TSPAN33 OTH6C0WU Strong Biomarker [2207]
TSPAN8 OT1F68WQ Strong Biomarker [2208]
TSPYL2 OTGGW2EF Strong Biomarker [2209]
TTC21B OTXXA87U Strong Biomarker [2210]
TTF1 OT4K90WD Strong Biomarker [469]
ABCE1 OTH19LOA Definitive Altered Expression [264]
ACTB OT1MCP2F Definitive Biomarker [1516]
ADA2 OTGCV24S Definitive Genetic Variation [2211]
AHRR OTSJ12W6 Definitive Biomarker [2212]
AHSA1 OTC7AFHT Definitive Biomarker [876]
ANAPC11 OTK2SJXR Definitive Altered Expression [2213]
ANKRD1 OTHJ7JV9 Definitive Genetic Variation [2214]
ARHGEF17 OTUGS4FL Definitive Biomarker [1189]
B3GNTL1 OTYWGHF1 Definitive Genetic Variation [2215]
BHLHE41 OTY9GJ1Y Definitive Biomarker [2216]
BICRA OTDTPGW0 Definitive Genetic Variation [2217]
C2CD5 OTI495RD Definitive Biomarker [2218]
CCBE1 OTO4UIDB Definitive Biomarker [570]
CDK5R2 OTNUTLPU Definitive Biomarker [2219]
CENPU OTQ4TZRS Definitive Biomarker [2220]
CHFR OTRAD2TT Definitive Altered Expression [2221]
CHI3L1 OT2Z7VJH Definitive Biomarker [2222]
CIP2A OTVS2GXA Definitive Altered Expression [2223]
CLCA2 OTF191LZ Definitive Altered Expression [2224]
CMTR2 OT82FBWS Definitive Genetic Variation [2225]
CTNNBL1 OT6KLHPA Definitive Altered Expression [2226]
CYB561D2 OT1ZXC66 Definitive Biomarker [2227]
DCSTAMP OTFKRP2H Definitive Altered Expression [2228]
DDX49 OT13VWB7 Definitive Biomarker [2229]
DOK4 OTUEWLG8 Definitive Altered Expression [2230]
DSP OTB2MOP8 Definitive Biomarker [2231]
ENO2 OTRODL0T Definitive Biomarker [2232]
EPB41L3 OTS6CHG2 Definitive Altered Expression [2233]
ESPL1 OTMGEVOK Definitive Biomarker [2234]
FOXO3 OTHXQG4P Definitive Altered Expression [2235]
FRMD3 OT0CD2GG Definitive Biomarker [2236]
GABPA OT9YB2SA Definitive Biomarker [871]
GAGE7 OTF8BTR9 Definitive Biomarker [2237]
GALNT3 OT7M67WT Definitive Altered Expression [2238]
GFER OTVK43OK Definitive Biomarker [2239]
GRAP2 OTS5NIZ3 Definitive Biomarker [876]
HCFC1R1 OTGDPS5C Definitive Altered Expression [2240]
HEBP2 OTVDIMLM Definitive Altered Expression [2241]
HIPK3 OT4WYQM2 Definitive Biomarker [2242]
HOXB2 OTTD6HMV Definitive Genetic Variation [2243]
ICMT OT8CNKBO Definitive Biomarker [2244]
IRF2 OTAZRUW3 Definitive Biomarker [2245]
ITPKB OTSVVPAV Definitive Biomarker [1727]
KIF14 OTXHT4JM Definitive Altered Expression [2246]
KIF15 OTJRJEXL Definitive Biomarker [2247]
KIFBP OT1XADKG Definitive Genetic Variation [2248]
LCP1 OTK61F2A Definitive Biomarker [2249]
LIPH OTRGYLKL Definitive Altered Expression [2250]
LZTFL1 OTIEIOEW Definitive Biomarker [2251]
MAGED4B OTO37U7W Definitive Biomarker [875]
MCPH1 OTYT3TT5 Definitive Biomarker [2252]
MOB4 OTOQRMAS Definitive Altered Expression [2253]
MORC2 OT52A8BJ Definitive Biomarker [2254]
MTHFS OTZ39JNR Definitive Genetic Variation [2255]
NDC1 OTF2GQC1 Definitive Biomarker [788]
NUDT21 OTZHKWAR Definitive Biomarker [2256]
PBXIP1 OTEAAUBY Definitive Altered Expression [2240]
PDSS1 OTXGVHAB Definitive Biomarker [2257]
PELP1 OTVXQNOT Definitive Altered Expression [2258]
PER3 OTVKYVJA Definitive Biomarker [387]
PIGR OT6GLSUL Definitive Altered Expression [2259]
PLAC8 OT3SYRUJ Definitive Biomarker [2260]
PLCH1 OT6Z1L2E Definitive Genetic Variation [2261]
POFUT1 OTOBJZIT Definitive Biomarker [1623]
POLDIP2 OT8SZSJ6 Definitive Biomarker [876]
POU5F1 OTDHHN7O Definitive Biomarker [2262]
PPP1R13L OTNCPLWE Definitive Posttranslational Modification [2263]
PRDX3 OTLB2WEU Definitive Biomarker [2264]
PRRG4 OT2SZQI7 Definitive Biomarker [2265]
QSOX1 OT4ZPK4P Definitive Biomarker [2266]
RAD21 OTQS84ZF Definitive Altered Expression [2157]
RASGRF2 OT67DAGF Definitive Altered Expression [2267]
RBM5 OTCBWHHV Definitive Biomarker [2268]
RFC5 OTAD79RT Definitive Biomarker [2269]
RHOJ OTWI65OA Definitive Biomarker [2270]
RIN2 OTCY73U9 Definitive Biomarker [218]
RNF19A OTKWCV80 Definitive Biomarker [876]
RPL19 OT33LM66 Definitive Altered Expression [2271]
S100A14 OTVFJJ91 Definitive Posttranslational Modification [2272]
S100A7A OTNM8DCP Definitive Posttranslational Modification [2272]
SEPHS1 OTZ19I59 Definitive Biomarker [2257]
SERINC2 OTZ039U0 Definitive Altered Expression [2273]
SFTPA1 OT87XL1U Definitive Biomarker [2274]
SGMS1 OTZQE7PW Definitive Altered Expression [2253]
SMC3 OTWGFRHD Definitive Biomarker [2275]
SMS OT8JYKNH Definitive Biomarker [2257]
SMYD5 OTE5VET6 Definitive Biomarker [2276]
SPAG4 OTVXS2SM Definitive Biomarker [2277]
STK11IP OTLQ6P8R Definitive Biomarker [1189]
SYNPO2 OTC3U0YH Definitive Altered Expression [780]
TBC1D7 OT1ALJ63 Definitive Biomarker [1153]
TBX2 OTTOT7A9 Definitive Biomarker [2278]
TBX4 OTW58FG4 Definitive Biomarker [2257]
TEAD1 OTK6971C Definitive Genetic Variation [2279]
TIMP1 OTOXC51H Definitive Biomarker [2280]
TLE4 OT4QEH6T Definitive Biomarker [2281]
TMPRSS11B OT2852G1 Definitive Biomarker [2282]
TPRG1L OTU7GPKK Definitive Biomarker [2283]
TRDMT1 OTAYQ8ZF Definitive Genetic Variation [2255]
TRIM44 OT0B1T2B Definitive Altered Expression [2284]
TRIM66 OT0VJCP6 Definitive Biomarker [2285]
TRMT9B OTU3UPEE Definitive Altered Expression [363]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1765 DOT(s)

References

1 New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.Biomed Pharmacother. 2017 Dec;96:659-666. doi: 10.1016/j.biopha.2017.10.041. Epub 2017 Nov 6.
2 Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):486-503. doi: 10.1016/j.bbamcr.2018.10.011. Epub 2018 Oct 13.
3 ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage.Neoplasia. 2019 Jun;21(6):602-614. doi: 10.1016/j.neo.2019.03.008. Epub 2019 May 6.
4 Potential therapeutic impact of CD13 expression in non-small cell lung cancer.PLoS One. 2017 Jun 12;12(6):e0177146. doi: 10.1371/journal.pone.0177146. eCollection 2017.
5 Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer.Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13456-13461. doi: 10.1073/pnas.1610456113. Epub 2016 Nov 9.
6 Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.Sci Rep. 2016 Jul 19;6:29721. doi: 10.1038/srep29721.
7 AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status.Oncogene. 2008 Mar 6;27(11):1650-6. doi: 10.1038/sj.onc.1210775. Epub 2007 Aug 27.
8 MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.Biochem Biophys Res Commun. 2009 Oct 23;388(3):483-9. doi: 10.1016/j.bbrc.2009.07.143. Epub 2009 Aug 3.
9 Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.Cancers (Basel). 2019 Nov 21;11(12):1835. doi: 10.3390/cancers11121835.
10 A novel BMX variant promotes tumor cell growth and migration in lung adenocarcinoma.Oncotarget. 2017 May 16;8(20):33405-33415. doi: 10.18632/oncotarget.16796.
11 Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer Cells.Cancer Res. 2019 Aug 1;79(15):3851-3861. doi: 10.1158/0008-5472.CAN-18-1037. Epub 2019 May 29.
12 The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.Mol Cell. 2018 Jan 4;69(1):87-99.e7. doi: 10.1016/j.molcel.2017.11.025. Epub 2017 Dec 14.
13 Comparative Molecular Immunological Activity of Physiological Metal Oxide Nanoparticle and its Anticancer Peptide and RNA Complexes.Nanomaterials (Basel). 2019 Nov 22;9(12):1670. doi: 10.3390/nano9121670.
14 lncRNAu50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.Oncol Rep. 2019 Nov;42(5):1946-1956. doi: 10.3892/or.2019.7302. Epub 2019 Sep 5.
15 A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression.PLoS One. 2018 Apr 4;13(4):e0193461. doi: 10.1371/journal.pone.0193461. eCollection 2018.
16 Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer.Exp Ther Med. 2018 Aug;16(2):730-738. doi: 10.3892/etm.2018.6274. Epub 2018 Jun 8.
17 High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.Am J Transl Res. 2019 Jan 15;11(1):442-452. eCollection 2019.
18 Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining.Stem Cell Rev Rep. 2019 Feb;15(1):23-34. doi: 10.1007/s12015-018-9865-2.
19 Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer.J Cancer Res Ther. 2016 Dec;12(Supplement):C186-C190. doi: 10.4103/0973-1482.200597.
20 Upregulation of Complement Factor H by SOCS-1/3STAT4 in Lung Cancer.Cancers (Basel). 2019 Apr 3;11(4):471. doi: 10.3390/cancers11040471.
21 Study on polymorphisms in CHRNA5/CHRNA3/CHRNB4 gene cluster and the associated with the risk of non-small cell lung cancer.Oncotarget. 2017 Dec 20;9(2):2435-2444. doi: 10.18632/oncotarget.23459. eCollection 2018 Jan 5.
22 Apigenin Combined With Gefitinib Blocks Autophagy Flux and Induces Apoptotic Cell Death Through Inhibition of HIF-1, c-Myc, p-EGFR, and Glucose Metabolism in EGFR L858R+T790M-Mutated H1975 Cells.Front Pharmacol. 2019 Mar 22;10:260. doi: 10.3389/fphar.2019.00260. eCollection 2019.
23 Interactive effect of smoking and NQO1 haplotypes on lung cancer risk.J Korean Med Sci. 2015 Mar;30(3):221-6. doi: 10.3346/jkms.2015.30.3.221. Epub 2015 Feb 16.
24 Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.Nat Genet. 2017 Jul;49(7):1126-1132. doi: 10.1038/ng.3892. Epub 2017 Jun 12.
25 Up-regulation of 5-lipoxygenase by inhibition of cathepsin G enhances TRAIL-induced apoptosis through down-regulation of survivin.Oncotarget. 2017 Nov 20;8(63):106672-106684. doi: 10.18632/oncotarget.22508. eCollection 2017 Dec 5.
26 Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer.J Thorac Oncol. 2018 Mar;13(3):399-412. doi: 10.1016/j.jtho.2017.11.126. Epub 2017 Dec 9.
27 Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.Chem Res Toxicol. 2017 Jan 17;30(1):53-60. doi: 10.1021/acs.chemrestox.6b00286. Epub 2016 Oct 26.
28 Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.Tumour Biol. 2014 Feb;35(2):1671-8. doi: 10.1007/s13277-013-1230-0. Epub 2013 Oct 2.
29 Relationship between DLK1 gene promoter region DNA methylation and non-small cell lung cancer biological behavior.Oncol Lett. 2017 Jun;13(6):4123-4126. doi: 10.3892/ol.2017.6019. Epub 2017 Apr 10.
30 Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-B signaling pathway.Onco Targets Ther. 2017 Sep 11;10:4443-4454. doi: 10.2147/OTT.S142244. eCollection 2017.
31 Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies.Oncotarget. 2017 Sep 1;8(43):73419-73432. doi: 10.18632/oncotarget.20621. eCollection 2017 Sep 26.
32 Downregulation of DLL4 predicts poor survival in nonsmall cell lung cancer patients due to promotion of lymph node metastasis.Oncol Rep. 2018 Nov;40(5):2988-2996. doi: 10.3892/or.2018.6679. Epub 2018 Aug 31.
33 Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation.Oncotarget. 2017 Jun 30;8(47):82123-82143. doi: 10.18632/oncotarget.18899. eCollection 2017 Oct 10.
34 MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a.Onco Targets Ther. 2019 Aug 28;12:7015-7024. doi: 10.2147/OTT.S213583. eCollection 2019.
35 The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.Carcinogenesis. 2019 Apr 29;40(2):324-334. doi: 10.1093/carcin/bgz009.
36 Long non-coding RNA FLVCR1-AS1 contributes to the proliferation and invasion of lung cancer by sponging miR-573 to upregulate the expression of E2F transcription factor 3.Biochem Biophys Res Commun. 2018 Nov 2;505(3):931-938. doi: 10.1016/j.bbrc.2018.09.057. Epub 2018 Oct 9.
37 Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.Oncotarget. 2017 Feb 14;8(7):11739-11747. doi: 10.18632/oncotarget.14340.
38 Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer.Biochem Genet. 2019 Feb;57(1):147-158. doi: 10.1007/s10528-018-9883-4. Epub 2018 Aug 2.
39 Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer.J Proteome Res. 2015 Apr 3;14(4):1739-51. doi: 10.1021/pr501097a. Epub 2015 Mar 13.
40 Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.Mol Cancer Ther. 2017 Aug;16(8):1470-1486. doi: 10.1158/1535-7163.MCT-17-0134. Epub 2017 Jun 1.
41 EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.Crit Rev Oncol Hematol. 2018 Jun;126:52-63. doi: 10.1016/j.critrevonc.2018.03.006. Epub 2018 Mar 21.
42 Reduced expression of EphA5 is associated with lymph node metastasis, advanced TNM stage, and poor prognosis in colorectal carcinoma.Histol Histopathol. 2017 May;32(5):491-497. doi: 10.14670/HH-11-815. Epub 2016 Sep 21.
43 Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors.Haematologica. 2020 Jan;105(1):218-225. doi: 10.3324/haematol.2019.217083. Epub 2019 May 2.
44 Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells.PLoS Comput Biol. 2016 Aug 5;12(8):e1005049. doi: 10.1371/journal.pcbi.1005049. eCollection 2016 Aug.
45 Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop.Carcinogenesis. 2017 Jun 1;38(6):604-614. doi: 10.1093/carcin/bgx039.
46 YC-1 Prevents Tumor-Associated Tissue Factor Expression and Procoagulant Activity in Hypoxic Conditions by Inhibiting p38/NF-B Signaling Pathway.Int J Mol Sci. 2019 Jan 9;20(2):244. doi: 10.3390/ijms20020244.
47 Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer.Int J Biol Sci. 2017 Jun 1;13(6):804-814. doi: 10.7150/ijbs.19398. eCollection 2017.
48 Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis.J Hematol Oncol. 2017 Mar 21;10(1):72. doi: 10.1186/s13045-017-0441-z.
49 Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.Arch Bronconeumol. 2016 Oct;52(10):505-11. doi: 10.1016/j.arbres.2015.10.016. Epub 2016 Feb 5.
50 The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
51 19p13.3-GADD45B common variants and 19q13.3-PPP1R13L and 19q13.3-CD3EAP in lung cancer risk among Chinese.Chem Biol Interact. 2017 Nov 1;277:74-78. doi: 10.1016/j.cbi.2017.08.018. Epub 2017 Sep 1.
52 BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cellderived microenvironment through the MAPK/ERK and NF-B pathways.Oncol Rep. 2016 Jul;36(1):410-8. doi: 10.3892/or.2016.4796. Epub 2016 May 9.
53 GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.Mol Cancer. 2016 Mar 18;15:25. doi: 10.1186/s12943-016-0508-4.
54 MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.Clin Cancer Res. 2017 Nov 15;23(22):7084-7096. doi: 10.1158/1078-0432.CCR-16-3006. Epub 2017 Aug 29.
55 WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics.Int J Biol Sci. 2018 Jun 8;14(9):1067-1080. doi: 10.7150/ijbs.23845. eCollection 2018.
56 A Prediction Model to Help with the Assessment of Adenopathy in Lung Cancer: HAL.Am J Respir Crit Care Med. 2017 Jun 15;195(12):1651-1660. doi: 10.1164/rccm.201607-1397OC.
57 HDAC10 promotes lung cancer proliferation via AKT phosphorylation.Oncotarget. 2016 Sep 13;7(37):59388-59401. doi: 10.18632/oncotarget.10673.
58 Knockdown of HNRNPA1 inhibits lung adenocarcinoma cell proliferation through cell cycle arrest at G0/G1 phase.Gene. 2016 Feb 1;576(2 Pt 2):791-7. doi: 10.1016/j.gene.2015.11.009. Epub 2015 Nov 12.
59 Nm23-H1-stabilized hnRNPA2/B1 promotes internal ribosomal entry site (IRES)-mediated translation of Sp1 in the lung cancer progression.Sci Rep. 2017 Aug 22;7(1):9166. doi: 10.1038/s41598-017-09558-7.
60 Glucose-Regulated Protein 78 Signaling Regulates Hypoxia-Induced Epithelial-Mesenchymal Transition in A549 Cells.Front Oncol. 2019 Mar 12;9:137. doi: 10.3389/fonc.2019.00137. eCollection 2019.
61 Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.Carcinogenesis. 2014 Dec;35(12):2698-705. doi: 10.1093/carcin/bgu203. Epub 2014 Sep 19.
62 Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer.Cell Death Dis. 2016 Jan 21;7(1):e2057. doi: 10.1038/cddis.2015.418.
63 Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway.Am J Transl Res. 2019 Jul 15;11(7):4077-4088. eCollection 2019.
64 The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC.EBioMedicine. 2018 Nov;37:188-204. doi: 10.1016/j.ebiom.2018.10.044. Epub 2018 Oct 30.
65 IFN regulatory factor-8 expression in macrophages governs an antimetastatic program.JCI Insight. 2019 Feb 7;4(3):e124267. doi: 10.1172/jci.insight.124267.
66 Jumonji domain containing 2C promotes cell migration and invasion through modulating CUL4A expression in lung cancer.Biomed Pharmacother. 2017 May;89:305-315. doi: 10.1016/j.biopha.2017.02.014. Epub 2017 Feb 24.
67 p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.Cell Prolif. 2019 May;52(3):e12585. doi: 10.1111/cpr.12585. Epub 2019 Feb 22.
68 Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer. Int J Oncol. 2017 Jun;50(6):2154-2170.
69 CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.Int J Cancer. 2002 Jun 20;99(6):839-45. doi: 10.1002/ijc.10416.
70 MALT1 is required for EGFR-induced NF-B activation and contributes to EGFR-driven lung cancer progression.Oncogene. 2016 Feb 18;35(7):919-28. doi: 10.1038/onc.2015.146. Epub 2015 May 18.
71 MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer.Int J Oncol. 2016 Oct;49(4):1437-44. doi: 10.3892/ijo.2016.3637. Epub 2016 Jul 29.
72 Baicalin attenuates DDP (cisplatin) resistance in lung cancer by downregulating MARK2 and p-Akt.Int J Oncol. 2017 Jan;50(1):93-100. doi: 10.3892/ijo.2016.3768. Epub 2016 Nov 15.
73 MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer.Carcinogenesis. 2017 Jan;38(1):64-75. doi: 10.1093/carcin/bgw110. Epub 2016 Oct 17.
74 Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.Clin Immunol. 2020 Jan;210:108262. doi: 10.1016/j.clim.2019.108262. Epub 2019 Oct 17.
75 T cell factor-4 functions as a co-activator to promote NF-B-dependent MMP-15 expression in lung carcinoma cells.Sci Rep. 2016 Apr 5;6:24025. doi: 10.1038/srep24025.
76 Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.Tumour Biol. 2016 Apr;37(4):5467-73. doi: 10.1007/s13277-015-4373-3. Epub 2015 Nov 13.
77 PAK4 Phosphorylates Fumarase and Blocks TGF-Induced Cell Growth Arrest in Lung Cancer Cells.Cancer Res. 2019 Apr 1;79(7):1383-1397. doi: 10.1158/0008-5472.CAN-18-2575. Epub 2019 Jan 25.
78 Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase.Front Pharmacol. 2019 Oct 22;10:1248. doi: 10.3389/fphar.2019.01248. eCollection 2019.
79 PCSK9 regulates apoptosis in human lung adenocarcinoma A549 cells via endoplasmic reticulum stress and mitochondrial signaling pathways.Exp Ther Med. 2017 May;13(5):1993-1999. doi: 10.3892/etm.2017.4218. Epub 2017 Mar 10.
80 Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer.Int J Gynecol Pathol. 2019 Sep;38(5):404-413. doi: 10.1097/PGP.0000000000000543.
81 Carbonic anhydrase-related protein VIII increases invasiveness of non-small cell lung adenocarcinoma.Virchows Arch. 2006 Jun;448(6):830-7. doi: 10.1007/s00428-006-0199-0. Epub 2006 Apr 12.
82 Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking -catenin and MAPK signaling.Oncotarget. 2017 Aug 27;8(41):69264-69280. doi: 10.18632/oncotarget.20566. eCollection 2017 Sep 19.
83 Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.Sci Transl Med. 2017 Nov 15;9(416):eaai9048. doi: 10.1126/scitranslmed.aai9048.
84 Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer.J Cell Mol Med. 2019 Nov;23(11):7749-7761. doi: 10.1111/jcmm.14649. Epub 2019 Sep 1.
85 Expression of Cytosolic Phospholipase A2 (cPLA2)-Arachidonic Acid (AA)-Cyclooxygenase-2 (COX-2) Pathway Factors in Lung Cancer Patients and Its Implication in Lung Cancer Early Detection and Prognosis.Med Sci Monit. 2019 Jul 26;25:5543-5551. doi: 10.12659/MSM.915314.
86 Identification of gene markers in the development of smoking-induced lung cancer.Gene. 2016 Jan 15;576(1 Pt 3):451-7. doi: 10.1016/j.gene.2015.10.060. Epub 2015 Oct 27.
87 HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis.Br J Cancer. 2019 Mar;120(5):499-511. doi: 10.1038/s41416-019-0400-2. Epub 2019 Feb 15.
88 pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery.Int J Nanomedicine. 2018 Oct 26;13:6885-6902. doi: 10.2147/IJN.S180119. eCollection 2018.
89 Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space.J Biol Chem. 2016 Dec 9;291(50):25799-25808. doi: 10.1074/jbc.M116.759803. Epub 2016 Nov 1.
90 Cyclophilin A promotes non-small cell lung cancer metastasis via p38 MAPK.Thorac Cancer. 2018 Jan;9(1):120-128. doi: 10.1111/1759-7714.12548. Epub 2017 Nov 7.
91 Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.Oncotarget. 2017 Oct 26;8(62):105196-105210. doi: 10.18632/oncotarget.22111. eCollection 2017 Dec 1.
92 DNA-PKc deficiency drives pre-malignant transformation by reducing DNA repair capacity in concert with reprogramming the epigenome in human bronchial epithelial cells.DNA Repair (Amst). 2019 Jul;79:1-9. doi: 10.1016/j.dnarep.2019.04.006. Epub 2019 Apr 27.
93 Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.Cancer Immunol Res. 2017 Apr;5(4):319-329. doi: 10.1158/2326-6066.CIR-16-0141. Epub 2017 Mar 2.
94 NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.Oncogene. 2019 Apr;38(16):2937-2952. doi: 10.1038/s41388-018-0639-8. Epub 2018 Dec 19.
95 Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion.Exp Cell Res. 2017 Aug 1;357(1):9-16. doi: 10.1016/j.yexcr.2017.04.020. Epub 2017 Apr 19.
96 High Expression of Rab-like 3 (Rabl3) is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer via Repression of MAPK8/9/10-Mediated Autophagy.Med Sci Monit. 2016 May 10;22:1582-8. doi: 10.12659/msm.898632.
97 Genetic polymorphisms in the TERT-CLPTM1L region and lung cancer susceptibility in Chinese males.Oncol Lett. 2017 Aug;14(2):1588-1594. doi: 10.3892/ol.2017.6289. Epub 2017 Jun 1.
98 IFN- restores the impaired function of RNase L and induces mitochondria-mediated apoptosis in lung cancer.Cell Death Dis. 2019 Sep 9;10(9):642. doi: 10.1038/s41419-019-1902-9.
99 Polymorphisms in cancer-related pathway genes and lung cancer.Eur Respir J. 2016 Oct;48(4):1184-1191. doi: 10.1183/13993003.02040-2015. Epub 2016 Sep 1.
100 Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer.Virchows Arch. 2017 May;470(5):553-560. doi: 10.1007/s00428-017-2102-6. Epub 2017 Mar 13.
101 Glycobiomarker, Fucosylated Short-Form Secretogranin III Levels Are Increased in Serum of Patients with Small Cell Lung Carcinoma.J Proteome Res. 2017 Dec 1;16(12):4495-4505. doi: 10.1021/acs.jproteome.7b00484. Epub 2017 Oct 12.
102 Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.Cancer Lett. 2019 Feb 1;442:287-298. doi: 10.1016/j.canlet.2018.10.031. Epub 2018 Nov 12.
103 Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.J Hum Genet. 2016 Dec;61(12):985-993. doi: 10.1038/jhg.2016.99. Epub 2016 Aug 4.
104 The target landscape of clinical kinase drugs.Science. 2017 Dec 1;358(6367):eaan4368. doi: 10.1126/science.aan4368.
105 MiR-339 depresses cell proliferation via directly targeting S-phase kinase-associated protein? mRNA in lung cancer.Thorac Cancer. 2018 Mar;9(3):408-414. doi: 10.1111/1759-7714.12597. Epub 2018 Jan 29.
106 SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells.Tumour Biol. 2016 May;37(5):6943-52. doi: 10.1007/s13277-015-4587-4. Epub 2015 Dec 11.
107 Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells.Chemosphere. 2017 Oct;184:289-298. doi: 10.1016/j.chemosphere.2017.05.152. Epub 2017 May 30.
108 Could lung cancer exosomes induce apoptosis of natural killer cells through the p75NTR-proNGF-sortilin axis?.Med Hypotheses. 2017 Oct;108:151-153. doi: 10.1016/j.mehy.2017.09.003. Epub 2017 Sep 6.
109 SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition.Oncotarget. 2017 Nov 6;9(13):10891-10904. doi: 10.18632/oncotarget.22443. eCollection 2018 Feb 16.
110 B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN.Biochem Biophys Res Commun. 2017 Jan 22;482(4):1246-1251. doi: 10.1016/j.bbrc.2016.12.021. Epub 2016 Dec 7.
111 Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.Int J Cancer. 2019 Mar 1;144(5):1104-1114. doi: 10.1002/ijc.31771. Epub 2018 Oct 9.
112 A Prolonged Air Leak Score for Lung Cancer Resection: An Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database.Ann Thorac Surg. 2019 Nov;108(5):1478-1483. doi: 10.1016/j.athoracsur.2019.05.069. Epub 2019 Jul 16.
113 Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux.Int J Biochem Cell Biol. 2018 Sep;102:20-30. doi: 10.1016/j.biocel.2018.06.006. Epub 2018 Jun 19.
114 TCTP promotes epithelial-mesenchymal transition in lung adenocarcinoma.Onco Targets Ther. 2019 Feb 27;12:1641-1653. doi: 10.2147/OTT.S184555. eCollection 2019.
115 Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical Significance.Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):83-90.
116 Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.Oncol Lett. 2019 Jan;17(1):1128-1138. doi: 10.3892/ol.2018.9702. Epub 2018 Nov 15.
117 USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro.Int J Mol Sci. 2019 Oct 24;20(21):5300. doi: 10.3390/ijms20215300.
118 Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study.J Hematol Oncol. 2017 Mar 23;10(1):74. doi: 10.1186/s13045-017-0440-0.
119 Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.Cancer Sci. 2018 Aug;109(8):2469-2478. doi: 10.1111/cas.13665. Epub 2018 Jul 20.
120 Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality.Biomed Pharmacother. 2019 Jun;114:108791. doi: 10.1016/j.biopha.2019.108791. Epub 2019 Mar 19.
121 MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.Biochem Pharmacol. 2019 Oct;168:237-248. doi: 10.1016/j.bcp.2019.07.009. Epub 2019 Jul 11.
122 RNA interference influenced the proliferation and invasion of XWLC-05 lung cancer cells through inhibiting aquaporin 3.Biochem Biophys Res Commun. 2017 Apr 8;485(3):627-634. doi: 10.1016/j.bbrc.2017.02.013. Epub 2017 Feb 9.
123 RB constrains lineage fidelity and multiple stages of tumour progression and metastasis.Nature. 2019 May;569(7756):423-427. doi: 10.1038/s41586-019-1172-9. Epub 2019 May 1.
124 IKK Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization.Comput Struct Biotechnol J. 2019 Feb 7;17:251-262. doi: 10.1016/j.csbj.2019.02.003. eCollection 2019.
125 Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.J Thorac Oncol. 2018 Oct;13(10):1483-1495. doi: 10.1016/j.jtho.2018.06.016. Epub 2018 Jul 4.
126 Bone turnover markers and novel biomarkers in lung cancer bone metastases.Biomarkers. 2018 Sep;23(6):518-526. doi: 10.1080/1354750X.2018.1463566. Epub 2018 Apr 23.
127 The inhibitory activity of gallic acid against DNA methylation: application of gallic acid on epigenetic therapy of human cancers.Oncotarget. 2017 Dec 7;9(1):361-374. doi: 10.18632/oncotarget.23015. eCollection 2018 Jan 2.
128 Basic fibroblast growth factor blockade enhances lung cancer cell invasion by activating the AKT/MMP-2/VEGF pathway.Basic Clin Pharmacol Toxicol. 2020 Jan;126(1):43-50. doi: 10.1111/bcpt.13290. Epub 2019 Aug 8.
129 Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O(2)-(2,4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer.Eur J Med Chem. 2018 Apr 10;149:269-280. doi: 10.1016/j.ejmech.2018.02.062. Epub 2018 Feb 23.
130 Recent advances in biosensor for detection of lung cancer biomarkers.Biosens Bioelectron. 2019 Sep 15;141:111416. doi: 10.1016/j.bios.2019.111416. Epub 2019 Jun 6.
131 CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2429-2435. doi: 10.1016/j.bbrc.2018.06.172. Epub 2018 Jul 6.
132 Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patients.Front Immunol. 2017 Feb 14;8:138. doi: 10.3389/fimmu.2017.00138. eCollection 2017.
133 Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.J Thorac Oncol. 2017 Jan;12(1):77-84. doi: 10.1016/j.jtho.2016.08.123. Epub 2016 Aug 18.
134 Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.PLoS One. 2017 May 31;12(5):e0177964. doi: 10.1371/journal.pone.0177964. eCollection 2017.
135 Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer.J Pathol. 2015 Dec;237(4):520-31. doi: 10.1002/path.4597. Epub 2015 Sep 28.
136 SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer.Cell Death Dis. 2019 May 1;10(5):363. doi: 10.1038/s41419-019-1592-3.
137 Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment.Cancers (Basel). 2019 Feb 1;11(2):166. doi: 10.3390/cancers11020166.
138 Variation of Trop2 on non-small-cell lung cancer and normal cell membranes revealed by super-resolution fluorescence imaging.Talanta. 2020 Jan 15;207:120312. doi: 10.1016/j.talanta.2019.120312. Epub 2019 Sep 3.
139 TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.Cancer Immunol Res. 2018 Feb;6(2):163-177. doi: 10.1158/2326-6066.CIR-17-0273. Epub 2018 Jan 16.
140 Association between Polymorphisms of Vitamin D Receptor and Lung Cancer Susceptibility: Evidence from an Updated Meta-analysis.J Cancer. 2019 Jun 9;10(16):3639-3649. doi: 10.7150/jca.33431. eCollection 2019.
141 Association between XPA gene rs1800975 polymorphism and susceptibility to lung cancer: a meta-analysis.Clin Respir J. 2018 Feb;12(2):448-458. doi: 10.1111/crj.12535. Epub 2016 Aug 21.
142 ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.Sci Rep. 2017 Nov 8;7(1):15108. doi: 10.1038/s41598-017-15159-1.
143 Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.BMC Genomics. 2014;15 Suppl 3(Suppl 3):S1. doi: 10.1186/1471-2164-15-S3-S1. Epub 2014 May 6.
144 Finding genes discriminating smokers from non-smokers by applying a growing self-organizing clustering method to large airway epithelium cell microarray data.Asian Pac J Cancer Prev. 2013;14(1):111-6. doi: 10.7314/apjcp.2013.14.1.111.
145 Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.Lung Cancer. 2015 Feb;87(2):98-106. doi: 10.1016/j.lungcan.2014.11.017. Epub 2014 Dec 3.
146 Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.Oncogene. 2015 Jul 30;34(31):4056-68. doi: 10.1038/onc.2014.333. Epub 2014 Nov 10.
147 Correlations between angiopoietin-2 gene polymorphisms and lung cancer progression in a Chinese Han population.J Cancer. 2019 Jun 2;10(13):2935-2941. doi: 10.7150/jca.31134. eCollection 2019.
148 MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.Oncol Lett. 2018 Apr;15(4):5893-5902. doi: 10.3892/ol.2018.8048. Epub 2018 Feb 14.
149 High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer.Int J Biol Markers. 2018 May;33(2):215-221. doi: 10.1177/1724600817753098. Epub 2018 Apr 30.
150 ADH IB expression, but not ADH III, is decreased in human lung cancer.PLoS One. 2012;7(12):e52995. doi: 10.1371/journal.pone.0052995. Epub 2012 Dec 28.
151 Association between BMP4 expression and pathology, CT characteristics and prognosis of non-small cell lung cancer.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5787-5794. doi: 10.26355/eurrev_201907_18317.
152 Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer.Clin Cancer Res. 2019 Jan 1;25(1):158-165. doi: 10.1158/1078-0432.CCR-18-2062. Epub 2018 Sep 17.
153 SUN2: A potential therapeutic target in cancer.Oncol Lett. 2019 Feb;17(2):1401-1408. doi: 10.3892/ol.2018.9764. Epub 2018 Nov 27.
154 Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy.Sci Rep. 2017 Apr 20;7(1):1097. doi: 10.1038/s41598-017-00957-4.
155 CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features.Biochimie. 2014 Feb;97:210-8. doi: 10.1016/j.biochi.2013.10.021. Epub 2013 Nov 6.
156 Caspase-2 impacts lung tumorigenesis and chemotherapy response in vivo.Cell Death Differ. 2015 May;22(5):719-30. doi: 10.1038/cdd.2014.159. Epub 2014 Oct 10.
157 A literature-based systematic HuGE review and meta-analysis show that CASP gene family polymorphisms are associated with risk of lung cancer.Genet Mol Res. 2013 Jan 4;12(3):3057-69. doi: 10.4238/2013.January.4.22.
158 A CBR framework with gradient boosting based feature selection for lung cancer subtype classification.Comput Biol Med. 2017 Jul 1;86:98-106. doi: 10.1016/j.compbiomed.2017.05.010. Epub 2017 May 13.
159 The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation.Cell Physiol Biochem. 2018;45(3):1270-1283. doi: 10.1159/000487460. Epub 2018 Feb 9.
160 Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer patients with and without human immunodeficiency virus (HIV) infection.Lung Cancer. 2018 Sep;123:87-90. doi: 10.1016/j.lungcan.2018.06.028. Epub 2018 Jun 26.
161 The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.Int J Cancer. 2016 Jun 1;138(11):2688-99. doi: 10.1002/ijc.29998. Epub 2016 Jan 25.
162 DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.Oncol Rep. 2018 May;39(5):2071-2080. doi: 10.3892/or.2018.6310. Epub 2018 Mar 13.
163 Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.Cancer Res. 2007 Feb 15;67(4):1744-9. doi: 10.1158/0008-5472.CAN-06-3090.
164 Mechanistic insight of cyclin-dependent kinase 5 in modulating lung cancer growth.Chin J Physiol. 2019 Nov-Dec;62(6):231-240. doi: 10.4103/CJP.CJP_67_19.
165 Anti-Tumorigenic Effects of Resveratrol in Lung Cancer Cells Through Modulation of c-FLIP.Curr Cancer Drug Targets. 2017;17(7):669-680. doi: 10.2174/1568009617666170315162932.
166 Use of C-Choline positron emission tomography/computed tomography to investigate the mechanism of choline metabolism in lung cancer.Mol Med Rep. 2015 May;11(5):3285-90. doi: 10.3892/mmr.2015.3200. Epub 2015 Jan 14.
167 Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer.Eur J Hum Genet. 2015 Aug;23(8):1019-24. doi: 10.1038/ejhg.2014.229. Epub 2014 Nov 19.
168 Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma.Oncol Lett. 2018 Feb;15(2):1874-1880. doi: 10.3892/ol.2017.7455. Epub 2017 Nov 21.
169 Genetic polymorphism of catechol-O-methyltransferase modulates the association of green tea consumption and lung cancer.Eur J Cancer Prev. 2019 Jul;28(4):316-322. doi: 10.1097/CEJ.0000000000000464.
170 Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer.Mol Cancer. 2014 Mar 12;13:56. doi: 10.1186/1476-4598-13-56.
171 Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.J Natl Cancer Inst. 2014 Dec 1;107(1):358. doi: 10.1093/jnci/dju358. Print 2015 Jan.
172 CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining.Cancers (Basel). 2018 Jul 31;10(8):252. doi: 10.3390/cancers10080252.
173 Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8948-E8957. doi: 10.1073/pnas.1806219115. Epub 2018 Aug 29.
174 Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.Cancer Prev Res (Phila). 2016 Sep;9(9):739-49. doi: 10.1158/1940-6207.CAPR-16-0023. Epub 2016 Jun 23.
175 Mechanism of decorin protein inhibiting invasion and metastasis of non-small cell lung cancer.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1520-1527. doi: 10.26355/eurrev_201902_17110.
176 Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients.Cancer Res Treat. 2017 Oct;49(4):1065-1076. doi: 10.4143/crt.2016.347. Epub 2017 Jan 25.
177 Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.Oncotarget. 2016 Jul 15;9(4):4395-4410. doi: 10.18632/oncotarget.10611. eCollection 2018 Jan 12.
178 Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.Oncol Lett. 2019 Jul;18(1):219-226. doi: 10.3892/ol.2019.10310. Epub 2019 May 3.
179 A DRD1 polymorphism predisposes to lung cancer among those exposed to secondhand smoke during childhood.Cancer Prev Res (Phila). 2014 Dec;7(12):1210-8. doi: 10.1158/1940-6207.CAPR-14-0158. Epub 2014 Oct 3.
180 Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.Cancer Biol Ther. 2009 Sep;8(17):1671-9. doi: 10.4161/cbt.8.17.9322. Epub 2009 Sep 20.
181 Formylated honokiol analogs showed antitumor activity against lung carcinoma.Anticancer Drugs. 2019 Sep;30(8):795-802. doi: 10.1097/CAD.0000000000000771.
182 Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.Lung Cancer. 2015 Dec;90(3):516-21. doi: 10.1016/j.lungcan.2015.10.005. Epub 2015 Oct 9.
183 EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer.Ther Adv Med Oncol. 2019 Jun 13;11:1758835919855228. doi: 10.1177/1758835919855228. eCollection 2019.
184 Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.Biomed Res Int. 2018 Feb 28;2018:7390104. doi: 10.1155/2018/7390104. eCollection 2018.
185 EphB4: A promising target for upper aerodigestive malignancies.Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):128-137. doi: 10.1016/j.bbcan.2018.01.003. Epub 2018 Jan 31.
186 Study of lung cancer regulatory network that involves erbB4 and tumor marker gene.Saudi J Biol Sci. 2017 Mar;24(3):649-657. doi: 10.1016/j.sjbs.2017.01.038. Epub 2017 Jan 27.
187 TGF upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells.Oncotarget. 2016 Oct 4;7(40):65471-65484. doi: 10.18632/oncotarget.11472.
188 Docosahexaenoic Acid Induces Cell Death in Human Non-Small Cell Lung Cancer Cells by Repressing mTOR via AMPK Activation and PI3K/Akt Inhibition.Biomed Res Int. 2015;2015:239764. doi: 10.1155/2015/239764. Epub 2015 Aug 3.
189 Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis.Am J Respir Crit Care Med. 2014 Sep 15;190(6):675-87. doi: 10.1164/rccm.201404-0714OC.
190 Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.Cancer Lett. 2018 Jul 28;427:38-48. doi: 10.1016/j.canlet.2018.04.019. Epub 2018 Apr 19.
191 The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.Sci Rep. 2018 Feb 5;8(1):2394. doi: 10.1038/s41598-018-20570-3.
192 Diet-induced unresolved ER stress hinders KRAS-driven lung tumorigenesis.Cell Metab. 2015 Jan 6;21(1):117-25. doi: 10.1016/j.cmet.2014.11.020. Epub 2014 Dec 18.
193 A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.Drug Deliv Transl Res. 2019 Feb;9(1):37-52. doi: 10.1007/s13346-018-0575-8.
194 FOSL1 Promotes Kras-induced Lung Cancer through Amphiregulin and Cell Survival Gene Regulation.Am J Respir Cell Mol Biol. 2018 May;58(5):625-635. doi: 10.1165/rcmb.2017-0164OC.
195 Glycine-extended gastrin promotes the growth of lung cancer.Cancer Res. 2004 Jan 1;64(1):196-201. doi: 10.1158/0008-5472.can-03-2112.
196 The role of GDF15 in bone metastasis of lung adenocarcinoma cells.Oncol Rep. 2019 Apr;41(4):2379-2388. doi: 10.3892/or.2019.7024. Epub 2019 Feb 21.
197 Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4.J Lipid Res. 2016 Sep;57(9):1659-69. doi: 10.1194/jlr.M066910. Epub 2016 Jul 19.
198 Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.Nucl Med Biol. 2017 Sep;52:57-62. doi: 10.1016/j.nucmedbio.2017.06.001. Epub 2017 Jun 10.
199 Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer.Bioinformatics. 2014 Mar 15;30(6):748-52. doi: 10.1093/bioinformatics/btt606. Epub 2013 Oct 24.
200 Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response.Clin Exp Pharmacol Physiol. 2014 Jun;41(6):408-15. doi: 10.1111/1440-1681.12232.
201 Coumarin Derivatives as Anticancer Agents for Lung Cancer Therapy: A Review.Anticancer Agents Med Chem. 2018;18(7):964-984. doi: 10.2174/1871520618666171229185926.
202 Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mousemodel of papillary lung adenocarcinomas.Oncotarget. 2015 Oct 13;6(31):31569-92. doi: 10.18632/oncotarget.5035.
203 Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer.Exp Mol Med. 2018 Sep 12;50(9):1-14. doi: 10.1038/s12276-018-0146-6.
204 Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels.PLoS One. 2014 Jul 9;9(7):e101679. doi: 10.1371/journal.pone.0101679. eCollection 2014.
205 IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer.Cancers (Basel). 2019 Jan 2;11(1):36. doi: 10.3390/cancers11010036.
206 The Contribution of Interleukin-12 Genetic Variations to Taiwanese Lung Cancer.Anticancer Res. 2018 Nov;38(11):6321-6327. doi: 10.21873/anticanres.12989.
207 IL-13 receptor 2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice.Oncotarget. 2015 Oct 20;6(32):32902-13. doi: 10.18632/oncotarget.5361.
208 Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.Mol Carcinog. 2015 Jun;54 Suppl 1(0 1):E172-84. doi: 10.1002/mc.22275. Epub 2015 Jan 18.
209 Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer.Mol Carcinog. 2019 Mar;58(3):358-365. doi: 10.1002/mc.22933. Epub 2018 Dec 5.
210 KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.Oncotarget. 2016 May 10;7(19):27959-74. doi: 10.18632/oncotarget.8563.
211 Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.Tumour Biol. 2015 Jan;36(1):271-8. doi: 10.1007/s13277-014-2630-5. Epub 2014 Sep 23.
212 KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.Biochem Biophys Res Commun. 2005 Apr 22;329(4):1260-6. doi: 10.1016/j.bbrc.2005.02.100.
213 LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway.Biomed Pharmacother. 2019 Jan;109:679-689. doi: 10.1016/j.biopha.2018.10.097. Epub 2018 Nov 5.
214 miR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation.Oncol Res. 2018 May 7;26(4):547-556. doi: 10.3727/096504017X15016337254605. Epub 2017 Aug 11.
215 Galectin-3 activates TLR4/NF-B signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression.BMC Cancer. 2018 May 22;18(1):580. doi: 10.1186/s12885-018-4461-z.
216 MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.Sci Rep. 2015 Jun 19;5:11471. doi: 10.1038/srep11471.
217 Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response.Exp Mol Med. 2019 Feb 21;51(2):1-20. doi: 10.1038/s12276-019-0209-3.
218 Construction of High Sensitive CD133 Immune PLGA Magnetic Spheres Platform for Lung Cancer Stem Cells Isolation and Its Property Evaluation.J Biomed Nanotechnol. 2018 Jun 1;14(6):1066-1074. doi: 10.1166/jbn.2018.2562.
219 Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma.Ann Thorac Surg. 2018 Dec;106(6):1682-1690. doi: 10.1016/j.athoracsur.2018.06.058. Epub 2018 Aug 8.
220 DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells.Oncoimmunology. 2018 Nov 2;8(1):e1509173. doi: 10.1080/2162402X.2018.1509173. eCollection 2019.
221 Impact of metallothionein gene polymorphisms on the risk of lung cancer in a Japanese population.Mol Carcinog. 2015 Jun;54 Suppl 1:E122-8. doi: 10.1002/mc.22198. Epub 2014 Aug 30.
222 MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.J Pathol. 2002 Apr;196(4):450-8. doi: 10.1002/path.1068.
223 ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.J Clin Invest. 2012 May;122(5):1869-80. doi: 10.1172/JCI61492. Epub 2012 Apr 16.
224 Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop.Nat Commun. 2019 Nov 6;10(1):5043. doi: 10.1038/s41467-019-12925-9.
225 Natriuretic peptide receptor A as a novel target for cancer.World J Surg Oncol. 2014 Jun 3;12:174. doi: 10.1186/1477-7819-12-174.
226 The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.J Cancer. 2019 Jul 8;10(17):4017-4030. doi: 10.7150/jca.28163. eCollection 2019.
227 The neuropilin 2 isoform NRP2b uniquely supports TGF-mediated progression in lung cancer.Sci Signal. 2017 Jan 17;10(462):eaag0528. doi: 10.1126/scisignal.aag0528.
228 The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer.PLoS One. 2014 Mar 24;9(3):e91577. doi: 10.1371/journal.pone.0091577. eCollection 2014.
229 Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D.Mol Cancer Ther. 2014 Oct;13(10):2463-73. doi: 10.1158/1535-7163.MCT-14-0297. Epub 2014 Aug 13.
230 A 5'-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling.Oncogene. 2005 Apr 14;24(16):2654-66. doi: 10.1038/sj.onc.1208336.
231 Expression and Prognostic Impact of VEGF, CD31 and SMA in Resected Primary Lung Cancers.Anticancer Res. 2018 Jul;38(7):4057-4063. doi: 10.21873/anticanres.12695.
232 Smoking out reproductive hormone actions in lung cancer.Mol Cancer Res. 2014 Jan;12(1):24-31. doi: 10.1158/1541-7786.MCR-13-0580. Epub 2014 Jan 7.
233 An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine.Sci Rep. 2016 Feb 26;6:22120. doi: 10.1038/srep22120.
234 Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial-mesenchymal transition phenotype.Lab Invest. 2016 Apr;96(4):391-8. doi: 10.1038/labinvest.2015.155. Epub 2016 Jan 11.
235 Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells.Asian Pac J Cancer Prev. 2014;15(20):8931-6. doi: 10.7314/apjcp.2014.15.20.8931.
236 Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.Sci Transl Med. 2019 Feb 6;11(478):eaau8866. doi: 10.1126/scitranslmed.aau8866.
237 Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.Int J Oncol. 2014 Sep;45(3):978-84. doi: 10.3892/ijo.2014.2486. Epub 2014 Jun 10.
238 Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer.Oncotarget. 2017 Jul 15;8(37):62248-62260. doi: 10.18632/oncotarget.19273. eCollection 2017 Sep 22.
239 Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.Biochem Biophys Res Commun. 2014 Sep 26;452(3):768-74. doi: 10.1016/j.bbrc.2014.08.147. Epub 2014 Sep 6.
240 Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target.Cancer Biol Ther. 2014 Jan;15(1):128-34. doi: 10.4161/cbt.27146. Epub 2013 Nov 19.
241 HOIL-1L functions as the PKC ubiquitin ligase to promote lung tumor growth.Am J Respir Crit Care Med. 2014 Sep 15;190(6):688-98. doi: 10.1164/rccm.201403-0463OC.
242 S100A3 a partner protein regulating the stability/activity of RAR and PML-RAR in cellular models of breast/lung cancer and acute myeloid leukemia.Oncogene. 2019 Apr;38(14):2482-2500. doi: 10.1038/s41388-018-0599-z. Epub 2018 Dec 7.
243 Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.Nat Commun. 2015 Jul 9;6:7679. doi: 10.1038/ncomms8679.
244 -Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.Cell Death Differ. 2018 Aug;25(8):1473-1485. doi: 10.1038/s41418-017-0055-6. Epub 2018 Feb 2.
245 Loss of transcriptional repression contributes to the ectopic expression of the calcitonin/alpha-CGRP gene in a human lung carcinoma cell line.FEBS Lett. 1992 Jul 20;306(2-3):229-33. doi: 10.1016/0014-5793(92)81006-8.
246 Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy.Cancer Med. 2019 May;8(5):2599-2611. doi: 10.1002/cam4.2088. Epub 2019 Mar 21.
247 MicroRNA-186 suppresses lung cancer progression by targeting SIRT6.Cancer Biomark. 2018 Feb 6;21(2):415-423. doi: 10.3233/CBM-170650.
248 Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.Cancer Chemother Pharmacol. 2015 May;75(5):985-91. doi: 10.1007/s00280-015-2723-x. Epub 2015 Mar 14.
249 Proteasome-dependent degradation of Smad7 is critical for lung cancer metastasis.Cell Death Differ. 2020 Jun;27(6):1795-1806. doi: 10.1038/s41418-019-0459-6. Epub 2019 Nov 26.
250 Increased SPK1 expression promotes cell growth by activating the ERK1/2 signaling in non-small-cell lung cancer.Anticancer Drugs. 2019 Jun;30(5):458-465. doi: 10.1097/CAD.0000000000000733.
251 Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation.Sci Signal. 2015 Jun 16;8(381):ra58. doi: 10.1126/scisignal.aaa4998.
252 Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro.Tumour Biol. 2015 Mar;36(3):2163-8. doi: 10.1007/s13277-014-2826-8. Epub 2014 Nov 15.
253 Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.Oncotarget. 2016 May 10;7(19):27584-98. doi: 10.18632/oncotarget.8488.
254 Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel.DNA Repair (Amst). 2014 Jan;13:1-9. doi: 10.1016/j.dnarep.2013.09.001. Epub 2013 Dec 16.
255 Elevated expression of DNA polymerase kappa in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53.Int J Oncol. 2004 Jul;25(1):161-5.
256 Risk factors for disseminated intravascular coagulation in patients with lung cancer.Thorac Cancer. 2018 Aug;9(8):931-938. doi: 10.1111/1759-7714.12766. Epub 2018 May 31.
257 Tie2-dependent deletion of 6 integrin subunit in mice reduces tumor growth and angiogenesis.Int J Oncol. 2014 Nov;45(5):2058-64. doi: 10.3892/ijo.2014.2631. Epub 2014 Sep 1.
258 MitochondrialDNAassociated TLR9 signalling is a potential serological biomarker for nonsmall cell lung cancer.Oncol Rep. 2019 Feb;41(2):999-1006. doi: 10.3892/or.2018.6855. Epub 2018 Nov 9.
259 Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.Mol Carcinog. 2019 Jul;58(7):1094-1104. doi: 10.1002/mc.23017. Epub 2019 Apr 15.
260 Two Gln187 mutants of human soluble APRIL inhibit proliferation of lung carcinoma A549 cells.Acta Biochim Pol. 2009;56(4):703-10. Epub 2009 Dec 7.
261 KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.Mol Carcinog. 2018 Oct;57(10):1396-1407. doi: 10.1002/mc.22853. Epub 2018 Jun 22.
262 High Expression of Ubiquitin-Specific Protease 8 (USP8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma.Med Sci Monit. 2018 Jul 16;24:4934-4943. doi: 10.12659/MSM.909235.
263 Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis.Oncogene. 2017 Dec 14;36(50):6863-6872. doi: 10.1038/onc.2017.297. Epub 2017 Sep 4.
264 Tip60-siRNA regulates ABCE1 acetylation to suppress lung cancer growth via activation of the apoptotic signaling pathway.Exp Ther Med. 2019 Apr;17(4):3195-3202. doi: 10.3892/etm.2019.7302. Epub 2019 Feb 22.
265 ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth. Sci Rep. 2014 Nov 4;4:6899.
266 Upregulation of COX-2 in the lung cancer promotes overexpression of multidrug resistance protein 4 (MRP4) via PGE2-dependent pathway.Eur J Pharm Sci. 2014 Oct 1;62:189-96. doi: 10.1016/j.ejps.2014.05.023. Epub 2014 Jun 5.
267 ABCG1 as a potential oncogene in lung cancer. Exp Ther Med. 2017 Jun;13(6):3189-3194.
268 Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma.Oncol Lett. 2019 Aug;18(2):1548-1556. doi: 10.3892/ol.2019.10427. Epub 2019 May 31.
269 Interaction of tobacco smoking and chewing with Angiotensin converting enzyme (insertion/deletion) gene polymorphisms and risk of lung cancer in a high risk area from northeast India.Asian Pac J Cancer Prev. 2014;15(24):10691-5. doi: 10.7314/apjcp.2014.15.24.10691.
270 Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression.Genes Dev. 2016 Sep 1;30(17):1956-70. doi: 10.1101/gad.283283.116.
271 Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization.J Am Coll Radiol. 2019 Apr;16(4 Pt A):427-434. doi: 10.1016/j.jacr.2018.12.016. Epub 2019 Feb 26.
272 Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.Hum Mol Genet. 2016 Feb 1;25(3):620-9. doi: 10.1093/hmg/ddv494. Epub 2016 Jan 4.
273 Correlation between serum adenosine deaminase activity and efficacy of anti-programmed cell death-1 antibody.Lung Cancer. 2019 Jul;133:4-9. doi: 10.1016/j.lungcan.2019.04.022. Epub 2019 Apr 27.
274 ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.EMBO Mol Med. 2019 Apr;11(4):e9976. doi: 10.15252/emmm.201809976.
275 Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer.Oncogene. 2010 Jul 1;29(26):3758-69. doi: 10.1038/onc.2010.130. Epub 2010 May 10.
276 Complement Activation via a C3a Receptor Pathway Alters CD4(+) T Lymphocytes and Mediates Lung Cancer Progression.Cancer Res. 2018 Jan 1;78(1):143-156. doi: 10.1158/0008-5472.CAN-17-0240. Epub 2017 Nov 8.
277 Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.Tumour Biol. 2016 Jul;37(7):8681-9. doi: 10.1007/s13277-015-4573-x. Epub 2016 Jan 6.
278 A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer.J Cancer. 2019 Nov 1;10(27):6848-6857. doi: 10.7150/jca.36614. eCollection 2019.
279 VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: a study in biopsy specimens.Peptides. 2003 Mar;24(3):429-36. doi: 10.1016/s0196-9781(03)00058-5.
280 Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: A preclinical study.Cancer Lett. 2019 May 1;449:125-134. doi: 10.1016/j.canlet.2019.01.025. Epub 2019 Jan 25.
281 Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.J Pharm Sci. 2017 Jan;106(1):385-394. doi: 10.1016/j.xphs.2016.08.023. Epub 2016 Oct 18.
282 The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer.Cancer Res. 2018 Dec 15;78(24):6728-6735. doi: 10.1158/0008-5472.CAN-17-3370. Epub 2018 Oct 17.
283 Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development.Nat Chem Biol. 2020 Jan;16(1):31-41. doi: 10.1038/s41589-019-0415-2. Epub 2019 Dec 2.
284 Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.Cancer Res. 1992 Jan 1;52(1):17-23.
285 Establishment of a Strong Link Between Smoking and Cancer Pathogenesis through DNA Methylation Analysis.Sci Rep. 2017 May 12;7(1):1811. doi: 10.1038/s41598-017-01856-4.
286 Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.Environ Mol Mutagen. 2009 May;50(4):285-90. doi: 10.1002/em.20452.
287 Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.Cancer Prev Res (Phila). 2011 Dec;4(12):1961-72. doi: 10.1158/1940-6207.CAPR-10-0280. Epub 2011 Aug 31.
288 Association of cooking oil fumes exposure with lung cancer: involvement of inhibitor of apoptosis proteins in cell survival and proliferation in vitro.Mutat Res. 2007 Apr 2;628(2):107-16. doi: 10.1016/j.mrgentox.2006.12.005. Epub 2006 Dec 22.
289 Sex-specific SNP-SNP interaction analyses within topologically associated domains reveals ANGPT1 as a novel tumor suppressor gene for lung cancer.Genes Chromosomes Cancer. 2020 Jan;59(1):13-22. doi: 10.1002/gcc.22793. Epub 2019 Aug 10.
290 ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.Lung. 2016 Aug;194(4):637-46. doi: 10.1007/s00408-016-9895-y. Epub 2016 May 11.
291 ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.Cancer Lett. 2017 Dec 1;410:191-200. doi: 10.1016/j.canlet.2017.09.038. Epub 2017 Sep 29.
292 TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer.Arch Iran Med. 2019 Jan 1;22(1):32-38.
293 Cul4A Modulates Invasion and Metastasis of Lung Cancer Through Regulation of ANXA10.Cancers (Basel). 2019 May 2;11(5):618. doi: 10.3390/cancers11050618.
294 Modulation of Vascular Endothelial Growth Factor and Annexin A2 in Response to 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone -Induced Inflammation via Swimming Training.Iran J Allergy Asthma Immunol. 2018 Oct 7;17(5):418-427.
295 Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest.Respir Res. 2018 May 21;19(1):96. doi: 10.1186/s12931-018-0804-1.
296 Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients.Biochim Biophys Acta. 2012 Apr;1824(4):692-700. doi: 10.1016/j.bbapap.2012.01.016. Epub 2012 Feb 2.
297 Expression in lung cancer of a transcribed sequence at the DNF15S2 locus at chromosome 3P21.Anticancer Res. 1990 Jan-Feb;10(1):23-7.
298 MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin.Thorac Cancer. 2019 Jun;10(6):1419-1430. doi: 10.1111/1759-7714.13087. Epub 2019 May 9.
299 Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer.Genes Chromosomes Cancer. 1999 Jun;25(2):154-9.
300 Protective potential of miR-146a-5p and its underlying molecular mechanism in diverse cancers: a comprehensive meta-analysis and bioinformatics analysis.Cancer Cell Int. 2019 Jun 24;19:167. doi: 10.1186/s12935-019-0886-y. eCollection 2019.
301 Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.Br J Cancer. 2018 Aug;119(5):580-590. doi: 10.1038/s41416-018-0200-0. Epub 2018 Aug 6.
302 hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis.Mol Biol Rep. 2014;41(4):2299-306. doi: 10.1007/s11033-014-3083-z. Epub 2014 Jan 17.
303 DDEFL1 correlated with Rho GTPases activity in breast cancer.Oncotarget. 2017 Oct 26;8(68):112487-112497. doi: 10.18632/oncotarget.22095. eCollection 2017 Dec 22.
304 Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell ... Sci Rep. 2018 Nov 30;8(1):17477.
305 NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.Int J Med Sci. 2018 Oct 20;15(13):1502-1507. doi: 10.7150/ijms.28055. eCollection 2018.
306 The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2 and ATF4 in Lung Cancer.Dis Markers. 2018 Sep 16;2018:5068701. doi: 10.1155/2018/5068701. eCollection 2018.
307 The effect and mechanism of miR-210 in down-regulating the autophagy of lung cancer cells.Pathol Res Pract. 2019 Mar;215(3):453-458. doi: 10.1016/j.prp.2018.12.018. Epub 2018 Dec 12.
308 Alterations in the ATP2A2 gene in correlation with colon and lung cancer.Cancer Genet Cytogenet. 2006 Dec;171(2):105-11. doi: 10.1016/j.cancergencyto.2006.06.016.
309 Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study.Cancer Manag Res. 2019 Sep 19;11:8539-8546. doi: 10.2147/CMAR.S222278. eCollection 2019.
310 The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients. Tumour Biol. 2014 Aug;35(8):8259-65.
311 RAD-ADAPT: Software for modelling clonogenic assay data in radiation biology.DNA Repair (Amst). 2017 Apr;52:24-30. doi: 10.1016/j.dnarep.2017.02.004. Epub 2017 Feb 20.
312 Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10.1158/0008-5472.CAN-15-2980. Epub 2016 Apr 20.
313 Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.PLoS One. 2018 Aug 16;13(8):e0202360. doi: 10.1371/journal.pone.0202360. eCollection 2018.
314 [Corrigendum] AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.Oncol Rep. 2019 Jan;41(1):719. doi: 10.3892/or.2018.6831. Epub 2018 Oct 29.
315 The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer.Thorac Cancer. 2019 Sep;10(9):1770-1778. doi: 10.1111/1759-7714.13139. Epub 2019 Jul 18.
316 Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.Cell. 2019 Jul 11;178(2):316-329.e18. doi: 10.1016/j.cell.2019.06.003. Epub 2019 Jun 27.
317 Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells.Clin Cancer Res. 2000 Mar;6(3):887-90.
318 Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells.Oncol Lett. 2018 Apr;15(4):5473-5480. doi: 10.3892/ol.2018.8036. Epub 2018 Feb 13.
319 Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.Cell Rep. 2019 Jul 9;28(2):512-525.e6. doi: 10.1016/j.celrep.2019.06.026.
320 Mendelian randomization study of telomere length and lung cancer risk in East Asian population.Cancer Med. 2019 Dec;8(17):7469-7476. doi: 10.1002/cam4.2590. Epub 2019 Oct 11.
321 A common genetic variant (97906C>A) of DAB2IP/AIP1 is associated with an increased risk and early onset of lung cancer in Chinese males.PLoS One. 2011;6(10):e26944. doi: 10.1371/journal.pone.0026944. Epub 2011 Oct 26.
322 CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer.J Cell Mol Med. 2020 Jan;24(1):618-631. doi: 10.1111/jcmm.14771. Epub 2019 Nov 13.
323 Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function.Am J Respir Crit Care Med. 2019 Aug 1;200(3):348-358. doi: 10.1164/rccm.201801-0080OC.
324 Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration.Diagn Pathol. 2014 Jun 19;9:123. doi: 10.1186/1746-1596-9-123.
325 Expression of bone morphogenetic protein 6 in non-small cell lung cancer and its significance.Oncol Lett. 2019 Feb;17(2):1946-1952. doi: 10.3892/ol.2018.9781. Epub 2018 Nov 30.
326 Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.RNA. 2008 May;14(5):844-52. doi: 10.1261/rna.939908. Epub 2008 Mar 28.
327 The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target.Cell J. 2017 Spring;19(Suppl 1):1-8. doi: 10.22074/cellj.2017.5060. Epub 2017 May 17.
328 Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.Pathol Int. 2018 Apr;68(4):232-240. doi: 10.1111/pin.12646. Epub 2018 Feb 12.
329 Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometry.Am J Transl Res. 2017 Sep 15;9(9):3918-3934. eCollection 2017.
330 Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.Am J Respir Crit Care Med. 2018 May 1;197(9):1164-1176. doi: 10.1164/rccm.201703-0660OC.
331 Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration.Molecules. 2019 Sep 19;24(18):3409. doi: 10.3390/molecules24183409.
332 Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.Oncogene. 2004 Jul 29;23(34):5719-28. doi: 10.1038/sj.onc.1207760.
333 Correction to: Toward clinically usable CAD for lung cancer screening with computed tomography.Eur Radiol. 2020 Mar;30(3):1822. doi: 10.1007/s00330-019-06512-1.
334 Differential regulation of the parathyroid hormone-related protein gene P1 and P3 promoters by cAMP.Mol Cell Endocrinol. 1998 Mar 16;138(1-2):173-84. doi: 10.1016/s0303-7207(97)00239-6.
335 Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.Strahlenther Onkol. 2018 Mar;194(3):196-205. doi: 10.1007/s00066-017-1213-y. Epub 2017 Sep 15.
336 Association of calcium/calmodulin-dependent protein kinase kinase1 rs7214723 polymorphism with lung cancer risk in a Chinese population.Biosci Rep. 2017 Aug 31;37(4):BSR20170762. doi: 10.1042/BSR20170762. Epub 2017 Jul 24.
337 Mutational analysis of caspase 1, 4, and 5 genes in common human cancers.Hum Pathol. 2008 Jun;39(6):895-900. doi: 10.1016/j.humpath.2007.10.015. Epub 2008 Apr 21.
338 MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.Oncotarget. 2015 Sep 8;6(26):21802-15. doi: 10.18632/oncotarget.5224.
339 Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma.Int J Mol Sci. 2019 Mar 5;20(5):1125. doi: 10.3390/ijms20051125.
340 Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina.Toxicol Appl Pharmacol. 2010 Sep 1;247(2):138-45. doi: 10.1016/j.taap.2010.06.006. Epub 2010 Jun 17.
341 Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.Cancer Lett. 2019 Jun 28;452:244-253. doi: 10.1016/j.canlet.2019.03.040. Epub 2019 Mar 27.
342 High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer.Lung Cancer. 2011 Dec;74(3):384-91. doi: 10.1016/j.lungcan.2011.04.004. Epub 2011 May 8.
343 CCR4 mediated chemotaxis of regulatory T cells suppress the activation of T cells and NK cells via TGF- pathway in human non-small cell lung cancer.Biochem Biophys Res Commun. 2017 Jun 17;488(1):196-203. doi: 10.1016/j.bbrc.2017.05.034. Epub 2017 May 6.
344 Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.Tumour Biol. 2011 Feb;32(1):197-202. doi: 10.1007/s13277-010-0113-x. Epub 2010 Sep 25.
345 [Corrigendum] Neutrophils in cancer development and progression: Roles, mechanisms, and implications (Review).Int J Oncol. 2017 Feb;50(2):745. doi: 10.3892/ijo.2016.3764. Epub 2016 Nov 9.
346 A reevaluation of CD22 expression in human lung cancer.Cancer Res. 2014 Jan 1;74(1):263-71. doi: 10.1158/0008-5472.CAN-13-1436.
347 Downregulation of CD24 suppresses bone metastasis of lung cancer.Cancer Sci. 2018 Jan;109(1):112-120. doi: 10.1111/cas.13435. Epub 2017 Nov 29.
348 CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma.PLoS One. 2013;8(4):e61024. doi: 10.1371/journal.pone.0061024. Epub 2013 Apr 2.
349 Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.Mol Carcinog. 2019 Mar;58(3):321-333. doi: 10.1002/mc.22930. Epub 2018 Nov 12.
350 A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.Mol Pharm. 2018 Aug 6;15(8):3032-3045. doi: 10.1021/acs.molpharmaceut.8b00076. Epub 2018 Jul 6.
351 A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.Oncotarget. 2017 Jan 24;8(4):6216-6221. doi: 10.18632/oncotarget.14053.
352 Inhibition of human lung adenocarcinoma growth and metastasis by JC polyomavirus-like particles packaged with an SP-B promoter-driven CD59-specific shRNA.Clin Sci (Lond). 2019 Nov 15;133(21):2159-2169. doi: 10.1042/CS20190395.
353 Unfavorable clinical implications of peripheral blood CD44+ and CD54+ lymphocytes in patients with lung cancer undergoing chemotherapy.Int J Biol Markers. 2018 May;33(2):208-214. doi: 10.5301/ijbm.5000309. Epub 2017 Nov 15.
354 Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.Oncotarget. 2017 May 23;8(43):74058-74067. doi: 10.18632/oncotarget.18202. eCollection 2017 Sep 26.
355 Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.Cancer Res. 2016 Feb 15;76(4):974-83. doi: 10.1158/0008-5472.CAN-15-2135. Epub 2016 Feb 2.
356 Replication-deficient adenovirus-mediated transfer of B7-1 (CD80) cDNA induces anti-tumour immunity in isolated human lung cancer.Respirology. 2001 Jun;6(2):135-44. doi: 10.1046/j.1440-1843.2001.00322.x.
357 A genome-wide comprehensive analysis of alterations in driver genes in non-small-cell lung cancer.Anticancer Drugs. 2018 Jan;29(1):10-18. doi: 10.1097/CAD.0000000000000571.
358 YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.Oncotarget. 2016 Dec 13;7(50):82139-82157. doi: 10.18632/oncotarget.10080.
359 The carcinogen (7R,8S)-dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene induces Cdc25B expression in human bronchial and lung cancer cells.Cancer Res. 2003 Feb 15;63(4):771-5.
360 Involvement of cdc25c in cell cycle alteration of a radioresistant lung cancer cell line established with fractionated ionizing radiation.Asian Pac J Cancer Prev. 2013;14(10):5725-30. doi: 10.7314/apjcp.2013.14.10.5725.
361 Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis.Cancer Res. 2007 May 1;67(9):4113-22. doi: 10.1158/0008-5472.CAN-06-4705.
362 Adducins inhibit lung cancer cell migration through mechanisms involving regulation of cell-matrix adhesion and cadherin-11 expression.Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):395-408. doi: 10.1016/j.bbamcr.2018.10.001. Epub 2018 Oct 2.
363 Expression of KIAA1456 in lung cancer tissue and its effects on proliferation, migration and invasion of lung cancer cells.Oncol Lett. 2018 Sep;16(3):3791-3795. doi: 10.3892/ol.2018.9119. Epub 2018 Jul 10.
364 Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.PLoS One. 2016 Jun 30;11(6):e0158395. doi: 10.1371/journal.pone.0158395. eCollection 2016.
365 Mutation analyses of 268 candidate genes in human tumor cell lines.Genomics. 2001 Jun 15;74(3):352-64. doi: 10.1006/geno.2001.6551.
366 Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.Cell Death Dis. 2019 Apr 1;10(4):297. doi: 10.1038/s41419-019-1528-y.
367 HuR facilitates cancer stemness of lung cancer cells via regulating miR-873/CDK3 and miR-125a-3p/CDK3 axis.Biotechnol Lett. 2018 Apr;40(4):623-631. doi: 10.1007/s10529-018-2512-9. Epub 2018 Jan 17.
368 Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.Mol Biol Cell. 2012 Aug;23(15):2856-66. doi: 10.1091/mbc.E10-12-1010. Epub 2012 Jun 13.
369 ER Stress Signaling Promotes the Survival of Cancer "Persister Cells" Tolerant to EGFR Tyrosine Kinase Inhibitors.Cancer Res. 2018 Feb 15;78(4):1044-1057. doi: 10.1158/0008-5472.CAN-17-1904. Epub 2017 Dec 19.
370 Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.Int J Biol Markers. 2011 Jan-Mar;26(1):9-21. doi: 10.5301/jbm.2011.6372.
371 Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma.Sci Rep. 2019 Sep 2;9(1):11607. doi: 10.1038/s41598-019-48104-5.
372 Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP expression.Sci Transl Med. 2016 Aug 3;8(350):350ra104. doi: 10.1126/scitranslmed.aad6066.
373 Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1913-1918. doi: 10.1073/pnas.1719760115. Epub 2018 Feb 6.
374 Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma.Gene. 2017 Apr 15;608:95-102. doi: 10.1016/j.gene.2017.01.007. Epub 2017 Jan 23.
375 Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine.Mol Oncol. 2019 Jul;13(7):1503-1518. doi: 10.1002/1878-0261.12497. Epub 2019 Jun 14.
376 Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.J Thorac Oncol. 2017 Nov;12(11):1673-1678. doi: 10.1016/j.jtho.2017.08.011. Epub 2017 Aug 24.
377 Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathway.Cell Death Dis. 2017 Feb 23;8(2):e2621. doi: 10.1038/cddis.2017.50.
378 Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans.Oncotarget. 2012 Nov;3(11):1428-38. doi: 10.18632/oncotarget.746.
379 Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer.Clin Lung Cancer. 2020 Mar;21(2):171-176. doi: 10.1016/j.cllc.2019.07.002. Epub 2019 Jul 17.
380 Naturally occurring variants of human 9 nicotinic receptor differentially affect bronchial cell proliferation and transformation.PLoS One. 2011;6(11):e27978. doi: 10.1371/journal.pone.0027978. Epub 2011 Nov 18.
381 Role of TGF--induced Claudin-4 expression through c-Jun signaling in non-small cell lung cancer.Cell Signal. 2016 Oct;28(10):1537-44. doi: 10.1016/j.cellsig.2016.07.006. Epub 2016 Jul 15.
382 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway. Chem Biol Interact. 2009 May 15;179(2-3):154-9. doi: 10.1016/j.cbi.2008.10.042. Epub 2008 Nov 5.
383 COL6A3 polymorphisms were associated with lung cancer risk in a Chinese population.Respir Res. 2019 Jul 8;20(1):143. doi: 10.1186/s12931-019-1114-y.
384 COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.J Thorac Dis. 2018 Mar;10(3):1596-1606. doi: 10.21037/jtd.2018.02.09.
385 Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients.Am J Hematol. 2004 Jul;76(3):214-9. doi: 10.1002/ajh.20079.
386 CRTC2 promotes non-small cell lung cancer A549 migration and invasion in vitro.Thorac Cancer. 2018 Jan;9(1):136-141. doi: 10.1111/1759-7714.12550. Epub 2017 Nov 3.
387 Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.BMC Med. 2018 Feb 19;16(1):20. doi: 10.1186/s12916-018-1010-1.
388 A rule-based expert system for the automatic classification of DNA "ploidy" histograms measured by the CAS 200 image analysis system.Cytometry. 1997 Feb 15;30(1):39-46. doi: 10.1002/(sici)1097-0320(19970215)30:1<39::aid-cyto6>3.0.co;2-a.
389 Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group.J Thorac Oncol. 2017 Feb;12(2):249-257. doi: 10.1016/j.jtho.2016.09.136. Epub 2016 Oct 25.
390 Tomorrow's genome medicine in lung cancer.Semin Cancer Biol. 2017 Feb;42:39-43. doi: 10.1016/j.semcancer.2016.11.003. Epub 2016 Nov 10.
391 The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.Mol Cancer. 2018 Feb 19;17(1):24. doi: 10.1186/s12943-018-0784-2.
392 Cathepsin D messenger RNA is downregulated in human lung cancer.Biomarkers. 2010 Nov;15(7):608-13. doi: 10.3109/1354750X.2010.504310. Epub 2010 Aug 19.
393 Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer.Cancer Res. 2006 Aug 15;66(16):7968-75. doi: 10.1158/0008-5472.CAN-05-4279.
394 Cathepsin L-mediated resistance of paclitaxel and cisplatin is mediated by distinct regulatory mechanisms. J Exp Clin Cancer Res. 2019 Aug 1;38(1):333. doi: 10.1186/s13046-019-1299-4.
395 Cathepsin-S degraded decorin are elevated in fibrotic lung disorders - development and biological validation of a new serum biomarker.BMC Pulm Med. 2017 Aug 9;17(1):110. doi: 10.1186/s12890-017-0455-x.
396 A water soluble vitamin B12-ReI fluorescent conjugate for cell uptake screens: use in the confirmation of cubilin in the lung cancer line A549.Chem Commun (Camb). 2011 Sep 21;47(35):9792-4. doi: 10.1039/c1cc13615a. Epub 2011 Aug 5.
397 CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway.Oncol Rep. 2019 Mar;41(3):1911-1917. doi: 10.3892/or.2019.6957. Epub 2019 Jan 9.
398 Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC.J Immunother Cancer. 2019 Feb 11;7(1):42. doi: 10.1186/s40425-019-0511-6.
399 Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.Cancer Sci. 2018 Jan;109(1):154-165. doi: 10.1111/cas.13422. Epub 2017 Nov 9.
400 The accessory proteins REEP5 and REEP6 refine CXCR1-mediated cellular responses and lung cancer progression.Sci Rep. 2016 Dec 14;6:39041. doi: 10.1038/srep39041.
401 Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.Cancer Res. 2015 Feb 1;75(3):566-75. doi: 10.1158/0008-5472.CAN-14-2101. Epub 2014 Dec 5.
402 The expression and significance of tumor associated macrophages and CXCR4 in non-small cell lung cancer.J BUON. 2018 Mar-Apr;23(2):398-402.
403 Induction of the cytochrome P450 gene CYP26 during mucous cell differentiation of normal human tracheobronchial epithelial cells. Mol Pharmacol. 2000 Sep;58(3):483-90.
404 Interaction between smoking and CYP2C19*3 polymorphism increased risk of lung cancer in a Chinese population.Tumour Biol. 2014 Jun;35(6):5295-8. doi: 10.1007/s13277-014-1689-3. Epub 2014 Feb 9.
405 Exosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.Cancer Lett. 2019 Mar 1;444:1-8. doi: 10.1016/j.canlet.2018.11.033. Epub 2018 Dec 1.
406 Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.Oncol Rep. 2013 Jun;29(6):2211-8. doi: 10.3892/or.2013.2366. Epub 2013 Mar 26.
407 Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.Artif Cells Nanomed Biotechnol. 2018;46(sup1):380-391. doi: 10.1080/21691401.2018.1426007. Epub 2018 Jan 16.
408 Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):237-44. doi: 10.1016/s0360-3016(02)02891-2.
409 Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.Clin Transl Oncol. 2016 Apr;18(4):398-404. doi: 10.1007/s12094-015-1382-z. Epub 2015 Aug 27.
410 Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation.Oncol Rep. 2019 May;41(5):3119-3126. doi: 10.3892/or.2019.7036. Epub 2019 Feb 28.
411 MiR-431 suppresses proliferation and metastasis of lung cancer via down-regulating DDX5.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):699-707. doi: 10.26355/eurrev_201901_16883.
412 Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion.Oncol Lett. 2018 Jun;15(6):8573-8581. doi: 10.3892/ol.2018.8436. Epub 2018 Apr 5.
413 Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI.PLoS One. 2011 Jan 20;6(1):e16062. doi: 10.1371/journal.pone.0016062.
414 Knockdown of second mitochondria-derived activator of caspase expression by RNAi enhances growth and cisplatin resistance of human lung cancer cells.Cancer Biother Radiopharm. 2010 Dec;25(6):705-12. doi: 10.1089/cbr.2010.0786.
415 Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north Indians.Future Oncol. 2017 Feb;13(3):213-232. doi: 10.2217/fon-2016-0117. Epub 2016 Sep 19.
416 Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease.BMC Cancer. 2018 Jul 13;18(1):739. doi: 10.1186/s12885-018-4659-0.
417 Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.Carcinogenesis. 2019 May 14;40(3):432-440. doi: 10.1093/carcin/bgy187.
418 Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation.J Biol Chem. 2012 Feb 17;287(8):5588-99. doi: 10.1074/jbc.M111.328138. Epub 2011 Dec 21.
419 Collapsin response mediator protein 2 is involved in regulating breast cancer progression.Breast Cancer. 2014 Nov;21(6):715-23. doi: 10.1007/s12282-013-0447-5. Epub 2013 Feb 5.
420 The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung.Am J Pathol. 2009 May;174(5):1629-37. doi: 10.2353/ajpath.2009.080778. Epub 2009 Mar 26.
421 DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.Oncogene. 2011 Feb 10;30(6):668-78. doi: 10.1038/onc.2010.449. Epub 2010 Oct 4.
422 Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.Biochem Biophys Res Commun. 2009 Dec 18;390(3):849-54. doi: 10.1016/j.bbrc.2009.10.061. Epub 2009 Oct 20.
423 A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.Biochim Biophys Acta. 2008 Jan;1782(1):41-50. doi: 10.1016/j.bbadis.2007.11.004. Epub 2007 Nov 22.
424 DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild-type NSCLC cells to AZD9291.J Cell Mol Med. 2019 Nov;23(11):7427-7437. doi: 10.1111/jcmm.14609. Epub 2019 Aug 27.
425 miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.Cell Death Dis. 2017 Oct 26;8(10):e3141. doi: 10.1038/cddis.2017.544.
426 Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation.Cancer Immunol Res. 2015 Aug;3(8):855-63. doi: 10.1158/2326-6066.CIR-15-0024. Epub 2015 May 26.
427 Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium.Am J Respir Cell Mol Biol. 2000 Apr;22(4):422-31. doi: 10.1165/ajrcmb.22.4.3795.
428 Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer.Int J Oncol. 2009 Feb;34(2):465-71.
429 Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.BMC Cancer. 2019 Aug 9;19(1):791. doi: 10.1186/s12885-019-6014-5.
430 PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.Biochim Biophys Acta Gene Regul Mech. 2019 Aug;1862(8):858-869. doi: 10.1016/j.bbagrm.2019.04.006. Epub 2019 May 7.
431 Correlation between SPARC, TGF1, Endoglin and angiogenesis mechanism in lung cancer.J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6):1525-1531.
432 Immune response evoked by tumor-associated NADH oxidase (tNOX) confers potential inhibitory effect on lung carcinoma in a mouse model.Am J Cancer Res. 2019 Apr 1;9(4):740-751. eCollection 2019.
433 Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features.Am J Cancer Res. 2019 Jan 1;9(1):134-144. eCollection 2019.
434 Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.Mol Cancer Ther. 2012 Sep;11(9):2021-32. doi: 10.1158/1535-7163.MCT-12-0030. Epub 2012 Jul 17.
435 Functional genomics lead to new therapies in follicular lymphoma.Ann N Y Acad Sci. 2013 Jul;1293:18-24. doi: 10.1111/nyas.12120. Epub 2013 May 15.
436 The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.Clin Cancer Res. 2010 Apr 15;16(8):2275-83. doi: 10.1158/1078-0432.CCR-09-2000. Epub 2010 Apr 6.
437 Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.Hum Genet. 2013 May;132(5):579-89. doi: 10.1007/s00439-013-1270-y. Epub 2013 Feb 1.
438 EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26.
439 ERR is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes.Cancer Manag Res. 2019 Sep 2;11:8111-8123. doi: 10.2147/CMAR.S204732. eCollection 2019.
440 Epidermal growth factor activates telomerase activity by direct binding of Ets-2 to hTERT promoter in lung cancer cells.Tumour Biol. 2015 Jul;36(7):5389-98. doi: 10.1007/s13277-015-3204-x. Epub 2015 Feb 14.
441 Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.Mol Cancer Ther. 2019 Sep;18(9):1484-1496. doi: 10.1158/1535-7163.MCT-18-1239. Epub 2019 Jul 8.
442 A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas.Ann Thorac Surg. 2019 Feb;107(2):393-400. doi: 10.1016/j.athoracsur.2018.08.056. Epub 2018 Oct 18.
443 Expression and purification of a rapidly degraded protein, TMEM8B-a, in mammalian cell line.Protein Expr Purif. 2018 Nov;151:38-45. doi: 10.1016/j.pep.2018.06.002. Epub 2018 Jun 8.
444 Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.Cancer Lett. 2019 Jan;440-441:23-34. doi: 10.1016/j.canlet.2018.09.032. Epub 2018 Oct 9.
445 In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer.Am J Respir Cell Mol Biol. 2003 Apr;28(4):428-35. doi: 10.1165/rcmb.2002-0114OC.
446 Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPAR activation exerting cancer growth suppression.EBioMedicine. 2019 Mar;41:134-145. doi: 10.1016/j.ebiom.2019.02.015. Epub 2019 Feb 10.
447 FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.Int J Oncol. 2015 Mar;46(3):999-1006. doi: 10.3892/ijo.2015.2817. Epub 2015 Jan 7.
448 MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
449 Isolation of human oncogene sequences (v-fes homolog) from a cosmid library.Science. 1982 Jun 4;216(4550):1136-8. doi: 10.1126/science.6281890.
450 Assessment of FGFR1 Over-Expression and Over-Activity in Lung Cancer Cells: A Toolkit for Anti-FGFR1 Drug Screening.Hum Gene Ther Methods. 2018 Feb;29(1):30-43. doi: 10.1089/hgtb.2017.104. Epub 2018 Jan 26.
451 Wavelet-based identification of DNA focal genomic aberrations from single nucleotide polymorphism arrays.BMC Bioinformatics. 2011 May 11;12:146. doi: 10.1186/1471-2105-12-146.
452 Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.Oncol Rep. 2017 Feb;37(2):1235-1242. doi: 10.3892/or.2016.5301. Epub 2016 Dec 7.
453 Eudesmane-Type Sesquiterpene Lactones Inhibit Nuclear Translocation of the Nuclear Factor B Subunit RelB in Response to a Lymphotoxin Stimulation.Biol Pharm Bull. 2017;40(10):1669-1677. doi: 10.1248/bpb.b17-00170.
454 68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.Clin Nucl Med. 2018 Feb;43(2):117-119. doi: 10.1097/RLU.0000000000001935.
455 Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer.Lung Cancer. 2017 Nov;113:59-68. doi: 10.1016/j.lungcan.2017.09.002. Epub 2017 Sep 5.
456 High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide.Mol Cancer Ther. 2016 Aug;15(8):1998-2008. doi: 10.1158/1535-7163.MCT-15-0950. Epub 2016 Jun 2.
457 Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):690-698. doi: 10.26355/eurrev_201901_16882.
458 High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.Ann Surg Oncol. 2020 Mar;27(3):933-942. doi: 10.1245/s10434-019-07878-8. Epub 2019 Sep 30.
459 RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations.Pathol Int. 2012 May;62(5):324-30. doi: 10.1111/j.1440-1827.2012.02797.x. Epub 2012 Mar 27.
460 Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments.Cell Rep. 2019 Sep 10;28(11):2824-2836.e8. doi: 10.1016/j.celrep.2019.08.011.
461 The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.Biochem Biophys Res Commun. 2019 May 7;512(3):479-485. doi: 10.1016/j.bbrc.2019.03.093. Epub 2019 Mar 21.
462 Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior.Cancer. 2011 Oct 1;117(19):4493-505. doi: 10.1002/cncr.26059. Epub 2011 Mar 22.
463 Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis.J Neurooncol. 2019 Jul;143(3):405-415. doi: 10.1007/s11060-019-03188-x. Epub 2019 May 18.
464 Prognostic significance of G6PD expression and localization in lung adenocarcinoma.Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):38-46. doi: 10.1016/j.bbapap.2018.05.005. Epub 2018 May 9.
465 GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.Oncotarget. 2016 May 31;7(22):32341-50. doi: 10.18632/oncotarget.8700.
466 Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States).Cancer Causes Control. 1997 Jul;8(4):554-9. doi: 10.1023/a:1018434027502.
467 DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11042-50. eCollection 2015.
468 Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.Sci Rep. 2017 Mar 8;7:43908. doi: 10.1038/srep43908.
469 Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.Hum Pathol. 2019 Feb;84:221-230. doi: 10.1016/j.humpath.2018.10.009. Epub 2018 Oct 31.
470 Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.Nat Commun. 2019 Apr 10;10(1):1665. doi: 10.1038/s41467-019-09295-7.
471 MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1.Cancer Res. 2019 Oct 1;79(19):4978-4993. doi: 10.1158/0008-5472.CAN-19-1402. Epub 2019 Aug 20.
472 Carboplatin AUC and gamma-glutamylcysteine synthetase gene expression in peripheral mononuclear cells of lung cancer patients.Anticancer Res. 2001 Nov-Dec;21(6A):3933-6.
473 A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation.Oncogene. 2018 Jan 25;37(4):489-501. doi: 10.1038/onc.2017.352. Epub 2017 Oct 2.
474 Inhibitor of ghrelin receptor reverses gefitinib resistance in lung cancer.Hum Cell. 2019 Jul;32(3):360-366. doi: 10.1007/s13577-019-00245-5. Epub 2019 Apr 24.
475 Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.Cancer Chemother Pharmacol. 2007 Aug;60(3):449-57. doi: 10.1007/s00280-006-0406-3. Epub 2007 Feb 16.
476 Insight into the Role and Regulation of Gap Junction Genes in Lung Cancer and Identification of Nuclear Cx43 as a Putative Biomarker of Poor Prognosis.Cancers (Basel). 2019 Mar 6;11(3):320. doi: 10.3390/cancers11030320.
477 Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.Oncogene. 2019 Feb;38(6):822-837. doi: 10.1038/s41388-018-0471-1. Epub 2018 Sep 3.
478 Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis.Cancer Gene Ther. 2010 Jan;17(1):20-7. doi: 10.1038/cgt.2009.45.
479 IL-24 Inhibits Lung Cancer Growth by Suppressing GLI1 and Inducing DNA Damage.Cancers (Basel). 2019 Nov 27;11(12):1879. doi: 10.3390/cancers11121879.
480 Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.Oncol Rep. 2002 Jan-Feb;9(1):125-8.
481 Expression of G protein-coupled receptor 19 in human lung cancer cells is triggered by entry into S-phase and supports G(2)-M cell-cycle progression.Mol Cancer Res. 2012 Oct;10(10):1343-58. doi: 10.1158/1541-7786.MCR-12-0139. Epub 2012 Aug 21.
482 A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis.Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E943-51. doi: 10.1073/pnas.1100132108. Epub 2011 Sep 26.
483 Knockdown of GluA2 induces apoptosis in non-small-cell lung cancer A549 cells through the p53 signaling pathway.Oncol Lett. 2017 Jul;14(1):1005-1010. doi: 10.3892/ol.2017.6234. Epub 2017 May 24.
484 Conjugation of carcinogens by theta class glutathione s-transferases: mechanisms and relevance to variations in human risk.Pharmacogenetics. 1995;5 Spec No:S103-7. doi: 10.1097/00008571-199512001-00010.
485 Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition.Exp Ther Med. 2017 Aug;14(2):1783-1788. doi: 10.3892/etm.2017.4663. Epub 2017 Jun 23.
486 Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes.Carcinogenesis. 2007 Jun;28(6):1287-93. doi: 10.1093/carcin/bgm021. Epub 2007 Jan 27.
487 Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).Cancer Biother Radiopharm. 2003 Jun;18(3):339-53. doi: 10.1089/108497803322285099.
488 HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFR(T790M).Anticancer Res. 2017 Jul;37(7):3825-3831. doi: 10.21873/anticanres.11761.
489 Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.FEBS Open Bio. 2019 Jan 30;9(3):478-489. doi: 10.1002/2211-5463.12585. eCollection 2019 Mar.
490 MiR-2861 Behaves as a Biomarker of Lung Cancer Stem Cells and Regulates the HDAC5-ERK System Genes.Cell Reprogram. 2018 Apr;20(2):99-106. doi: 10.1089/cell.2017.0045. Epub 2018 Mar 13.
491 Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.Int J Oncol. 2019 Mar;54(3):1112-1122. doi: 10.3892/ijo.2019.4682. Epub 2019 Jan 9.
492 Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.Lung Cancer. 2015 Aug;89(2):99-103. doi: 10.1016/j.lungcan.2015.05.011. Epub 2015 Jun 4.
493 p53 negatively regulates the hepatoma growth factor HDGF.Cancer Res. 2011 Nov 15;71(22):7038-47. doi: 10.1158/0008-5472.CAN-11-1053. Epub 2011 Oct 17.
494 Metformin alleviates nickel-induced autophagy and apoptosis via inhibition of hexokinase-2, activating lipocalin-2, in human bronchial epithelial cells.Oncotarget. 2017 Nov 6;8(62):105536-105552. doi: 10.18632/oncotarget.22317. eCollection 2017 Dec 1.
495 Fine-mapping the MHC region in Asian populations identified novel variants modifying susceptibility to lung cancer.Lung Cancer. 2017 Oct;112:169-175. doi: 10.1016/j.lungcan.2017.08.016. Epub 2017 Aug 31.
496 Pro-inflammatory Cytokines Alter the Immunopeptidome Landscape by Modulation of HLA-B Expression.Front Immunol. 2019 Feb 18;10:141. doi: 10.3389/fimmu.2019.00141. eCollection 2019.
497 An inverse interaction between HOXA11 and HOXA11-AS is associated with cisplatin resistance in lung adenocarcinoma.Epigenetics. 2019 Oct;14(10):949-960. doi: 10.1080/15592294.2019.1625673. Epub 2019 Jun 3.
498 The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.Oncol Lett. 2018 Jun;15(6):8556-8572. doi: 10.3892/ol.2018.8381. Epub 2018 Mar 29.
499 HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer.J Cancer. 2017 Apr 9;8(6):1071-1081. doi: 10.7150/jca.17295. eCollection 2017.
500 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.Cell Death Dis. 2019 Jul 8;10(7):525. doi: 10.1038/s41419-019-1756-1.
501 Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer.Oncotarget. 2018 Apr 10;9(27):19294-19306. doi: 10.18632/oncotarget.25022. eCollection 2018 Apr 10.
502 2016 Annual report from the Italian VATS Group.Future Oncol. 2018 Mar;14(6s):23-28. doi: 10.2217/fon-2017-0423.
503 Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.Lung Cancer. 2015 Feb;87(2):107-16. doi: 10.1016/j.lungcan.2014.12.012. Epub 2014 Dec 25.
504 Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922.Cells. 2019 Sep 28;8(10):1166. doi: 10.3390/cells8101166.
505 Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses.PLoS One. 2019 Jan 31;14(1):e0211490. doi: 10.1371/journal.pone.0211490. eCollection 2019.
506 uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non-Small-Cell Lung Cancer.Mol Ther Nucleic Acids. 2018 Sep 7;12:174-183. doi: 10.1016/j.omtn.2018.05.004. Epub 2018 May 29.
507 Intronic polymorphism (1541-1542delGT) of the constitutive heat shock protein 70 gene has functional significance and shows evidence of association with lung cancer risk.Mol Carcinog. 2004 Mar;39(3):155-63. doi: 10.1002/mc.20009.
508 Human immunodeficiency virus Tat-TIP30 interaction promotes metastasis by enhancing the nuclear translocation of Snail in lung cancer cell lines.Cancer Sci. 2018 Oct;109(10):3105-3114. doi: 10.1111/cas.13768. Epub 2018 Sep 3.
509 Baicalein Inhibits Orthotopic Human Non-Small Cell Lung Cancer Xenografts via Src/Id1 Pathway.Evid Based Complement Alternat Med. 2019 Mar 4;2019:9806062. doi: 10.1155/2019/9806062. eCollection 2019.
510 The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung.Int J Cancer. 2015 Aug 15;137(4):837-47. doi: 10.1002/ijc.29444. Epub 2015 Feb 5.
511 JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models.Cancer Gene Ther. 2019 Nov;26(11-12):411-418. doi: 10.1038/s41417-018-0074-6. Epub 2019 Jan 9.
512 lncINS-IGF2 Promotes Cell Proliferation and Migration by Promoting G1/S Transition in Lung Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033818823029. doi: 10.1177/1533033818823029.
513 M6P/IGF2R is mutated in squamous cell carcinoma of the lung.Oncogene. 2000 Mar 16;19(12):1572-8. doi: 10.1038/sj.onc.1203437.
514 Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.Sci Rep. 2018 Mar 2;8(1):3917. doi: 10.1038/s41598-018-22257-1.
515 Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. Int J Oncol. 2012 Nov;41(5):1751-61. doi: 10.3892/ijo.2012.1599. Epub 2012 Aug 22.
516 IKK targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.Lung Cancer. 2019 Apr;130:169-178. doi: 10.1016/j.lungcan.2019.02.027. Epub 2019 Feb 25.
517 miR?9a suppresses IL?3induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells.Oncol Rep. 2018 Jun;39(6):2613-2623. doi: 10.3892/or.2018.6352. Epub 2018 Apr 4.
518 Circulating Inflammation Proteins Associated With Lung Cancer in African Americans.J Thorac Oncol. 2019 Jul;14(7):1192-1203. doi: 10.1016/j.jtho.2019.03.014. Epub 2019 Apr 3.
519 IL-25 promotes cisplatin resistance of lung cancer cells by activating NF-B signaling pathway to increase of major vault protein.Cancer Med. 2019 Jul;8(7):3491-3501. doi: 10.1002/cam4.2213. Epub 2019 May 1.
520 Association between ADRB2, IL33, and IL2RB gene polymorphisms and lung cancer risk in a Chinese Han population.Int Immunopharmacol. 2019 Dec;77:105930. doi: 10.1016/j.intimp.2019.105930. Epub 2019 Nov 2.
521 The Role of Interleukin-31 Polymorphisms in Non-Small Cell Lung Cancer Genetic Susceptibility and Clinical Outcome.Genet Test Mol Biomarkers. 2018 May;22(5):314-319. doi: 10.1089/gtmb.2017.0256.
522 Functional variants in DCAF4 associated with lung cancer risk in European populations.Carcinogenesis. 2017 May 1;38(5):541-551. doi: 10.1093/carcin/bgx033.
523 IL-32 suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.Cell Death Dis. 2019 Jul 1;10(7):506. doi: 10.1038/s41419-019-1737-4.
524 Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.J Exp Clin Cancer Res. 2016 Jan 20;35:13. doi: 10.1186/s13046-016-0293-3.
525 Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.J Thorac Oncol. 2018 May;13(5):649-659. doi: 10.1016/j.jtho.2018.01.022. Epub 2018 Mar 23.
526 Biomarkers in the diagnosis of pleural diseases: a 2018 update.Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808660. doi: 10.1177/1753466618808660.
527 Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-B-mediated upregulation of matrix metalloproteinase-9.Int J Med Sci. 2013 Jun 14;10(8):995-1002. doi: 10.7150/ijms.5963. Print 2013.
528 SHIP1 inhibits cell growth, migration, and invasion in nonsmall cell lung cancer through the PI3K/AKT pathway.Oncol Rep. 2019 Apr;41(4):2337-2350. doi: 10.3892/or.2019.6990. Epub 2019 Jan 30.
529 TGF--induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.Oncogene. 2011 May 26;30(21):2475-84. doi: 10.1038/onc.2010.619. Epub 2011 Jan 31.
530 Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.Genet Mol Biol. 2019 Feb 25;42(1):15-25. doi: 10.1590/1678-4685-gmb-2017-0307. Print 2019 Jan-Mar.
531 Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration.Tumour Biol. 2015 Aug;36(8):6507-13. doi: 10.1007/s13277-015-3341-2. Epub 2015 Mar 29.
532 Up-regulation of interferon-stimulated gene 15 and its conjugation machinery, UbE1L and UbcH8 expression by tumor necrosis factor- through p38 MAPK and JNK signaling pathways in human lung carcinoma.Mol Cell Biochem. 2019 Dec;462(1-2):51-59. doi: 10.1007/s11010-019-03609-5. Epub 2019 Aug 19.
533 Inhibition of ITCH Suppresses Proliferation and Induces Apoptosis of Lung Cancer Cells.Cell Physiol Biochem. 2018;48(4):1703-1709. doi: 10.1159/000492295. Epub 2018 Aug 3.
534 Integrin 11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.Cancer Sci. 2020 Jan;111(1):200-208. doi: 10.1111/cas.14257. Epub 2019 Dec 18.
535 Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants.Biochem J. 2013 Sep 15;454(3):501-13. doi: 10.1042/BJ20121750.
536 Integrin v promotes proliferation by activating ERK 1/2 in the human lung cancer cell line A549.Mol Med Rep. 2015 Feb;11(2):1266-71. doi: 10.3892/mmr.2014.2860. Epub 2014 Nov 4.
537 Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.Tumour Biol. 2016 Mar;37(3):3469-77. doi: 10.1007/s13277-015-4171-y. Epub 2015 Oct 8.
538 Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin 1-PI3K-AKT Pathway in Lung Cancer.J Cancer. 2019 Jan 1;10(2):293-304. doi: 10.7150/jca.25163. eCollection 2019.
539 Acquired Resistance to EGFR TKIs Mediated by TGF1/Integrin 3 Signaling in EGFR-Mutant Lung Cancer.Mol Cancer Ther. 2019 Dec;18(12):2357-2367. doi: 10.1158/1535-7163.MCT-19-0181. Epub 2019 Sep 9.
540 Alteration in metastasis potential and gene expression in human lung cancer cell lines by ITGB8 silencing.Anat Rec (Hoboken). 2012 Sep;295(9):1446-54. doi: 10.1002/ar.22521. Epub 2012 Jul 2.
541 MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1.Am J Transl Res. 2018 Apr 15;10(4):1164-1171. eCollection 2018.
542 Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.Cancer Immunol Immunother. 2002 Dec;51(11-12):614-20. doi: 10.1007/s00262-002-0328-9. Epub 2002 Oct 18.
543 TASK-1 induces gefitinib resistance by promoting cancer initiating cell formation and epithelial-mesenchymal transition in lung cancer.Exp Ther Med. 2018 Jan;15(1):365-370. doi: 10.3892/etm.2017.5426. Epub 2017 Nov 1.
544 The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.Int J Cancer. 2012 Aug 1;131(3):E179-89. doi: 10.1002/ijc.26501. Epub 2011 Dec 21.
545 Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.Oncol Rep. 2016 Jan;35(1):352-8. doi: 10.3892/or.2015.4349. Epub 2015 Oct 26.
546 JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.Tumour Biol. 2015 Sep;36(9):7133-42. doi: 10.1007/s13277-015-3418-y. Epub 2015 Apr 16.
547 A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer.Clin Cancer Res. 2019 May 15;25(10):3026-3034. doi: 10.1158/1078-0432.CCR-18-3041. Epub 2019 Feb 14.
548 Multiplex measurement of twelve tumor markers using a GMR multi-biomarker immunoassay biosensor.Biosens Bioelectron. 2019 Jan 1;123:204-210. doi: 10.1016/j.bios.2018.08.060. Epub 2018 Aug 25.
549 Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.Clin Chem. 2010 Jun;56(6):987-97. doi: 10.1373/clinchem.2009.138917. Epub 2010 Apr 1.
550 Biomarkers for the lung cancer diagnosis and their advances in proteomics.BMB Rep. 2008 Sep 30;41(9):615-25. doi: 10.5483/bmbrep.2008.41.9.615.
551 MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cells.Mol Med Rep. 2019 Jan;19(1):213-220. doi: 10.3892/mmr.2018.9676. Epub 2018 Nov 20.
552 Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis.Cancer Manag Res. 2019 Aug 7;11:7485-7497. doi: 10.2147/CMAR.S218926. eCollection 2019.
553 L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.Clin Cancer Res. 2012 Apr 1;18(7):1914-24. doi: 10.1158/1078-0432.CCR-11-2893. Epub 2012 Feb 3.
554 miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3.Cancer Res. 2016 Oct 1;76(19):5777-5787. doi: 10.1158/0008-5472.CAN-15-2936.
555 LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.Sci Rep. 2015 Sep 7;5:13846. doi: 10.1038/srep13846.
556 Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.Int J Oncol. 2018 Jan;52(1):179-188. doi: 10.3892/ijo.2017.4201. Epub 2017 Nov 10.
557 Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.Cancer Res. 2018 Sep 1;78(17):4929-4942. doi: 10.1158/0008-5472.CAN-18-0152. Epub 2018 Jul 2.
558 The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.Adv Exp Med Biol. 2016;890:57-74. doi: 10.1007/978-3-319-24932-2_4.
559 Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients.Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):506-513. doi: 10.1016/j.arbres.2019.10.017. Epub 2019 Nov 25.
560 Downregulation of LIMK1 level inhibits migration of lung cancer cells and enhances sensitivity to chemotherapy drugs.Oncol Res. 2013;20(11):491-8. doi: 10.3727/096504013X13657689382699.
561 Long non-coding RNA Linc00662 promotes cell invasion and contributes to cancer stem cell-like phenotypes in lung cancer cells.J Biochem. 2018 Dec 1;164(6):461-469. doi: 10.1093/jb/mvy078.
562 Clinical and biological significance of an isozyme tumor marker--PLAP.Clin Biochem. 1987 Dec;20(6):387-92. doi: 10.1016/0009-9120(87)90003-8.
563 Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer.Mol Cancer. 2014 Oct 24;13:240. doi: 10.1186/1476-4598-13-240.
564 Ionizing radiation attracts tumor targeting and apoptosis by radiotropic lysyl oxidase traceable nanoparticles.Nanomedicine. 2020 Feb;24:102141. doi: 10.1016/j.nano.2019.102141. Epub 2019 Dec 10.
565 ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis.Oncogene. 2017 Apr 6;36(14):1925-1938. doi: 10.1038/onc.2016.358. Epub 2016 Oct 3.
566 Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.Tumour Biol. 2010 Aug;31(4):341-9. doi: 10.1007/s13277-010-0043-7. Epub 2010 May 18.
567 CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes.Am J Respir Cell Mol Biol. 2008 Jun;38(6):671-8. doi: 10.1165/rcmb.2007-0205OC. Epub 2008 Jan 24.
568 Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination.Cancer Immunol Immunother. 2018 Jun;67(6):949-964. doi: 10.1007/s00262-018-2152-x. Epub 2018 Mar 22.
569 Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors.Oncotarget. 2018 Jun 8;9(44):27346-27362. doi: 10.18632/oncotarget.25213. eCollection 2018 Jun 8.
570 Clinical significance of CCBE1 expression in lung cancer.Mol Med Rep. 2018 Feb;17(2):2107-2112. doi: 10.3892/mmr.2017.8187. Epub 2017 Nov 29.
571 Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer.J Med Genet. 2010 Sep;47(9):616-22. doi: 10.1136/jmg.2009.074252. Epub 2010 Jun 1.
572 Attenuated plasmodium sporozoite expressing MAGE-A3 induces antigen-specific CD8+ T cell response against lung cancer in mice.Cancer Biol Med. 2019 May;16(2):288-298. doi: 10.20892/j.issn.2095-3941.2018.0309.
573 Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status.Int J Oncol. 2018 Aug;53(2):713-724. doi: 10.3892/ijo.2018.4425. Epub 2018 May 31.
574 HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma.Lab Invest. 2003 Aug;83(8):1185-92. doi: 10.1097/01.lab.0000080605.73839.96.
575 Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines.Oncogene. 1997 Mar 13;14(10):1231-4. doi: 10.1038/sj.onc.1200947.
576 The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.J Thorac Oncol. 2019 Jun;14(6):1046-1060. doi: 10.1016/j.jtho.2019.02.004. Epub 2019 Feb 13.
577 DIAPH3 promotes the tumorigenesis of lung adenocarcinoma.Exp Cell Res. 2019 Dec 1;385(1):111662. doi: 10.1016/j.yexcr.2019.111662. Epub 2019 Oct 3.
578 Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.Mol Carcinog. 2018 Feb;57(2):216-224. doi: 10.1002/mc.22748. Epub 2017 Oct 31.
579 Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells.Ann Transl Med. 2019 Oct;7(20):539. doi: 10.21037/atm.2019.10.07.
580 TPL2 kinase is a suppressor of lung carcinogenesis.Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1470-9. doi: 10.1073/pnas.1215938110. Epub 2013 Mar 26.
581 Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.J Biol Chem. 2018 Oct 19;293(42):16193-16205. doi: 10.1074/jbc.RA118.003699. Epub 2018 Aug 30.
582 KIF20A silence inhibits the migration, invasion and proliferation of non-small cell lung cancer and regulates the JNK pathway.Clin Exp Pharmacol Physiol. 2020 Jan;47(1):135-142. doi: 10.1111/1440-1681.13183. Epub 2019 Oct 22.
583 The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells.Mol Cell Biol. 1999 Mar;19(3):1938-49. doi: 10.1128/MCB.19.3.1938.
584 A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer.Am J Hum Genet. 2012 Aug 10;91(2):384-90. doi: 10.1016/j.ajhg.2012.07.003.
585 Biological role of mannose binding lectin: From newborns to centenarians.Clin Chim Acta. 2015 Dec 7;451(Pt A):78-81. doi: 10.1016/j.cca.2015.03.007. Epub 2015 Mar 14.
586 The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2.Cell Death Dis. 2019 Jul 18;10(8):554. doi: 10.1038/s41419-019-1789-5.
587 CD146-mediated acquisition of stemness phenotype enhances tumour invasion and metastasis after EGFR-TKI resistance in lung cancer.Clin Respir J. 2019 Jan;13(1):23-33. doi: 10.1111/crj.12976.
588 Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer.PLoS One. 2013 Aug 16;8(8):e71093. doi: 10.1371/journal.pone.0071093. eCollection 2013.
589 Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.Mol Cancer Ther. 2015 Sep;14(9):2014-22. doi: 10.1158/1535-7163.MCT-15-0116. Epub 2015 Jul 10.
590 Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.Cell Death Dis. 2018 Jan 18;9(2):36. doi: 10.1038/s41419-017-0188-z.
591 Chromate exposure induces DNA hypermethylation of the mismatch repair gene MLH1 in lung cancer.Mol Carcinog. 2020 Jan;59(1):24-31. doi: 10.1002/mc.23125. Epub 2019 Oct 3.
592 Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.PLoS One. 2012;7(4):e35040. doi: 10.1371/journal.pone.0035040. Epub 2012 Apr 24.
593 The Association of MMP-11 Promoter Polymorphisms With Susceptibility to Lung Cancer in Taiwan.Anticancer Res. 2019 Oct;39(10):5375-5380. doi: 10.21873/anticanres.13731.
594 The Precise Diagnosis of Cancer Invasion/Metastasis via 2D Laser Ablation Mass Mapping of Metalloproteinase in Primary Cancer Tissue.ACS Nano. 2018 Nov 27;12(11):11139-11151. doi: 10.1021/acsnano.8b05584. Epub 2018 Oct 31.
595 Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.BMC Cancer. 2012 Sep 11;12:405. doi: 10.1186/1471-2407-12-405.
596 Functional Polymorphism in the MSI1 Gene Promoter Confers a Decreased Risk of Lung Cancer in Chinese by Reducing MSI1 Expression.Curr Genomics. 2018 Aug;19(5):375-383. doi: 10.2174/1389202919666171128151544.
597 Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy.J Exp Clin Cancer Res. 2013 May 17;32(1):28. doi: 10.1186/1756-9966-32-28.
598 Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.Tumour Biol. 2013 Apr;34(2):749-57. doi: 10.1007/s13277-012-0604-z. Epub 2012 Nov 29.
599 Function of macrophage scavenger receptor 1 gene polymorphisms in chronic obstructive pulmonary disease with and without lung cancer in China.Oncol Lett. 2018 May;15(5):8046-8052. doi: 10.3892/ol.2018.8311. Epub 2018 Mar 21.
600 Brain Metastases from Lung Cancer: Is MET an Actionable Target?.Cancers (Basel). 2019 Feb 26;11(3):271. doi: 10.3390/cancers11030271.
601 Myostatin promotes the epithelial-to-mesenchymal transition of the dermomyotome during somitogenesis.Dev Dyn. 2018 Dec;247(12):1241-1252. doi: 10.1002/dvdy.24681. Epub 2018 Nov 22.
602 MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.J Exp Clin Cancer Res. 2015 Dec 23;34:157. doi: 10.1186/s13046-015-0263-1.
603 Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.J Biol Chem. 2011 Feb 11;286(6):4902-11. doi: 10.1074/jbc.M110.198374. Epub 2010 Dec 6.
604 Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression.Oncotarget. 2017 Jun 28;8(37):61901-61916. doi: 10.18632/oncotarget.18717. eCollection 2017 Sep 22.
605 Association of Three Single Nucleotide Polymorphisms in MTR and MTRR Genes with Lung Cancer in a Turkish Population.Genet Test Mol Biomarkers. 2017 Jul;21(7):428-432. doi: 10.1089/gtmb.2017.0062. Epub 2017 May 24.
606 Membrane-bound (MUC1) and secretory (MUC2, MUC3, and MUC4) mucin gene expression in human lung cancer.Tumour Biol. 1996;17(3):176-92. doi: 10.1159/000217980.
607 Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer.Pathol Res Pract. 2019 Mar;215(3):459-465. doi: 10.1016/j.prp.2018.12.011. Epub 2018 Dec 10.
608 Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.Pathol Oncol Res. 2019 Oct;25(4):1327-1340. doi: 10.1007/s12253-017-0372-6. Epub 2017 Dec 5.
609 Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.Tumour Biol. 2016 May;37(5):6017-25. doi: 10.1007/s13277-015-4436-5. Epub 2015 Nov 23.
610 MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.Tumour Biol. 2014 Dec;35(12):12189-200. doi: 10.1007/s13277-014-2527-3. Epub 2014 Sep 2.
611 Protective effect of transferrin C3 in lung cancer?.Oncology. 1999;56(4):328-31. doi: 10.1159/000011987.
612 Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.PLoS One. 2017 May 22;12(5):e0178286. doi: 10.1371/journal.pone.0178286. eCollection 2017.
613 Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?.Wien Klin Wochenschr. 2019 Sep;131(17-18):419-426. doi: 10.1007/s00508-019-01537-4. Epub 2019 Aug 22.
614 Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.EBioMedicine. 2019 Jul;45:81-91. doi: 10.1016/j.ebiom.2019.06.005. Epub 2019 Jun 14.
615 NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.Int J Cancer. 2014 May 15;134(10):2294-304. doi: 10.1002/ijc.28568. Epub 2013 Nov 15.
616 NIMA-related kinase 2 overexpression is associated with poor survival in cancer patients: a systematic review and meta-analysis.Cancer Manag Res. 2019 Jan 3;11:455-465. doi: 10.2147/CMAR.S188347. eCollection 2019.
617 Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.Anticancer Res. 2004 Sep-Oct;24(5A):2665-73.
618 Effect of NELL1 on lung cancer stemlike cell differentiation.Oncol Rep. 2019 Mar;41(3):1817-1826. doi: 10.3892/or.2019.6954. Epub 2019 Jan 3.
619 p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.Thorac Cancer. 2018 Jan;9(1):152-158. doi: 10.1111/1759-7714.12564. Epub 2017 Nov 21.
620 Cigarette smoke induces methylation of the tumor suppressor gene NISCH.Epigenetics. 2013 Apr;8(4):383-8. doi: 10.4161/epi.24195. Epub 2013 Mar 15.
621 Nm23-H1 inhibits hypoxia induced epithelial-mesenchymal transition and stemness in non-small cell lung cancer cells.Biol Chem. 2019 May 27;400(6):765-776. doi: 10.1515/hsz-2018-0351.
622 Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo.J Med Chem. 2017 Jun 22;60(12):5162-5192. doi: 10.1021/acs.jmedchem.7b00608. Epub 2017 Jun 12.
623 Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.Clin Cancer Res. 1997 Oct;3(10):1873-7.
624 Common Variants rs3815188 and rs1043994 on Notch3 Gene Confer Susceptibility to Lung Cancer: A Hospital-Based Case-Control Study.J Environ Pathol Toxicol Oncol. 2019;38(1):61-68. doi: 10.1615/JEnvironPatholToxicolOncol.2018028403.
625 Stability and utility of the unique human small cell carcinoma line SHP-77.Cancer Res. 1985 Jun;45(6):2725-31.
626 The multi-faceted high order polymorphic synergistic interactions among nucleotide excision repair genes increase the risk of lung cancer in North Indians.Mutat Res. 2019 Nov;816-818:111673. doi: 10.1016/j.mrfmmm.2019.111673. Epub 2019 Jun 8.
627 Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure.Bioorg Med Chem. 2020 Jan 1;28(1):115186. doi: 10.1016/j.bmc.2019.115186. Epub 2019 Nov 11.
628 Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.Oncotarget. 2018 May 25;9(40):26072-26085. doi: 10.18632/oncotarget.25437. eCollection 2018 May 25.
629 Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells.Carcinogenesis. 2009 Sep;30(9):1606-13. doi: 10.1093/carcin/bgp161. Epub 2009 Jul 1.
630 Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.Oncogene. 2019 Mar;38(12):2108-2122. doi: 10.1038/s41388-018-0566-8. Epub 2018 Nov 19.
631 Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.Cancer Med. 2019 Mar;8(3):1232-1245. doi: 10.1002/cam4.1992. Epub 2019 Feb 10.
632 Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells.J Immunother Cancer. 2018 Dec 4;6(1):136. doi: 10.1186/s40425-018-0441-8.
633 Netrin? interference potentiates epithelialtomesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of nonsmall cell lung cancer.Int J Oncol. 2019 Apr;54(4):1457-1465. doi: 10.3892/ijo.2019.4716. Epub 2019 Feb 15.
634 Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer.Cancers (Basel). 2019 Apr 2;11(4):462. doi: 10.3390/cancers11040462.
635 Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.Oncotarget. 2014 Sep 30;5(18):8252-69. doi: 10.18632/oncotarget.1633.
636 Ornithine aminotransferase promoted the proliferation and metastasis of non-small cell lung cancer via upregulation of miR-21.J Cell Physiol. 2019 Aug;234(8):12828-12838. doi: 10.1002/jcp.27939. Epub 2018 Dec 13.
637 Adenovirus-mediated expression of both antisense ornithine decarboxylase and S-adenosylmethionine decarboxylase inhibits lung cancer cell growth.Acta Biochim Biophys Sin (Shanghai). 2007 Jun;39(6):423-30. doi: 10.1111/j.1745-7270.2007.00294.x.
638 Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study.Anesth Analg. 2016 Dec;123(6):1429-1436. doi: 10.1213/ANE.0000000000001293.
639 Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.Int J Clin Exp Pathol. 2015 May 1;8(5):5080-8. eCollection 2015.
640 Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung.Lung Cancer. 2005 Nov;50(2):177-88. doi: 10.1016/j.lungcan.2005.05.027. Epub 2005 Jul 25.
641 Correlation of P2RX7 gene rs1718125 polymorphism with postoperative fentanyl analgesia in patients with lung cancer.Medicine (Baltimore). 2019 Feb;98(7):e14445. doi: 10.1097/MD.0000000000014445.
642 Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.Int J Cancer. 2007 Jun 15;120(12):2538-44. doi: 10.1002/ijc.22585.
643 PADI4mediated epithelialmesenchymal transition in lung cancer cells.Mol Med Rep. 2019 Apr;19(4):3087-3094. doi: 10.3892/mmr.2019.9968. Epub 2019 Feb 19.
644 Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort.Carcinogenesis. 2014 Sep;35(9):2047-54. doi: 10.1093/carcin/bgu098. Epub 2014 Apr 29.
645 Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.Appl Immunohistochem Mol Morphol. 2020 Sep;28(8):602-610. doi: 10.1097/PAI.0000000000000803.
646 Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.Lung Cancer. 1999 Mar;23(3):209-22. doi: 10.1016/s0169-5002(99)00015-x.
647 Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors.Biochem Biophys Res Commun. 2020 Jan 29;522(1):121-126. doi: 10.1016/j.bbrc.2019.11.050. Epub 2019 Nov 18.
648 PCNA and GSK3 interact with each other to regulate H1299 lung adenocarcinoma cells apoptosis.Neoplasma. 2020 Jan;67(1):15-26. doi: 10.4149/neo_2019_190116N48. Epub 2019 Oct 8.
649 Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?.Eur J Cancer. 2019 May;113:28-31. doi: 10.1016/j.ejca.2019.02.016. Epub 2019 Apr 6.
650 Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells.Eur J Med Chem. 2018 Feb 10;145:551-558. doi: 10.1016/j.ejmech.2018.01.024. Epub 2018 Jan 10.
651 Expression in lung carcinomas of platelet-derived growth factor and its receptors.Lab Invest. 1997 Nov;77(5):431-6.
652 PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.Biosci Rep. 2019 May 14;39(5):BSR20182099. doi: 10.1042/BSR20182099. Print 2019 May 31.
653 PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3.J Drug Target. 2019 Apr;27(4):460-465. doi: 10.1080/1061186X.2018.1550648. Epub 2018 Dec 4.
654 Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.Am J Pathol. 2001 Oct;159(4):1345-52. doi: 10.1016/S0002-9440(10)62521-7.
655 Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling.Cells. 2019 May 10;8(5):442. doi: 10.3390/cells8050442.
656 Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.J Biol Chem. 2019 Jul 5;294(27):10530-10543. doi: 10.1074/jbc.RA119.007784. Epub 2019 May 24.
657 YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation.Carcinogenesis. 2020 Jul 10;41(5):541-550. doi: 10.1093/carcin/bgz152.
658 Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis.Mol Cell Biochem. 2018 Feb;439(1-2):163-169. doi: 10.1007/s11010-017-3145-3. Epub 2017 Aug 31.
659 Characteristic analysis of pulmonary ground-glass lesions with the help of 64-slice CT technology.Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3212-3217.
660 Differential expression and subcellular localization of Prohibitin 1 are related to tumorigenesis and progression of non-small cell lung cancer.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2092-101. eCollection 2013.
661 The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer.Biochem Biophys Res Commun. 2014 Aug 15;451(1):119-25. doi: 10.1016/j.bbrc.2014.07.076. Epub 2014 Jul 24.
662 Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase.Theranostics. 2018 Feb 12;8(7):1808-1823. doi: 10.7150/thno.23177. eCollection 2018.
663 Downregulation of Pim-2 induces cell cycle arrest in the G(0)/G(1) phase via the p53-non-dependent p21 signaling pathway.Oncol Lett. 2018 Apr;15(4):4079-4086. doi: 10.3892/ol.2018.7865. Epub 2018 Jan 26.
664 Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.Oncol Rep. 2018 Jan;39(1):53-60. doi: 10.3892/or.2017.6086. Epub 2017 Nov 9.
665 Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.Lung Cancer. 2009 Aug;65(2):237-41. doi: 10.1016/j.lungcan.2008.11.012. Epub 2008 Dec 31.
666 PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.Cell Cycle. 2014;13(19):3132-42. doi: 10.4161/15384101.2014.949212.
667 Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.Mol Carcinog. 2012 Jul;51(7):546-52. doi: 10.1002/mc.20819. Epub 2011 Jul 7.
668 DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.Mol Cancer Res. 2017 Mar;15(3):269-280. doi: 10.1158/1541-7786.MCR-16-0227-T. Epub 2017 Jan 10.
669 A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein.Cancer Gene Ther. 2005 May;12(5):497-508. doi: 10.1038/sj.cgt.7700817.
670 Suppression of PPN/MG61 attenuates Wnt/beta-catenin signaling pathway and induces apoptosis in human lung cancer.Oncogene. 2008 May 29;27(24):3483-8. doi: 10.1038/sj.onc.1211006. Epub 2008 Jan 14.
671 Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.Lung Cancer. 2014 Sep;85(3):449-56. doi: 10.1016/j.lungcan.2014.06.014. Epub 2014 Jun 27.
672 Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.Br J Cancer. 2015 Mar 17;112(6):1114-20. doi: 10.1038/bjc.2015.79.
673 Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.Acta Pharmacol Sin. 2017 Feb;38(2):223-232. doi: 10.1038/aps.2016.114. Epub 2016 Dec 5.
674 Zinc suppresses stem cell properties of lung cancer cells through protein kinase C-mediated -catenin degradation.Am J Physiol Cell Physiol. 2017 Apr 1;312(4):C487-C499. doi: 10.1152/ajpcell.00173.2016. Epub 2017 Jan 25.
675 Co-dependency of PKC and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.Oncogene. 2017 Jul 27;36(30):4370-4378. doi: 10.1038/onc.2017.27. Epub 2017 Apr 3.
676 PKC maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.Mol Cancer Res. 2013 Dec;11(12):1624-35. doi: 10.1158/1541-7786.MCR-13-0371-T. Epub 2013 Oct 30.
677 Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, -catenin, and Twist pathways. Environ Toxicol. 2019 Feb;34(2):203-209. doi: 10.1002/tox.22674. Epub 2018 Nov 12.
678 Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.Immunobiology. 2020 Mar;225(2):151891. doi: 10.1016/j.imbio.2019.11.026. Epub 2019 Nov 27.
679 T-cell receptor V delta gene usage by tumour reactive gamma delta T lymphocytes infiltrating human lung cancer.Immunology. 1994 Feb;81(2):234-9.
680 Stabilization of PTGES by deubiquitinase USP9X promotes metastatic features of lung cancer via PGE(2) signaling.Am J Cancer Res. 2019 Jun 1;9(6):1145-1160. eCollection 2019.
681 Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer.Oncol Rep. 2014 Jun;31(6):2708-12. doi: 10.3892/or.2014.3164. Epub 2014 Apr 30.
682 miR-339-5p Increases Radiosensitivity of Lung Cancer Cells by Targeting Phosphatases of Regenerating Liver-1 (PRL-1).Med Sci Monit. 2018 Nov 21;24:8408-8416. doi: 10.12659/MSM.910808.
683 Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.Oncol Rep. 2012 Feb;27(2):535-40. doi: 10.3892/or.2011.1495. Epub 2011 Oct 6.
684 Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer.Gene. 2012 Dec 15;511(2):169-76. doi: 10.1016/j.gene.2012.09.079. Epub 2012 Oct 2.
685 Protein tyrosine phosphatase L1 inhibits high-grade serous ovarian carcinoma progression by targeting IB.Onco Targets Ther. 2018 Oct 30;11:7603-7612. doi: 10.2147/OTT.S167106. eCollection 2018.
686 Implication of a protein-tyrosine-phosphatase in human lung cancer.Cell Mol Biol (Noisy-le-grand). 1994 Jul;40(5):677-85.
687 Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer.J Cell Biochem. 2017 Oct;118(10):3391-3400. doi: 10.1002/jcb.25995. Epub 2017 May 3.
688 Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma.Biol Chem. 2020 Mar 26;401(4):517-531. doi: 10.1515/hsz-2019-0329.
689 RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.Mol Carcinog. 2017 Nov;56(11):2391-2399. doi: 10.1002/mc.22663. Epub 2017 Sep 15.
690 Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.Mol Cancer Ther. 2019 Mar;18(3):656-666. doi: 10.1158/1535-7163.MCT-18-0067. Epub 2018 Nov 26.
691 Anticancer activity of 2'-hydroxyflavanone towards lung cancer.Oncotarget. 2018 Nov 16;9(90):36202-36219. doi: 10.18632/oncotarget.26329. eCollection 2018 Nov 16.
692 Epac1 is involved in cell cycle progression in lung cancer through PKC and Cx43 regulation.Folia Histochem Cytobiol. 2018;56(1):21-26. doi: 10.5603/FHC.a2018.0004. Epub 2018 Mar 12.
693 Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci. 2007 Feb;98(2):169-73. doi: 10.1111/j.1349-7006.2006.00367.x.
694 REG I gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms.Oncol Rep. 2013 Dec;30(6):2625-31. doi: 10.3892/or.2013.2739. Epub 2013 Sep 19.
695 REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression.J Cancer Res Clin Oncol. 2019 Sep;145(9):2273-2283. doi: 10.1007/s00432-019-02988-y. Epub 2019 Aug 19.
696 Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.Ann Oncol. 2017 Mar 1;28(3):547-554. doi: 10.1093/annonc/mdw669.
697 ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).Anticancer Res. 2019 Mar;39(3):1267-1273. doi: 10.21873/anticanres.13237.
698 Caveolin-1 knockdown increases the therapeutic sensitivity of lung cancer to cisplatin-induced apoptosis by repressing Parkin-related mitophagy and activating the ROCK1 pathway.J Cell Physiol. 2020 Feb;235(2):1197-1208. doi: 10.1002/jcp.29033. Epub 2019 Jul 4.
699 Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.Cancer Treat Rev. 2019 Jul;77:11-19. doi: 10.1016/j.ctrv.2019.05.006. Epub 2019 May 29.
700 Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2.BMC Mol Biol. 2008 Jan 23;9:11. doi: 10.1186/1471-2199-9-11.
701 R-spondin family members as novel biomarkers and prognostic factors in lung cancer.Oncol Lett. 2019 Oct;18(4):4008-4015. doi: 10.3892/ol.2019.10778. Epub 2019 Aug 22.
702 NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.Cancer Res. 1994 Sep 1;54(17):4769-76.
703 Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.Tumour Biol. 2019 May;41(5):1010428319851014. doi: 10.1177/1010428319851014.
704 Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles.J Comput Biol. 2019 Oct;26(10):1140-1155. doi: 10.1089/cmb.2019.0046. Epub 2019 Jul 15.
705 S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2.J Biol Chem. 2019 May 3;294(18):7516-7527. doi: 10.1074/jbc.RA118.004365. Epub 2019 Mar 18.
706 S100A6/miR193a regulates the proliferation, invasion, migration and angiogenesis of lung cancer cells through the P53 acetylation.Am J Transl Res. 2019 Aug 15;11(8):4634-4649. eCollection 2019.
707 Neuroplastin- mediates S100A8/A9-induced lung cancer disseminative progression.Mol Carcinog. 2019 Jun;58(6):980-995. doi: 10.1002/mc.22987. Epub 2019 Feb 27.
708 Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis.Lung. 2019 Aug;197(4):523-531. doi: 10.1007/s00408-019-00238-z. Epub 2019 May 21.
709 TGF-/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.J Biol Chem. 2016 Dec 30;291(53):27343-27353. doi: 10.1074/jbc.M116.740084. Epub 2016 Nov 17.
710 Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer.J Med Biochem. 2019 May 11;38(3):332-341. doi: 10.2478/jomb-2018-0036. eCollection 2019 Jul.
711 Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival.Mol Med Rep. 2017 Dec;16(6):8842-8848. doi: 10.3892/mmr.2017.7683. Epub 2017 Oct 2.
712 SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals.Cancer Cell Int. 2019 Apr 18;19:103. doi: 10.1186/s12935-019-0809-y. eCollection 2019.
713 Development of a Novel AOP for Cyp2F2-Mediated Lung Cancer in Mice.Toxicol Sci. 2019 Nov 1;172(1):1-10. doi: 10.1093/toxsci/kfz185.
714 Serum antibodies to lipophilin B detected in late stage breast cancer patients. Clin Cancer Res. 2003 Feb;9(2):749-54.
715 Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.J Thorac Oncol. 2016 Mar;11(3):346-360. doi: 10.1016/j.jtho.2015.11.004. Epub 2015 Dec 25.
716 Syndecan-1 Controls Lung Tumorigenesis by Regulating miRNAs Packaged in Exosomes.Am J Pathol. 2018 Apr;188(4):1094-1103. doi: 10.1016/j.ajpath.2017.12.009. Epub 2018 Jan 31.
717 Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness.Am J Respir Cell Mol Biol. 2019 Jun;60(6):659-666. doi: 10.1165/rcmb.2018-0118OC.
718 Sema4D expression and secretion are increased by HIF-1 and inhibit osteogenesis in bone metastases of lung cancer.Clin Exp Metastasis. 2019 Feb;36(1):39-56. doi: 10.1007/s10585-018-9951-5. Epub 2019 Jan 7.
719 Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells.Tumour Biol. 2014 Jul;35(7):6557-65. doi: 10.1007/s13277-014-1879-z. Epub 2014 Apr 2.
720 Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES.Virus Res. 2007 Jun;126(1-2):216-25. doi: 10.1016/j.virusres.2007.03.003. Epub 2007 Apr 9.
721 Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury.Mol Cell Biol. 2011 Jul;31(14):2902-19. doi: 10.1128/MCB.05452-11. Epub 2011 May 16.
722 Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.Cancer Res. 2004 Oct 1;64(19):6900-5. doi: 10.1158/0008-5472.CAN-04-1657.
723 Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.Mol Cancer. 2019 Jun 20;18(1):108. doi: 10.1186/s12943-019-1027-x.
724 Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells.J Cancer. 2017 Jul 5;8(11):2069-2078. doi: 10.7150/jca.19143. eCollection 2017.
725 High-order gene interactions between the genetic polymorphisms in Wnt and AhR pathway in modulating lung cancer susceptibility.Per Med. 2017 Nov;14(6):487-502. doi: 10.2217/pme-2017-0018. Epub 2017 Nov 28.
726 Lentivirus-mediated siRNA interference targeting SGO-1 inhibits human NSCLC cell growth.Tumour Biol. 2012 Apr;33(2):515-21. doi: 10.1007/s13277-011-0284-0. Epub 2011 Dec 8.
727 SHCBP1 regulates apoptosis in lung cancer cells through phosphatase and tensin homolog.Oncol Lett. 2019 Aug;18(2):1888-1894. doi: 10.3892/ol.2019.10520. Epub 2019 Jun 24.
728 The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.Cancer Discov. 2019 Nov;9(11):1606-1627. doi: 10.1158/2159-8290.CD-18-1261. Epub 2019 Jul 26.
729 miR?50 promotes the proliferation and migration of nonsmall cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.Oncol Rep. 2018 Aug;40(2):943-951. doi: 10.3892/or.2018.6487. Epub 2018 Jun 12.
730 SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer.Sci Rep. 2015 Dec 10;5:17940. doi: 10.1038/srep17940.
731 UTE-SENCEFUL: first results for 3D high-resolution lung ventilation imaging.Magn Reson Med. 2019 Apr;81(4):2464-2473. doi: 10.1002/mrm.27576. Epub 2018 Nov 4.
732 Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):387-393. doi: 10.21873/cgp.20097.
733 Folate/homocysteine metabolism and lung cancer risk among smokers.PLoS One. 2019 Apr 2;14(4):e0214462. doi: 10.1371/journal.pone.0214462. eCollection 2019.
734 Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.Mol Imaging Biol. 2016 Feb;18(1):18-23. doi: 10.1007/s11307-015-0862-4.
735 Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases.Sci Rep. 2015 Aug 27;5:13502. doi: 10.1038/srep13502.
736 The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia.Front Oncol. 2018 May 25;8:170. doi: 10.3389/fonc.2018.00170. eCollection 2018.
737 The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines.Mol Cell Biochem. 2009 Jan;320(1-2):163-71. doi: 10.1007/s11010-008-9918-y. Epub 2008 Oct 1.
738 MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/-catenin pathway.Oncotarget. 2016 Mar 22;7(12):14569-85. doi: 10.18632/oncotarget.7538.
739 TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers.PLoS One. 2016 Jun 13;11(6):e0157453. doi: 10.1371/journal.pone.0157453. eCollection 2016.
740 Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.Mol Cancer Ther. 2018 Sep;17(9):2024-2033. doi: 10.1158/1535-7163.MCT-17-1178. Epub 2018 Jun 29.
741 Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.Am J Pathol. 2011 Jul;179(1):513-23. doi: 10.1016/j.ajpath.2011.03.025. Epub 2011 May 7.
742 MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer.Int J Oncol. 2019 Jan;54(1):199-208. doi: 10.3892/ijo.2018.4599. Epub 2018 Oct 19.
743 Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.Clin Transl Oncol. 2015 Oct;17(10):795-802. doi: 10.1007/s12094-015-1307-x. Epub 2015 Jun 27.
744 QSurface: fast identification of surface expression markers in cancers.BMC Syst Biol. 2018 Mar 19;12(Suppl 2):17. doi: 10.1186/s12918-018-0541-6.
745 Up-regulation of long noncoding RNA MINCR promotes non-small cell of lung cancer growth by negatively regulating miR-126/SLC7A5 axis.Biochem Biophys Res Commun. 2019 Jan 15;508(3):780-784. doi: 10.1016/j.bbrc.2018.11.162. Epub 2018 Dec 6.
746 Influx transporter variants as predictors of cancer chemotherapy-induced toxicity: systematic review and meta-analysis.Pharmacogenomics. 2016 Jul;17(10):1189-1205. doi: 10.2217/pgs-2015-0005. Epub 2016 Jul 6.
747 Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells.Biochem Biophys Res Commun. 2012 Feb 24;418(4):818-23. doi: 10.1016/j.bbrc.2012.01.115. Epub 2012 Jan 30.
748 Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9175-81. eCollection 2015.
749 Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.Oncogene. 2007 Aug 30;26(40):5900-10. doi: 10.1038/sj.onc.1210400. Epub 2007 Mar 19.
750 Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.Cancer Sci. 2013 Nov;104(11):1483-91. doi: 10.1111/cas.12266. Epub 2013 Sep 19.
751 Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics.JCI Insight. 2019 Oct 17;4(20):e131340. doi: 10.1172/jci.insight.131340.
752 CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target.Int J Cancer. 2013 Apr 15;132(8):1761-70. doi: 10.1002/ijc.27873. Epub 2012 Oct 29.
753 Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling.Thorac Cancer. 2019 Mar;10(3):428-436. doi: 10.1111/1759-7714.12944. Epub 2019 Feb 7.
754 Activation of Src mediates acquired cisplatin resistance in human lung carcinoma cells.Anticancer Drugs. 2020 Feb;31(2):123-130. doi: 10.1097/CAD.0000000000000829.
755 Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.Oncogene. 2017 Apr 27;36(17):2457-2471. doi: 10.1038/onc.2016.404. Epub 2016 Nov 7.
756 Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines.Life Sci. 1994;55(23):1797-806. doi: 10.1016/0024-3205(94)90090-6.
757 Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.Cell Oncol (Dordr). 2011 Oct;34(5):435-41. doi: 10.1007/s13402-011-0025-9. Epub 2011 Apr 19.
758 ZEB1-responsive genes in non-small cell lung cancer.Cancer Lett. 2011 Jan 1;300(1):66-78. doi: 10.1016/j.canlet.2010.09.007. Epub 2010 Oct 25.
759 CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.Lung Cancer. 2010 Jul;69(1):19-25. doi: 10.1016/j.lungcan.2009.09.001. Epub 2009 Sep 30.
760 ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.Carcinogenesis. 2020 Jul 10;41(5):711-721. doi: 10.1093/carcin/bgz144.
761 Mesenchymal stromal cells protect cancer cells from ROS-induced apoptosis and enhance the Warburg effect by secreting STC1.Mol Ther. 2012 Feb;20(2):417-23. doi: 10.1038/mt.2011.259. Epub 2011 Dec 6.
762 Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer.Int J Cancer. 2019 Sep 15;145(6):1609-1624. doi: 10.1002/ijc.32487. Epub 2019 Jun 25.
763 Withdrawal Notice: STK33-Dependent Transcriptional Regulation of SFTA3 Induces Cisplatin-Resistance in Lung Adenocarcinoma.Anticancer Agents Med Chem. 2019 May 6. doi: 10.2174/1871520619666190507100912. Online ahead of print.
764 Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.Cancer Biomark. 2017;19(1):35-43. doi: 10.3233/CBM-160239.
765 SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma.Biomarkers. 2010 Mar;15(2):104-10. doi: 10.3109/13547500903311910.
766 STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma.Biochem Biophys Res Commun. 2019 Nov 19;519(4):659-666. doi: 10.1016/j.bbrc.2019.09.032. Epub 2019 Sep 18.
767 Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor.Mol Cell. 2020 Jan 16;77(2):213-227.e5. doi: 10.1016/j.molcel.2019.10.023. Epub 2019 Nov 14.
768 Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.FEBS J. 2018 Nov;285(22):4229-4245. doi: 10.1111/febs.14665. Epub 2018 Oct 8.
769 The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.Oncol Rep. 2016 Jan;35(1):436-46. doi: 10.3892/or.2015.4373. Epub 2015 Nov 2.
770 An investigation of the relationship between SULT1A1 Arg(213)His polymorphism and lung cancer susceptibility in a Turkish population.Cell Biochem Funct. 2009 Jun;27(4):211-5. doi: 10.1002/cbf.1558.
771 TDP-43 regulates cancer-associated microRNAs.Protein Cell. 2018 Oct;9(10):848-866. doi: 10.1007/s13238-017-0480-9. Epub 2017 Sep 26.
772 TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.Cancer Res. 2017 Sep 15;77(18):5077-5094. doi: 10.1158/0008-5472.CAN-17-0829. Epub 2017 Jul 17.
773 Identification of genes differentially expressed in human primary lung squamous cell carcinoma.Lung Cancer. 2007 Jun;56(3):307-17. doi: 10.1016/j.lungcan.2007.01.016. Epub 2007 Feb 20.
774 Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.Mol Carcinog. 2014 Aug;53(8):659-66. doi: 10.1002/mc.22020. Epub 2013 Mar 8.
775 ERK3 regulates TDP2-mediated DNA damage response and chemoresistance in lung cancer cells.Oncotarget. 2016 Feb 9;7(6):6665-75. doi: 10.18632/oncotarget.6682.
776 Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.Genes Chromosomes Cancer. 1998 Jun;22(2):152-6. doi: 10.1002/(sici)1098-2264(199806)22:2<152::aid-gcc10>3.0.co;2-s.
777 Multiple cancer pathways regulate telomereprotection.EMBO Mol Med. 2019 Jul;11(7):e10292. doi: 10.15252/emmm.201910292. Epub 2019 Jun 13.
778 Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility.Lung Cancer. 2009 Nov;66(2):157-61. doi: 10.1016/j.lungcan.2009.02.005. Epub 2009 Mar 13.
779 Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.Int J Nanomedicine. 2019 Apr 24;14:2879-2902. doi: 10.2147/IJN.S192219. eCollection 2019.
780 Molecular Changes of Lung Malignancy in HIV Infection.Sci Rep. 2018 Sep 3;8(1):13128. doi: 10.1038/s41598-018-31572-6.
781 Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.Biomed Res Int. 2017;2017:8983763. doi: 10.1155/2017/8983763. Epub 2017 Jan 26.
782 Transglutaminase 2 Promotes Migration and Invasion of Lung Cancer Cells.Oncol Res. 2018 Sep 14;26(8):1175-1182. doi: 10.3727/096504018X15149761920868. Epub 2018 Jan 4.
783 Plasma Fibrinogen and sP-Selectin are Associated with the Risk of Lung Cancer in a Prospective Study.Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1221-1227. doi: 10.1158/1055-9965.EPI-18-1285. Epub 2019 Apr 23.
784 Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro.Acta Biochim Biophys Sin (Shanghai). 2004 Aug;36(8):537-40. doi: 10.1093/abbs/36.8.537.
785 Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression.PLoS Genet. 2019 Oct 7;15(10):e1008439. doi: 10.1371/journal.pgen.1008439. eCollection 2019 Oct.
786 Toll-like receptor 5 agonist inhibition of growth of A549 lung cancer cells in vivo in a Myd88 dependent manner.Asian Pac J Cancer Prev. 2012;13(6):2807-12. doi: 10.7314/apjcp.2012.13.6.2807.
787 Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells.Lung Cancer. 2013 Jun;80(3):270-7. doi: 10.1016/j.lungcan.2013.02.016. Epub 2013 Mar 14.
788 TMEM Proteins in Cancer: A Review.Front Pharmacol. 2018 Dec 6;9:1345. doi: 10.3389/fphar.2018.01345. eCollection 2018.
789 Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.Acta Biochim Biophys Sin (Shanghai). 2016 Sep;48(9):788-94. doi: 10.1093/abbs/gmw070. Epub 2016 Aug 12.
790 Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5625-E5634. doi: 10.1073/pnas.1707054114. Epub 2017 Jun 26.
791 miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.J Cell Biochem. 2020 Jan;121(1):779-787. doi: 10.1002/jcb.29323. Epub 2019 Aug 26.
792 Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.Mol Cancer Res. 2014 Apr;12(4):550-9. doi: 10.1158/1541-7786.MCR-13-0458. Epub 2014 Jan 27.
793 The clinical significance of serum adipocytokines level in patients with lung cancer.J Thorac Dis. 2019 Aug;11(8):3547-3555. doi: 10.21037/jtd.2019.07.66.
794 Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models.Mol Pharm. 2018 Apr 2;15(4):1627-1634. doi: 10.1021/acs.molpharmaceut.7b01168. Epub 2018 Mar 20.
795 Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity.Clin Transl Immunology. 2019 Sep 27;8(10):e01081. doi: 10.1002/cti2.1081. eCollection 2019.
796 TNFSF15 promoter polymorphisms increase the susceptibility to small cell lung cancer: a case-control study.BMC Med Genet. 2019 Feb 8;20(1):29. doi: 10.1186/s12881-019-0762-6.
797 Evidence for tankyrases as antineoplastic targets in lung cancer.BMC Cancer. 2013 Apr 28;13:211. doi: 10.1186/1471-2407-13-211.
798 C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator oftranscription 3.J Thorac Cardiovasc Surg. 2015 Jan;149(1):369-75. doi: 10.1016/j.jtcvs.2014.08.087. Epub 2014 Sep 18.
799 ATM Activation and H2AX Phosphorylation Induced by Genotoxic Agents Assessed by Flow- and Laser Scanning Cytometry.Methods Mol Biol. 2017;1599:183-196. doi: 10.1007/978-1-4939-6955-5_14.
800 Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.Br J Cancer. 1993 Oct;68(4):793-800. doi: 10.1038/bjc.1993.430.
801 Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer.Onco Targets Ther. 2019 Jan 21;12:709-720. doi: 10.2147/OTT.S183944. eCollection 2019.
802 TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.J Cancer Res Clin Oncol. 2019 Jun;145(6):1509-1519. doi: 10.1007/s00432-019-02921-3. Epub 2019 Apr 23.
803 Sodium butyrate-activated TRAF6-TXNIP pathway affects A549 cells proliferation and migration.Cancer Med. 2020 May;9(10):3477-3488. doi: 10.1002/cam4.2564. Epub 2019 Oct 2.
804 Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer.Sci Rep. 2018 Jul 17;8(1):10766. doi: 10.1038/s41598-018-28971-0.
805 An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.J Cell Mol Med. 2019 Feb;23(2):1458-1469. doi: 10.1111/jcmm.14052. Epub 2018 Dec 4.
806 Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance.Cancer Cell. 2018 Jun 11;33(6):985-1003.e7. doi: 10.1016/j.ccell.2018.05.001. Epub 2018 May 24.
807 TRPM2 Silencing Causes G2/M Arrest and Apoptosis in Lung Cancer Cells via Increasing Intracellular ROS and RNS Levels and Activating the JNK Pathway.Cell Physiol Biochem. 2019;52(4):742-757. doi: 10.33594/000000052.
808 TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90/uPA/MMP2 signaling pathway.BMC Cancer. 2018 Nov 26;18(1):1167. doi: 10.1186/s12885-018-5050-x.
809 Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.Int J Mol Sci. 2016 Mar 24;17(4):437. doi: 10.3390/ijms17040437.
810 TSG101, identified by screening a cancer cDNA library and soft agar assay, promotes cell proliferation in human lung cancer.Mol Biol Rep. 2010 Jul;37(6):2829-38. doi: 10.1007/s11033-009-9835-5. Epub 2009 Sep 29.
811 Effects of Cigarette Smoke on TSPO-related Mitochondrial Processes.Cells. 2019 Jul 10;8(7):694. doi: 10.3390/cells8070694.
812 LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer.Oncotarget. 2018 Jul 3;9(51):29601-29618. doi: 10.18632/oncotarget.25642. eCollection 2018 Jul 3.
813 Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells.J Immunol. 2019 Feb 1;202(3):991-1002. doi: 10.4049/jimmunol.1800736. Epub 2018 Dec 19.
814 HR23A-knockdown lung cancer cells exhibit epithelial-to-mesenchymal transition and gain stemness properties through increased Twist1 stability.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118537. doi: 10.1016/j.bbamcr.2019.118537. Epub 2019 Sep 2.
815 Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.Oncogene. 2019 Mar;38(11):1892-1904. doi: 10.1038/s41388-018-0534-3. Epub 2018 Nov 2.
816 MicroRNA-124 regulates the radiosensitivity of non-small cell lung cancer cells by targeting TXNRD1.Oncol Lett. 2017 Apr;13(4):2071-2078. doi: 10.3892/ol.2017.5701. Epub 2017 Feb 8.
817 Synthesis and secretion of the anticoagulant protein S and coexpression of the Tyro3 receptor in human lung carcinoma cells.Cancer. 1999 Jul 1;86(1):43-9. doi: 10.1002/(sici)1097-0142(19990701)86:1<43::aid-cncr8>3.0.co;2-d.
818 UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.Oncotarget. 2017 Aug 28;8(46):80278-80285. doi: 10.18632/oncotarget.20571. eCollection 2017 Oct 6.
819 Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1).Biol Pharm Bull. 2019;42(11):1839-1845. doi: 10.1248/bpb.b19-00357.
820 A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.Int J Cancer. 2017 Sep 1;141(5):958-966. doi: 10.1002/ijc.30788. Epub 2017 May 29.
821 Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.Crit Rev Oncol Hematol. 2018 Aug;128:96-109. doi: 10.1016/j.critrevonc.2018.06.004. Epub 2018 Jun 11.
822 Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling.Biomed Pharmacother. 2019 Jun;114:108831. doi: 10.1016/j.biopha.2019.108831. Epub 2019 Apr 12.
823 Radiation Enhances the Epithelial- Mesenchymal Transition of A549 Cells via miR3591-5p/USP33/PPM1A.Cell Physiol Biochem. 2018;50(2):721-733. doi: 10.1159/000494238. Epub 2018 Oct 11.
824 USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis.J Clin Invest. 2012 Dec;122(12):4362-74. doi: 10.1172/JCI63084. Epub 2012 Nov 26.
825 The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry.Medicine (Baltimore). 2019 Nov;98(48):e18228. doi: 10.1097/MD.0000000000018228.
826 Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells.Mol Ther Nucleic Acids. 2019 Sep 6;17:24-37. doi: 10.1016/j.omtn.2019.05.003. Epub 2019 May 18.
827 Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells.J Cell Physiol. 2012 Dec;227(12):3778-86. doi: 10.1002/jcp.24086.
828 Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.Mol Carcinog. 2015 Feb;54(2):148-55. doi: 10.1002/mc.22082. Epub 2013 Sep 24.
829 von Hippel-Lindau protein promotes the assembly of actin and vinculin and inhibits cell motility.Cancer Res. 2001 May 15;61(10):4184-9.
830 Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis.J Cancer Res Ther. 2018 Jun;14(Supplement):S437-S443. doi: 10.4103/0973-1482.176174.
831 Gene expression of vasoactive intestinal peptide receptors in human lung cancer.Int J Oncol. 2011 Oct;39(4):1019-24. doi: 10.3892/ijo.2011.1122. Epub 2011 Jul 13.
832 Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.Clin Cancer Res. 2017 Jan 15;23(2):370-378. doi: 10.1158/1078-0432.CCR-16-0150. Epub 2016 Jul 20.
833 FOXD3 Suppresses Tumor-Initiating Features in Lung Cancer via Transcriptional Repression of WDR5.Stem Cells. 2019 May;37(5):582-592. doi: 10.1002/stem.2984. Epub 2019 Mar 12.
834 Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib.Lung Cancer. 2019 Mar;129:92-94. doi: 10.1016/j.lungcan.2018.12.011. Epub 2018 Dec 19.
835 Clinical significance of aberrant Wnt7a promoter methylation in human non-small cell lung cancer in Koreans.J Korean Med Sci. 2015 Feb;30(2):155-61. doi: 10.3346/jkms.2015.30.2.155. Epub 2015 Jan 21.
836 XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28.
837 YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.Am J Respir Crit Care Med. 2019 Oct 1;200(7):888-899. doi: 10.1164/rccm.201807-1292OC.
838 ZWINT is the next potential target for lung cancer therapy.J Cancer Res Clin Oncol. 2019 Mar;145(3):661-673. doi: 10.1007/s00432-018-2823-1. Epub 2019 Jan 14.
839 Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis.Mol Med Rep. 2019 Mar;19(3):2029-2040. doi: 10.3892/mmr.2019.9878. Epub 2019 Jan 18.
840 Frequent down-regulation of hRAB37 in metastatic tumor by genetic and epigenetic mechanisms in lung cancer.Lung Cancer. 2009 Mar;63(3):360-7. doi: 10.1016/j.lungcan.2008.06.014. Epub 2008 Aug 8.
841 Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.Nat Med. 2019 Jan;25(1):111-118. doi: 10.1038/s41591-018-0264-7. Epub 2018 Nov 26.
842 Yap-Hippo promotes A549 lung cancer cell death via modulating MIEF1-related mitochondrial stress and activating JNK pathway.Biomed Pharmacother. 2019 May;113:108754. doi: 10.1016/j.biopha.2019.108754. Epub 2019 Mar 12.
843 Hyaluronic acid - dihydroartemisinin conjugate: Synthesis, characterization and in vitro evaluation in lung cancer cells.Int J Biol Macromol. 2019 Jul 15;133:495-502. doi: 10.1016/j.ijbiomac.2019.04.124. Epub 2019 Apr 17.
844 Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.Cancer Res. 2018 Sep 15;78(18):5340-5348. doi: 10.1158/0008-5472.CAN-18-1119. Epub 2018 Jul 19.
845 Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.Int J Cancer. 2014 Nov 1;135(9):2206-14. doi: 10.1002/ijc.28857. Epub 2014 Apr 8.
846 A microfluidic device for studying chemotaxis mechanism of bacterial cancer targeting.Sci Rep. 2018 Apr 23;8(1):6394. doi: 10.1038/s41598-018-24748-7.
847 A meta-analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR-193a-5p in lung cancer.Oncol Lett. 2018 Oct;16(4):4114-4128. doi: 10.3892/ol.2018.9174. Epub 2018 Jul 19.
848 Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.PLoS One. 2010 Jul 2;5(7):e11418. doi: 10.1371/journal.pone.0011418.
849 Polymorphism in CYP24A1 Is Associated with Lung Cancer Risk: A Case-Control Study in Chinese Female Nonsmokers.DNA Cell Biol. 2019 Mar;38(3):243-249. doi: 10.1089/dna.2018.4510. Epub 2019 Feb 6.
850 The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.Cancer Biomark. 2018;23(3):323-331. doi: 10.3233/CBM-181245.
851 Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.Lung Cancer. 2007 Apr;56(1):17-23. doi: 10.1016/j.lungcan.2006.11.007. Epub 2006 Dec 18.
852 Transcription factor E2F1 positively regulates interferon regulatory factor 5 expression in non-small cell lung cancer.Onco Targets Ther. 2019 Aug 23;12:6907-6915. doi: 10.2147/OTT.S215701. eCollection 2019.
853 Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.Lung Cancer. 2018 Oct;124:31-39. doi: 10.1016/j.lungcan.2018.07.027. Epub 2018 Jul 21.
854 EIF5A2 is a novel chemoresistance gene in breast cancer.Breast Cancer. 2015 Nov;22(6):602-7. doi: 10.1007/s12282-014-0526-2. Epub 2014 Mar 18.
855 Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review.Front Physiol. 2019 Mar 19;10:216. doi: 10.3389/fphys.2019.00216. eCollection 2019.
856 Coagulation factor IV is an indicator of symptomatic pulmonary embolism in patients with primary lung cancer.Clin Respir J. 2020 Feb;14(2):124-131. doi: 10.1111/crj.13109. Epub 2019 Dec 9.
857 Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum.Appl Microbiol Biotechnol. 2018 Nov;102(22):9585-9594. doi: 10.1007/s00253-018-9291-z. Epub 2018 Aug 24.
858 Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells.J Oncol. 2019 Jan 6;2019:6164807. doi: 10.1155/2019/6164807. eCollection 2019.
859 Arsenic induces gender difference of estrogen receptor in AECII cells from ICR fetal mice.Toxicol In Vitro. 2019 Apr;56:133-140. doi: 10.1016/j.tiv.2019.01.014. Epub 2019 Jan 23.
860 8-bromo-7-methoxychrysin targets NF-B and FoxM1 to inhibit lung cancer stem cells induced by pro-inflammatory factors.J Cancer. 2019 Aug 28;10(21):5244-5255. doi: 10.7150/jca.30143. eCollection 2019.
861 Long non-coding RNA FOXO1 inhibits lung cancer cell growth through down-regulating PI3K/AKT signaling pathway.Iran J Basic Med Sci. 2019 May;22(5):491-498. doi: 10.22038/ijbms.2019.31000.7480.
862 Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer.Int J Cancer. 2018 Jun 1;142(11):2355-2362. doi: 10.1002/ijc.31245. Epub 2018 Jan 30.
863 Association of serum follistatin levels with histological types and progression of tumor in human lung cancer.Cancer Cell Int. 2018 Oct 20;18:162. doi: 10.1186/s12935-018-0664-2. eCollection 2018.
864 N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.Anticancer Res. 2019 Nov;39(11):6317-6324. doi: 10.21873/anticanres.13842.
865 HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer.Oncogenesis. 2019 Aug 20;8(9):45. doi: 10.1038/s41389-019-0158-7.
866 Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.Mol Cancer Res. 2020 Jan;18(1):105-117. doi: 10.1158/1541-7786.MCR-19-0239. Epub 2019 Oct 18.
867 Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors.PLoS One. 2019 Mar 14;14(3):e0213984. doi: 10.1371/journal.pone.0213984. eCollection 2019.
868 Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.J Cell Biochem. 2019 Apr;120(4):5232-5243. doi: 10.1002/jcb.27798. Epub 2018 Oct 30.
869 PCAF-mediated acetylation of Lin28B increases let-7 biogenesis in lung adenocarcinoma H1299 cells.BMC Cancer. 2018 Jan 4;18(1):27. doi: 10.1186/s12885-017-3959-0.
870 The combination astemizole-gefitinib as a potential therapy for human lung cancer.Onco Targets Ther. 2017 Dec 6;10:5795-5803. doi: 10.2147/OTT.S144506. eCollection 2017.
871 The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.Cancer Med. 2019 Mar;8(3):1157-1168. doi: 10.1002/cam4.1949. Epub 2019 Feb 8.
872 Caged-xanthone from Cratoxylum formosum ssp. pruniflorum inhibits malignant cancer phenotypes in multidrug-resistant human A549 lung cancer cells through down-regulation of NF-B.Bioorg Med Chem. 2019 Jun 15;27(12):2368-2375. doi: 10.1016/j.bmc.2018.12.042. Epub 2018 Dec 31.
873 A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer.Mol Ther Nucleic Acids. 2019 Dec 6;18:991-998. doi: 10.1016/j.omtn.2019.10.029. Epub 2019 Nov 2.
874 Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.Int J Cancer. 2006 Feb 15;118(4):797-801. doi: 10.1002/ijc.21462.
875 A new strategy for the diagnosis of MAGE-expressing cancers.J Immunol Methods. 2002 Aug 1;266(1-2):79-86. doi: 10.1016/s0022-1759(02)00105-9.
876 Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38 siRNA in Lung Adenocarcinoma Cancer Cells.Anticancer Agents Med Chem. 2019;19(5):638-644. doi: 10.2174/1871520619666190301125203.
877 K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3(K18ac) through the MDM2-GCN5-SIRT7 axis.Pharm Biol. 2019 Dec;57(1):701-709. doi: 10.1080/13880209.2019.1672756.
878 Nicotine induces cell survival and chemoresistance by stimulating Mcl-1 phosphorylation and its interaction with Bak in lung cancer.J Cell Physiol. 2019 Sep;234(9):15934-15940. doi: 10.1002/jcp.28251. Epub 2019 Feb 11.
879 Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.Oncogene. 2019 Feb;38(9):1477-1488. doi: 10.1038/s41388-018-0522-7. Epub 2018 Oct 10.
880 A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma.PeerJ. 2019 Jun 17;7:e7125. doi: 10.7717/peerj.7125. eCollection 2019.
881 New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions.Lab Invest. 2017 Nov;97(11):1268-1270. doi: 10.1038/labinvest.2017.91.
882 PRDX4 and Its Roles in Various Cancers.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819864313. doi: 10.1177/1533033819864313.
883 Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.J Cell Mol Med. 2019 Feb;23(2):1333-1342. doi: 10.1111/jcmm.14036. Epub 2018 Nov 20.
884 Network analysis of differentially expressed smoking-associated mRNAs, lncRNAs and miRNAs reveals key regulators in smoking-associated lung cancer.Exp Ther Med. 2018 Dec;16(6):4991-5002. doi: 10.3892/etm.2018.6891. Epub 2018 Oct 23.
885 SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors.Cancer Res. 2019 May 15;79(10):2761-2774. doi: 10.1158/0008-5472.CAN-18-1545. Epub 2019 Mar 15.
886 SOX2 promoter hypermethylation in non-smoking Taiwanese adults residing in air pollution areas.Clin Epigenetics. 2019 Mar 12;11(1):46. doi: 10.1186/s13148-019-0647-8.
887 High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-B-Dependent Manner.Biomed Res Int. 2018 Apr 19;2018:3453706. doi: 10.1155/2018/3453706. eCollection 2018.
888 SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.PLoS One. 2016 Feb 16;11(2):e0148911. doi: 10.1371/journal.pone.0148911. eCollection 2016.
889 A serine in exon 11 determines the full transcriptional activity of TCF-4 in lung carcinoma cells.Biochem Biophys Res Commun. 2019 Jan 15;508(3):675-681. doi: 10.1016/j.bbrc.2018.11.161. Epub 2018 Dec 5.
890 XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway.Oncol Lett. 2018 Jun;15(6):8973-8982. doi: 10.3892/ol.2018.8491. Epub 2018 Apr 13.
891 Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer.Arthritis Res Ther. 2018 Aug 9;20(1):176. doi: 10.1186/s13075-018-1678-9.
892 TRIM37 targets AKT in the growth of lung cancer cells.Onco Targets Ther. 2018 Nov 8;11:7935-7945. doi: 10.2147/OTT.S183303. eCollection 2018.
893 Molecular analysis of the protein tyrosine phosphatase gamma gene in human lung cancer cell lines.Cancer Res. 1992 Jun 15;52(12):3506-9.
894 GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.Cancer Sci. 2007 Oct;98(10):1625-32. doi: 10.1111/j.1349-7006.2007.00578.x. Epub 2007 Aug 16.
895 Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells.Oncotarget. 2015 Oct 6;6(30):29428-39. doi: 10.18632/oncotarget.5005.
896 ABCA3 Phenotype in Non-Small Cell Lung Cancer Indicates Poor Outcome.Oncology. 2017;93(4):270-278. doi: 10.1159/000477619. Epub 2017 Jul 6.
897 Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort.BMC Cancer. 2019 Mar 19;19(1):246. doi: 10.1186/s12885-019-5438-2.
898 ABCC11/MRP8 confers pemetrexed resistance in lung cancer. Cancer Sci. 2010 Nov;101(11):2404-10.
899 Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.Int J Cancer. 2001 Nov 1;94(3):432-7. doi: 10.1002/ijc.1490.
900 Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN- and TRAIL and suppress the growth of H460 human lung cancer cells.Cancer Lett. 2019 Jan;440-441:202-210. doi: 10.1016/j.canlet.2018.10.017. Epub 2018 Oct 26.
901 Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.Mol Carcinog. 2016 Nov;55(11):1822-1832. doi: 10.1002/mc.22430. Epub 2015 Oct 29.
902 Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model.Oncotarget. 2014 Jul 15;5(13):4811-20. doi: 10.18632/oncotarget.2038.
903 Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.Int J Cancer. 2009 Apr 1;124(7):1669-74. doi: 10.1002/ijc.23956.
904 Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.Medicine (Baltimore). 2018 Jun;97(26):e11116. doi: 10.1097/MD.0000000000011116.
905 Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.Int J Cancer. 1997 Apr 22;74(2):189-92. doi: 10.1002/(sici)1097-0215(19970422)74:2<189::aid-ijc9>3.0.co;2-v.
906 The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.Oncotarget. 2017 Feb 28;8(9):16036-16051. doi: 10.18632/oncotarget.13917.
907 SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer.Sci Rep. 2017 Aug 3;7(1):7211. doi: 10.1038/s41598-017-07830-4.
908 Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy.Pharmacol Res. 2013 Oct;76:119-31. doi: 10.1016/j.phrs.2013.07.011. Epub 2013 Aug 13.
909 Autocrine stimulation of motility in SBC-5 human lung carcinoma cells by a two-kringle variant of HGF.Cancer Lett. 1994 Aug 15;83(1-2):235-43. doi: 10.1016/0304-3835(94)90325-5.
910 Proteinase-activated receptor-2 enhances Bcl2-like protein-12 expression in lung cancer cells to suppress p53 expression.Arch Med Sci. 2019 Sep;15(5):1147-1153. doi: 10.5114/aoms.2019.86980. Epub 2019 Aug 2.
911 Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer. 2013 Mar;79(3):198-204.
912 TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.Oncotarget. 2017 Jun 13;8(24):38426-38443. doi: 10.18632/oncotarget.16430.
913 LCAL1 enhances lung cancer survival via inhibiting AMPK-related antitumor functions.Mol Cell Biochem. 2019 Jul;457(1-2):11-20. doi: 10.1007/s11010-019-03507-w. Epub 2019 Feb 11.
914 Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population.Environ Mol Mutagen. 2017 Jul;58(6):411-422. doi: 10.1002/em.22104. Epub 2017 Jun 22.
915 Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase.Cancer Gene Ther. 2016 Sep;23(9):287-94. doi: 10.1038/cgt.2016.28. Epub 2016 Jul 22.
916 Associations between abnormal vitamin D metabolism pathway function and non-small cell lung cancer.Oncol Lett. 2017 Dec;14(6):7538-7544. doi: 10.3892/ol.2017.7162. Epub 2017 Oct 10.
917 Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival.Cancer Res. 2019 Sep 15;79(18):4754-4766. doi: 10.1158/0008-5472.CAN-18-4080. Epub 2019 Jul 29.
918 Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer.BMC Cancer. 2017 Jul 5;17(1):467. doi: 10.1186/s12885-017-3452-9.
919 DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients.Tumour Biol. 2017 Jun;39(6):1010428317714625. doi: 10.1177/1010428317714625.
920 UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis.Nature. 2019 Jul;571(7763):127-131. doi: 10.1038/s41586-019-1340-y. Epub 2019 Jun 26.
921 Coronary artery calcification in lung cancer screening.Transl Lung Cancer Res. 2018 Jun;7(3):361-367. doi: 10.21037/tlcr.2018.05.05.
922 HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.Thorac Cancer. 2019 Apr;10(4):601-606. doi: 10.1111/1759-7714.12954. Epub 2019 Feb 26.
923 CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients.Int J Biol Markers. 2008 Jan-Mar;23(1):24-30.
924 alpha-2,3-Sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma.Cancer. 1997 May 1;79(9):1678-85. doi: 10.1002/(sici)1097-0142(19970501)79:9<1678::aid-cncr7>3.0.co;2-8.
925 Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients.Cell Mol Biol (Noisy-le-grand). 2018 May 15;64(6):71-76.
926 Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.Int J Mol Sci. 2018 Jul 20;19(7):2115. doi: 10.3390/ijms19072115.
927 Genetic variants of SULT1A1 and XRCC1 genes and risk of lung cancer in Bangladeshi population.Tumour Biol. 2017 Nov;39(11):1010428317729270. doi: 10.1177/1010428317729270.
928 Effects of ABO and FUT2 genetic transcription absence on ABH histo-blood group antigen expression in lung cancer patients.Asian Pac J Cancer Prev. 2011;12(12):3201-6.
929 Chemotherapy agents induce tartrate-resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients.Eur J Pharmacol. 2019 Mar 5;846:38-48. doi: 10.1016/j.ejphar.2019.01.011. Epub 2019 Jan 15.
930 S-nitrosoglutathione reductase in human lung cancer.Am J Respir Cell Mol Biol. 2012 Jan;46(1):63-70. doi: 10.1165/rcmb.2011-0147OC.
931 Prognostic and therapeutic potential of Adenylate kinase 2 in lung adenocarcinoma.Sci Rep. 2019 Nov 28;9(1):17757. doi: 10.1038/s41598-019-53594-4.
932 Alcohol Consumption and Lung Cancer According to Ile349Val Polymorphism in ADH3 Gene: Beyond the Tobacco Smoking Effect.J Cancer. 2017 Jul 20;8(12):2296-2302. doi: 10.7150/jca.18853. eCollection 2017.
933 AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.Theranostics. 2018 Jan 1;8(3):676-692. doi: 10.7150/thno.21463. eCollection 2018.
934 Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer.Br J Pharmacol. 2015 Aug;172(16):4089-106. doi: 10.1111/bph.13189. Epub 2015 Jun 26.
935 Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.Mol Carcinog. 2019 Nov;58(11):2026-2039. doi: 10.1002/mc.23095. Epub 2019 Aug 9.
936 Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer.Cancer Chemother Pharmacol. 2001 Jul;48(1):42-6. doi: 10.1007/s002800100291.
937 Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.Drug Metab Pharmacokinet. 2011;26(5):516-22. doi: 10.2133/dmpk.dmpk-11-rg-046. Epub 2011 Jul 26.
938 Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus.Mol Carcinog. 2017 Jun;56(6):1663-1672. doi: 10.1002/mc.22622. Epub 2017 Feb 23.
939 Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.Cancer Discov. 2013 Aug;3(8):870-9. doi: 10.1158/2159-8290.CD-13-0015. Epub 2013 May 28.
940 Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1 and pyruvate kinase M2.J Thorac Dis. 2019 Sep;11(9):3941-3950. doi: 10.21037/jtd.2019.08.124.
941 Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.J Pathol. 2006 Oct;210(2):192-204. doi: 10.1002/path.2039.
942 Knockdown of glutamate cysteine ligase catalytic subunit by siRNA causes the gold nanoparticles-induced cytotoxicity in lung cancer cells.PLoS One. 2015 Mar 19;10(3):e0118870. doi: 10.1371/journal.pone.0118870. eCollection 2015.
943 -Glutamylcyclotransferase Knockdown Inhibits Growth of Lung Cancer Cells Through G0/G1 Phase Arrest.Cancer Biother Radiopharm. 2015 Jun;30(5):211-6. doi: 10.1089/cbr.2014.1807. Epub 2015 May 5.
944 Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells.Front Oncol. 2018 Jun 1;8:196. doi: 10.3389/fonc.2018.00196. eCollection 2018.
945 Phosphorylation of glutaminase by PKC is essential for its enzymatic activity and critically contributes to tumorigenesis.Cell Res. 2018 Jun;28(6):655-669. doi: 10.1038/s41422-018-0021-y. Epub 2018 Mar 7.
946 Association between polymorphisms in the GSTA4 gene and risk of lung cancer: a case-control study in a Southeastern Chinese population.Mol Carcinog. 2009 Mar;48(3):253-259. doi: 10.1002/mc.20478.
947 A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer.Lung Cancer. 2002 Aug;37(2):143-6. doi: 10.1016/s0169-5002(02)00078-8.
948 Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):37-40. doi: 10.1016/j.prostaglandins.2011.06.005. Epub 2011 Jul 6.
949 Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):133-40.
950 MicroRNA-133 inhibits the growth and metastasis of the human lung cancer cells by targeting epidermal growth factor receptor.J BUON. 2019 May-Jun;24(3):929-935.
951 Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):141-7. doi: 10.1158/1055-9965.EPI-07-0553.
952 RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma.EMBO J. 2019 Jul 1;38(13):e100532. doi: 10.15252/embj.2018100532. Epub 2019 May 27.
953 High Expression of PTGR1 Promotes NSCLC Cell Growth via Positive Regulation of Cyclin-Dependent Protein Kinase Complex.Biomed Res Int. 2016;2016:5230642. doi: 10.1155/2016/5230642. Epub 2016 Jun 26.
954 Discovery of EST-SSRs in lung cancer: tagged ESTs with SSRs lead to differential amino acid and protein expression patterns in cancerous tissues.PLoS One. 2011;6(11):e27118. doi: 10.1371/journal.pone.0027118. Epub 2011 Nov 4.
955 Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer.Cancer Sci. 2019 Sep;110(9):2734-2747. doi: 10.1111/cas.14125. Epub 2019 Aug 23.
956 UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population.PLoS One. 2012;7(8):e42873. doi: 10.1371/journal.pone.0042873. Epub 2012 Aug 17.
957 The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.Cancer Epidemiol. 2012 Aug;36(4):e201-6. doi: 10.1016/j.canep.2012.02.004. Epub 2012 Mar 7.
958 Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation.Lung Cancer (Auckl). 2018 Nov 8;9:111-116. doi: 10.2147/LCTT.S186804. eCollection 2018.
959 miR-338 inhibits the metastasis of lung cancer by targeting integrin 3.Oncol Rep. 2016 Sep;36(3):1467-74. doi: 10.3892/or.2016.4928. Epub 2016 Jul 11.
960 The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers.J Clin Lab Anal. 2020 Jan;34(1):e23049. doi: 10.1002/jcla.23049. Epub 2019 Sep 25.
961 The Pattern of Underlying Cause of Death in Patients with Inflammatory Bowel Disease in England: A Record Linkage Study.J Crohns Colitis. 2017 May 1;11(5):578-585. doi: 10.1093/ecco-jcc/jjw192.
962 Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKC-p53-p21 signaling pathway.Cell Death Dis. 2017 May 18;8(5):e2793. doi: 10.1038/cddis.2017.202.
963 Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.PLoS One. 2016 May 12;11(5):e0155660. doi: 10.1371/journal.pone.0155660. eCollection 2016.
964 Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.Cancer Res. 2009 Aug 15;69(16):6633-41. doi: 10.1158/0008-5472.CAN-09-0680. Epub 2009 Aug 4.
965 Association of polymorphisms in the telomere-related gene ACYP2 with lung cancer risk in the Chinese Han population.Oncotarget. 2016 Dec 27;7(52):87473-87478. doi: 10.18632/oncotarget.13870.
966 Targeting high transcriptional control activity of long mononucleotide A-T repeats in cancer by Argonaute 1.Gene. 2019 May 30;699:54-61. doi: 10.1016/j.gene.2019.03.010. Epub 2019 Mar 9.
967 Feedback regulation of ALDOA activates the HIF-1/MMP9 axis to promote lung cancer progression.Cancer Lett. 2017 Sep 10;403:28-36. doi: 10.1016/j.canlet.2017.06.001. Epub 2017 Jun 10.
968 ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.Br J Cancer. 2011 Feb 15;104(4):700-6. doi: 10.1038/sj.bjc.6606012. Epub 2011 Feb 1.
969 The roles of ARHGAP10 in the proliferation, migration and invasion of lung cancer cells.Oncol Lett. 2017 Oct;14(4):4613-4618. doi: 10.3892/ol.2017.6729. Epub 2017 Aug 7.
970 A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.Clin Cancer Res. 2006 Jan 1;12(1):191-7. doi: 10.1158/1078-0432.CCR-05-1206.
971 An intron SNP rs807185 in ATG4A decreases the risk of lung cancer in a southwest Chinese population.Eur J Cancer Prev. 2016 Jul;25(4):255-8. doi: 10.1097/CEJ.0000000000000174.
972 The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.Nature. 2019 Nov;575(7784):688-692. doi: 10.1038/s41586-019-1705-2. Epub 2019 Oct 21.
973 Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.Cell Physiol Biochem. 2018;51(1):337-355. doi: 10.1159/000495233. Epub 2018 Nov 19.
974 Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines.Mol Carcinog. 2016 Oct;55(10):1477-85. doi: 10.1002/mc.22402. Epub 2015 Sep 1.
975 WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.Cell Signal. 2016 Nov;28(11):1673-82. doi: 10.1016/j.cellsig.2016.07.008. Epub 2016 Jul 21.
976 Asbestos-associated genome-wide DNA methylation changes in lung cancer.Int J Cancer. 2017 Nov 15;141(10):2014-2029. doi: 10.1002/ijc.30897. Epub 2017 Aug 2.
977 Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.Acta Pharmacol Sin. 2013 Apr;34(4):531-40. doi: 10.1038/aps.2012.196. Epub 2013 Mar 18.
978 Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.Oncol Rep. 2013 Oct;30(4):1639-44. doi: 10.3892/or.2013.2607. Epub 2013 Jul 9.
979 Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells.Cell Immunol. 2015 Nov-Dec;298(1-2):18-24. doi: 10.1016/j.cellimm.2015.08.004. Epub 2015 Aug 18.
980 Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2.Tumour Biol. 2017 Oct;39(10):1010428317712443. doi: 10.1177/1010428317712443.
981 Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.Oncotarget. 2017 Nov 25;8(66):110273-110288. doi: 10.18632/oncotarget.22681. eCollection 2017 Dec 15.
982 Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.Mol Med Rep. 2019 May;19(5):4344-4352. doi: 10.3892/mmr.2019.10100. Epub 2019 Mar 28.
983 Clinical significance of CD151 gene expression in non-small cell lung cancer.Clin Cancer Res. 2001 Dec;7(12):4109-14.
984 CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling.Oncotarget. 2016 Aug 9;8(33):54115-54135. doi: 10.18632/oncotarget.11132. eCollection 2017 Aug 15.
985 Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.Cancer Med. 2019 Nov;8(16):7065-7073. doi: 10.1002/cam4.2573. Epub 2019 Sep 27.
986 Cancer-associated mutations in the canonical cleavage site do not influence CD99 shedding by the metalloprotease meprin but alter cell migration in vitro.Oncotarget. 2017 Jul 4;8(33):54873-54888. doi: 10.18632/oncotarget.18966. eCollection 2017 Aug 15.
987 YdjC chitooligosaccharide deacetylase homolog induces keratin reorganization in lung cancer cells: involvement of interaction between YDJC and CDC16.Oncotarget. 2018 May 1;9(33):22915-22928. doi: 10.18632/oncotarget.25145. eCollection 2018 May 1.
988 Study on expression of CDH4 in lung cancer.World J Surg Oncol. 2017 Jan 17;15(1):26. doi: 10.1186/s12957-016-1083-2.
989 CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.Oncogene. 2017 Sep 14;36(37):5321-5330. doi: 10.1038/onc.2017.161. Epub 2017 May 22.
990 CGK062, a small chemical molecule, inhibits cancer upregulated gene 2induced oncogenesis through NEK2 and catenin.Int J Oncol. 2019 Apr;54(4):1295-1305. doi: 10.3892/ijo.2019.4724. Epub 2019 Feb 22.
991 Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.Sensors (Basel). 2017 Feb 4;17(2):287. doi: 10.3390/s17020287.
992 Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma.Sci Rep. 2017 Sep 19;7(1):11893. doi: 10.1038/s41598-017-12131-x.
993 A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer.Oncogene. 2017 May 25;36(21):2946-2956. doi: 10.1038/onc.2016.465. Epub 2017 Jan 16.
994 Spi-B-Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors.Cancer Res. 2017 Sep 15;77(18):4809-4822. doi: 10.1158/0008-5472.CAN-17-0020. Epub 2017 Jul 28.
995 Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis.CNS Neurosci Ther. 2017 Dec;23(12):947-960. doi: 10.1111/cns.12764. Epub 2017 Sep 29.
996 miR-26 suppresses renal cell cancer via down-regulating coronin-3.Mol Cell Biochem. 2020 Jan;463(1-2):137-146. doi: 10.1007/s11010-019-03636-2. Epub 2019 Oct 8.
997 Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer.Sci Rep. 2017 Jun 20;7(1):3896. doi: 10.1038/s41598-017-04248-w.
998 Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: A pilot study.Int J Cancer. 2017 Jan 15;140(2):370-380. doi: 10.1002/ijc.30455. Epub 2016 Oct 17.
999 Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.J Cancer Res Clin Oncol. 2016 Apr;142(4):723-32. doi: 10.1007/s00432-015-2070-7. Epub 2015 Nov 21.
1000 Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.
1001 DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.J Cell Mol Med. 2017 Aug;21(8):1532-1544. doi: 10.1111/jcmm.13084. Epub 2017 Feb 17.
1002 DHX33 Transcriptionally Controls Genes Involved in the Cell Cycle.Mol Cell Biol. 2016 Nov 14;36(23):2903-2917. doi: 10.1128/MCB.00314-16. Print 2016 Dec 1.
1003 Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer.Sci Rep. 2017 Aug 14;7(1):8072. doi: 10.1038/s41598-017-08615-5.
1004 Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer.Cancer Res. 2008 Feb 15;68(4):1037-45. doi: 10.1158/0008-5472.CAN-07-5782.
1005 Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis.J Clin Invest. 2019 Jan 2;129(1):215-222. doi: 10.1172/JCI99699. Epub 2018 Nov 26.
1006 Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.Oncoimmunology. 2017 Mar 31;6(5):e1310359. doi: 10.1080/2162402X.2017.1310359. eCollection 2017.
1007 Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells.FEBS Lett. 2017 Feb;591(4):636-645. doi: 10.1002/1873-3468.12566. Epub 2017 Feb 20.
1008 EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer.Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):199-211. doi: 10.1016/j.bbcan.2017.04.004. Epub 2017 Apr 10.
1009 Epithelial membrane protein 2 regulates sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization: Changes of PP2A expression by interaction with alpha4 and caveolin-1 in lung cancer cells.Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1157-69. doi: 10.1016/j.bbamcr.2016.02.007. Epub 2016 Feb 10.
1010 The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis.Int J Med Sci. 2017 Jun 23;14(7):675-679. doi: 10.7150/ijms.19355. eCollection 2017.
1011 Diagnostic value of -enolase expression and serum -enolase autoantibody levels in lung cancer.J Bras Pneumol. 2018 Jan-Feb;44(1):18-23. doi: 10.1590/S1806-37562016000000241.
1012 Intersectin-1s deficiency in pulmonary pathogenesis.Respir Res. 2017 Sep 6;18(1):168. doi: 10.1186/s12931-017-0652-4.
1013 ERCC6/CSB gene polymorphisms and lung cancer risk.Cancer Lett. 2009 Jan 8;273(1):172-6. doi: 10.1016/j.canlet.2008.08.002. Epub 2008 Sep 11.
1014 ERGIC3 Silencing Additively Enhances the Growth Inhibition of BFA on Lung Adenocarcinoma Cells.Curr Cancer Drug Targets. 2020;20(1):67-75. doi: 10.2174/1568009619666190917145906.
1015 ERP44 inhibits human lung cancer cell migration mainly via IP3R2.Aging (Albany NY). 2016 Jun;8(6):1276-86. doi: 10.18632/aging.100984.
1016 Identification of Serological Biomarkers for Early Diagnosis of Lung Cancer Using a Protein Array-Based Approach.Mol Cell Proteomics. 2017 Dec;16(12):2069-2078. doi: 10.1074/mcp.RA117.000212. Epub 2017 Oct 11.
1017 INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.BioDrugs. 2003;17(3):216-22. doi: 10.2165/00063030-200317030-00010.
1018 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Staging of Patients with Non-Small Cell Lung Cancer without Mediastinal Involvement at Positron Emission Tomography-Computed Tomography.Respiration. 2017;94(3):279-284. doi: 10.1159/000477625. Epub 2017 Jul 6.
1019 IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin-5.Open Biol. 2018 Oct 10;8(10):180086. doi: 10.1098/rsob.180086.
1020 FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation.Cancer Gene Ther. 2017 Aug;24(8):342-347. doi: 10.1038/cgt.2017.24. Epub 2017 Aug 4.
1021 Screening of genes related to lung cancer caused by smoking with RNA-Seq.Eur Rev Med Pharmacol Sci. 2014;18(1):117-25.
1022 Genetic risk analysis for an individual according to the theory of programmed onset, illustrated by lung and liver cancers.Gene. 2018 Oct 5;673:107-111. doi: 10.1016/j.gene.2018.06.044. Epub 2018 Jun 15.
1023 High-yield of biologically active recombinant human fibroblast growth factor-16 in E. coli and its mechanism of proliferation in NCL-H460 cells.Prep Biochem Biotechnol. 2017 Aug 9;47(7):720-729. doi: 10.1080/10826068.2017.1315599. Epub 2017 Apr 14.
1024 LncRNA-RMRP Acts as an Oncogene in Lung Cancer.PLoS One. 2016 Dec 1;11(12):e0164845. doi: 10.1371/journal.pone.0164845. eCollection 2016.
1025 Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.Gene. 2019 Feb 15;685:202-210. doi: 10.1016/j.gene.2018.11.022. Epub 2018 Nov 9.
1026 DNA methylation of the Fthl17 5'-upstream region regulates differential Fthl17 expression in lung cancer cells and germline stem cells.PLoS One. 2017 Feb 16;12(2):e0172219. doi: 10.1371/journal.pone.0172219. eCollection 2017.
1027 An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.Cancer Immunol Res. 2019 Aug;7(8):1267-1279. doi: 10.1158/2326-6066.CIR-18-0874. Epub 2019 Jun 11.
1028 Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway.Acta Biochim Biophys Sin (Shanghai). 2017 Jul 1;49(7):581-587. doi: 10.1093/abbs/gmx046.
1029 FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression.Clin Cancer Res. 2018 Feb 15;24(4):916-926. doi: 10.1158/1078-0432.CCR-17-1347. Epub 2017 Dec 7.
1030 Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer.Br J Cancer. 2005 Oct 17;93(8):949-52. doi: 10.1038/sj.bjc.6602790.
1031 Polymorphisms in GEMIN4 and AGO1 Genes Are Associated with the Risk of Lung Cancer: A Case-Control Study in Chinese Female Non-Smokers.Int J Environ Res Public Health. 2016 Sep 23;13(10):939. doi: 10.3390/ijerph13100939.
1032 EGF-stimulated activation of Rab35 regulates RUSC2-GIT2 complex formation to stabilize GIT2 during directional lung cancer cell migration.Cancer Lett. 2016 Aug 28;379(1):70-83. doi: 10.1016/j.canlet.2016.05.027. Epub 2016 May 26.
1033 Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A.Cell Prolif. 2017 Oct;50(5):e12364. doi: 10.1111/cpr.12364. Epub 2017 Jul 24.
1034 Carboxamide analog ITR-284 evokes apoptosis and inhibits migration ability in human lung adenocarcinoma A549 cells.Oncol Rep. 2017 Mar;37(3):1786-1792. doi: 10.3892/or.2017.5374. Epub 2017 Jan 16.
1035 GPR78 promotes lung cancer cell migration and metastasis by activation of Gq-Rho GTPase pathway.BMB Rep. 2016 Nov;49(11):623-628. doi: 10.5483/bmbrep.2016.49.11.133.
1036 MiR-921 directly downregulates GPx3 in A549 lung cancer cells.Gene. 2019 Jun 5;700:163-167. doi: 10.1016/j.gene.2019.02.086. Epub 2019 Mar 19.
1037 Combined effects of glutathione S-transferase M1 and T1 polymorphisms on risk of lung cancer: Evidence from a meta-analysis.Oncotarget. 2017 Apr 25;8(17):28135-28143. doi: 10.18632/oncotarget.15943.
1038 Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium.Carcinogenesis. 2016 Sep;37(9):888-896. doi: 10.1093/carcin/bgw070. Epub 2016 Jun 10.
1039 Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer.Asian Pac J Cancer Prev. 2011;12(8):2039-43.
1040 Persistence of Gamma-H2AX Foci in Bronchial Cells Correlates with Susceptibility to Radiation Associated Lung Cancer in Mice.Radiat Res. 2019 Jan;191(1):67-75. doi: 10.1667/RR14979.1. Epub 2018 Nov 6.
1041 HIST1H3D: A promising therapeutic target for lung cancer.Int J Oncol. 2017 Mar;50(3):815-822. doi: 10.3892/ijo.2017.3856. Epub 2017 Jan 19.
1042 The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function.Oncogenesis. 2017 Jun 12;6(6):e348. doi: 10.1038/oncsis.2017.45.
1043 HAT1 induces lung cancer cell apoptosis via up regulating Fas.Oncotarget. 2017 Sep 23;8(52):89970-89977. doi: 10.18632/oncotarget.21205. eCollection 2017 Oct 27.
1044 Prognostic value of TIM-1 expression in human non-small-cell lung cancer.J Transl Med. 2019 May 28;17(1):178. doi: 10.1186/s12967-019-1931-2.
1045 LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer.J Exp Clin Cancer Res. 2019 Jun 28;38(1):280. doi: 10.1186/s13046-019-1276-y.
1046 HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.Clin Cancer Res. 2017 Feb 1;23(3):825-832. doi: 10.1158/1078-0432.CCR-15-3071. Epub 2016 Aug 23.
1047 Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer.Front Immunol. 2017 Sep 29;8:1215. doi: 10.3389/fimmu.2017.01215. eCollection 2017.
1048 PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.Nucleic Acids Res. 2016 Dec 15;44(22):10662-10675. doi: 10.1093/nar/gkw808. Epub 2016 Sep 8.
1049 HOXC10 Promotes the Metastasis of Human Lung Adenocarcinoma and Indicates Poor Survival Outcome.Front Physiol. 2017 Aug 2;8:557. doi: 10.3389/fphys.2017.00557. eCollection 2017.
1050 Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.Neuro Oncol. 2016 Jun;18(6):819-29. doi: 10.1093/neuonc/nov281. Epub 2015 Nov 17.
1051 Targeted blockade of TGF- and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts.Sci Rep. 2017 Aug 17;7(1):8660. doi: 10.1038/s41598-017-09020-8.
1052 Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.Lung Cancer. 2017 Nov;113:18-29. doi: 10.1016/j.lungcan.2017.08.026. Epub 2017 Sep 1.
1053 Immunohistochemical profile of ING3 protein in normal and cancerous tissues.Oncol Lett. 2017 Mar;13(3):1631-1636. doi: 10.3892/ol.2017.5632. Epub 2017 Jan 23.
1054 miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B.Life Sci. 2016 Jun 15;155:110-5. doi: 10.1016/j.lfs.2016.05.014. Epub 2016 May 12.
1055 Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.Tumour Biol. 2017 Jun;39(6):1010428317691177. doi: 10.1177/1010428317691177.
1056 Knockdown of Importin 7 Inhibits Lung Tumorigenesis in K-ras(LA1) Lung Cancer Mice.Anticancer Res. 2017 May;37(5):2381-2386. doi: 10.21873/anticanres.11576.
1057 Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.Nat Genet. 2017 Jan;49(1):65-74. doi: 10.1038/ng.3722. Epub 2016 Nov 21.
1058 MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.J Biol Chem. 2017 Jan 6;292(1):82-99. doi: 10.1074/jbc.M116.750950. Epub 2016 Nov 16.
1059 Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.Biochem Biophys Res Commun. 2017 Sep 2;490(4):1407-1413. doi: 10.1016/j.bbrc.2017.07.048. Epub 2017 Jul 8.
1060 Tumour-suppression function of KLF12 through regulation of anoikis.Oncogene. 2016 Jun 23;35(25):3324-34. doi: 10.1038/onc.2015.394. Epub 2015 Oct 12.
1061 RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):27-38. doi: 10.1093/abbs/gmv090. Epub 2015 Sep 7.
1062 CYLD Promotes TNF--Induced Cell Necrosis Mediated by RIP-1 in Human Lung Cancer Cells.Mediators Inflamm. 2016;2016:1542786. doi: 10.1155/2016/1542786. Epub 2016 Sep 25.
1063 BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.Cancer Lett. 2017 Sep 10;403:48-58. doi: 10.1016/j.canlet.2017.05.019. Epub 2017 Jun 10.
1064 Antitumor activity of kinetochore-associated protein 2 siRNA against lung cancer patient-derived tumor xenografts.Oncol Lett. 2018 Apr;15(4):4676-4682. doi: 10.3892/ol.2018.7890. Epub 2018 Jan 29.
1065 Integrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPD.Sci Rep. 2017 May 18;7(1):2121. doi: 10.1038/s41598-017-02405-9.
1066 Genome-wide association study of familial lung cancer.Carcinogenesis. 2018 Sep 21;39(9):1135-1140. doi: 10.1093/carcin/bgy080.
1067 The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.J Cell Physiol. 2019 Aug;234(8):13220-13232. doi: 10.1002/jcp.27994. Epub 2018 Dec 19.
1068 miR-515-5p controls cancer cell migration through MARK4 regulation.EMBO Rep. 2016 Apr;17(4):570-84. doi: 10.15252/embr.201540970. Epub 2016 Feb 10.
1069 Streptomyces artemisiae MCCB 248 isolated from Arctic fjord sediments has unique PKS and NRPS biosynthetic genes and produces potential new anticancer natural products.3 Biotech. 2017 May;7(1):32. doi: 10.1007/s13205-017-0610-3. Epub 2017 Apr 11.
1070 Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.Front Med (Lausanne). 2017 Mar 17;4:30. doi: 10.3389/fmed.2017.00030. eCollection 2017.
1071 Loss of imprinting of PEG1/MEST in lung cancer cell lines.Oncol Rep. 2004 Dec;12(6):1273-8.
1072 MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.Oncogene. 2015 Oct 29;34(44):5570-81. doi: 10.1038/onc.2015.14. Epub 2015 Mar 9.
1073 Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients.Cancer Immunol Res. 2017 Sep;5(9):821-829. doi: 10.1158/2326-6066.CIR-16-0392. Epub 2017 Aug 3.
1074 Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-B.Oncotarget. 2016 Oct 4;7(40):66032-66050. doi: 10.18632/oncotarget.11797.
1075 B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.Int J Mol Sci. 2017 May 27;18(6):860. doi: 10.3390/ijms18060860.
1076 Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.Mol Cancer Res. 2017 Oct;15(10):1354-1365. doi: 10.1158/1541-7786.MCR-17-0191. Epub 2017 Jul 11.
1077 NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression.Nat Commun. 2017 Oct 13;8(1):928. doi: 10.1038/s41467-017-00988-5.
1078 UPregulated single-stranded DNA-binding protein 1 induces cell chemoresistance to cisplatin in lung cancer cell lines.Mol Cell Biochem. 2017 Jul;431(1-2):21-27. doi: 10.1007/s11010-017-2970-8. Epub 2017 Feb 16.
1079 The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.Tumour Biol. 2014 May;35(5):4425-34. doi: 10.1007/s13277-013-1582-5. Epub 2014 Jan 10.
1080 Polymorphisms in DNA repair genes in lung cancer patients living in a coal-mining region.Eur J Cancer Prev. 2019 Nov;28(6):522-528. doi: 10.1097/CEJ.0000000000000504.
1081 Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.Mol Med Rep. 2017 Oct;16(4):5129-5136. doi: 10.3892/mmr.2017.7244. Epub 2017 Aug 14.
1082 DNA damage-induced apoptosis suppressor (DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer.Biochim Biophys Acta. 2016 Jan;1863(1):40-9. doi: 10.1016/j.bbamcr.2015.10.011. Epub 2015 Oct 25.
1083 A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.Mol Oncol. 2016 Nov;10(9):1437-1449. doi: 10.1016/j.molonc.2016.08.001. Epub 2016 Aug 9.
1084 Ninjurin1 suppresses metastatic property of lung cancer cells through inhibition of interleukin 6 signaling pathway.Int J Cancer. 2016 Jul 15;139(2):383-95. doi: 10.1002/ijc.30021. Epub 2016 Feb 16.
1085 OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3/snail/E-cadherin signaling.Oncotarget. 2016 Mar 1;7(9):10402-13. doi: 10.18632/oncotarget.7224.
1086 Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery.Int J Pharm. 2017 Mar 15;519(1-2):240-249. doi: 10.1016/j.ijpharm.2017.01.032. Epub 2017 Jan 19.
1087 PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.Mol Cancer Ther. 2016 Jul;15(7):1669-81. doi: 10.1158/1535-7163.MCT-15-0182. Epub 2016 May 11.
1088 MicroRNA?915?p prevents the apoptosis of lung cancer cells by downregulating DRG2 and PBX2.Mol Med Rep. 2016 Jan;13(1):505-12. doi: 10.3892/mmr.2015.4565. Epub 2015 Nov 13.
1089 MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.Tumour Biol. 2016 Nov;37(11):15221-15228. doi: 10.1007/s13277-016-5347-9. Epub 2016 Sep 28.
1090 Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study.Exp Lung Res. 2016 Aug;42(6):307-13. doi: 10.1080/01902148.2016.1214191. Epub 2016 Aug 2.
1091 LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of -catenin.J Cancer. 2017 Aug 2;8(13):2561-2574. doi: 10.7150/jca.19972. eCollection 2017.
1092 The PDRG1 is an oncogene in lung cancer cells, promoting radioresistance via the ATM-P53 signaling pathway.Biomed Pharmacother. 2016 Oct;83:1471-1477. doi: 10.1016/j.biopha.2016.08.034. Epub 2016 Sep 7.
1093 Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling.Cell Death Dis. 2018 Jul 23;9(8):802. doi: 10.1038/s41419-018-0817-1.
1094 Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.Tumour Biol. 2014 Oct;35(10):10341-9. doi: 10.1007/s13277-014-2284-3. Epub 2014 Jul 21.
1095 Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.Oncogene. 2017 Feb 16;36(7):885-898. doi: 10.1038/onc.2016.257. Epub 2016 Oct 3.
1096 A novel serine protease SNC19 associated with human colorectal cancer.Chin Med J (Engl). 2001 Jul;114(7):726-30.
1097 PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage.Cell Signal. 2013 Jan;25(1):74-84. doi: 10.1016/j.cellsig.2012.09.009. Epub 2012 Sep 11.
1098 PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.Cancer Med. 2019 May;8(5):2429-2441. doi: 10.1002/cam4.2115. Epub 2019 Apr 1.
1099 PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5766-E5775. doi: 10.1073/pnas.1804779115. Epub 2018 Jun 4.
1100 Identification and characterization of RASSF1C piRNA target genes in lung cancer cells.Oncotarget. 2017 May 23;8(21):34268-34282. doi: 10.18632/oncotarget.15965.
1101 Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.Cancer Res. 2005 Aug 15;65(16):7102-10. doi: 10.1158/0008-5472.CAN-04-1877.
1102 PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.Am J Pathol. 2013 Nov;183(5):1634-1644. doi: 10.1016/j.ajpath.2013.07.028. Epub 2013 Sep 17.
1103 Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.Clin Cancer Res. 2017 Feb 15;23(4):1104-1116. doi: 10.1158/1078-0432.CCR-16-1585. Epub 2016 Sep 2.
1104 Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Cancer Sci. 2017 Mar;108(3):528-535. doi: 10.1111/cas.13142.
1105 S-nitrosylation of the Peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway.Cell Death Dis. 2019 Apr 15;10(5):329. doi: 10.1038/s41419-019-1561-x.
1106 The role of Necl-5 in the invasive activity of lung adenocarcinoma.Exp Mol Pathol. 2013 Apr;94(2):330-5. doi: 10.1016/j.yexmp.2012.12.003. Epub 2012 Dec 28.
1107 Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion.BMC Cancer. 2017 Mar 28;17(1):224. doi: 10.1186/s12885-017-3219-3.
1108 Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.Aging (Albany NY). 2016 Nov 29;8(11):2790-2798. doi: 10.18632/aging.101087.
1109 Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential.Clin Exp Metastasis. 1999 May;17(3):213-9. doi: 10.1023/a:1006617016451.
1110 Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells.Oncotarget. 2016 Apr 5;7(14):18371-83. doi: 10.18632/oncotarget.7813.
1111 Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma.Lung Cancer. 2011 Jan;71(1):19-27. doi: 10.1016/j.lungcan.2010.04.006.
1112 Transforming Growth Factor--Induced RBFOX3 Inhibition Promotes Epithelial-Mesenchymal Transition of Lung Cancer Cells.Mol Cells. 2016 Aug 31;39(8):625-30. doi: 10.14348/molcells.2016.0150. Epub 2016 Jul 19.
1113 RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.Oncogene. 2016 Sep 22;35(38):5000-9. doi: 10.1038/onc.2016.35. Epub 2016 Feb 29.
1114 MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3390-3400. doi: 10.26355/eurrev_201904_17703.
1115 A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).Oncotarget. 2017 Jul 11;8(28):45345-45355. doi: 10.18632/oncotarget.17477.
1116 Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers.Mutat Res. 1998 Nov;406(1):9-23. doi: 10.1016/s1383-5726(98)00006-5.
1117 A precision-guided MWNT mediated reawakening the sunk synergy in RAS for anti-angiogenesis lung cancer therapy.Biomaterials. 2017 Sep;139:75-90. doi: 10.1016/j.biomaterials.2017.05.046. Epub 2017 May 31.
1118 TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis.Biochim Biophys Acta. 2016 Dec;1866(2):189-196. doi: 10.1016/j.bbcan.2016.09.003. Epub 2016 Sep 15.
1119 Inhibition of rhotekin exhibits antitumor effects in lung cancer cells.Oncol Rep. 2016 May;35(5):2529-34. doi: 10.3892/or.2016.4634. Epub 2016 Feb 24.
1120 Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.J Clin Invest. 2017 Aug 1;127(8):2982-2997. doi: 10.1172/JCI89957. Epub 2017 Jul 10.
1121 WW45, a Gli1 binding protein, negatively regulated Hedgehog signaling in lung cancer.Oncotarget. 2016 Oct 18;7(42):68966-68975. doi: 10.18632/oncotarget.12155.
1122 Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.Oncotarget. 2016 Jan 19;7(3):3297-316. doi: 10.18632/oncotarget.6489.
1123 ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.PLoS One. 2016 Nov 1;11(11):e0165181. doi: 10.1371/journal.pone.0165181. eCollection 2016.
1124 Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population.PLoS One. 2016 Oct 10;11(10):e0164358. doi: 10.1371/journal.pone.0164358. eCollection 2016.
1125 Selenium-binding protein 1 is down-regulated in malignant melanoma.Oncotarget. 2018 Jan 2;9(12):10445-10456. doi: 10.18632/oncotarget.23853. eCollection 2018 Feb 13.
1126 Neuropilin-2 Is upregulated in lung cancer cells during TGF-1-induced epithelial-mesenchymal transition.Cancer Res. 2013 Dec 1;73(23):7111-21. doi: 10.1158/0008-5472.CAN-13-1755. Epub 2013 Oct 11.
1127 Methylation analysis in spontaneous sputum for lung cancer diagnosis.Lung Cancer. 2014 May;84(2):127-33. doi: 10.1016/j.lungcan.2014.01.019. Epub 2014 Jan 31.
1128 Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.Oncotarget. 2017 May 22;8(37):61253-61263. doi: 10.18632/oncotarget.18056. eCollection 2017 Sep 22.
1129 SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression.Cancer Res. 2016 Jan 15;76(2):358-69. doi: 10.1158/0008-5472.CAN-15-1879. Epub 2015 Nov 17.
1130 Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.Oncotarget. 2017 Jan 10;8(2):2681-2693. doi: 10.18632/oncotarget.13153.
1131 Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes.QJM. 2019 Aug 1;112(8):581-590. doi: 10.1093/qjmed/hcz093.
1132 Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.PLoS One. 2017 Aug 14;12(8):e0181601. doi: 10.1371/journal.pone.0181601. eCollection 2017.
1133 A herpes simplex virus type 2-encoded microRNA promotes tumor cell metastasis by targeting suppressor of cytokine signaling 2 in lung cancer.Tumour Biol. 2017 May;39(5):1010428317701633. doi: 10.1177/1010428317701633.
1134 Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.Am J Transl Res. 2017 Sep 15;9(9):4003-4014. eCollection 2017.
1135 miR-539 inhibits prostate cancer progression by directly targeting SPAG5.J Exp Clin Cancer Res. 2016 Apr 1;35:60. doi: 10.1186/s13046-016-0337-8.
1136 SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma.Oncotarget. 2016 Jul 12;7(28):44417-44429. doi: 10.18632/oncotarget.10088.
1137 Alternative splicing in lung cancer.Biochim Biophys Acta Gene Regul Mech. 2019 Nov-Dec;1862(11-12):194388. doi: 10.1016/j.bbagrm.2019.05.006. Epub 2019 May 29.
1138 Oxymatrine Attenuates Tumor Growth and Deactivates STAT5 Signaling in a Lung Cancer Xenograft Model.Cancers (Basel). 2019 Jan 7;11(1):49. doi: 10.3390/cancers11010049.
1139 Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.Sci Rep. 2017 Feb 15;7:42573. doi: 10.1038/srep42573.
1140 TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-B pathway.Tumour Biol. 2016 Mar;37(3):3851-61. doi: 10.1007/s13277-015-3896-y. Epub 2015 Oct 17.
1141 XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.Tumour Biol. 2015 May;36(5):3745-50. doi: 10.1007/s13277-014-3014-6. Epub 2015 Jan 8.
1142 Clinicopathological significance of p14(ARF) expression in lung cancer: a meta-analysis.Onco Targets Ther. 2017 May 8;10:2491-2499. doi: 10.2147/OTT.S131954. eCollection 2017.
1143 Thrombospondin enhances RANKL-dependent osteoclastogenesis and facilitates lung cancer bone metastasis.Biochem Pharmacol. 2019 Aug;166:23-32. doi: 10.1016/j.bcp.2019.05.005. Epub 2019 May 7.
1144 The association of transporter genes polymorphisms and lung cancer chemotherapy response.PLoS One. 2014 Mar 18;9(3):e91967. doi: 10.1371/journal.pone.0091967. eCollection 2014.
1145 TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.Tumour Biol. 2016 Sep;37(9):12181-12191. doi: 10.1007/s13277-016-5063-5. Epub 2016 May 26.
1146 TIPE1 function as a prognosis predictor and negative regulator of lung cancer.Oncotarget. 2017 Jul 28;8(45):78496-78506. doi: 10.18632/oncotarget.19655. eCollection 2017 Oct 3.
1147 Expression of LUN gene that encodes a novel RING finger protein is correlated with development and progression of non-small cell lung cancer.Lung Cancer. 2004 Oct;46(1):21-8. doi: 10.1016/j.lungcan.2004.03.009.
1148 High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):190-196. doi: 10.1016/j.clinre.2016.09.010. Epub 2017 Jan 5.
1149 Tripartite motifcontaining11 regulates the proliferation and apoptosis of breast cancer cells.Oncol Rep. 2019 Apr;41(4):2567-2574. doi: 10.3892/or.2019.7015. Epub 2019 Feb 14.
1150 Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.Technol Cancer Res Treat. 2016 Oct;15(5):707-15. doi: 10.1177/1533034615595903. Epub 2015 Jun 25.
1151 Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer.J Pathol. 2014 Sep;234(1):108-19. doi: 10.1002/path.4385. Epub 2014 Jul 16.
1152 Elevated expression of thyroid hormone receptor-interacting protein 13 drives tumorigenesis and affects clinical outcome.Biomark Med. 2017 Jan;11(1):19-31. doi: 10.2217/bmm-2016-0169. Epub 2016 Nov 9.
1153 Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis.Genes Chromosomes Cancer. 2010 Apr;49(4):353-67. doi: 10.1002/gcc.20747.
1154 MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.Clin Cancer Res. 2017 Jul 15;23(14):3906-3917. doi: 10.1158/1078-0432.CCR-16-2530. Epub 2017 Feb 14.
1155 Identification of a novel transcript isoform of the TTLL12 gene in human cancers.Oncol Rep. 2016 Dec;36(6):3172-3180. doi: 10.3892/or.2016.5135. Epub 2016 Sep 28.
1156 AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development.Mol Cancer Res. 2018 Aug;16(8):1287-1298. doi: 10.1158/1541-7786.MCR-17-0726. Epub 2018 May 3.
1157 ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.Cancer Res. 2005 Dec 15;65(24):11314-25. doi: 10.1158/0008-5472.CAN-05-1507.
1158 Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.Cell Signal. 2018 Jun;46:83-91. doi: 10.1016/j.cellsig.2018.02.014. Epub 2018 Mar 1.
1159 Effect of cytokine-induced killer cells combined with dendritic cells on the survival rate and expression of 14-3-3 and p-Bad proteins in Lewis lung cancer cell lines.Oncol Lett. 2018 Aug;16(2):1815-1820. doi: 10.3892/ol.2018.8834. Epub 2018 May 30.
1160 Human basonuclin 2 up-regulates a cascade set of interferon-stimulated genes with anti-cancerous properties in a lung cancer model.Cancer Cell Int. 2017 Feb 6;17:18. doi: 10.1186/s12935-017-0394-x. eCollection 2017.
1161 Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.Nat Med. 2017 Mar;23(3):291-300. doi: 10.1038/nm.4285. Epub 2017 Feb 13.
1162 EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.Biochim Biophys Acta. 2015 Jul;1852(7):1540-9. doi: 10.1016/j.bbadis.2015.04.020. Epub 2015 Apr 23.
1163 Long non-coding RNA CRYBG3 regulates glycolysis of lung cancer cells by interacting with lactate dehydrogenase A.J Cancer. 2018 Jun 23;9(14):2580-2588. doi: 10.7150/jca.24896. eCollection 2018.
1164 The Expression Pattern of p120-Catenin is Associated With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.Appl Immunohistochem Mol Morphol. 2018 Jan;26(1):64-70. doi: 10.1097/PAI.0000000000000381.
1165 A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis.Cancer Res. 2005 Jul 1;65(13):5638-46. doi: 10.1158/0008-5472.CAN-05-0600.
1166 Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells.Cancer Res. 2006 Dec 15;66(24):11907-12. doi: 10.1158/0008-5472.CAN-06-2754.
1167 ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.Mol Carcinog. 2020 Jan;59(1):73-86. doi: 10.1002/mc.23130. Epub 2019 Oct 31.
1168 Aberrant methylation of FBN2 in human non-small cell lung cancer.Lung Cancer. 2005 Oct;50(1):43-9. doi: 10.1016/j.lungcan.2005.04.013.
1169 Cigarette Smoking Condensate Disrupts Endoplasmic Reticulum-Golgi Network Homeostasis Through GOLPH3 Expression in Normal Lung Epithelial Cells.Nicotine Tob Res. 2016 Sep;18(9):1877-1885. doi: 10.1093/ntr/ntw079. Epub 2016 Mar 31.
1170 Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3.Int J Cancer. 2018 Nov 15;143(10):2470-2478. doi: 10.1002/ijc.31756. Epub 2018 Sep 19.
1171 A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South.Ir J Med Sci. 2017 Nov;186(4):855-857. doi: 10.1007/s11845-017-1579-y. Epub 2017 Feb 9.
1172 Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor .Int J Oncol. 2015 Jul;47(1):106-14. doi: 10.3892/ijo.2015.2988. Epub 2015 May 6.
1173 RASSF10 suppresses lung cancer proliferation and invasion by decreasing the level of phosphorylated LRP6.Mol Carcinog. 2019 Jul;58(7):1168-1180. doi: 10.1002/mc.23000. Epub 2019 Mar 4.
1174 Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitro.Mol Cell Biochem. 2017 Jun;430(1-2):37-46. doi: 10.1007/s11010-017-2952-x. Epub 2017 Feb 8.
1175 TGF-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.Mol Cancer Res. 2018 Dec;16(12):1991-2002. doi: 10.1158/1541-7786.MCR-18-0366. Epub 2018 Aug 2.
1176 Plasma selenoprotein P concentration and lung cancer risk: results from a case-control study nested within the Shanghai Men's Health Study.Carcinogenesis. 2018 Dec 13;39(11):1352-1358. doi: 10.1093/carcin/bgy103.
1177 Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.PLoS One. 2013 Aug 16;8(8):e71816. doi: 10.1371/journal.pone.0071816. eCollection 2013.
1178 MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1.Oncol Res. 2019 Aug 8;27(8):879-887. doi: 10.3727/096504018X15451308507747. Epub 2019 Apr 14.
1179 TIFA Promotes Cell Survival and Migration in Lung Adenocarcinoma.Cell Physiol Biochem. 2018;47(5):2097-2108. doi: 10.1159/000491478. Epub 2018 Jul 5.
1180 A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling.Cell Death Dis. 2018 May 1;9(5):443. doi: 10.1038/s41419-018-0467-3.
1181 DAC can restore expression of NALP1 to suppress tumor growth in colon cancer.Cell Death Dis. 2015 Jan 22;6(1):e1602. doi: 10.1038/cddis.2014.532.
1182 MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR.Cell Physiol Biochem. 2015;35(3):997-1007. doi: 10.1159/000369755. Epub 2015 Feb 2.
1183 Selective Inhibition of ADAM28 Suppresses Lung Carcinoma Cell Growth and Metastasis.Mol Cancer Ther. 2018 Nov;17(11):2427-2438. doi: 10.1158/1535-7163.MCT-17-1198. Epub 2018 Sep 6.
1184 Single nucleotide polymorphisms in VTI1A gene contribute to the susceptibility of Chinese population to non-small cell lung cancer.Int J Biol Markers. 2015 Jul 22;30(3):e286-93. doi: 10.5301/jbm.5000140.
1185 AP-2 downregulation by cigarette smoke condensate is counteracted by p53 in human lung cancer cells.Int J Mol Med. 2014 Oct;34(4):1094-100. doi: 10.3892/ijmm.2014.1857. Epub 2014 Jul 17.
1186 Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379.
1187 Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.Biomed Res Int. 2015;2015:358125. doi: 10.1155/2015/358125. Epub 2015 Feb 23.
1188 Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-B signaling.BMC Cancer. 2014 Sep 20;14:686. doi: 10.1186/1471-2407-14-686.
1189 Typing tumors using pathways selected by somatic evolution.Nat Commun. 2018 Oct 8;9(1):4159. doi: 10.1038/s41467-018-06464-y.
1190 The association between three AXIN2 variants and cancer risk.J Cell Biochem. 2019 Sep;120(9):15561-15571. doi: 10.1002/jcb.28823. Epub 2019 Apr 30.
1191 Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.Oncol Rep. 2015 Jan;33(1):283-91. doi: 10.3892/or.2014.3584. Epub 2014 Nov 3.
1192 Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations.Am J Hum Genet. 2015 May 7;96(5):832-40. doi: 10.1016/j.ajhg.2015.03.009. Epub 2015 Apr 30.
1193 Gamma Irradiation Upregulates B-cell Translocation Gene 2 to Attenuate Cell Proliferation of Lung Cancer Cells Through the JNK and NF-B Pathways.Oncol Res. 2017 Aug 7;25(7):1199-1205. doi: 10.3727/096504017X14873444858101. Epub 2017 Mar 2.
1194 USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and -TrCP and promotes cancer malignancy.Nat Commun. 2018 Sep 28;9(1):3996. doi: 10.1038/s41467-018-06178-1.
1195 Depletion of CABYR-a/b sensitizes lung cancer cells to TRAIL-induced apoptosis through YAP/p73-mediated DR5 upregulation.Oncotarget. 2016 Feb 23;7(8):9513-24. doi: 10.18632/oncotarget.7069.
1196 Proteomic analysis of proteins related to prognosis of lung adenocarcinoma.J Proteome Res. 2014 Nov 7;13(11):4686-94. doi: 10.1021/pr4012969. Epub 2014 Jul 8.
1197 Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells.Cell Mol Life Sci. 2006 Jun;63(12):1425-39. doi: 10.1007/s00018-006-5521-5.
1198 Erratum: miR-23b suppresses lung carcinoma cell proliferation through CCNG1.Oncol Lett. 2019 Feb;17(2):2005. doi: 10.3892/ol.2018.9790. Epub 2018 Dec 4.
1199 Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients.Onco Targets Ther. 2019 Jan 29;12:921-932. doi: 10.2147/OTT.S180507. eCollection 2019.
1200 CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.Cancer Res. 2015 May 15;75(10):2029-38. doi: 10.1158/0008-5472.CAN-14-1494. Epub 2015 Mar 25.
1201 CEMP1 Induces Transformation in Human Gingival Fibroblasts.PLoS One. 2015 May 26;10(5):e0127286. doi: 10.1371/journal.pone.0127286. eCollection 2015.
1202 Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells.Mol Med Rep. 2015 Mar;11(3):2118-24. doi: 10.3892/mmr.2014.2936. Epub 2014 Nov 13.
1203 Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.J Thorac Oncol. 2015 Aug;10(8):1181-8. doi: 10.1097/JTO.0000000000000592.
1204 PKC-iPLA2-PGE2-PPAR signaling cascade mediates TNF- induced Claudin 1 expression in human lung carcinoma cells.Cell Signal. 2015 Mar;27(3):568-77. doi: 10.1016/j.cellsig.2014.12.015. Epub 2015 Jan 3.
1205 Proteome analysis for downstream targets of oncogenic KRAS--the potential participation of CLIC4 in carcinogenesis in the lung.PLoS One. 2014 Feb 4;9(2):e87193. doi: 10.1371/journal.pone.0087193. eCollection 2014.
1206 TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases.Mol Cancer. 2014 Sep 12;13:211. doi: 10.1186/1476-4598-13-211.
1207 CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation.Lung Cancer. 2014 Aug;85(2):147-51. doi: 10.1016/j.lungcan.2014.05.018. Epub 2014 Jun 2.
1208 -Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma.Oncol Rep. 2018 Feb;39(2):809-817. doi: 10.3892/or.2017.6140. Epub 2017 Dec 8.
1209 Involvement of CXCL14 in osteolytic bone metastasis from lung cancer.Int J Oncol. 2014 Apr;44(4):1316-24. doi: 10.3892/ijo.2014.2293. Epub 2014 Feb 10.
1210 X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells.J Exp Clin Cancer Res. 2018 Dec 14;37(1):315. doi: 10.1186/s13046-018-1000-3.
1211 Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration.Biochem Cell Biol. 2018 Oct;96(5):602-609. doi: 10.1139/bcb-2017-0279. Epub 2018 Mar 28.
1212 Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors.Oncol Rep. 2003 Jul-Aug;10(4):1031-3.
1213 Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.Exp Cell Res. 2018 Oct 1;371(1):50-62. doi: 10.1016/j.yexcr.2018.07.040. Epub 2018 Jul 26.
1214 META-GSA: Combining Findings from Gene-Set Analyses across Several Genome-Wide Association Studies.PLoS One. 2015 Oct 26;10(10):e0140179. doi: 10.1371/journal.pone.0140179. eCollection 2015.
1215 Identification and validation of gene module associated with lung cancer through coexpression network analysis.Gene. 2015 May 25;563(1):56-62. doi: 10.1016/j.gene.2015.03.008. Epub 2015 Mar 7.
1216 Diacylglycerol kinase modulates oncogenic properties of lung cancer cells.Clin Transl Oncol. 2014 Jan;16(1):29-35. doi: 10.1007/s12094-013-1036-y. Epub 2013 Apr 10.
1217 13q14 deletions in CLL involve cooperating tumor suppressors.Blood. 2010 May 13;115(19):3916-22. doi: 10.1182/blood-2009-10-249367. Epub 2010 Jan 13.
1218 Paradoxical roles of dual oxidases in cancer biology.Free Radic Biol Med. 2017 Sep;110:117-132. doi: 10.1016/j.freeradbiomed.2017.05.024. Epub 2017 May 31.
1219 Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes.Int J Cancer. 2018 Apr 15;142(8):1602-1610. doi: 10.1002/ijc.31182. Epub 2017 Dec 12.
1220 Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer.BMC Cancer. 2014 Dec 3;14:913. doi: 10.1186/1471-2407-14-913.
1221 Role of fibulin-3 in lung cancer: in vivo and in vitro analyses.Oncol Rep. 2014 Jan;31(1):79-86. doi: 10.3892/or.2013.2799. Epub 2013 Oct 18.
1222 Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.Lung Cancer. 2015 Nov;90(2):175-81. doi: 10.1016/j.lungcan.2015.08.019. Epub 2015 Sep 3.
1223 Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.Oncotarget. 2016 Apr 26;7(17):24242-51. doi: 10.18632/oncotarget.8168.
1224 ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.PLoS One. 2015 Mar 20;10(3):e0120046. doi: 10.1371/journal.pone.0120046. eCollection 2015.
1225 RNA interference targeting enhancer of polycomb1 exerts anti-tumor effects in lung cancer.Int J Clin Exp Pathol. 2015 Jan 1;8(1):361-7. eCollection 2015.
1226 XPF polymorphism toward lung cancer susceptibility and survival in patients treated with platinum-based chemotherapy.Future Oncol. 2018 May;14(11):1071-1089. doi: 10.2217/fon-2017-0569. Epub 2018 May 9.
1227 Conversion of MIG6 peptide from the nonbinder to binder of lung cancer-related EGFR by phosphorylation and cyclization.Artif Cells Nanomed Biotechnol. 2017 Aug;45(5):1023-1028. doi: 10.1080/21691401.2016.1200058. Epub 2016 Jun 25.
1228 TCRP1 promotes NIH/3T3 cell transformation by over-activating PDK1 and AKT1.Oncogenesis. 2017 Apr 24;6(4):e323. doi: 10.1038/oncsis.2017.18.
1229 ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549.Tumour Biol. 2014 Feb;35(2):1377-82. doi: 10.1007/s13277-013-1188-y. Epub 2013 Sep 27.
1230 Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.BMC Cancer. 2015 Oct 5;15:649. doi: 10.1186/s12885-015-1649-3.
1231 Inactivation of the ubiquitin-specific protease 19 deubiquitinating enzyme protects against muscle wasting.FASEB J. 2015 Sep;29(9):3889-98. doi: 10.1096/fj.15-270579. Epub 2015 Jun 5.
1232 Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.Cancer Immunol Immunother. 2012 Jan;61(1):79-88. doi: 10.1007/s00262-011-1078-3. Epub 2011 Aug 17.
1233 FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1.Neoplasia. 2018 Oct;20(10):996-1007. doi: 10.1016/j.neo.2018.08.004. Epub 2018 Sep 10.
1234 Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.Cancer Res. 2019 Dec 15;79(24):6113-6125. doi: 10.1158/0008-5472.CAN-19-0842. Epub 2019 Oct 25.
1235 GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer.J Thorac Oncol. 2014 Jun;9(6):784-93. doi: 10.1097/JTO.0000000000000165.
1236 Correlation between survivin genetic polymorphisms and lung cancer susceptibility.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7426-30. eCollection 2015.
1237 Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population.Dis Markers. 2015;2015:824304. doi: 10.1155/2015/824304. Epub 2015 Apr 27.
1238 In vitro study of Nucleostemin gene as a potential therapeutic target for human lung carcinoma.Biomed Environ Sci. 2012 Feb;25(1):91-7. doi: 10.3967/0895-3988.2012.01.013.
1239 HBP1 promoter methylation augments the oncogenic -catenin to correlate with prognosis in NSCLC.J Cell Mol Med. 2014 Sep;18(9):1752-61. doi: 10.1111/jcmm.12318. Epub 2014 Jun 4.
1240 A cancer-associated mutation inactivates a region of the high-mobility group protein HMG20b essential for cytokinesis.Cell Cycle. 2014;13(16):2554-63. doi: 10.4161/15384101.2014.942204.
1241 Expression of HNF4G and its potential functions in lung cancer.Oncotarget. 2017 Dec 4;9(26):18018-18028. doi: 10.18632/oncotarget.22933. eCollection 2018 Apr 6.
1242 Transcriptional analysis of hnRNPA0, A1, A2, B1, and A3 in lung cancer cell lines in response to acidosis, hypoxia, and serum deprivation conditions.Exp Lung Res. 2014 Feb;40(1):12-21. doi: 10.3109/01902148.2013.856049. Epub 2013 Nov 18.
1243 Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect.Immunol Lett. 2018 Aug;200:33-42. doi: 10.1016/j.imlet.2018.06.004. Epub 2018 Jun 9.
1244 Antagonism between HTRA3 and TGF1 Contributes to Metastasis in Non-Small Cell Lung Cancer.Cancer Res. 2019 Jun 1;79(11):2853-2864. doi: 10.1158/0008-5472.CAN-18-2507. Epub 2019 Apr 2.
1245 LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.Gene. 2019 Sep 5;712:143963. doi: 10.1016/j.gene.2019.143963. Epub 2019 Jul 5.
1246 IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro.Onco Targets Ther. 2019 Feb 21;12:1447-1454. doi: 10.2147/OTT.S173207. eCollection 2019.
1247 Hepatitis B virus upregulates the expression of kinesin family member 4A.Mol Med Rep. 2015 Sep;12(3):3503-3507. doi: 10.3892/mmr.2015.3792. Epub 2015 May 15.
1248 IQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells.PLoS One. 2014 May 21;9(5):e97578. doi: 10.1371/journal.pone.0097578. eCollection 2014.
1249 Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.PLoS One. 2017 Mar 2;12(3):e0173048. doi: 10.1371/journal.pone.0173048. eCollection 2017.
1250 S100P interacts with integrin 7 and increases cancer cell migration and invasion in lung cancer.Oncotarget. 2015 Oct 6;6(30):29585-98. doi: 10.18632/oncotarget.4987.
1251 The EDA-containing cellular fibronectin induces epithelial-mesenchymal transition in lung cancer cells through integrin 91-mediated activation of PI3-K/AKT and Erk1/2.Carcinogenesis. 2014 Jan;35(1):184-91. doi: 10.1093/carcin/bgt276. Epub 2013 Aug 8.
1252 Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.Oncogene. 2014 Nov 20;33(47):5457-66. doi: 10.1038/onc.2013.486. Epub 2013 Nov 18.
1253 Kinesin KIF4A is associated with chemotherapeutic drug resistance by regulating intracellular trafficking of lung resistance-related protein.J Zhejiang Univ Sci B. 2017 Dec.;18(12):1046-1054. doi: 10.1631/jzus.B1700129.
1254 MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.Int J Clin Exp Pathol. 2015 Mar 1;8(3):2829-34. eCollection 2015.
1255 Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.Biosci Rep. 2017 Nov 6;37(6):BSR20171086. doi: 10.1042/BSR20171086. Print 2017 Dec 22.
1256 Identification of a nuclear protein, LRRC42, involved in lung carcinogenesis.Int J Oncol. 2014 Jul;45(1):147-56. doi: 10.3892/ijo.2014.2418. Epub 2014 May 6.
1257 Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia.J Natl Cancer Inst. 2014 Apr;106(4):dju061. doi: 10.1093/jnci/dju061. Epub 2014 Mar 28.
1258 Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel.Onco Targets Ther. 2017 Jan 18;10:439-446. doi: 10.2147/OTT.S125789. eCollection 2017.
1259 HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.Oncotarget. 2017 Mar 21;8(12):19342-19353. doi: 10.18632/oncotarget.14258.
1260 MicroRNA-125b may function as an oncogene in lung cancer cells.Mol Med Rep. 2015 May;11(5):3880-7. doi: 10.3892/mmr.2014.3142. Epub 2014 Dec 31.
1261 Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer.Sci Rep. 2014 Dec 18;4:7545. doi: 10.1038/srep07545.
1262 Germline mutations causing familial lung cancer.J Hum Genet. 2015 Oct;60(10):597-603. doi: 10.1038/jhg.2015.75. Epub 2015 Jul 16.
1263 A Newfound association between MDC1 functional polymorphism and lung cancer risk in Chinese.PLoS One. 2014 Sep 8;9(9):e106794. doi: 10.1371/journal.pone.0106794. eCollection 2014.
1264 LCMR1 interacts with DEK to suppress apoptosis in lung cancer cells.Mol Med Rep. 2017 Oct;16(4):4159-4164. doi: 10.3892/mmr.2017.7095. Epub 2017 Jul 27.
1265 miR?4 may be a negative regulator of menin in lung cancer.Oncol Rep. 2018 May;39(5):2342-2350. doi: 10.3892/or.2018.6327. Epub 2018 Mar 20.
1266 MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.Int J Med Sci. 2019 Jan 1;16(1):68-74. doi: 10.7150/ijms.27595. eCollection 2019.
1267 Non-small cell lung cancer invasion and metastasis promoted by MMP-26.Mol Med Rep. 2011 Nov-Dec;4(6):1201-9. doi: 10.3892/mmr.2011.540. Epub 2011 Jul 26.
1268 miR-25 targets the modulator of apoptosis 1 gene in lung cancer.Carcinogenesis. 2015 Aug;36(8):925-35. doi: 10.1093/carcin/bgv068. Epub 2015 May 21.
1269 Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.Int J Cancer. 2018 Oct 1;143(7):1696-1705. doi: 10.1002/ijc.31542. Epub 2018 May 7.
1270 Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model.Int J Cancer. 2015 Sep 1;137(5):1107-18. doi: 10.1002/ijc.29372. Epub 2015 Jan 14.
1271 S6K1 phosphorylation-dependent degradation of Mxi1 by -Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer.Theranostics. 2018 Feb 2;8(5):1286-1300. doi: 10.7150/thno.22552. eCollection 2018.
1272 Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.PLoS One. 2013 Apr 16;8(4):e61008. doi: 10.1371/journal.pone.0061008. Print 2013.
1273 Lentivirus-Mediated Silencing of Myosin VI Inhibits Proliferation and Cell Cycle Progression in Human Lung Cancer Cells.Chem Biol Drug Des. 2015 Oct;86(4):606-13. doi: 10.1111/cbdd.12528. Epub 2015 Feb 19.
1274 Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.J Clin Invest. 2015 Nov 3;125(12):4407-20. doi: 10.1172/JCI81673.
1275 Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy.Mol Med Rep. 2015 May;11(5):3523-32. doi: 10.3892/mmr.2014.3141. Epub 2014 Dec 30.
1276 HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population.Acta Pharmacol Sin. 2014 May;35(5):636-44. doi: 10.1038/aps.2014.11.
1277 Etoposide induced NMI promotes cell apoptosis by activating the ARF-p53 signaling pathway in lung carcinoma.Biochem Biophys Res Commun. 2018 Jan 1;495(1):368-374. doi: 10.1016/j.bbrc.2017.10.010. Epub 2017 Oct 10.
1278 NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer.Biochem Biophys Res Commun. 2015 Mar 6;458(2):381-6. doi: 10.1016/j.bbrc.2015.01.124. Epub 2015 Jan 31.
1279 Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.Sci Rep. 2017 Jul 5;7(1):4676. doi: 10.1038/s41598-017-04611-x.
1280 The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.Anticancer Agents Med Chem. 2017;17(10):1363-1373. doi: 10.2174/1871520617666170213115756.
1281 PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis.Oncol Rep. 2014 Nov;32(5):2159-67. doi: 10.3892/or.2014.3469. Epub 2014 Sep 9.
1282 Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema.Lung Cancer. 2011 Oct;74(1):12-24. doi: 10.1016/j.lungcan.2011.02.006. Epub 2011 Mar 11.
1283 Phospholipase C -1 inhibits p53 expression in lung cancer.Cell Biochem Funct. 2014 Apr;32(3):294-8. doi: 10.1002/cbf.3015. Epub 2013 Dec 20.
1284 Role of the CKIP1 gene in proliferation and apoptosis of the human lung cancer cell line H1299.Genet Mol Res. 2015 Apr 27;14(2):4005-14. doi: 10.4238/2015.April.27.15.
1285 Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.Oncogene. 2005 Sep 1;24(38):5821-6. doi: 10.1038/sj.onc.1208880.
1286 Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression.Oncotarget. 2015 Sep 8;6(26):22139-51. doi: 10.18632/oncotarget.4192.
1287 Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1/Parkin-mediated mitophagy in lung cancer cells.Acta Pharmacol Sin. 2020 Jan;41(1):93-100. doi: 10.1038/s41401-019-0260-6. Epub 2019 Jul 8.
1288 Weak sharing of genetic association signals in three lung cancer subtypes: evidence at the SNP, gene, regulation, and pathway levels.Genome Med. 2018 Feb 27;10(1):16. doi: 10.1186/s13073-018-0522-9.
1289 Diagnostic Accuracy of Interleukin-27 in Bronchoalveolar Lavage Fluids for Pulmonary Tuberculosis.Infect Drug Resist. 2019 Dec 2;12:3755-3763. doi: 10.2147/IDR.S231215. eCollection 2019.
1290 Network analysis of DEGs and verification experiments reveal the notable roles of PTTG1 and MMP9 in lung cancer.Oncol Lett. 2018 Jan;15(1):257-263. doi: 10.3892/ol.2017.7329. Epub 2017 Nov 2.
1291 Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotype.Int J Cancer. 2018 Oct 1;143(7):1753-1763. doi: 10.1002/ijc.31569. Epub 2018 Jul 3.
1292 RanGTPase: a candidate for Myc-mediated cancer progression.J Natl Cancer Inst. 2013 Apr 3;105(7):475-88. doi: 10.1093/jnci/djt028. Epub 2013 Mar 6.
1293 Expression and DNA methylation status of the Rap2B gene in human bronchial epithelial cells treated by cigarette smoke condensate.Inhal Toxicol. 2015;27(10):502-9. doi: 10.3109/08958378.2015.1076546. Epub 2015 Aug 26.
1294 Study on lung cancer cells expressing VEGFR2 and the impact on the effect of RHES combined with radiotherapy in the treatment of brain metastases.Clin Lung Cancer. 2014 Mar;15(2):e23-9. doi: 10.1016/j.cllc.2013.11.012. Epub 2013 Nov 20.
1295 Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy.Onco Targets Ther. 2017 Jan 11;10:339-345. doi: 10.2147/OTT.S125250. eCollection 2017.
1296 Overexpression of the regulator of G-protein signaling5 reduces the survival rate and enhances the radiation response of human lung cancer cells.Oncol Rep. 2015 Jun;33(6):2899-907. doi: 10.3892/or.2015.3917. Epub 2015 Apr 20.
1297 microRNA-802/Rnd3 pathway imposes on carcinogenesis and metastasis of fine particulate matter exposure.Oncotarget. 2016 Jun 7;7(23):35026-43. doi: 10.18632/oncotarget.9019.
1298 Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma.Int J Cancer. 2014 Jun 1;134(11):2595-604. doi: 10.1002/ijc.28600. Epub 2013 Nov 29.
1299 Effects of ribosomal protein l39-L on the drug resistance mechanisms of lung cancer A549 cells.Asian Pac J Cancer Prev. 2014;15(7):3093-7. doi: 10.7314/apjcp.2014.15.7.3093.
1300 Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer.Oncogenesis. 2018 Apr 25;7(4):36. doi: 10.1038/s41389-018-0045-7.
1301 Lentivirus-mediated silencing of SCIN inhibits proliferation of human lung carcinoma cells.Gene. 2015 Jan 1;554(1):32-9. doi: 10.1016/j.gene.2014.10.013. Epub 2014 Oct 7.
1302 Differentially expressed protein-coding genes and long noncoding RNA in early-stage lung cancer.Tumour Biol. 2015 Dec;36(12):9969-78. doi: 10.1007/s13277-015-3714-6. Epub 2015 Jul 16.
1303 Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.Oncogene. 2014 Nov 27;33(48):5523-33. doi: 10.1038/onc.2013.498. Epub 2013 Nov 25.
1304 SEL1L expression in non-small cell lung cancer.Hum Pathol. 2006 May;37(5):505-12. doi: 10.1016/j.humpath.2005.12.012. Epub 2006 Mar 20.
1305 MiR-563 restrains cell proliferation via targeting LIN28B in human lung cancer.Thorac Cancer. 2020 Jan;11(1):55-61. doi: 10.1111/1759-7714.13257. Epub 2019 Nov 25.
1306 Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report.Med Oncol. 2014 Apr;31(4):917. doi: 10.1007/s12032-014-0917-4. Epub 2014 Mar 16.
1307 An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.PLoS One. 2015 May 11;10(5):e0124033. doi: 10.1371/journal.pone.0124033. eCollection 2015.
1308 Diverse Targets of -Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.Cancer Res. 2015 Aug 15;75(16):3398-410. doi: 10.1158/0008-5472.CAN-14-3265. Epub 2015 Jun 29.
1309 MicroRNA-144-3p suppressed TGF-1-induced lung cancer cell invasion and adhesion by regulating the Src-Akt-Erk pathway.Cell Biol Int. 2020 Jan;44(1):51-61. doi: 10.1002/cbin.11158. Epub 2019 May 18.
1310 Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.PLoS One. 2012;7(10):e46539. doi: 10.1371/journal.pone.0046539. Epub 2012 Oct 10.
1311 Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer.J Cell Commun Signal. 2018 Jun;12(2):423-432. doi: 10.1007/s12079-017-0418-2. Epub 2017 Oct 30.
1312 TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/-catenin pathway.J Surg Res. 2013 Nov;185(1):255-63. doi: 10.1016/j.jss.2013.05.075. Epub 2013 Jun 11.
1313 Genome-Epigenome-Senescence: Is TET1 a Caretaker of p53-Injured Lung Cancer Cells?.Cancer Res. 2019 Apr 15;79(8):1751-1752. doi: 10.1158/0008-5472.CAN-19-0645.
1314 TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation.Oncogene. 2017 Mar;36(11):1585-1596. doi: 10.1038/onc.2016.328. Epub 2016 Sep 5.
1315 Thoc1 inhibits cell growth via induction of cell cycle arrest and apoptosis in lung cancer cells.Mol Med Rep. 2014 Jun;9(6):2321-7. doi: 10.3892/mmr.2014.2088. Epub 2014 Mar 28.
1316 Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2.Biomacromolecules. 2018 Apr 9;19(4):1285-1293. doi: 10.1021/acs.biomac.8b00107. Epub 2018 Mar 19.
1317 The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis.Cell Death Differ. 2020 Jun;27(6):1747-1764. doi: 10.1038/s41418-019-0458-7. Epub 2019 Nov 20.
1318 Tight junction protein 1 is regulated by transforming growth factor- and contributes to cell motility in NSCLC cells.BMB Rep. 2015 Feb;48(2):115-20. doi: 10.5483/bmbrep.2015.48.2.035.
1319 The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells.PLoS One. 2014 Jul 8;9(7):e101564. doi: 10.1371/journal.pone.0101564. eCollection 2014.
1320 Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7.Oncotarget. 2014 Jun 15;5(11):3931-43. doi: 10.18632/oncotarget.2040.
1321 Tyrosylprotein sulfotransferase 1 expression is negatively correlated with cMet and lymph node metastasis in human lung cancer.Mol Med Rep. 2015 Oct;12(4):5217-22. doi: 10.3892/mmr.2015.4096. Epub 2015 Jul 20.
1322 Histochemical analysis of testis specific gene 13 in human normal and malignant tissues.Cell Tissue Res. 2015 Dec;362(3):653-63. doi: 10.1007/s00441-015-2227-3. Epub 2015 Jun 27.
1323 TSPAN2 is involved in cell invasion and motility during lung cancer progression.Cell Rep. 2014 Apr 24;7(2):527-538. doi: 10.1016/j.celrep.2014.03.027. Epub 2014 Apr 13.
1324 Angio-associated migratory cell protein interacts with epidermal growth factor receptor and enhances proliferation and drug resistance in human non-small cell lung cancer cells.Cell Signal. 2019 Sep;61:10-19. doi: 10.1016/j.cellsig.2019.05.004. Epub 2019 May 7.
1325 AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.Oncogene. 2018 Mar;37(11):1503-1518. doi: 10.1038/s41388-017-0054-6. Epub 2018 Jan 11.
1326 Cancer-associated loss of TARSH gene expression in human primary lung cancer.J Cancer Res Clin Oncol. 2006 Jan;132(1):28-34. doi: 10.1007/s00432-005-0032-1. Epub 2005 Oct 4.
1327 Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence.Cell Metab. 2017 Dec 5;26(6):842-855.e5. doi: 10.1016/j.cmet.2017.09.018. Epub 2017 Oct 19.
1328 Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer.PLoS One. 2013 Jul 23;8(7):e69392. doi: 10.1371/journal.pone.0069392. Print 2013.
1329 Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.Cell Rep. 2016 Aug 9;16(6):1614-1628. doi: 10.1016/j.celrep.2016.07.009. Epub 2016 Jul 28.
1330 Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.Cell Cycle. 2018;17(5):616-626. doi: 10.1080/15384101.2017.1417709. Epub 2018 Jan 22.
1331 The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.J Cell Sci. 2009 Aug 15;122(Pt 16):2906-13. doi: 10.1242/jcs.050468. Epub 2009 Jul 28.
1332 Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.J Cell Physiol. 2019 May;234(5):6965-6975. doi: 10.1002/jcp.27439. Epub 2018 Nov 11.
1333 Clinical verification of plasma messenger RNA as novel noninvasive biomarker identified through bioinformatics analysis for lung cancer.Oncotarget. 2017 Jul 4;8(27):43978-43989. doi: 10.18632/oncotarget.16701.
1334 Function of low ADARB1 expression in lung adenocarcinoma.PLoS One. 2019 Sep 6;14(9):e0222298. doi: 10.1371/journal.pone.0222298. eCollection 2019.
1335 AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression.Oncogene. 2019 Oct;38(41):6723-6736. doi: 10.1038/s41388-019-0928-x. Epub 2019 Aug 9.
1336 Adenylosuccinate synthetase 1 gene is a novel target of deletion in lung adenocarcinoma.Mol Carcinog. 2009 Dec;48(12):1116-22. doi: 10.1002/mc.20563.
1337 Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.Oncol Res. 2019 Jun 21;27(6):653-661. doi: 10.3727/096504018X15420748671075. Epub 2019 Mar 4.
1338 HMGA2 functions as a competing endogenous RNA to promote lung cancer progression.Nature. 2014 Jan 9;505(7482):212-7. doi: 10.1038/nature12785. Epub 2013 Dec 4.
1339 Antitumor activity of the novel human cytokine AIMP1 in an in vivo tumor model.Mol Cells. 2006 Apr 30;21(2):213-7.
1340 Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1 to drive lung adenocarcinoma metastasis.J Hematol Oncol. 2019 Jan 29;12(1):12. doi: 10.1186/s13045-019-0698-5.
1341 Methylation of AKAP12{alpha} promoter in lung cancer.Anticancer Res. 2010 Nov;30(11):4595-600.
1342 Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma.Oncol Rep. 2012 Nov;28(5):1792-8. doi: 10.3892/or.2012.2002. Epub 2012 Aug 30.
1343 Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis.Acta Pharmacol Sin. 2005 Oct;26(10):1253-8. doi: 10.1111/j.1745-7254.2005.00184.x.
1344 Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.Cell Cycle. 2013 Nov 1;12(21):3390-404. doi: 10.4161/cc.26417. Epub 2013 Sep 17.
1345 Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression.Biochem J. 2005 Nov 1;391(Pt 3):503-11. doi: 10.1042/BJ20050533.
1346 Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.ACS Chem Biol. 2018 Aug 17;13(8):1970-1977. doi: 10.1021/acschembio.8b00381. Epub 2018 Jul 23.
1347 N 6-Hydroxymethyladenine: a hydroxylation derivative of N6-methyladenine in genomic DNA of mammals.Nucleic Acids Res. 2019 Feb 20;47(3):1268-1277. doi: 10.1093/nar/gky1218.
1348 15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma.Prostaglandins Other Lipid Mediat. 2018 Sep;138:31-40. doi: 10.1016/j.prostaglandins.2018.07.003. Epub 2018 Aug 12.
1349 Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers.Sci Rep. 2016 Jun 10;6:27350. doi: 10.1038/srep27350.
1350 Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer. Int J Cancer. 2014 Mar 15;134(6):1311-22. doi: 10.1002/ijc.28472. Epub 2013 Nov 11.
1351 Autocrine motility factor receptor: a clinical review.Expert Rev Anticancer Ther. 2008 Feb;8(2):207-17. doi: 10.1586/14737140.8.2.207.
1352 AMMECR1 Inhibits Apoptosis and Promotes Cell-cycle Progression and Proliferation of the A549 Human Lung Cancer Cell Line.Anticancer Res. 2019 Sep;39(9):4637-4642. doi: 10.21873/anticanres.13644.
1353 Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers.Cancer Lett. 2001 Jan 26;162(2):201-5. doi: 10.1016/s0304-3835(00)00675-3.
1354 AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway.Lasers Med Sci. 2019 Apr;34(3):473-478. doi: 10.1007/s10103-018-2616-4. Epub 2018 Aug 24.
1355 Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.J Clin Invest. 2013 Mar;123(3):1082-95. doi: 10.1172/JCI64044. Epub 2013 Feb 22.
1356 ANKRD18A as a novel epigenetic regulation gene in lung cancer.Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):180-5. doi: 10.1016/j.bbrc.2012.10.116. Epub 2012 Nov 3.
1357 Association of MAGE A1-6 Expression with Lung Cancer Progression.J Cancer. 2017 May 12;8(8):1324-1329. doi: 10.7150/jca.18086. eCollection 2017.
1358 Effect of silencing TEM8 gene on proliferation, apoptosis, migration and invasion of XWLC?5 lung cancer cells.Mol Med Rep. 2018 Jan;17(1):911-917. doi: 10.3892/mmr.2017.7959. Epub 2017 Nov 3.
1359 Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.Cancer Sci. 2019 May;110(5):1609-1620. doi: 10.1111/cas.13998. Epub 2019 Apr 9.
1360 A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.Oncotarget. 2016 May 24;7(21):29927-36. doi: 10.18632/oncotarget.9179.
1361 MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.Cancer Gene Ther. 2012 Nov;19(11):773-8. doi: 10.1038/cgt.2012.60. Epub 2012 Sep 21.
1362 APOBEC3A/B deletion polymorphism and cancer risk.Carcinogenesis. 2018 Feb 9;39(2):118-124. doi: 10.1093/carcin/bgx131.
1363 High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer.Onco Targets Ther. 2018 Aug 17;11:4979-4990. doi: 10.2147/OTT.S165750. eCollection 2018.
1364 The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.Nat Commun. 2016 Sep 21;7:12918. doi: 10.1038/ncomms12918.
1365 APPBP2 enhances non-small cell lung cancer proliferation and invasiveness through regulating PPM1D and SPOP.EBioMedicine. 2019 Jun;44:138-149. doi: 10.1016/j.ebiom.2019.05.028. Epub 2019 May 16.
1366 Silencing of aquaporin5 inhibits the growth of A549 lung cancer cells in vitro and in vivo.Int J Oncol. 2018 May;52(5):1643-1650. doi: 10.3892/ijo.2018.4326. Epub 2018 Mar 16.
1367 AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression.Am J Cancer Res. 2018 Feb 1;8(2):266-279. eCollection 2018.
1368 ARHGAP6 regulates the proliferation, migration and invasion of lung cancer cells.Oncol Rep. 2019 Apr;41(4):2281-2888. doi: 10.3892/or.2019.7031. Epub 2019 Feb 25.
1369 ARHGAP15 regulates lung cancer cell proliferation and metastasis via the STAT3 pathway.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5840-5850. doi: 10.26355/eurrev_201907_18326.
1370 The tumor suppressive roles of ARHGAP25 in lung cancer cells.Onco Targets Ther. 2019 Aug 19;12:6699-6710. doi: 10.2147/OTT.S207540. eCollection 2019.
1371 Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.Oncogene. 2014 Feb 27;33(9):1181-9. doi: 10.1038/onc.2013.42. Epub 2013 Mar 11.
1372 A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans.Cancer. 2006 Jun 15;106(12):2716-24. doi: 10.1002/cncr.21944.
1373 ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.Int J Cancer. 2018 Apr 1;142(7):1379-1391. doi: 10.1002/ijc.31169. Epub 2017 Dec 4.
1374 Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer.Cancer. 1992 Mar 1;69(5):1130-6. doi: 10.1002/cncr.2820690512.
1375 ARLTS1 - a novel tumor suppressor gene.Cancer Lett. 2008 Jun 8;264(1):11-20. doi: 10.1016/j.canlet.2008.02.021. Epub 2008 Mar 28.
1376 Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.Mol Cancer Ther. 2019 Mar;18(3):602-612. doi: 10.1158/1535-7163.MCT-18-0824. Epub 2019 Jan 15.
1377 Comparative proteomics and global genome-wide expression data implicate role of ARMC8 in lung cancer.Asian Pac J Cancer Prev. 2015;16(9):3691-6. doi: 10.7314/apjcp.2015.16.9.3691.
1378 Alex3 suppresses non-small cell lung cancer invasion via AKT/Slug/E-cadherin pathway.Tumour Biol. 2017 Jul;39(7):1010428317701441. doi: 10.1177/1010428317701441.
1379 MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function.Cell Death Differ. 2012 Jun;19(6):1038-48. doi: 10.1038/cdd.2011.190. Epub 2011 Dec 23.
1380 Role of artemin in non-small cell lung cancer.Thorac Cancer. 2018 May;9(5):555-562. doi: 10.1111/1759-7714.12615. Epub 2018 Mar 25.
1381 Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.J Lipid Res. 2019 Jul;60(7):1225-1235. doi: 10.1194/jlr.M092247. Epub 2019 Apr 15.
1382 Deaf patient-provider communication and lung cancer screening: Health Information National Trends survey in American Sign Language (HINTS-ASL).Patient Educ Couns. 2018 Jul;101(7):1232-1239. doi: 10.1016/j.pec.2018.03.003. Epub 2018 Mar 5.
1383 Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing.J Hematol Oncol. 2013 Sep 8;6:68. doi: 10.1186/1756-8722-6-68.
1384 Activating transcription factor 1 promoted migration and invasion in lung cancer cells through regulating EGFR and MMP-2.Mol Carcinog. 2019 Oct;58(10):1919-1924. doi: 10.1002/mc.23086. Epub 2019 Aug 16.
1385 MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5554-5561. doi: 10.26355/eurrev_201809_15818.
1386 Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.Int J Cancer. 2016 Oct 1;139(7):1564-73. doi: 10.1002/ijc.30205. Epub 2016 Jun 15.
1387 The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.Autophagy. 2017 Jun 3;13(6):1053-1063. doi: 10.1080/15548627.2017.1308997. Epub 2017 Apr 25.
1388 Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.PLoS One. 2012;7(10):e48532. doi: 10.1371/journal.pone.0048532. Epub 2012 Oct 31.
1389 Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage.APMIS. 2013 Feb;121(2):111-9. doi: 10.1111/j.1600-0463.2012.02946.x. Epub 2012 Jul 4.
1390 Knockdown of copper chaperone antioxidant-1 by RNA interference inhibits copper-stimulated proliferation of non-small cell lung carcinoma cells.Oncol Rep. 2013 Jul;30(1):269-75. doi: 10.3892/or.2013.2436. Epub 2013 Apr 29.
1391 MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12845-52. eCollection 2015.
1392 Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double-strand break repair.Mol Cancer Ther. 2013 Jun;12(6):1073-84. doi: 10.1158/1535-7163.MCT-13-0065. Epub 2013 Apr 2.
1393 Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology.Cancer Res. 1991 Nov 15;51(22):6142-9.
1394 B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells.J Clin Med. 2019 Nov 9;8(11):1928. doi: 10.3390/jcm8111928.
1395 Bag-1 Silence Sensitizes Non-Small Cell Lung Cancer Cells To Cisplatin Through Multiple Gene Pathways.Onco Targets Ther. 2019 Oct 31;12:8977-8989. doi: 10.2147/OTT.S218182. eCollection 2019.
1396 BAI1associated protein 2like 2 is a potential biomarker in lung cancer.Oncol Rep. 2019 Feb;41(2):1304-1312. doi: 10.3892/or.2018.6883. Epub 2018 Nov 26.
1397 Downregulation of the TGF Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGF Signaling and Invasion.Cancer Res. 2016 Jul 1;76(13):3785-801. doi: 10.1158/0008-5472.CAN-15-1326. Epub 2016 May 17.
1398 Decreased SARI expression predicts poor prognosis of Chinese patients with non-small cell lung cancer.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2056-63. eCollection 2013.
1399 Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.Tumour Biol. 2016 Nov;37(11):15157-15164. doi: 10.1007/s13277-016-5411-5. Epub 2016 Sep 27.
1400 Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.Cell Physiol Biochem. 2018;49(4):1615-1632. doi: 10.1159/000493497. Epub 2018 Sep 17.
1401 BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via -catenin pathway.Life Sci. 2018 Sep 1;208:284-294. doi: 10.1016/j.lfs.2018.07.023. Epub 2018 Jul 23.
1402 Delineating the interaction of combretastatin A-4 with tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach.J Biomol Struct Dyn. 2020 Feb;38(2):426-438. doi: 10.1080/07391102.2019.1577174. Epub 2019 Mar 4.
1403 The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells.Tumour Biol. 2013 Jun;34(3):1641-50. doi: 10.1007/s13277-013-0697-z. Epub 2013 Feb 20.
1404 BID is a critical factor controlling cell viability regulated by IFN-.J Immunother. 2012 Jan;35(1):23-31. doi: 10.1097/CJI.0b013e3182372dcf.
1405 Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell line.Hum Mol Genet. 1994 Aug;3(8):1341-4. doi: 10.1093/hmg/3.8.1341.
1406 Upregulation of AMPK by 4-O-methylascochlorin promotes autophagy via the HIF-1 expression.J Cell Mol Med. 2018 Dec;22(12):6345-6356. doi: 10.1111/jcmm.13933. Epub 2018 Oct 19.
1407 Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.Clin Lung Cancer. 2013 Sep;14(5):513-20. doi: 10.1016/j.cllc.2013.04.007. Epub 2013 Jun 27.
1408 Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.J Cell Physiol. 2019 Aug;234(8):13843-13850. doi: 10.1002/jcp.28064. Epub 2019 Jan 7.
1409 Identification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1.Oncotarget. 2017 May 16;8(20):32821-32832. doi: 10.18632/oncotarget.15826.
1410 Metastatic potential of lung squamous cell carcinoma associated with HSPC300 through its interaction with WAVE2.Lung Cancer. 2009 Sep;65(3):299-305. doi: 10.1016/j.lungcan.2009.06.001. Epub 2009 Jul 2.
1411 BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300.Cancer Res. 2013 Feb 15;73(4):1308-17. doi: 10.1158/0008-5472.CAN-12-2489. Epub 2012 Dec 26.
1412 CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production.mBio. 2019 Aug 27;10(4):e01949-19. doi: 10.1128/mBio.01949-19.
1413 Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133(+) Lung Carcinoma A549 Cells.Oncol Res. 2017 May 24;25(5):819-829. doi: 10.3727/096504016X14772349843854. Epub 2016 Oct 26.
1414 Downregulation of BTG3 in non-small cell lung cancer.Biochem Biophys Res Commun. 2013 Jul 19;437(1):173-8. doi: 10.1016/j.bbrc.2013.06.062. Epub 2013 Jun 26.
1415 The promoter region of the human BUBR1 gene and its expression analysis in lung cancer.Lung Cancer. 2002 Dec;38(3):229-34. doi: 10.1016/s0169-5002(02)00218-0.
1416 Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis.Sci Rep. 2019 Oct 10;9(1):14624. doi: 10.1038/s41598-019-50874-x.
1417 Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1.FASEB J. 2003 Nov;17(14):2068-81. doi: 10.1096/fj.03-0256com.
1418 Nanoclusters prepared from ruthenium(II) and quercetin for fluorometric detection of cobalt(II), and a method for screening their anticancer drug activity.Mikrochim Acta. 2019 Jul 17;186(8):539. doi: 10.1007/s00604-019-3657-5.
1419 CD10(+)GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.Cell. 2018 Feb 8;172(4):841-856.e16. doi: 10.1016/j.cell.2018.01.009. Epub 2018 Jan 25.
1420 Cables1 complex couples survival signaling to the cell death machinery.Cancer Res. 2015 Jan 1;75(1):147-158. doi: 10.1158/0008-5472.CAN-14-0036. Epub 2014 Oct 31.
1421 CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells.Biochem Biophys Res Commun. 2013 Jul 19;437(1):108-13. doi: 10.1016/j.bbrc.2013.06.048. Epub 2013 Jun 24.
1422 The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretnn.Pathol Oncol Res. 2017 Jul;23(3):487-491. doi: 10.1007/s12253-016-0135-9. Epub 2016 Oct 19.
1423 Evaluation of peroxidative stress of cancer cells in vitro by real-time quantification of volatile aldehydes in culture headspace.Rapid Commun Mass Spectrom. 2017 Aug 30;31(16):1344-1352. doi: 10.1002/rcm.7911.
1424 Loss of CAMSAP3 promotes EMT via the modification of microtubule-Akt machinery.J Cell Sci. 2018 Oct 29;131(21):jcs216168. doi: 10.1242/jcs.216168.
1425 miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.Clin Transl Oncol. 2018 Apr;20(4):457-466. doi: 10.1007/s12094-017-1730-2. Epub 2017 Sep 4.
1426 Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.Med Oncol. 2015 Mar;32(3):51. doi: 10.1007/s12032-015-0500-7. Epub 2015 Jan 31.
1427 Methacrylic acid/butyl acrylate onto feruloylated bagasse xylan: Graft copolymerization and biological activity.Mater Sci Eng C Mater Biol Appl. 2019 May;98:594-601. doi: 10.1016/j.msec.2018.12.103. Epub 2018 Dec 30.
1428 Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression.PLoS One. 2012;7(5):e36903. doi: 10.1371/journal.pone.0036903. Epub 2012 May 15.
1429 CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.Int J Cancer. 2019 Oct 15;145(8):2225-2237. doi: 10.1002/ijc.32355. Epub 2019 May 6.
1430 Interactive potential of genetic polymorphism in Xenobiotic metabolising and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians.Mutat Res Genet Toxicol Environ Mutagen. 2018 Feb;826:15-24. doi: 10.1016/j.mrgentox.2017.12.006. Epub 2017 Dec 21.
1431 CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis.J Cell Biochem. 2018 Dec;119(12):10186-10194. doi: 10.1002/jcb.27360. Epub 2018 Aug 21.
1432 Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women.Semin Oncol. 2009 Dec;36(6):572-80. doi: 10.1053/j.seminoncol.2009.10.007.
1433 A systematic analysis reveals gene expression alteration of serum deprivation response (SDPR) gene is significantly associated with the survival of patients with cancer.Oncol Rep. 2019 Sep;42(3):1161-1172. doi: 10.3892/or.2019.7212. Epub 2019 Jun 26.
1434 Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation.Oncogene. 2005 Sep 15;24(41):6249-55. doi: 10.1038/sj.onc.1208775.
1435 ADA activity is decreased in lymphocytes from patients with advanced stage of lung cancer.Med Oncol. 2019 Aug 2;36(9):78. doi: 10.1007/s12032-019-1301-1.
1436 DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.Exp Cell Res. 2019 Jan 15;374(2):304-314. doi: 10.1016/j.yexcr.2018.12.001. Epub 2018 Dec 4.
1437 Network biology of tumor stem-like cells identified a regulatory role of CBX5 in lung cancer.Sci Rep. 2012;2:584. doi: 10.1038/srep00584. Epub 2012 Aug 16.
1438 CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.J Exp Clin Cancer Res. 2019 Mar 18;38(1):131. doi: 10.1186/s13046-019-1137-8.
1439 The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.Mol Cancer. 2018 Feb 19;17(1):46. doi: 10.1186/s12943-018-0799-8.
1440 Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.Hum Pathol. 2016 Oct;56:64-73. doi: 10.1016/j.humpath.2016.06.001. Epub 2016 Jun 21.
1441 CCDC85B promotes non-small cell lung cancer cell proliferation and invasion.Mol Carcinog. 2019 Jan;58(1):126-134. doi: 10.1002/mc.22914. Epub 2018 Oct 9.
1442 Girdin protein: A potential metastasis predictor associated with prognosis in lung cancer.Exp Ther Med. 2018 Mar;15(3):2837-2843. doi: 10.3892/etm.2018.5773. Epub 2018 Jan 19.
1443 The serum level of CC chemokine ligand 18 correlates with the prognosis of non-small cell lung cancer.Int J Biol Markers. 2019 Jun;34(2):156-162. doi: 10.1177/1724600819829758. Epub 2019 May 3.
1444 CCL19-producing fibroblastic stromal cells restrain lung carcinoma growth by promoting local antitumor T-cell responses.J Allergy Clin Immunol. 2018 Oct;142(4):1257-1271.e4. doi: 10.1016/j.jaci.2017.12.998. Epub 2018 Jan 31.
1445 CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.Med Oncol. 2015 Mar;32(3):66. doi: 10.1007/s12032-015-0531-0. Epub 2015 Feb 18.
1446 Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases.PLoS One. 2015 Nov 17;10(11):e0143169. doi: 10.1371/journal.pone.0143169. eCollection 2015.
1447 Occupational exposure to diesel engine exhaust and serum cytokine levels.Environ Mol Mutagen. 2018 Mar;59(2):144-150. doi: 10.1002/em.22142. Epub 2017 Oct 12.
1448 The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury.Stem Cells Int. 2017;2017:4782820. doi: 10.1155/2017/4782820. Epub 2017 Aug 16.
1449 Discrimination of human lung neoplasm from normal lung by two target genes.Am J Respir Crit Care Med. 2004 Sep 1;170(5):516-9. doi: 10.1164/rccm.200401-127OC.
1450 The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.Cancer Immunol Res. 2019 Nov;7(11):1775-1788. doi: 10.1158/2326-6066.CIR-19-0168. Epub 2019 Sep 4.
1451 Anti-proliferative effect of 8-tigloyloxyhirsutinolide-13-O-acetate (8TGH) isolated from Vernonia cinerea on oral squamous cell carcinoma through inhibition of STAT3 and STAT2 phosphorylation.Phytomedicine. 2019 Jan;52:238-246. doi: 10.1016/j.phymed.2018.09.211. Epub 2018 Sep 26.
1452 National practice trends for the surgical management of lung cancer in the CMS population: an atlas of care.J Thorac Dis. 2019 Mar;11(Suppl 4):S500-S508. doi: 10.21037/jtd.2019.01.05.
1453 Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects.PLoS One. 2013 Oct 16;8(10):e76115. doi: 10.1371/journal.pone.0076115. eCollection 2013.
1454 Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy.Clin Sci (Lond). 2002 Mar;102(3):353-61.
1455 Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.BMC Complement Altern Med. 2017 Jan 9;17(1):30. doi: 10.1186/s12906-016-1512-3.
1456 Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer.PLoS One. 2009 Jun 9;4(6):e5611. doi: 10.1371/journal.pone.0005611.
1457 A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.Cancer Sci. 2011 Apr;102(4):697-705. doi: 10.1111/j.1349-7006.2011.01865.x. Epub 2011 Feb 10.
1458 AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.Oncotarget. 2017 Jan 3;8(1):354-363. doi: 10.18632/oncotarget.13396.
1459 Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis.EBioMedicine. 2018 Mar;29:112-127. doi: 10.1016/j.ebiom.2018.02.001. Epub 2018 Feb 5.
1460 CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer.Theranostics. 2018 Jan 1;8(3):650-662. doi: 10.7150/thno.21963. eCollection 2018.
1461 Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.Int J Cancer. 2003 Oct 10;106(6):913-8. doi: 10.1002/ijc.11322.
1462 Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2.J Hematol Oncol. 2015 May 29;8(1):57. doi: 10.1186/s13045-015-0153-1.
1463 Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.Oncogene. 2001 Nov 22;20(53):7787-96. doi: 10.1038/sj.onc.1204970.
1464 Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.J Clin Invest. 2016 Jan;126(1):254-65. doi: 10.1172/JCI79775. Epub 2015 Dec 7.
1465 Detection of sputum cofilin-1 as indicator of malignancy.Braz J Med Biol Res. 2018;51(8):e7138. doi: 10.1590/1414-431x20187138. Epub 2018 May 28.
1466 Cell-specific diversity in the expression and organization of cytoplasmic plaque proteins of apical junctions.Ann N Y Acad Sci. 2017 Oct;1405(1):160-176. doi: 10.1111/nyas.13391. Epub 2017 Jun 15.
1467 CHTM1 regulates cancer cell sensitivity to metabolic stress via p38-AIF1 pathway.J Exp Clin Cancer Res. 2019 Jun 20;38(1):271. doi: 10.1186/s13046-019-1253-5.
1468 CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.Lung Cancer. 2012 Jun;76(3):324-31. doi: 10.1016/j.lungcan.2011.11.019. Epub 2011 Dec 18.
1469 CHL1 gene polymorphisms increase lung cancer susceptibility.Oncotarget. 2018 Jan 6;9(17):13545-13550. doi: 10.18632/oncotarget.24057. eCollection 2018 Mar 2.
1470 CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation.Int J Mol Sci. 2015 Dec 24;17(1):18. doi: 10.3390/ijms17010018.
1471 Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells.Oncol Lett. 2017 Feb;13(2):715-721. doi: 10.3892/ol.2016.5466. Epub 2016 Dec 6.
1472 Gefitinib enhances the antitumor activity of CPT-11 in vitro and in vivo by inhibiting ABCG2 but not ABCB1: a new clue to circumvent gastrointestinal toxicity risk.Chemotherapy. 2013;59(4):260-72. doi: 10.1159/000357772. Epub 2014 Jan 17.
1473 Combined effect between CHRNB3-CHRNA6 region gene variant (rs6474412) and smoking in psoriasis vulgaris severity.Gene. 2014 Jul 10;544(2):123-7. doi: 10.1016/j.gene.2014.04.070. Epub 2014 Apr 30.
1474 Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.Oncotarget. 2016 May 3;7(18):26436-43. doi: 10.18632/oncotarget.8510.
1475 Serum carbohydrate sulfotransferase 7 in lung cancer and non-malignant pulmonary inflammations.Clin Chem Lab Med. 2018 Jul 26;56(8):1328-1335. doi: 10.1515/cclm-2017-1157.
1476 Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1).Tumour Biol. 2015 Sep;36(9):6909-17. doi: 10.1007/s13277-015-3397-z. Epub 2015 Apr 9.
1477 Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.Mol Cancer Res. 2011 Dec;9(12):1746-54. doi: 10.1158/1541-7786.MCR-11-0286. Epub 2011 Oct 12.
1478 Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.BMC Cancer. 2018 Aug 14;18(1):818. doi: 10.1186/s12885-018-4705-y.
1479 3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways.Biochem Pharmacol. 2017 Jul 1;135:35-49. doi: 10.1016/j.bcp.2017.03.007. Epub 2017 Mar 11.
1480 MicroRNA-146-5p promotes proliferation, migration and invasion in lung cancer cells by targeting claudin-12.Cancer Biomark. 2019;25(1):89-99. doi: 10.3233/CBM-182374.
1481 Genome-wide analysis of expression quantitative trait loci identified potential lung cancer susceptibility variants among Asian populations.Carcinogenesis. 2019 Apr 29;40(2):263-268. doi: 10.1093/carcin/bgy165.
1482 Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/-catenin Signaling Pathway.Int J Med Sci. 2018 Feb 5;15(4):339-351. doi: 10.7150/ijms.22927. eCollection 2018.
1483 Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.Oncoimmunology. 2018 Jan 29;7(5):e1423184. doi: 10.1080/2162402X.2017.1423184. eCollection 2018.
1484 Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.Clin Cancer Res. 2000 Jan;6(1):203-12.
1485 CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression.Apoptosis. 2019 Aug;24(7-8):673-685. doi: 10.1007/s10495-019-01550-y.
1486 Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.Cancer J. 2006 Mar-Apr;12(2):136-46.
1487 The reciprocal relationship between coping mechanisms and lung cancer diagnosis: findings of a prospective study.Cancer Manag Res. 2018 Jan 4;10:33-40. doi: 10.2147/CMAR.S148341. eCollection 2018.
1488 Silencing of the COPS3 gene by siRNA reduces proliferation of lung cancer cells most likely via induction of cell cycle arrest and apoptosis.Asian Pac J Cancer Prev. 2012;13(3):1043-8. doi: 10.7314/apjcp.2012.13.3.1043.
1489 COX7A1 suppresses the viability of human non-small cell lung cancer cells via regulating autophagy.Cancer Med. 2019 Dec;8(18):7762-7773. doi: 10.1002/cam4.2659. Epub 2019 Oct 30.
1490 microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.DNA Cell Biol. 2016 Nov;35(11):715-721. doi: 10.1089/dna.2016.3398. Epub 2016 Aug 5.
1491 High expression of Copine1 promotes cell growth and metastasis in human lung adenocarcinoma.Int J Oncol. 2018 Dec;53(6):2369-2378. doi: 10.3892/ijo.2018.4558. Epub 2018 Sep 12.
1492 Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC.J Proteome Res. 2013 Jul 5;12(7):3423-33. doi: 10.1021/pr400273z. Epub 2013 Jun 6.
1493 Hypermethylation of PGCP gene is associated with human bronchial epithelial cells immortalization.Gene. 2018 Feb 5;642:505-512. doi: 10.1016/j.gene.2017.11.063. Epub 2017 Nov 28.
1494 Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.Biochim Biophys Acta Mol Cell Res. 2019 Oct;1866(10):1533-1543. doi: 10.1016/j.bbamcr.2019.07.001. Epub 2019 Jul 10.
1495 Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin 1/FAK/ERK Signaling.Sci Rep. 2019 Jan 29;9(1):845. doi: 10.1038/s41598-018-37443-4.
1496 Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer.Lung Cancer. 2019 Sep;135:130-137. doi: 10.1016/j.lungcan.2019.06.019. Epub 2019 Jun 18.
1497 Expression and potential mechanism of metabolism-related genes and CRLS1 in non-small cell lung cancer.Oncol Lett. 2018 Feb;15(2):2661-2668. doi: 10.3892/ol.2017.7591. Epub 2017 Dec 12.
1498 Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.Carcinogenesis. 2012 Jul;33(7):1270-6. doi: 10.1093/carcin/bgs148. Epub 2012 Apr 17.
1499 Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer.Oncotarget. 2017 Dec 20;9(18):14084-14098. doi: 10.18632/oncotarget.23505. eCollection 2018 Mar 6.
1500 Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.Pathol Res Pract. 2017 Dec;213(12):1568-1574. doi: 10.1016/j.prp.2017.06.007. Epub 2017 Jun 6.
1501 Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.Clin Cancer Res. 2011 Sep 15;17(18):5889-900. doi: 10.1158/1078-0432.CCR-11-0240. Epub 2011 Aug 3.
1502 Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.Int J Cancer. 2009 Jun 15;124(12):2893-8. doi: 10.1002/ijc.24296.
1503 Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.Genes Chromosomes Cancer. 2006 Apr;45(4):392-400. doi: 10.1002/gcc.20298.
1504 Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.J Immunother Cancer. 2019 Aug 28;7(1):229. doi: 10.1186/s40425-019-0678-x.
1505 Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis.Lab Invest. 2004 Aug;84(8):999-1012. doi: 10.1038/labinvest.3700129.
1506 The Alteration of CTNNBIP1 in Lung Cancer.Int J Mol Sci. 2019 Nov 13;20(22):5684. doi: 10.3390/ijms20225684.
1507 miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.J Exp Clin Cancer Res. 2018 Jul 9;37(1):141. doi: 10.1186/s13046-018-0824-1.
1508 Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma.Mol Oncol. 2017 Mar;11(3):305-319. doi: 10.1002/1878-0261.12038. Epub 2017 Feb 21.
1509 The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells.Elife. 2019 Jul 11;8:e44288. doi: 10.7554/eLife.44288.
1510 High CXC Chemokine Ligand 16 (CXCL16) Expression Promotes Proliferation and Metastasis of Lung Cancer via Regulating the NF-B Pathway.Med Sci Monit. 2018 Jan 21;24:405-411. doi: 10.12659/msm.906230.
1511 Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17.Cell Oncol (Dordr). 2020 Apr;43(2):311-320. doi: 10.1007/s13402-019-00491-7. Epub 2019 Dec 12.
1512 CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p.Biomed Pharmacother. 2018 Jan;97:1182-1188. doi: 10.1016/j.biopha.2017.11.004. Epub 2017 Nov 11.
1513 Np63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.Oncogene. 2016 Mar 24;35(12):1493-503. doi: 10.1038/onc.2015.222. Epub 2015 Jun 22.
1514 Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility.Cancer Med. 2019 Aug;8(10):4892-4905. doi: 10.1002/cam4.2367. Epub 2019 Jul 1.
1515 Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.Pharmacogenetics. 1998 Feb;8(1):7-14. doi: 10.1097/00008571-199802000-00002.
1516 PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization.Oncogene. 2019 Oct;38(44):7002-7016. doi: 10.1038/s41388-019-0948-6. Epub 2019 Aug 12.
1517 Low Expression of ASK1-Interacting Protein-1 Is Significantly Correlated with Tumor Angiogenesis and Poor Survival in Patients with Early Stage Non-Small Cell Lung Cancer.Onco Targets Ther. 2019 Dec 10;12:10739-10747. doi: 10.2147/OTT.S222332. eCollection 2019.
1518 Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.PLoS One. 2014 Nov 6;9(11):e112336. doi: 10.1371/journal.pone.0112336. eCollection 2014.
1519 Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography.Nucl Med Commun. 2019 May;40(5):508-516. doi: 10.1097/MNM.0000000000000993.
1520 Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.Drug Des Devel Ther. 2015 Mar 24;9:1785-96. doi: 10.2147/DDDT.S78012. eCollection 2015.
1521 Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer.Medicine (Baltimore). 2019 Aug;98(31):e16712. doi: 10.1097/MD.0000000000016712.
1522 Novel centrosome protein, TCC52, is a cancer-testis antigen.Cancer Sci. 2008 Nov;99(11):2274-9. doi: 10.1111/j.1349-7006.2008.00937.x. Epub 2008 Oct 14.
1523 Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancer.Int J Biol Markers. 2016 May 28;31(2):e144-52. doi: 10.5301/jbm.5000180.
1524 New therapeutic perspectives in CCDC6 deficient lung cancer cells.Int J Cancer. 2015 May 1;136(9):2146-57. doi: 10.1002/ijc.29263. Epub 2014 Oct 24.
1525 Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study.Carcinogenesis. 2006 Jul;27(7):1475-80. doi: 10.1093/carcin/bgi350. Epub 2006 Mar 7.
1526 DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.Oncogene. 2018 Mar;37(9):1251-1262. doi: 10.1038/s41388-017-0025-y. Epub 2017 Dec 15.
1527 miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).Cancer Lett. 2018 Aug 1;428:55-68. doi: 10.1016/j.canlet.2018.04.028. Epub 2018 Apr 24.
1528 Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer.Mol Carcinog. 2018 Mar;57(3):305-318. doi: 10.1002/mc.22756. Epub 2017 Nov 14.
1529 DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.Oncogene. 2014 Mar 20;33(12):1515-26. doi: 10.1038/onc.2013.107. Epub 2013 Apr 15.
1530 SAGE mRNA expression in advanced-stage lung cancers.Eur J Surg Oncol. 2003 Dec;29(10):900-3. doi: 10.1016/j.ejso.2003.06.001.
1531 EGFR and Ras regulate DDX59 during lung cancer development.Gene. 2018 Feb 5;642:95-102. doi: 10.1016/j.gene.2017.11.029. Epub 2017 Nov 10.
1532 Antitumor activity of BJ-1207, a 6-amino-2,4,5-trimethylpyridin-3-ol derivative, in human lung cancer.Chem Biol Interact. 2018 Oct 1;294:1-8. doi: 10.1016/j.cbi.2018.08.007. Epub 2018 Aug 17.
1533 EGFR-targeting, -defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis.Acta Pharmacol Sin. 2018 Nov;39(11):1777-1786. doi: 10.1038/s41401-018-0069-8. Epub 2018 Jul 16.
1534 Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D.Lung Cancer. 2013 Feb;79(2):104-10. doi: 10.1016/j.lungcan.2012.10.012. Epub 2012 Nov 20.
1535 Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.Am J Pathol. 2013 Mar;182(3):954-64. doi: 10.1016/j.ajpath.2012.11.019. Epub 2013 Jan 7.
1536 The subpopulation of CD44-positive cells promoted tumorigenicity and metastatic ability in lung adenocarcinoma.J Chin Med Assoc. 2019 Mar;82(3):196-201. doi: 10.1097/JCMA.0000000000000056.
1537 Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer.Cell Biol Int. 2009 Mar;33(3):276-82. doi: 10.1016/j.cellbi.2008.11.014. Epub 2008 Dec 11.
1538 RNA helicase DHX9 may be a therapeutic target in lung cancer and inhibited by enoxacin.Am J Transl Res. 2017 Feb 15;9(2):674-682. eCollection 2017.
1539 Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro.Mol Biol Rep. 2013 Mar;40(3):2671-8. doi: 10.1007/s11033-012-2353-x. Epub 2012 Dec 18.
1540 KIAA1735 gene on human chromosome 11q23.1 encodes a novel protein with myosine-tail homologous domain and C-terminal DIX domain.Int J Oncol. 2003 Jul;23(1):145-50.
1541 Multiscale in situ analysis of the role of dyskerin in lung cancer cells.Integr Biol (Camb). 2013 Feb;5(2):402-13. doi: 10.1039/c2ib20219k.
1542 Genetic Variants in the Wingless Antagonist Genes (sFRP, DKK, and Axin2) Predict the Overall Survival and Prognosis of North Indian Lung Cancer Patients Treated with Platinum-Based Doublet Chemotherapy.Cancer Biother Radiopharm. 2018 Dec;33(10):466-477. doi: 10.1089/cbr.2018.2491. Epub 2018 Oct 20.
1543 Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.Cancer Res. 2012 Nov 15;72(22):5900-11. doi: 10.1158/0008-5472.CAN-12-2368. Epub 2012 Sep 25.
1544 Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A. 1999 Nov23;96(24):13989-94.
1545 Role of DMP1 and its future in lung cancer diagnostics.Expert Rev Mol Diagn. 2008 Jul;8(4):435-47. doi: 10.1586/14737159.8.4.435.
1546 Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese.Am J Hum Genet. 2012 Nov 2;91(5):928-34. doi: 10.1016/j.ajhg.2012.09.009. Epub 2012 Oct 25.
1547 TdIF1: a putative oncogene in NSCLC tumor progression.Signal Transduct Target Ther. 2018 Oct 19;3:28. doi: 10.1038/s41392-018-0030-9. eCollection 2018.
1548 Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer.Int J Oncol. 2006 Feb;28(2):321-8.
1549 Identification of DOK genes as lung tumor suppressors.Nat Genet. 2010 Mar;42(3):216-23. doi: 10.1038/ng.527. Epub 2010 Feb 7.
1550 DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways.Int J Oncol. 2019 Jan;54(1):381-389. doi: 10.3892/ijo.2018.4624. Epub 2018 Nov 5.
1551 Inhibition of cell-adhesion protein DPYSL3 promotes metastasis of lung cancer.Respir Res. 2018 Mar 7;19(1):41. doi: 10.1186/s12931-018-0740-0.
1552 NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.J Thorac Oncol. 2012 May;7(5):779-89. doi: 10.1097/JTO.0b013e31824c92b4.
1553 High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.Oncotarget. 2015 Sep 15;6(27):23399-416. doi: 10.18632/oncotarget.4351.
1554 The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer.Carcinogenesis. 2012 Dec;33(12):2326-33. doi: 10.1093/carcin/bgs273. Epub 2012 Aug 31.
1555 SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.J Exp Clin Cancer Res. 2018 May 31;37(1):111. doi: 10.1186/s13046-018-0778-3.
1556 Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.Clin Cancer Res. 2004 Dec 15;10(24):8501-11. doi: 10.1158/1078-0432.CCR-04-1072.
1557 Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.Ann Surg Oncol. 2019 Oct;26(11):3756-3764. doi: 10.1245/s10434-019-07614-2. Epub 2019 Jul 16.
1558 The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.BMC Cancer. 2016 Feb 1;16:49. doi: 10.1186/s12885-016-2087-6.
1559 Dual-specificity phosphatase 6 genetic variants associated with risk of lung squamous cell carcinoma in Han Chinese.J Cancer Res Ther. 2018;14(Supplement):S72-S78. doi: 10.4103/0973-1482.172108.
1560 Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin.Int J Mol Sci. 2014 Jun 13;15(6):10635-51. doi: 10.3390/ijms150610635.
1561 Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells.Lung Cancer. 1996 Nov;15(3):341-54. doi: 10.1016/0169-5002(95)00597-8.
1562 Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells.Oncotarget. 2017 Oct 6;8(60):101509-101519. doi: 10.18632/oncotarget.21552. eCollection 2017 Nov 24.
1563 Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.Clin Respir J. 2018 Jan;12(1):279-284. doi: 10.1111/crj.12527. Epub 2016 Jul 21.
1564 Association of 12 polymorphic variants conferring genetic risk to lung cancer in Indian population: An extensive meta-analysis.Environ Mol Mutagen. 2017 Dec;58(9):688-700. doi: 10.1002/em.22149. Epub 2017 Oct 27.
1565 The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers.PLoS One. 2018 Jan 17;13(1):e0191377. doi: 10.1371/journal.pone.0191377. eCollection 2018.
1566 Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.Int J Nanomedicine. 2013;8:4481-94. doi: 10.2147/IJN.S41782. Epub 2013 Nov 21.
1567 Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers.Clin Chem. 2004 Mar;50(3):490-9. doi: 10.1373/clinchem.2003.026849. Epub 2004 Jan 15.
1568 NF-B-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.Cell Death Dis. 2018 Apr 1;9(4):418. doi: 10.1038/s41419-018-0447-7.
1569 Needle-based confocal laser endomicroscopy for real-time diagnosingand staging of lung cancer.Eur Respir J. 2019 Jun 20;53(6):1801520. doi: 10.1183/13993003.01520-2018. Print 2019 Jun.
1570 Circular RNA screening from EIF3a in lung cancer.Cancer Med. 2019 Aug;8(9):4159-4168. doi: 10.1002/cam4.2338. Epub 2019 Jun 13.
1571 Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGF Signaling Pathway.Mol Cancer Res. 2015 Oct;13(10):1421-30. doi: 10.1158/1541-7786.MCR-14-0645. Epub 2015 Jun 8.
1572 Association between eIF3 polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.Br J Clin Pharmacol. 2013 Feb;75(2):516-23. doi: 10.1111/j.1365-2125.2012.04379.x.
1573 Downregulation of EIF4A2 in non-small-cell lung cancer associates with poor prognosis.Clin Lung Cancer. 2013 Nov;14(6):658-65. doi: 10.1016/j.cllc.2013.04.011. Epub 2013 Jul 16.
1574 Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.Eur J Cancer. 2018 Sep;101:165-180. doi: 10.1016/j.ejca.2018.07.001. Epub 2018 Aug 1.
1575 Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.Nat Commun. 2019 Nov 28;10(1):5438. doi: 10.1038/s41467-019-13295-y.
1576 Selective requirement for Mediator MED23 in Ras-active lung cancer.Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2813-22. doi: 10.1073/pnas.1204311109. Epub 2012 Sep 17.
1577 Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer.Front Oncol. 2019 May 7;9:363. doi: 10.3389/fonc.2019.00363. eCollection 2019.
1578 Correction: LCE: an open web portal to explore gene expression and clinical associations in lung cancer.Oncogene. 2020 Jan;39(3):718-719. doi: 10.1038/s41388-019-1000-6.
1579 Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.Exp Mol Pathol. 2013 Dec;95(3):313-8. doi: 10.1016/j.yexmp.2013.07.001. Epub 2013 Aug 3.
1580 EMX2 is epigenetically silenced and suppresses growth in human lung cancer. Oncogene. 2010 Nov 4;29(44):5969-75. doi: 10.1038/onc.2010.330. Epub 2010 Aug 9.
1581 Overexpression and Selective Anticancer Efficacy of ENO3 in STK11 Mutant Lung Cancers.Mol Cells. 2019 Nov 30;42(11):804-809. doi: 10.14348/molcells.2019.0099.
1582 Enhanced recovery after surgery and video-assisted thoracic surgery lobectomy: the Italian VATS Group surgical protocol.J Thorac Dis. 2018 Mar;10(Suppl 4):S564-S570. doi: 10.21037/jtd.2018.01.157.
1583 Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1336-40. doi: 10.1158/1055-9965.EPI-06-0194.
1584 Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways.Cancer Res. 2010 Dec 1;70(23):9949-58. doi: 10.1158/0008-5472.CAN-10-1055. Epub 2010 Nov 30.
1585 Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer.Microb Pathog. 2018 Feb;115:189-193. doi: 10.1016/j.micpath.2017.12.040. Epub 2017 Dec 20.
1586 Circular RNA circNOL10 Inhibits Lung Cancer Development by Promoting SCLM1-Mediated Transcriptional Regulation of the Humanin Polypeptide Family.Adv Sci (Weinh). 2018 Nov 16;6(2):1800654. doi: 10.1002/advs.201800654. eCollection 2019 Jan 23.
1587 Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date.Lung Cancer (Auckl). 2019 Sep 9;10:87-94. doi: 10.2147/LCTT.S190786. eCollection 2019.
1588 A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer.Cancer Res. 1999 Jan 1;59(1):35-43.
1589 The exonuclease 1 Glu589Lys gene polymorphism and cancer susceptibility: evidence based on a meta-analysis.Asian Pac J Cancer Prev. 2014;15(6):2571-6. doi: 10.7314/apjcp.2014.15.6.2571.
1590 Sec3 knockdown inhibits TGF- induced epithelial-mesenchymal transition through the down-regulation of Akt phosphorylation in A549 cells.Biochem Biophys Res Commun. 2019 Nov 5;519(2):253-260. doi: 10.1016/j.bbrc.2019.08.145. Epub 2019 Sep 5.
1591 miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.Cell Prolif. 2018 Feb;51(1):e12406. doi: 10.1111/cpr.12406. Epub 2017 Nov 12.
1592 Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.Oncol Rep. 2009 Nov;22(5):1069-75.
1593 FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma.Onco Targets Ther. 2019 Apr 17;12:2829-2842. doi: 10.2147/OTT.S190934. eCollection 2019.
1594 FAM13A as a Novel Hypoxia-Induced Gene in Non-Small Cell Lung Cancer.J Cancer. 2017 Oct 23;8(19):3933-3938. doi: 10.7150/jca.20342. eCollection 2017.
1595 Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway.Int J Biochem Cell Biol. 2013 Mar;45(3):684-91. doi: 10.1016/j.biocel.2012.12.003. Epub 2012 Dec 12.
1596 FAM98A promotes proliferation of non-small cell lung cancer cells via the P38-ATF2 signaling pathway.Cancer Manag Res. 2018 Jul 27;10:2269-2278. doi: 10.2147/CMAR.S163323. eCollection 2018.
1597 Function and cancer genomics of FAT family genes (review).Int J Oncol. 2012 Dec;41(6):1913-8. doi: 10.3892/ijo.2012.1669. Epub 2012 Oct 17.
1598 The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.Mol Biol Rep. 2019 Aug;46(4):4001-4008. doi: 10.1007/s11033-019-04846-z. Epub 2019 May 8.
1599 Establishment and characterization of primary lung cancer cell lines from Chinese population.Acta Pharmacol Sin. 2011 Mar;32(3):385-92. doi: 10.1038/aps.2010.214.
1600 FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.Cell Death Dis. 2019 Jun 19;10(7):486. doi: 10.1038/s41419-019-1732-9.
1601 Noncanonical Role of FBXO6 in Regulating Antiviral Immunity.J Immunol. 2019 Aug 15;203(4):1012-1020. doi: 10.4049/jimmunol.1801557. Epub 2019 Jul 15.
1602 FBXW2 suppresses migration and invasion of lung cancer cells via promoting -catenin ubiquitylation and degradation.Nat Commun. 2019 Mar 27;10(1):1382. doi: 10.1038/s41467-019-09289-5.
1603 Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.J Natl Cancer Inst. 2011 Sep 7;103(17):1323-37. doi: 10.1093/jnci/djr290. Epub 2011 Aug 10.
1604 Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction.Cancer Prev Res (Phila). 2011 Apr;4(4):552-61. doi: 10.1158/1940-6207.CAPR-10-0183. Epub 2011 Mar 16.
1605 Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.Cancer Res. 2005 Feb 15;65(4):1207-12. doi: 10.1158/0008-5472.CAN-04-3461.
1606 Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor.Cancer Gene Ther. 2002 Aug;9(8):633-40. doi: 10.1038/sj.cgt.7700478.
1607 Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma.Cancer. 2006 Jan 1;106(1):146-55. doi: 10.1002/cncr.21581.
1608 Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms.Lung Cancer. 2018 May;119:25-35. doi: 10.1016/j.lungcan.2018.02.015. Epub 2018 Mar 2.
1609 Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer.FASEB J. 2015 May;29(5):1986-98. doi: 10.1096/fj.14-264580. Epub 2015 Feb 9.
1610 Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.Int J Clin Exp Pathol. 2015 Jan 1;8(1):601-7. eCollection 2015.
1611 Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis.Cancer Res. 2009 Nov 15;69(22):8629-35. doi: 10.1158/0008-5472.CAN-09-1568. Epub 2009 Nov 3.
1612 FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness.Cancers (Basel). 2019 Nov 28;11(12):1897. doi: 10.3390/cancers11121897.
1613 Characterization of germline mutations in familial lung cancer from the Chinese population.Gene. 2018 Jan 30;641:94-104. doi: 10.1016/j.gene.2017.10.020. Epub 2017 Oct 17.
1614 Profiling analysis of FOX gene family members identified FOXE1 as potential regulator of NSCLC development.Cell Mol Biol (Noisy-le-grand). 2016 Sep 30;62(11):57-62.
1615 Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis.Biochem Biophys Res Commun. 2018 Apr 15;498(4):1009-1015. doi: 10.1016/j.bbrc.2018.03.105. Epub 2018 Mar 16.
1616 Expression of Frat1 correlates with expression of -catenin and is associated with a poor clinical outcome in human SCC and AC.Tumour Biol. 2012 Oct;33(5):1437-44. doi: 10.1007/s13277-012-0394-3. Epub 2012 Apr 17.
1617 FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming.Int J Cancer. 2020 Jan 1;146(1):208-222. doi: 10.1002/ijc.32530. Epub 2019 Jul 26.
1618 FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression.FEBS Lett. 2012 Sep 21;586(19):3044-50. doi: 10.1016/j.febslet.2012.07.019. Epub 2012 Jul 27.
1619 FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells.Cancer Manag Res. 2019 Apr 18;11:3395-3410. doi: 10.2147/CMAR.S194512. eCollection 2019.
1620 miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT.J Cell Mol Med. 2018 Jul;22(7):3526-3536. doi: 10.1111/jcmm.13629. Epub 2018 Apr 17.
1621 Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients.Oncotarget. 2017 Feb 14;8(7):12186-12193. doi: 10.18632/oncotarget.14575.
1622 Clinical significance and biological function of fucosyltransferase 2 in lung adenocarcinoma.Oncotarget. 2017 Oct 19;8(57):97246-97259. doi: 10.18632/oncotarget.21896. eCollection 2017 Nov 14.
1623 An integromic signature for lung cancer early detection.Oncotarget. 2018 May 15;9(37):24684-24692. doi: 10.18632/oncotarget.25227. eCollection 2018 May 15.
1624 Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis.Am J Pathol. 2009 Dec;175(6):2646-56. doi: 10.2353/ajpath.2009.080571. Epub 2009 Nov 5.
1625 FXYD5 (dysadherin) may mediate metastatic progression through regulation of the -Na(+)-K(+)-ATPase subunit in the 4T1 mouse breast cancer model.Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C108-C117. doi: 10.1152/ajpcell.00206.2016. Epub 2017 May 17.
1626 miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1.Biomed Pharmacother. 2016 Dec;84:123-129. doi: 10.1016/j.biopha.2016.09.027. Epub 2016 Sep 16.
1627 Frizzled-8 as a putative therapeutic target in human lung cancer.Biochem Biophys Res Commun. 2012 Jan 6;417(1):62-6. doi: 10.1016/j.bbrc.2011.11.055. Epub 2011 Nov 25.
1628 Identification of G0S2 as a gene frequently methylated in squamous lung cancer by combination of in silico and experimental approaches.Int J Cancer. 2010 Apr 15;126(8):1895-1902. doi: 10.1002/ijc.24947.
1629 Polymorphisms of rs1347093 and rs1397529 are associated with lung cancer risk in northeast Chinese population.Oncotarget. 2017 Oct 24;8(55):94862-94871. doi: 10.18632/oncotarget.22030. eCollection 2017 Nov 7.
1630 Docking protein Gab2 regulates mucin expression and goblet cell hyperplasia through TYK2/STAT6 pathway.FASEB J. 2012 Nov;26(11):4603-13. doi: 10.1096/fj.12-211755. Epub 2012 Aug 2.
1631 Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153".Biol Pharm Bull. 2010;33(8):1291-9. doi: 10.1248/bpb.33.1291.
1632 Review of transcriptomic responses to hexavalent chromium exposure in lung cells supports a role of epigenetic mediators in carcinogenesis. Toxicol Lett. 2019 May 1;305:40-50.
1633 Radiation-induced lung adenocarcinoma is associated with increased frequency of genes inactivated by promoter hypermethylation.Radiat Res. 2007 Oct;168(4):409-14. doi: 10.1667/RR0825.1.
1634 Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers.Clin Genet. 2020 Jan;97(1):64-72. doi: 10.1111/cge.13630. Epub 2019 Aug 28.
1635 In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.Nat Commun. 2018 Jul 16;9(1):2732. doi: 10.1038/s41467-018-04572-3.
1636 Clinicopathological significance of core 2 beta1,6-N-acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization.Cancer Res. 2001 Mar 1;61(5):2226-31.
1637 The mechanism of miR-16-5p protection on LPS-induced A549 cell injury by targeting CXCR3.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1200-1206. doi: 10.1080/21691401.2019.1593998.
1638 A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study.BMC Cancer. 2008 Feb 20;8:54. doi: 10.1186/1471-2407-8-54.
1639 Bioinformatics analysis of Rab GDP dissociation inhibitor beta and its expression in non-small cell lung cancer.Diagn Pathol. 2014 Nov 4;9:201. doi: 10.1186/s13000-014-0201-0.
1640 Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.Cancer Res. 2004 Oct 1;64(19):6874-82. doi: 10.1158/0008-5472.CAN-04-0633.
1641 Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231. doi: 10.1073/pnas.1818865116. Epub 2019 Jan 18.
1642 Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors.Int J Mol Med. 2002 May;9(5):509-13.
1643 Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway.J Exp Clin Cancer Res. 2019 Feb 21;38(1):96. doi: 10.1186/s13046-019-1057-7.
1644 D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo.Br J Cancer. 2011 Jun 28;105(1):74-82. doi: 10.1038/bjc.2011.170. Epub 2011 Jun 7.
1645 Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma.Cancer Epidemiol. 2009 Oct;33(3-4):281-7. doi: 10.1016/j.canep.2009.08.006. Epub 2009 Sep 30.
1646 Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.Oncogene. 1996 Mar 21;12(6):1289-97.
1647 GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapy.Mol Ther. 2012 Nov;20(11):2052-63. doi: 10.1038/mt.2012.125. Epub 2012 Jun 26.
1648 Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).Target Oncol. 2019 Oct;14(5):577-590. doi: 10.1007/s11523-019-00667-z.
1649 Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.Clin Cancer Res. 2012 Dec 15;18(24):6599-608. doi: 10.1158/1078-0432.CCR-12-0838. Epub 2012 Oct 10.
1650 Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.Oncotarget. 2016 Nov 29;7(48):79736-79746. doi: 10.18632/oncotarget.12945.
1651 Development of transcriptomic biomarker signature in human saliva to detect lung cancer.Cell Mol Life Sci. 2012 Oct;69(19):3341-3350. doi: 10.1007/s00018-012-1027-0. Epub 2012 Jun 12.
1652 Molecular Targeted Therapies Elicit Concurrent Apoptotic and GSDME-Dependent Pyroptotic Tumor Cell Death.Clin Cancer Res. 2018 Dec 1;24(23):6066-6077. doi: 10.1158/1078-0432.CCR-18-1478. Epub 2018 Jul 30.
1653 Pore-forming spider venom peptides show cytotoxicity to hyperpolarized cancer cells expressing K+ channels: A lentiviral vector approach.PLoS One. 2019 Apr 12;14(4):e0215391. doi: 10.1371/journal.pone.0215391. eCollection 2019.
1654 Chromosome 4q31 locus in COPD is also associated with lung cancer.Eur Respir J. 2010 Dec;36(6):1375-82. doi: 10.1183/09031936.00033310.
1655 Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.Cancer Biol Ther. 2009 Aug;8(16):1540-9. doi: 10.4161/cbt.8.16.8950. Epub 2009 Aug 8.
1656 Thromboxane A2 receptor promotes tumor growth through an autoregulatory feedback pathway.J Mol Cell Biol. 2013 Dec;5(6):380-90. doi: 10.1093/jmcb/mjt038. Epub 2013 Oct 9.
1657 Evaluating the association of polymorphisms in the HAP1 gene with lung cancer risk: a meta-analysis.Tumour Biol. 2014 Nov;35(11):10825-31. doi: 10.1007/s13277-014-2236-y. Epub 2014 Aug 1.
1658 Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis.Am J Respir Cell Mol Biol. 2000 Jan;22(1):92-6. doi: 10.1165/ajrcmb.22.1.3637.
1659 Depletion of hepatoma-derived growth factor-related protein-3 induces apoptotic sensitization of radioresistant A549 cells via reactive oxygen species-dependent p53 activation.Biochem Biophys Res Commun. 2013 Sep 27;439(3):333-9. doi: 10.1016/j.bbrc.2013.08.086. Epub 2013 Sep 6.
1660 The Emerging Roles of the HERC Ubiquitin Ligases in Cancer.Curr Pharm Des. 2018;24(15):1676-1681. doi: 10.2174/1381612824666180528081024.
1661 Identification of HERC5 and its potential role in NSCLC progression.Int J Cancer. 2015 May 15;136(10):2264-72. doi: 10.1002/ijc.29298. Epub 2014 Nov 9.
1662 Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression.Int J Med Sci. 2019 Mar 9;16(3):470-476. doi: 10.7150/ijms.28139. eCollection 2019.
1663 Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.Cancer Res. 2007 Sep 1;67(17):8051-7. doi: 10.1158/0008-5472.CAN-07-1022.
1664 Correlation between lung cancer and the HHIP polymorphisms of chronic obstructive pulmonary disease (COPD) in the Chinese Han population.Genes Immun. 2019 Apr;20(4):273-280. doi: 10.1038/s41435-018-0033-0. Epub 2018 Jun 19.
1665 Loss of hypermethylated in cancer 1 (HIC1) promotes lung cancer progression.Cell Signal. 2019 Jan;53:162-169. doi: 10.1016/j.cellsig.2018.10.006. Epub 2018 Oct 10.
1666 Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer.Cancer Lett. 2009 Jun 18;278(2):183-191. doi: 10.1016/j.canlet.2009.01.012. Epub 2009 Feb 8.
1667 Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC).BMC Cancer. 2018 Apr 16;18(1):429. doi: 10.1186/s12885-018-4215-y.
1668 A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation.Transl Oncol. 2017 Oct;10(5):818-827. doi: 10.1016/j.tranon.2017.07.008. Epub 2017 Aug 29.
1669 Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells.Asian Pac J Cancer Prev. 2012;13(7):3223-8. doi: 10.7314/apjcp.2012.13.7.3223.
1670 Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-1-mediated epithelial to mesenchymal transition in lung cancer cells.BMC Cancer. 2019 Sep 6;19(1):894. doi: 10.1186/s12885-019-6119-x.
1671 The prognostic significance of SHP2 and its binding protein Hook1 in non-small cell lung cancer.Onco Targets Ther. 2019 Jul 22;12:5897-5906. doi: 10.2147/OTT.S210223. eCollection 2019.
1672 HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer.J Pathol. 2015 Feb;235(3):397-407. doi: 10.1002/path.4469. Epub 2014 Dec 18.
1673 Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.Cancer Epidemiol. 2014 Aug;38(4):414-8. doi: 10.1016/j.canep.2014.03.013. Epub 2014 May 3.
1674 Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.Front Immunol. 2018 Mar 12;9:473. doi: 10.3389/fimmu.2018.00473. eCollection 2018.
1675 HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells.Cell Death Dis. 2018 May 1;9(5):465. doi: 10.1038/s41419-018-0497-x.
1676 Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion.Cell Oncol (Dordr). 2019 Jun;42(3):275-285. doi: 10.1007/s13402-019-00424-4. Epub 2019 Jan 29.
1677 HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype.Oncogene. 2018 Jun;37(26):3575-3588. doi: 10.1038/s41388-018-0229-9. Epub 2018 Mar 26.
1678 Homeobox C8 is a transcriptional repressor of E-cadherin gene expression in non-small cell lung cancer.Int J Biochem Cell Biol. 2019 Sep;114:105557. doi: 10.1016/j.biocel.2019.06.005. Epub 2019 Jun 13.
1679 HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.Int J Biochem Cell Biol. 2017 Jul;88:1-13. doi: 10.1016/j.biocel.2017.04.011. Epub 2017 Apr 27.
1680 Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations.Dis Markers. 2019 Mar 3;2019:8170759. doi: 10.1155/2019/8170759. eCollection 2019.
1681 Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.PLoS One. 2013 Nov 12;8(11):e79634. doi: 10.1371/journal.pone.0079634. eCollection 2013.
1682 Isolation and characterization of novel human short-chain dehydrogenase/reductase SCDR10B which is highly expressed in the brain and acts as hydroxysteroid dehydrogenase.Acta Biochim Pol. 2009;56(2):279-89. Epub 2009 May 12.
1683 The relationship between three heat shock protein 70 gene polymorphisms and susceptibility to lung cancer.Clin Chem Lab Med. 2010 Nov;48(11):1657-63. doi: 10.1515/CCLM.2010.304. Epub 2010 Aug 13.
1684 JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.PLoS One. 2016 Mar 1;11(3):e0150355. doi: 10.1371/journal.pone.0150355. eCollection 2016.
1685 Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):482-7. doi: 10.1158/1078-0432.CCR-06-1593.
1686 ICAM3 mediates inflammatory signaling to promote cancer cell stemness.Cancer Lett. 2018 May 28;422:29-43. doi: 10.1016/j.canlet.2018.02.034. Epub 2018 Mar 2.
1687 Inhibitor of DNA-Binding Protein 4 Suppresses Cancer Metastasis through the Regulation of Epithelial Mesenchymal Transition in Lung Adenocarcinoma.Cancers (Basel). 2019 Dec 14;11(12):2021. doi: 10.3390/cancers11122021.
1688 Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients.Onco Targets Ther. 2019 Oct 3;12:8139-8149. doi: 10.2147/OTT.S220698. eCollection 2019.
1689 Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1).Biomed Res Int. 2019 May 8;2019:9085435. doi: 10.1155/2019/9085435. eCollection 2019.
1690 RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.J Exp Clin Cancer Res. 2019 Nov 27;38(1):478. doi: 10.1186/s13046-019-1479-2.
1691 Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.IUBMB Life. 2019 Nov;71(11):1806-1814. doi: 10.1002/iub.2152. Epub 2019 Aug 16.
1692 Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured.BMC Cancer. 2014 Sep 25;14:713. doi: 10.1186/1471-2407-14-713.
1693 Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3.Int J Mol Med. 2010 May;25(5):807-12.
1694 The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21.Hum Genet. 1997 Mar;99(3):334-41. doi: 10.1007/s004390050368.
1695 IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.Nucleic Acids Res. 2019 Jan 10;47(1):375-390. doi: 10.1093/nar/gky1012.
1696 Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.Tumour Biol. 2017 Apr;39(4):1010428317695928. doi: 10.1177/1010428317695928.
1697 Insulin-like growth factor binding protein-4 inhibits cell growth, migration and invasion, and downregulates COX-2 expression in A549 lung cancer cells.Cell Biol Int. 2017 Apr;41(4):384-391. doi: 10.1002/cbin.10732. Epub 2017 Feb 21.
1698 Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments.Int J Oncol. 2020 Jan;56(1):193-205. doi: 10.3892/ijo.2019.4926. Epub 2019 Nov 28.
1699 Ectopic Ikaros expression positively correlates with lung cancer progression.Anat Rec (Hoboken). 2013 Jun;296(6):907-13. doi: 10.1002/ar.22700. Epub 2013 Apr 12.
1700 Comprehensive genomic and prognostic analysis of the IL?7 family genes in lung cancer.Mol Med Rep. 2019 Jun;19(6):4906-4918. doi: 10.3892/mmr.2019.10164. Epub 2019 Apr 15.
1701 A positive feedback loop of IL-17B-IL-17RB activates ERK/-catenin to promote lung cancer metastasis.Cancer Lett. 2018 May 28;422:44-55. doi: 10.1016/j.canlet.2018.02.037. Epub 2018 Feb 26.
1702 High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.Sci Rep. 2018 Jan 11;8(1):418. doi: 10.1038/s41598-017-18796-8.
1703 Interaction between epidermal growth factor receptor and interleukin-6 receptor in NSCLC progression.J Cell Biochem. 2019 Jan;120(1):872-881. doi: 10.1002/jcb.27448. Epub 2018 Aug 21.
1704 Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.Nat Med. 2012 Aug;18(8):1248-53. doi: 10.1038/nm.2856. Epub 2012 Jul 8.
1705 EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.Lung Cancer. 2018 Feb;116:80-89. doi: 10.1016/j.lungcan.2017.12.017. Epub 2017 Dec 29.
1706 C6orf106 enhances NSCLC cell invasion by upregulating vimentin, and downregulating E-cadherin and P120ctn.Tumour Biol. 2015 Aug;36(8):5979-85. doi: 10.1007/s13277-015-3274-9. Epub 2015 Mar 4.
1707 Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):434-42. doi: 10.1158/1078-0432.CCR-06-1297.
1708 Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Clin Cancer Res. 2016 Jul 15;22(14):3618-29. doi: 10.1158/1078-0432.CCR-15-2946. Epub 2016 Mar 9.
1709 Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.Oncol Rep. 2011 Apr;25(4):1073-81. doi: 10.3892/or.2011.1172. Epub 2011 Jan 31.
1710 Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.Oncol Rep. 2006 Mar;15(3):545-9.
1711 MicroRNA?14 upregulates HIF? and VEGF by targeting ING4 in lung cancer cells.Mol Med Rep. 2019 Jun;19(6):4935-4945. doi: 10.3892/mmr.2019.10170. Epub 2019 Apr 16.
1712 ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/-catenin pathway.Thorac Cancer. 2019 Apr;10(4):848-855. doi: 10.1111/1759-7714.13013. Epub 2019 Feb 27.
1713 INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.Oncogene. 2017 Mar;36(10):1430-1439. doi: 10.1038/onc.2016.311. Epub 2016 Sep 19.
1714 Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.J Natl Cancer Inst. 2019 Jul 1;111(7):664-674. doi: 10.1093/jnci/djy166.
1715 Gender differences and lung cancer risk in occupational chefs: analyzing more than 350,000 chefs in Taiwan, 1984-2011.Int Arch Occup Environ Health. 2019 Jan;92(1):101-109. doi: 10.1007/s00420-018-1358-8. Epub 2018 Sep 18.
1716 Wnt3 knockdown sensitizes human non-small cell type lung cancer (NSCLC) cells to cisplatin via regulating the cell proliferation and apoptosis.Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1323-1332. doi: 10.26355/eurrev_201803_14474.
1717 Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens.BMC Mol Biol. 2008 Nov 17;9:103. doi: 10.1186/1471-2199-9-103.
1718 Transcriptome-wide association study reveals candidate causal genes for lung cancer.Int J Cancer. 2020 Apr 1;146(7):1862-1878. doi: 10.1002/ijc.32771. Epub 2019 Dec 9.
1719 A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.Biochem Biophys Res Commun. 2017 Apr 29;486(2):545-550. doi: 10.1016/j.bbrc.2017.03.083. Epub 2017 Mar 18.
1720 Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses.PLoS One. 2011;6(12):e28683. doi: 10.1371/journal.pone.0028683. Epub 2011 Dec 14.
1721 Regulation of OLC1 protein expression by the anaphase-promoting complex.Oncol Lett. 2019 Mar;17(3):2639-2646. doi: 10.3892/ol.2019.9881. Epub 2019 Jan 2.
1722 Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.Int J Mol Med. 2013 Jan;31(1):33-42. doi: 10.3892/ijmm.2012.1171. Epub 2012 Nov 1.
1723 Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.Carcinogenesis. 2013 Nov;34(11):2600-9. doi: 10.1093/carcin/bgt281. Epub 2013 Aug 16.
1724 Elevated integrin 64 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.Hum Pathol. 2016 Aug;54:174-83. doi: 10.1016/j.humpath.2016.04.003. Epub 2016 Apr 20.
1725 Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.BMC Cancer. 2008 Jan 28;8:25. doi: 10.1186/1471-2407-8-25.
1726 Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.Epigenetics. 2015;10(10):903-12. doi: 10.1080/15592294.2015.1078049. Epub 2015 Aug 7.
1727 Effect of the actin- and calcium-regulating activities of ITPKB on the metastatic potential of lung cancer cells.Biochem J. 2018 Jun 26;475(12):2057-2071. doi: 10.1042/BCJ20180238.
1728 A simple robust method of synthesis of copper-silver core-shell nano-particle: evaluation of its structural and chemical properties with anticancer potency.Nanotechnology. 2018 Aug 10;29(32):325102. doi: 10.1088/1361-6528/aac372. Epub 2018 May 9.
1729 Hydrophobic oxime ethers: a versatile class of pDNA and siRNA transfection lipids.ChemMedChem. 2011 Nov 4;6(11):2063-9. doi: 10.1002/cmdc.201100259. Epub 2011 Aug 31.
1730 Ultrasensitive Detection of Circulating Tumor DNA of Lung Cancer via an Enzymatically Amplified SERS-Based Frequency Shift Assay.ACS Appl Mater Interfaces. 2019 May 22;11(20):18145-18152. doi: 10.1021/acsami.9b02953. Epub 2019 May 10.
1731 Selective Surface Enhanced Raman Scattering for Quantitative Detection of Lung Cancer Biomarkers in Superparticle@MOF Structure.Adv Mater. 2018 Feb;30(5). doi: 10.1002/adma.201702275. Epub 2017 Dec 11.
1732 Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.Lung Cancer. 2016 Aug;98:33-42. doi: 10.1016/j.lungcan.2016.05.008. Epub 2016 May 13.
1733 Copy number variations of chromosome 17p13.1 might be linked to high risk of lung cancer in heavy smokers.Mol Biol Rep. 2011 Nov;38(8):5211-7. doi: 10.1007/s11033-010-0672-3. Epub 2011 Jan 4.
1734 The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma.Anticancer Res. 2016 Sep;36(9):4841-6. doi: 10.21873/anticanres.11046.
1735 K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification.Clin Chem. 2000 Dec;46(12):1929-38.
1736 Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing.Lung Cancer. 2018 Apr;118:27-29. doi: 10.1016/j.lungcan.2017.08.019. Epub 2017 Sep 4.
1737 Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.Cancer Gene Ther. 2012 Nov;19(11):767-72. doi: 10.1038/cgt.2012.57. Epub 2012 Sep 7.
1738 An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma.Oncogene. 2017 Jan 5;36(1):110-121. doi: 10.1038/onc.2016.181. Epub 2016 May 23.
1739 KIF3A binds to -arrestin for suppressing Wnt/-catenin signalling independently of primary cilia in lung cancer.Sci Rep. 2016 Sep 6;6:32770. doi: 10.1038/srep32770.
1740 Correction to: KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer.Mol Cancer. 2019 Nov 19;18(1):164. doi: 10.1186/s12943-019-1093-0.
1741 Overexpression of Klotho Inhibits HELF Fibroblasts SASP-related Protumoral Effects on Non-small Cell Lung Cancer Cells.J Cancer. 2018 Mar 14;9(7):1248-1258. doi: 10.7150/jca.23967. eCollection 2018.
1742 Kinesin light chain-4 depletion induces apoptosis of radioresistant cancer cells by mitochondrial dysfunction via calcium ion influx.Cell Death Dis. 2018 May 1;9(5):496. doi: 10.1038/s41419-018-0549-2.
1743 Radiotherapy in combination with hyperthermia suppresses lung cancer progression via increased NR4A3 and KLF11 expression.Int J Radiat Biol. 2019 Dec;95(12):1696-1707. doi: 10.1080/09553002.2019.1665213. Epub 2019 Sep 17.
1744 Krppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma.Oncotarget. 2017 Jun 13;8(24):38743-38754. doi: 10.18632/oncotarget.17020.
1745 Smurf1 ubiquitin ligase targets Kruppel-like factor KLF2 for ubiquitination and degradation in human lung cancer H1299 cells.Biochem Biophys Res Commun. 2011 Apr 1;407(1):254-9. doi: 10.1016/j.bbrc.2011.03.016. Epub 2011 Mar 5.
1746 MiR-326/Sp1/KLF3: A novel regulatory axis in lung cancer progression.Cell Prolif. 2019 Mar;52(2):e12551. doi: 10.1111/cpr.12551. Epub 2018 Nov 28.
1747 Krppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.Cell Physiol Biochem. 2014;33(1):1-10. doi: 10.1159/000356645. Epub 2014 Jan 2.
1748 Krppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.Cancer Biol Ther. 2019;20(5):680-691. doi: 10.1080/15384047.2018.1550570. Epub 2018 Dec 27.
1749 KLF8 overexpression promotes the growth of human lung cancer cells by promoting the expression of JMJD2A.Cancer Cell Int. 2019 Oct 7;19:258. doi: 10.1186/s12935-019-0970-3. eCollection 2019.
1750 Decreased kallikrein 11 messenger RNA expression in lung cancer.Clin Lung Cancer. 2006 Jul;8(1):45-8. doi: 10.3816/CLC.2006.n.032.
1751 CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer.Cell Cycle. 2019 Sep;18(18):2323-2331. doi: 10.1080/15384101.2019.1646562. Epub 2019 Aug 5.
1752 Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation.Biochem Biophys Res Commun. 2011 Jun 10;409(3):442-7. doi: 10.1016/j.bbrc.2011.05.022. Epub 2011 May 8.
1753 Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression.J Transl Med. 2013 Sep 26;11:232. doi: 10.1186/1479-5876-11-232.
1754 YY1-mediated overexpression of long noncoding RNA MCM3AP-AS1 accelerates angiogenesis and progression in lung cancer by targeting miR-340-5p/KPNA4 axis.J Cell Biochem. 2020 Mar;121(3):2258-2267. doi: 10.1002/jcb.29448. Epub 2019 Nov 6.
1755 Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation.Oncogene. 2019 Sep;38(36):6354-6369. doi: 10.1038/s41388-019-0889-0. Epub 2019 Jul 18.
1756 Isolation of cancer stem like cells from human adenosquamous carcinoma of the lung supports a monoclonal origin from a multipotential tissue stem cell.PLoS One. 2013 Dec 4;8(12):e79456. doi: 10.1371/journal.pone.0079456. eCollection 2013.
1757 Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP.Molecules. 2018 Nov 20;23(11):3030. doi: 10.3390/molecules23113030.
1758 Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis.Exp Mol Med. 2008 Apr 30;40(2):229-36. doi: 10.3858/emm.2008.40.2.229.
1759 TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.Mol Carcinog. 2018 Feb;57(2):159-166. doi: 10.1002/mc.22740. Epub 2017 Dec 5.
1760 Down-regulation of layilin, a novel hyaluronan receptor, via RNA interference, inhibits invasion and lymphatic metastasis of human lung A549 cells.Biotechnol Appl Biochem. 2008 Jun;50(Pt 2):89-96. doi: 10.1042/BA20070138.
1761 Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas.Clin Cancer Res. 2013 Feb 15;19(4):773-84. doi: 10.1158/1078-0432.CCR-12-2638. Epub 2012 Dec 6.
1762 Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer.Cancers (Basel). 2019 Jan 9;11(1):63. doi: 10.3390/cancers11010063.
1763 Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1.PLoS One. 2010 Sep 2;5(9):e12535. doi: 10.1371/journal.pone.0012535.
1764 Lectin, Galactoside-Binding Soluble 3 Binding Protein Promotes 17-N-Allylamino-17-demethoxygeldanamycin Resistance through PI3K/Akt Pathway in Lung Cancer Cell Line.Mol Cancer Ther. 2017 Jul;16(7):1355-1365. doi: 10.1158/1535-7163.MCT-16-0574. Epub 2017 Mar 23.
1765 Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line.Gene. 2001 Aug 22;274(1-2):253-62. doi: 10.1016/s0378-1119(01)00598-4.
1766 Leucine-rich glioma inactivated 3: Integrative analyses reveal its potential prognostic role in cancer.Mol Med Rep. 2018 Mar;17(3):3993-4002. doi: 10.3892/mmr.2017.8279. Epub 2017 Dec 14.
1767 Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4.Cancer Sci. 2009 Aug;100(8):1485-93. doi: 10.1111/j.1349-7006.2009.01187.x. Epub 2009 May 19.
1768 LIMD1 phosphorylation in mitosis is required for mitotic progression and its tumor-suppressing activity.FEBS J. 2019 Mar;286(5):963-974. doi: 10.1111/febs.14743. Epub 2019 Jan 16.
1769 Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET.J Exp Med. 2019 Jun 3;216(6):1377-1395. doi: 10.1084/jem.20181394. Epub 2019 Apr 23.
1770 LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.Lung Cancer. 2018 Nov;125:174-184. doi: 10.1016/j.lungcan.2018.09.017. Epub 2018 Sep 24.
1771 Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.J Cell Physiol. 2019 Aug;234(10):18679-18687. doi: 10.1002/jcp.28508. Epub 2019 Apr 16.
1772 Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.Carcinogenesis. 2016 Jan;37(1):96-105. doi: 10.1093/carcin/bgv165. Epub 2015 Nov 20.
1773 Lipin-1 determines lung cancer cell survival and chemotherapy sensitivity by regulation of endoplasmic reticulum homeostasis and autophagy.Cancer Med. 2018 Jun;7(6):2541-2554. doi: 10.1002/cam4.1483. Epub 2018 Apr 16.
1774 Single nucleotide polymorphism in the 3' untranslated region of LPP is a risk factor for lung cancer: a case-control study.BMC Cancer. 2019 Jan 8;19(1):35. doi: 10.1186/s12885-018-5241-5.
1775 Stromal LRP1 in lung adenocarcinoma predicts clinical outcome.Clin Cancer Res. 2011 Apr 15;17(8):2426-33. doi: 10.1158/1078-0432.CCR-10-2385. Epub 2011 Feb 15.
1776 Downregulation of lumican accelerates lung cancer cell invasion through p120 catenin.Cell Death Dis. 2018 Apr 1;9(4):414. doi: 10.1038/s41419-017-0212-3.
1777 Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of 7 nicotinic acetylcholine receptors.PLoS One. 2019 May 31;14(5):e0217339. doi: 10.1371/journal.pone.0217339. eCollection 2019.
1778 Exposure to asbestos and the risk of colorectal cancer mortality: a systematic review and meta-analysis.Occup Environ Med. 2019 Nov;76(11):861-871. doi: 10.1136/oemed-2019-105735. Epub 2019 Oct 8.
1779 MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.Nat Commun. 2013;4:1877. doi: 10.1038/ncomms2876.
1780 Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3 signaling pathway in lung cancer.J Histochem Cytochem. 2013 Sep;61(9):659-70. doi: 10.1369/0022155413495875. Epub 2013 Jun 12.
1781 Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.Acta Biochim Biophys Sin (Shanghai). 2018 Aug 1;50(8):748-756. doi: 10.1093/abbs/gmy074.
1782 Histone macroH2A isoforms predict the risk of lung cancer recurrence.Oncogene. 2009 Sep 24;28(38):3423-8. doi: 10.1038/onc.2009.26. Epub 2009 Aug 3.
1783 Mitotic Arrest-Deficient Protein 2B Overexpressed in Lung Cancer Promotes Proliferation, EMT, and Metastasis.Oncol Res. 2019 Aug 8;27(8):859-869. doi: 10.3727/096504017X15049209129277. Epub 2017 Sep 11.
1784 Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer.PLoS One. 2010 Aug 3;5(8):e11934. doi: 10.1371/journal.pone.0011934.
1785 Silencing of NRAGE induces autophagy via AMPK/Ulk1/Atg13 signaling pathway in NSCLC cells.Tumour Biol. 2017 Jun;39(6):1010428317709676. doi: 10.1177/1010428317709676.
1786 Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.Virchows Arch. 2019 Jan;474(1):29-37. doi: 10.1007/s00428-018-2478-y. Epub 2018 Oct 30.
1787 t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma.J Pediatr Surg. 2007 Jul;42(7):E23-9. doi: 10.1016/j.jpedsurg.2007.04.031.
1788 Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1047-59. doi: 10.1007/s00210-013-0905-9. Epub 2013 Aug 3.
1789 Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.Biochem Pharmacol. 2013 Feb 15;85(4):583-94. doi: 10.1016/j.bcp.2012.12.001. Epub 2012 Dec 7.
1790 Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer.PLoS One. 2017 Sep 13;12(9):e0184755. doi: 10.1371/journal.pone.0184755. eCollection 2017.
1791 Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors.EBioMedicine. 2018 Apr;30:120-128. doi: 10.1016/j.ebiom.2018.03.009. Epub 2018 Mar 17.
1792 Knockdown of end-binding protein 1 induces apoptosis in radioresistant A549 lung cancer cells via p38 kinase-dependent COX-2 upregulation.Oncol Rep. 2018 Apr;39(4):1565-1572. doi: 10.3892/or.2018.6278. Epub 2018 Feb 22.
1793 Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells.Anticancer Res. 1997 Sep-Oct;17(5A):3493-7.
1794 Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers.Carcinogenesis. 2014 Jun;35(6):1248-57. doi: 10.1093/carcin/bgt494. Epub 2014 Jan 7.
1795 Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients.Int J Cancer. 1999 May 5;81(3):325-9. doi: 10.1002/(sici)1097-0215(19990505)81:3<325::aid-ijc2>3.0.co;2-s.
1796 A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.J Cancer Res Clin Oncol. 2019 Nov;145(11):2713-2723. doi: 10.1007/s00432-019-03032-9. Epub 2019 Sep 24.
1797 Methyl-CpG binding domain 1 gene polymorphisms and lung cancer risk in a Chinese population.Biomarkers. 2008 Sep;13(6):607-17. doi: 10.1080/13547500802168031.
1798 Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLC.Clin Epigenetics. 2018 Apr 2;10:41. doi: 10.1186/s13148-018-0474-3. eCollection 2018.
1799 Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer.Int J Oncol. 2019 Dec;55(6):1349-1360. doi: 10.3892/ijo.2019.4899. Epub 2019 Oct 14.
1800 Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma.Onco Targets Ther. 2018 Aug 20;11:5025-5034. doi: 10.2147/OTT.S169002. eCollection 2018.
1801 MCMs expression in lung cancer: implication of prognostic significance.J Cancer. 2017 Oct 9;8(18):3641-3647. doi: 10.7150/jca.20777. eCollection 2017.
1802 Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer.Genes Chromosomes Cancer. 2013 Mar;52(3):305-15. doi: 10.1002/gcc.22030. Epub 2012 Dec 8.
1803 Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.Oncotarget. 2016 Apr 26;7(17):23043-23055. doi: 10.18632/oncotarget.8469.
1804 Absent expression of miR-30a promotes the growth of lung cancer cells by targeting MEF2D.Oncol Lett. 2018 Jul;16(1):1173-1179. doi: 10.3892/ol.2018.8719. Epub 2018 May 16.
1805 Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cells.Immunol Lett. 2014 Mar-Apr;158(1-2):175-82. doi: 10.1016/j.imlet.2014.01.004. Epub 2014 Jan 16.
1806 Prognostic significance of MEOX2 in gliomas.Mod Pathol. 2019 Jun;32(6):774-786. doi: 10.1038/s41379-018-0192-6. Epub 2019 Jan 18.
1807 Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.EBioMedicine. 2019 Dec;50:55-66. doi: 10.1016/j.ebiom.2019.11.012. Epub 2019 Nov 21.
1808 miR-600 inhibits lung cancer via downregulating the expression of METTL3.Cancer Manag Res. 2019 Feb 1;11:1177-1187. doi: 10.2147/CMAR.S181058. eCollection 2019.
1809 A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.Mol Cancer. 2011 Jul 7;10:81. doi: 10.1186/1476-4598-10-81.
1810 Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.Cancer Discov. 2017 Dec;7(12):1420-1435. doi: 10.1158/2159-8290.CD-17-0593. Epub 2017 Oct 12.
1811 Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells.J Food Biochem. 2019 Jul;43(7):e12861. doi: 10.1111/jfbc.12861. Epub 2019 Apr 24.
1812 C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.Oncogene. 2011 Sep 29;30(39):4107-17. doi: 10.1038/onc.2011.116. Epub 2011 Apr 18.
1813 Aquaporin 1 promotes the proliferation and migration of lung cancer cell invitro.Oncol Rep. 2015 Sep;34(3):1440-8. doi: 10.3892/or.2015.4107. Epub 2015 Jul 3.
1814 A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.Nat Genet. 2011 Jul 3;43(8):792-6. doi: 10.1038/ng.875.
1815 MLKL-PITP signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.Cancer Lett. 2018 Feb 1;414:136-146. doi: 10.1016/j.canlet.2017.10.047.
1816 Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer.Biochem Biophys Res Commun. 2014 Jul 18;450(1):844-50. doi: 10.1016/j.bbrc.2014.06.075. Epub 2014 Jun 24.
1817 Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.Am J Respir Crit Care Med. 2014 Oct 1;190(7):780-90. doi: 10.1164/rccm.201310-1903OC.
1818 Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.J Cell Sci. 2006 Sep 15;119(Pt 18):3856-65. doi: 10.1242/jcs.03157. Epub 2006 Aug 29.
1819 Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.Oncol Rep. 2018 Apr;39(4):1765-1774. doi: 10.3892/or.2018.6258. Epub 2018 Feb 12.
1820 Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.Proteomics Clin Appl. 2018 Nov;12(6):e1800015. doi: 10.1002/prca.201800015. Epub 2018 Jul 5.
1821 MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.Oncogene. 2017 Jul 20;36(29):4201-4211. doi: 10.1038/onc.2017.58. Epub 2017 Mar 27.
1822 RAGE may act as a tumour suppressor to regulate lung cancer development.Gene. 2018 Apr 20;651:86-93. doi: 10.1016/j.gene.2018.02.009. Epub 2018 Feb 5.
1823 Biomarkers in non-small cell lung cancer prevention.Eur J Cancer Prev. 2004 Oct;13(5):425-36. doi: 10.1097/00008469-200410000-00011.
1824 Enzymatic MPG DNA repair assays for two different oxidative DNA lesions reveal associations with increased lung cancer risk.Carcinogenesis. 2014 Dec;35(12):2763-70. doi: 10.1093/carcin/bgu214. Epub 2014 Oct 29.
1825 HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.Cancer Lett. 2019 Mar 1;444:94-104. doi: 10.1016/j.canlet.2018.12.006. Epub 2018 Dec 21.
1826 Screening of key genes and prediction of therapeutic agents in Arsenic-induced lung carcinoma.Cancer Biomark. 2019;25(4):351-360. doi: 10.3233/CBM-182333.
1827 Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.Ann Surg Oncol. 2016 Nov;23(12):3924-3933. doi: 10.1245/s10434-016-5305-1. Epub 2016 Jul 13.
1828 Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.J Exp Clin Cancer Res. 2019 Feb 8;38(1):62. doi: 10.1186/s13046-019-1027-0.
1829 Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.Mol Med Rep. 2016 Dec;14(6):5093-5103. doi: 10.3892/mmr.2016.5911. Epub 2016 Nov 1.
1830 Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China.Cancer Manag Res. 2019 Jun 28;11:5785-5797. doi: 10.2147/CMAR.S186217. eCollection 2019.
1831 Methylenetetrahydrofolate Dehydrogenase 1 Silencing Expedites the Apoptosis of Non-Small Cell Lung Cancer Cells via Modulating DNA Methylation.Med Sci Monit. 2018 Oct 21;24:7499-7507. doi: 10.12659/MSM.910265.
1832 Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.Protein Cell. 2017 Jun;8(6):455-466. doi: 10.1007/s13238-017-0393-7. Epub 2017 Mar 31.
1833 MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.Sci Rep. 2018 Jan 9;8(1):134. doi: 10.1038/s41598-017-18545-x.
1834 Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.Carcinogenesis. 2012 Sep;33(9):1797-805. doi: 10.1093/carcin/bgs210. Epub 2012 Jun 13.
1835 Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.Oncogene. 1994 Feb;9(2):611-9.
1836 Integrative system genetic analysis reveals mRNA-lncRNA network associated with mouse spontaneous lung cancer susceptibility.Oncotarget. 2019 Jan 8;10(3):339-351. doi: 10.18632/oncotarget.26554. eCollection 2019 Jan 8.
1837 Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer.Cancer Invest. 2009 Dec;27(10):978-83. doi: 10.3109/07357900902769723.
1838 Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells.Am J Pathol. 2010 Jul;177(1):70-83. doi: 10.2353/ajpath.2010.091164. Epub 2010 May 20.
1839 Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.Tumour Biol. 2015 May;36(5):3693-701. doi: 10.1007/s13277-014-3008-4. Epub 2015 Mar 1.
1840 Tumorsphere assay provides a better in vitro method for cancer stem-like cells enrichment in A549 lung adenocarcinoma cells.Tissue Cell. 2019 Oct;60:21-24. doi: 10.1016/j.tice.2019.07.003. Epub 2019 Jul 16.
1841 Nanos genes and their role in development and beyond.Cell Mol Life Sci. 2018 Jun;75(11):1929-1946. doi: 10.1007/s00018-018-2766-3. Epub 2018 Feb 3.
1842 NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.J Cell Mol Med. 2019 Oct;23(10):6965-6977. doi: 10.1111/jcmm.14581. Epub 2019 Aug 26.
1843 Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress.Thorac Cancer. 2019 Apr;10(4):676-685. doi: 10.1111/1759-7714.12984. Epub 2019 Feb 2.
1844 The opposite prognostic effect of NDUFS1 and NDUFS8 in lung cancer reflects the oncojanus role of mitochondrial complex I.Sci Rep. 2016 Aug 12;6:31357. doi: 10.1038/srep31357.
1845 miR-93 promotes TGF--induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.Tumour Biol. 2016 Apr;37(4):5645-51. doi: 10.1007/s13277-015-4328-8. Epub 2015 Nov 18.
1846 NEIL2 protects against oxidative DNA damage induced by sidestream smoke in human cells.PLoS One. 2014 Mar 3;9(3):e90261. doi: 10.1371/journal.pone.0090261. eCollection 2014.
1847 NEK4 kinase regulates EMT to promote lung cancer metastasis.J Cell Mol Med. 2018 Dec;22(12):5877-5887. doi: 10.1111/jcmm.13857. Epub 2018 Sep 24.
1848 Drosophila caliban, a nuclear export mediator, can function as a tumor suppressor in human lung cancer cells.Oncogene. 2005 Dec 15;24(56):8229-39. doi: 10.1038/sj.onc.1208962.
1849 ERBB2-induced inflammation in lung carcinogenesis.Mol Biol Rep. 2012 Aug;39(8):7911-7. doi: 10.1007/s11033-012-1635-7. Epub 2012 May 1.
1850 Copy number variation, increased gene expression, and molecular mechanisms of neurofascin in lung cancer.Mol Carcinog. 2017 Sep;56(9):2076-2085. doi: 10.1002/mc.22664. Epub 2017 May 2.
1851 High expression of NFAT2 contributes to carboplatin resistance in lung cancer.Exp Mol Pathol. 2019 Oct;110:104290. doi: 10.1016/j.yexmp.2019.104290. Epub 2019 Jul 27.
1852 Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signaling.Oncogene. 2020 Jan;39(2):385-398. doi: 10.1038/s41388-019-0994-0. Epub 2019 Sep 2.
1853 NF-YA Overexpression in Lung Cancer: LUSC.Genes (Basel). 2019 Nov 17;10(11):937. doi: 10.3390/genes10110937.
1854 Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer.Cancer Detect Prev. 2009;32(5-6):403-15. doi: 10.1016/j.cdp.2009.02.004. Epub 2009 Mar 17.
1855 Evaluating the effect of nicotinic cholinergic receptor genes on the risk of nonsyndromic cleft lip with or without cleft palate.Oral Dis. 2018 Sep;24(6):1068-1072. doi: 10.1111/odi.12879. Epub 2018 Jun 8.
1856 FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.EBioMedicine. 2019 Jul;45:25-38. doi: 10.1016/j.ebiom.2019.06.022. Epub 2019 Jun 28.
1857 Silencing NID2 by DNA Hypermethylation Promotes Lung Cancer.Pathol Oncol Res. 2020 Apr;26(2):801-811. doi: 10.1007/s12253-019-00609-0. Epub 2019 Mar 2.
1858 Profiling Lung Cancer Patients Using Electronic Health Records.J Med Syst. 2018 May 31;42(7):126. doi: 10.1007/s10916-018-0975-9.
1859 Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway.Onco Targets Ther. 2018 Apr 5;11:1941-1948. doi: 10.2147/OTT.S158655. eCollection 2018.
1860 Nitrilase 1 modulates lung tumor progression in vitro and in vivo.Oncotarget. 2016 Apr 19;7(16):21381-92. doi: 10.18632/oncotarget.7820.
1861 Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.BMC Cancer. 2011 May 20;11:186. doi: 10.1186/1471-2407-11-186.
1862 Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.Clin Cancer Res. 2011 Feb 15;17(4):690-9. doi: 10.1158/1078-0432.CCR-10-1892. Epub 2010 Dec 10.
1863 Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis.Curr Cancer Drug Targets. 2019;19(8):674-680. doi: 10.2174/1568009618666181119150521.
1864 Is NLRP3 or NLRP6 inflammasome activation associated with inflammation-related lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide?.Ecotoxicol Environ Saf. 2019 Dec 15;185:109687. doi: 10.1016/j.ecoenv.2019.109687. Epub 2019 Sep 24.
1865 Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.Eur J Pharmacol. 2010 Jul 10;637(1-3):38-45. doi: 10.1016/j.ejphar.2010.03.057. Epub 2010 Apr 11.
1866 Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells.J Biol Chem. 1991 Oct 5;266(28):18771-9.
1867 CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.Am J Respir Crit Care Med. 2015 Jul 1;192(1):64-75. doi: 10.1164/rccm.201411-1957OC.
1868 The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.Cancer Res. 2006 Oct 1;66(19):9408-19. doi: 10.1158/0008-5472.CAN-06-1349.
1869 Association between CLOCK, PER3 and CCRN4L with nonsmall cell lung cancer in Brazilian patients.Mol Med Rep. 2014 Jul;10(1):435-40. doi: 10.3892/mmr.2014.2224. Epub 2014 May 8.
1870 Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway.J Biol Chem. 2011 Oct 28;286(43):37335-46. doi: 10.1074/jbc.M111.256156. Epub 2011 Sep 1.
1871 Cerium oxide and barium sulfate nanoparticle inhalation affects gene expression in alveolar epithelial cells type II.J Nanobiotechnology. 2018 Feb 20;16(1):16. doi: 10.1186/s12951-018-0343-4.
1872 EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.Int J Cancer. 2003 Jul 10;105(5):706-9. doi: 10.1002/ijc.11130.
1873 Molecular cloning of human TAK1 and its mutational analysis in human lung cancer.Int J Cancer. 1998 Feb 9;75(4):559-63. doi: 10.1002/(sici)1097-0215(19980209)75:4<559::aid-ijc11>3.0.co;2-4.
1874 Overexpression of COUPTFII suppresses proliferation and metastasis of human gastric cancer cells.Mol Med Rep. 2018 Feb;17(2):2393-2401. doi: 10.3892/mmr.2017.8164. Epub 2017 Nov 27.
1875 NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation.Sci Rep. 2016 Sep 8;6:32952. doi: 10.1038/srep32952.
1876 Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.Nat Chem Biol. 2019 Aug;15(8):822-829. doi: 10.1038/s41589-019-0310-x. Epub 2019 Jul 8.
1877 Comprehensive assessment of P21 polymorphisms and lung cancer risk.J Hum Genet. 2008;53(1):87-95. doi: 10.1007/s10038-007-0222-6. Epub 2007 Nov 28.
1878 DNA Base-Excision Repair Genes OGG1 and NTH1 in Brazilian Lung Cancer Patients.Mol Diagn Ther. 2015 Dec;19(6):389-95. doi: 10.1007/s40291-015-0164-1.
1879 Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.Protein Sci. 2017 Aug;26(8):1639-1652. doi: 10.1002/pro.3202. Epub 2017 Jun 11.
1880 Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.Cancer Lett. 2019 Mar 1;444:147-161. doi: 10.1016/j.canlet.2018.12.007. Epub 2018 Dec 21.
1881 Nesfatin-1 in advanced lung cancer patients with weight loss.Regul Pept. 2013 Feb 10;181:1-3. doi: 10.1016/j.regpep.2012.11.005. Epub 2012 Dec 23.
1882 CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7492-7. doi: 10.1073/pnas.131590998.
1883 MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?.BMC Cancer. 2018 Apr 16;18(1):423. doi: 10.1186/s12885-018-4332-7.
1884 RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.Mol Cell. 2013 Dec 12;52(5):720-33. doi: 10.1016/j.molcel.2013.11.010.
1885 Critical function for nuclear envelope protein TMEM209 in human pulmonary carcinogenesis.Cancer Res. 2012 Aug 15;72(16):4110-8. doi: 10.1158/0008-5472.CAN-12-0159. Epub 2012 Jun 19.
1886 NUP58 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the GSK-3/Snail signaling pathway.Am J Transl Res. 2019 Jan 15;11(1):393-405. eCollection 2019.
1887 Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.PLoS One. 2012;7(8):e42086. doi: 10.1371/journal.pone.0042086. Epub 2012 Aug 2.
1888 NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.Pathol Res Pract. 2015 May;211(5):404-8. doi: 10.1016/j.prp.2014.10.013. Epub 2014 Nov 13.
1889 Regulatory roles of OASL in lung cancer cell sensitivity to Actinidia chinensis Planch root extract (acRoots).Cell Biol Toxicol. 2018 Jun;34(3):207-218. doi: 10.1007/s10565-018-9422-4. Epub 2018 Mar 5.
1890 Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma.Oncol Rep. 2018 Jul;40(1):454-462. doi: 10.3892/or.2018.6408. Epub 2018 May 2.
1891 Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.Sci Rep. 2017 Sep 6;7(1):10607. doi: 10.1038/s41598-017-10886-x.
1892 Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition.J Biol Chem. 2013 Oct 25;288(43):31206-16. doi: 10.1074/jbc.M113.480285. Epub 2013 Sep 10.
1893 Anti-Tumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation.J Clin Med. 2019 Sep 3;8(9):1380. doi: 10.3390/jcm8091380.
1894 Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.Int J Biochem Cell Biol. 2016 Jan;70:68-75. doi: 10.1016/j.biocel.2015.11.006. Epub 2015 Nov 10.
1895 Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and -catenin.Cancer Sci. 2018 Jun;109(6):1799-1810. doi: 10.1111/cas.13614. Epub 2018 May 23.
1896 The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.Nat Commun. 2019 Jul 2;10(1):2914. doi: 10.1038/s41467-019-10824-7.
1897 Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and Adenocarcinoma.Front Oncol. 2019 Sep 11;9:862. doi: 10.3389/fonc.2019.00862. eCollection 2019.
1898 OVCA2 is downregulated and degraded during retinoid-induced apoptosis.Int J Cancer. 2002 May 10;99(2):185-92. doi: 10.1002/ijc.10334.
1899 Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.J Control Release. 2018 Sep 10;285:230-243. doi: 10.1016/j.jconrel.2018.07.014. Epub 2018 Jul 25.
1900 Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer.Exp Cell Res. 2018 Feb 1;363(1):121-128. doi: 10.1016/j.yexcr.2017.12.020. Epub 2017 Dec 23.
1901 Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications.Curr Cancer Drug Targets. 2019;19(11):919-929. doi: 10.2174/1871525717666190717162646.
1902 Anticancer Activity and Cisplatin Binding Ability of Bis-Quinoline and Bis-Isoquinoline Derived [Pd(2)L(4)](4+) Metallosupramolecular Cages.Front Chem. 2018 Nov 22;6:563. doi: 10.3389/fchem.2018.00563. eCollection 2018.
1903 Gene fusions PAFAH1B1-USP6 and RUNX2-USP6 in aneurysmal bone cysts identified by next generation sequencing.Cancer Genet. 2017 Apr;212-213:13-18. doi: 10.1016/j.cancergen.2017.03.007. Epub 2017 Mar 24.
1904 Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12426-31. doi: 10.1073/pnas.1305207110. Epub 2013 Jul 8.
1905 Protein secretion is required for pregnancy-associated plasma protein-A to promote lung cancer growth in vivo.PLoS One. 2012;7(11):e48799. doi: 10.1371/journal.pone.0048799. Epub 2012 Nov 9.
1906 Progesterone inhibits the migration and invasion of A549 lung cancer cells through membrane progesterone receptor -mediated mechanisms.Oncol Rep. 2013 May;29(5):1873-80. doi: 10.3892/or.2013.2336. Epub 2013 Mar 6.
1907 Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.Cancer Biomark. 2012-2013;12(1):11-9. doi: 10.3233/CBM-2012-00280.
1908 Modulation of Mutant Kras(G12D) -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function.Mol Cancer Res. 2019 Feb;17(2):594-603. doi: 10.1158/1541-7786.MCR-18-0739. Epub 2018 Nov 8.
1909 The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6225-6230. doi: 10.1073/pnas.1719871115. Epub 2018 May 29.
1910 Cancers Due to Excess Weight, Low Physical Activity, and Unhealthy Diet.Dtsch Arztebl Int. 2018 Sep 3;115(35-36):578-585. doi: 10.3238/arztebl.2018.0578.
1911 Dual expression of shAkt1 and Pdcd4 suppresses lung tumorigenesis in K-rasLA1 mice.Anticancer Res. 2015 Apr;35(4):2015-9.
1912 Expression of programmed cell death 5 protein inhibits progression of lung carcinoma in vitro and in vivo via the mitochondrial apoptotic pathway.Mol Med Rep. 2014 Oct;10(4):2059-64. doi: 10.3892/mmr.2014.2454. Epub 2014 Aug 5.
1913 Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer.Onco Targets Ther. 2019 Aug 9;12:6237-6244. doi: 10.2147/OTT.S205544. eCollection 2019.
1914 CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.Lung Cancer. 2017 May;107:14-21. doi: 10.1016/j.lungcan.2016.05.026. Epub 2016 Jun 1.
1915 HOXA4-Dependent Transcriptional Activation of AXL Promotes Cisplatin- Resistance in Lung Adenocarcinoma Cells.Anticancer Agents Med Chem. 2018;18(14):2062-2067. doi: 10.2174/1871520619666181203110835.
1916 Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance.Nat Commun. 2019 Nov 22;10(1):5324. doi: 10.1038/s41467-019-13331-x.
1917 Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.Histopathology. 2018 Feb;72(3):490-499. doi: 10.1111/his.13390. Epub 2017 Nov 27.
1918 Sp1 Mediates the Constitutive Expression and Repression of the PDSS2 Gene in Lung Cancer Cells.Genes (Basel). 2019 Nov 27;10(12):977. doi: 10.3390/genes10120977.
1919 EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties.Oncol Lett. 2018 May;15(5):6655-6665. doi: 10.3892/ol.2018.8129. Epub 2018 Feb 27.
1920 Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.J Natl Cancer Inst. 2017 Jun 1;109(6):djw297. doi: 10.1093/jnci/djw297.
1921 Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.Cell Death Differ. 2017 Mar;24(3):469-480. doi: 10.1038/cdd.2016.143. Epub 2016 Dec 23.
1922 PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGF.Cancer Biol Ther. 2011 Dec 15;12(12):1114-9. doi: 10.4161/cbt.12.12.18435. Epub 2011 Dec 15.
1923 MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.Oncol Rep. 2017 May;37(5):3146-3154. doi: 10.3892/or.2017.5566. Epub 2017 Apr 11.
1924 Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro.Mol Med Rep. 2015 May;11(5):3767-73. doi: 10.3892/mmr.2015.3159. Epub 2015 Jan 8.
1925 A novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesis.Oncotarget. 2017 Mar 21;8(12):19684-19698. doi: 10.18632/oncotarget.14962.
1926 USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.J Cancer Res Clin Oncol. 2012 Jul;138(7):1231-8. doi: 10.1007/s00432-012-1193-3. Epub 2012 Mar 20.
1927 Knockdown of 14-kDa phosphohistidine phosphatase expression suppresses lung cancer cell growth in vivo possibly through inhibition of NF-B signaling pathway.Neoplasma. 2016;63(4):540-7. doi: 10.4149/neo_2016_407.
1928 PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status.Int J Cancer. 2014 Mar 1;134(5):1045-54. doi: 10.1002/ijc.28448. Epub 2013 Sep 23.
1929 Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis.J Exp Clin Cancer Res. 2019 Jan 6;38(1):5. doi: 10.1186/s13046-018-0996-8.
1930 Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15043-8. doi: 10.1073/pnas.1307107110. Epub 2013 Aug 26.
1931 MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway.Mol Biol Cell. 2013 Jan;24(1):42-55. doi: 10.1091/mbc.E12-07-0519. Epub 2012 Nov 7.
1932 PINK1 Expression Is Associated with Poor Prognosis in Lung Adenocarcinoma.Tohoku J Exp Med. 2018 Jun;245(2):115-121. doi: 10.1620/tjem.245.115.
1933 Decreased PITX1 homeobox gene expression in human lung cancer.Lung Cancer. 2007 Mar;55(3):287-94. doi: 10.1016/j.lungcan.2006.11.001. Epub 2006 Dec 8.
1934 Plakophilin 1 is methylated and has a tumor suppressive activity in human lung cancer.Exp Mol Pathol. 2019 Jun;108:73-79. doi: 10.1016/j.yexmp.2019.04.001. Epub 2019 Apr 1.
1935 Ameliorating effect of lipo-ATRA treatment on the expression of TIG3 and its suppressing effect on PPAR gene expression in lung cancer animal model.Mol Cell Biochem. 2019 Oct;460(1-2):105-112. doi: 10.1007/s11010-019-03574-z. Epub 2019 Jul 12.
1936 Genomic structure of the human PLCD1 (phospholipase C delta 1) locus on 3p22-->p21.3.Cytogenet Cell Genet. 1997;78(1):58-60. doi: 10.1159/000134629.
1937 Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells.Sci Rep. 2019 Oct 18;9(1):14954. doi: 10.1038/s41598-019-51004-3.
1938 Intron/exon organization and polymorphisms of the PLK3/PRK gene in human lung carcinoma cell lines.Genes Chromosomes Cancer. 2001 Dec;32(4):384-9. doi: 10.1002/gcc.1204.
1939 PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway.Cell Death Dis. 2019 Feb 15;10(3):156. doi: 10.1038/s41419-019-1405-8.
1940 Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca(2+)-permeable Cationic Channel in lung carcinoma cells.Mol Cancer. 2017 Aug 29;16(1):147. doi: 10.1186/s12943-017-0717-5.
1941 TMEPAI inhibits TGF- signaling by promoting lysosome degradation of TGF- receptor and contributes to lung cancer development.Cell Signal. 2014 Sep;26(9):2030-9. doi: 10.1016/j.cellsig.2014.06.001. Epub 2014 Jun 13.
1942 EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.Cancer Res. 2019 May 1;79(9):2257-2270. doi: 10.1158/0008-5472.CAN-18-3238. Epub 2019 Mar 12.
1943 Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells.BMC Genomics. 2016 Dec 22;17(Suppl 13):1029. doi: 10.1186/s12864-016-3322-x.
1944 Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.Sci Rep. 2019 Oct 31;9(1):15767. doi: 10.1038/s41598-019-52414-z.
1945 siRNA of DNA polymerase iota inhibits the migration and invasion in the lung cancer cell A549.Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):929-933. doi: 10.1093/abbs/gmy089.
1946 POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma.Cancers (Basel). 2019 May 24;11(5):722. doi: 10.3390/cancers11050722.
1947 Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p, and 4q.Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):434-442. doi: 10.1158/1055-9965.EPI-19-0887. Epub 2019 Dec 11.
1948 RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer.Cancer Med. 2012 Aug;1(1):68-75. doi: 10.1002/cam4.13. Epub 2012 Jul 12.
1949 PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner.Oncogenesis. 2019 Sep 24;8(10):53. doi: 10.1038/s41389-019-0162-y.
1950 CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.Cancer Med. 2018 Feb;7(2):325-335. doi: 10.1002/cam4.1292. Epub 2018 Jan 22.
1951 Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762.Cancer Prev Res (Phila). 2018 Mar;11(3):143-156. doi: 10.1158/1940-6207.CAPR-17-0264. Epub 2017 Dec 15.
1952 Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.Ann Oncol. 2017 Jul 1;28(7):1625-1630. doi: 10.1093/annonc/mdx161.
1953 Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population.Nat Genet. 2012 Jul 15;44(8):895-9. doi: 10.1038/ng.2351.
1954 Clonal divergence in lung cancer development is associated with allelic loss on chromosome 4.Genes Chromosomes Cancer. 2007 Sep;46(9):852-60. doi: 10.1002/gcc.20472.
1955 A B56gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A.Oncogene. 2010 Jul 8;29(27):3933-41. doi: 10.1038/onc.2010.161. Epub 2010 May 17.
1956 Functional genetic polymorphisms in PP2A subunit genes confer increased risks of lung cancer in southern and eastern Chinese.PLoS One. 2013 Oct 29;8(10):e77285. doi: 10.1371/journal.pone.0077285. eCollection 2013.
1957 p53 and lung cancer.Pathol Biol (Paris). 1997 Dec;45(10):852-63.
1958 Potential Oncogenic Role of the Papillary Renal Cell Carcinoma Gene in Non-Small Cell Lung Cancers.Yonsei Med J. 2019 Apr;60(4):326-335. doi: 10.3349/ymj.2019.60.4.326.
1959 Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis.Tumour Biol. 2017 Apr;39(4):1010428317695929. doi: 10.1177/1010428317695929.
1960 PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.J Exp Clin Cancer Res. 2019 Jan 25;38(1):35. doi: 10.1186/s13046-019-1042-1.
1961 Genetic polymorphisms in the Rb-binding zinc finger gene RIZ and the risk of lung cancer.Carcinogenesis. 2007 Sep;28(9):1971-7. doi: 10.1093/carcin/bgm156. Epub 2007 Aug 11.
1962 Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma.Tumour Biol. 2014 May;35(5):4509-16. doi: 10.1007/s13277-013-1593-2. Epub 2014 Jan 7.
1963 Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis.Int J Oncol. 2013 Jul;43(1):72-8. doi: 10.3892/ijo.2013.1918. Epub 2013 Apr 24.
1964 Changes in gene expression in lungs of mice exposed to traffic-related air pollution.Mol Cell Probes. 2018 Jun;39:33-40. doi: 10.1016/j.mcp.2018.03.005. Epub 2018 Apr 3.
1965 MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells.Int J Cancer. 2010 Jul 15;127(2):313-20. doi: 10.1002/ijc.25049.
1966 Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines.Acta Pharmacol Sin. 2020 Jan;41(1):110-118. doi: 10.1038/s41401-019-0290-0. Epub 2019 Sep 12.
1967 PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages.Mol Cancer Res. 2020 Jan;18(1):166-178. doi: 10.1158/1541-7786.MCR-19-0204. Epub 2019 Oct 16.
1968 Inhibition of cellular growth and migration by suppression of endothelial protein C receptor (EPCR) in lung carcinoma cells.Oncol Res. 2012;20(5-6):231-40. doi: 10.3727/096504013x13589503482932.
1969 PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.BMB Rep. 2019 Feb;52(2):157-162. doi: 10.5483/BMBRep.2019.52.2.207.
1970 PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.PLoS One. 2019 Oct 9;14(10):e0218839. doi: 10.1371/journal.pone.0218839. eCollection 2019.
1971 Proscillaridin A Promotes Oxidative Stress and ER Stress, Inhibits STAT3 Activation, and Induces Apoptosis in A549 Lung Adenocarcinoma Cells.Oxid Med Cell Longev. 2018 Jan 11;2018:3853409. doi: 10.1155/2018/3853409. eCollection 2018.
1972 Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.Cancer Sci. 2017 Apr;108(4):732-743. doi: 10.1111/cas.13185. Epub 2017 Apr 25.
1973 Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas.Mol Carcinog. 2011 Apr;50(4):301-9. doi: 10.1002/mc.20632.
1974 PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells.Regul Pept. 2002 Nov 15;109(1-3):135-40. doi: 10.1016/s0167-0115(02)00196-9.
1975 Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway.Mol Cells. 2019 Aug 31;42(8):604-616. doi: 10.14348/molcells.2019.0160.
1976 Identification of a novel mouse p53 target gene DDA3.Oncogene. 1999 Dec 16;18(54):7765-74. doi: 10.1038/sj.onc.1203167.
1977 CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth.Br J Cancer. 2011 Feb 1;104(3):496-504. doi: 10.1038/sj.bjc.6606033. Epub 2011 Jan 4.
1978 Metformin Inhibit Lung Cancer Cell Growth and Invasion in Vitro as Well as Tumor Formation in Vivo Partially by Activating PP2A.Med Sci Monit. 2019 Jan 29;25:836-846. doi: 10.12659/MSM.912059.
1979 SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.EBioMedicine. 2018 Dec;38:113-126. doi: 10.1016/j.ebiom.2018.11.007. Epub 2018 Nov 11.
1980 A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.Genes Chromosomes Cancer. 2010 Apr;49(4):342-52. doi: 10.1002/gcc.20746.
1981 Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21.Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5036-40. doi: 10.1073/pnas.88.11.5036.
1982 Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.Oncol Rep. 2015 Sep;34(3):1137-45. doi: 10.3892/or.2015.4082. Epub 2015 Jun 25.
1983 A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes.Cancer Res. 2000 Nov 15;60(22):6448-56.
1984 Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.Oncol Lett. 2018 Jan;15(1):731-740. doi: 10.3892/ol.2017.7400. Epub 2017 Nov 14.
1985 Quaking-5 suppresses aggressiveness of lung cancer cells through inhibiting -catenin signaling pathway.Oncotarget. 2017 Jul 7;8(47):82174-82184. doi: 10.18632/oncotarget.19066. eCollection 2017 Oct 10.
1986 Hypermethylation of the GATA genes in lung cancer.Clin Cancer Res. 2004 Dec 1;10(23):7917-24. doi: 10.1158/1078-0432.CCR-04-1140.
1987 Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):571-5. doi: 10.1158/1055-9965.EPI-04-0472.
1988 Sublocalization of Rab23, a mediator of Sonic hedgehog signaling pathway, in hepatocellular carcinoma cell lines.Mol Med Rep. 2012 Dec;6(6):1276-80. doi: 10.3892/mmr.2012.1094. Epub 2012 Sep 20.
1989 Suppression of Tobacco Carcinogen-Induced Lung Tumorigenesis by Aerosol-Delivered Glycerol Propoxylate Triacrylate-Spermine Copolymer/Short Hairpin Rab25 RNA Complexes in Female A/J Mice.J Aerosol Med Pulm Drug Deliv. 2017 Apr;30(2):81-90. doi: 10.1089/jamp.2016.1301. Epub 2016 Oct 28.
1990 Targeted Delivery of Rab26 siRNA with Precisely Tailored DNA Prism for Lung Cancer Therapy.Chembiochem. 2019 May 2;20(9):1139-1144. doi: 10.1002/cbic.201800761. Epub 2019 Feb 27.
1991 Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors.BMC Cancer. 2009 Dec 4;9:423. doi: 10.1186/1471-2407-9-423.
1992 Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.Nanomedicine. 2018 Feb;14(2):373-384. doi: 10.1016/j.nano.2017.11.010. Epub 2017 Nov 16.
1993 RAC2 promotes abnormal proliferation of quiescent cells by enhanced JUNB expression via the MAL-SRF pathway.Cell Cycle. 2018;17(9):1115-1123. doi: 10.1080/15384101.2018.1480217. Epub 2018 Jul 9.
1994 Interruption of lung cancer cell migration and proliferation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.J Agric Food Chem. 2013 Dec 11;61(49):12044-52. doi: 10.1021/jf4030272. Epub 2013 Nov 22.
1995 Human Rad17 is phosphorylated upon DNA damage and also overexpressed in primary non-small cell lung cancer tissues.Cancer Res. 2001 Oct 15;61(20):7417-21.
1996 Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China.Int J Cancer. 2005 Sep 20;116(5):768-73. doi: 10.1002/ijc.21117.
1997 Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.Carcinogenesis. 2018 Mar 8;39(3):407-417. doi: 10.1093/carcin/bgx122.
1998 Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.PLoS One. 2019 Jul 16;14(7):e0219317. doi: 10.1371/journal.pone.0219317. eCollection 2019.
1999 RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.PLoS One. 2016 May 5;11(5):e0154840. doi: 10.1371/journal.pone.0154840. eCollection 2016.
2000 miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers.PLoS One. 2012;7(6):e39167. doi: 10.1371/journal.pone.0039167. Epub 2012 Jun 18.
2001 Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1.
2002 RASEF is a novel diagnostic biomarker and a therapeutic target for lung cancer.Mol Cancer Res. 2013 Aug;11(8):937-51. doi: 10.1158/1541-7786.MCR-12-0685-T. Epub 2013 May 16.
2003 RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.Mod Pathol. 2013 Aug;26(8):1111-22. doi: 10.1038/modpathol.2013.32. Epub 2013 Mar 29.
2004 RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion.Tumour Biol. 2016 Apr;37(4):4865-71. doi: 10.1007/s13277-015-4343-9. Epub 2015 Nov 2.
2005 The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer.Oncotarget. 2017 Aug 12;8(45):78734-78748. doi: 10.18632/oncotarget.20223. eCollection 2017 Oct 3.
2006 Identification of RASSF8 as a candidate lung tumor suppressor gene.Oncogene. 2006 Jun 29;25(28):3934-8. doi: 10.1038/sj.onc.1209422. Epub 2006 Feb 6.
2007 Association of genetic variants in the retinoblastoma binding protein 6 gene with the risk of glioma: a case-control study in a Chinese Han population.J Neurosurg. 2014 Nov;121(5):1209-18. doi: 10.3171/2014.6.JNS132240. Epub 2014 Aug 15.
2008 Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.BMC Genomics. 2010 Nov 30;11:676. doi: 10.1186/1471-2164-11-676.
2009 Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.Clin Cancer Res. 1997 Oct;3(10):1691-7.
2010 Functional role of RBM10 in lung adenocarcinoma proliferation.Int J Oncol. 2019 Feb;54(2):467-478. doi: 10.3892/ijo.2018.4643. Epub 2018 Nov 22.
2011 Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.Tumour Biol. 2017 Oct;39(10):1010428317711662. doi: 10.1177/1010428317711662.
2012 RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation.BMC Cancer. 2018 Jan 10;18(1):67. doi: 10.1186/s12885-017-3908-y.
2013 RCCD1 depletion attenuates TGF--induced EMT and cell migration bystabilizing cytoskeletal microtubules in NSCLC cells.Cancer Lett. 2017 Aug 1;400:18-29. doi: 10.1016/j.canlet.2017.04.021. Epub 2017 Apr 26.
2014 SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.Oncogene. 2006 Jan 19;25(3):470-9. doi: 10.1038/sj.onc.1209068.
2015 RAD52 motifcontaining protein1 promotes nonsmall cell lung cancer cell proliferation and survival via cell cycle regulation.Oncol Rep. 2018 Aug;40(2):833-840. doi: 10.3892/or.2018.6459. Epub 2018 May 23.
2016 Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.Oncol Rep. 2019 Jul;42(1):283-290. doi: 10.3892/or.2019.7162. Epub 2019 May 15.
2017 Effects of RECQ1 helicase silencing on non-small cell lung cancer cells.Biomed Pharmacother. 2016 Oct;83:1227-1232. doi: 10.1016/j.biopha.2016.07.053. Epub 2016 Aug 23.
2018 Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers.Int J Cancer. 2008 Jul 15;123(2):457-463. doi: 10.1002/ijc.23524.
2019 Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.Oncol Rep. 2018 Dec;40(6):3392-3404. doi: 10.3892/or.2018.6736. Epub 2018 Sep 26.
2020 MAG-2 promotes invasion, mobility and adherence capability of lung cancer cells by MMP-2, CD44 and intracellular calcium in vitro.Oncol Rep. 2009 Mar;21(3):697-706.
2021 Effects of polymorphisms in translesion DNA synthesis genes on lung cancer risk and prognosis in Chinese men.Cancer Epidemiol. 2013 Dec;37(6):917-22. doi: 10.1016/j.canep.2013.08.003. Epub 2013 Sep 5.
2022 Absence of REV3L promotes p53-regulated cancer cell metabolism in cisplatin-treated lung carcinoma cells.Biochem Biophys Res Commun. 2018 Jan 29;496(1):199-204. doi: 10.1016/j.bbrc.2018.01.026. Epub 2018 Jan 4.
2023 Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.Mol Cell Biochem. 2014 Sep;394(1-2):109-18. doi: 10.1007/s11010-014-2086-3. Epub 2014 May 16.
2024 Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development.Oncotarget. 2019 Mar 5;10(19):1760-1774. doi: 10.18632/oncotarget.26678. eCollection 2019 Mar 5.
2025 Diagnosing the RGS11 Lung Cancer Biomarker: The Integration of Competitive Immunoassay and Isothermal Nucleic Acid Exponential Amplification Reaction.Anal Chem. 2019 Mar 5;91(5):3327-3335. doi: 10.1021/acs.analchem.8b04374. Epub 2019 Feb 15.
2026 The RHOV gene is overexpressed in human non-small cell lung cancer.Cancer Genet. 2013 Nov;206(11):393-7. doi: 10.1016/j.cancergen.2013.10.006. Epub 2013 Nov 5.
2027 Polycomb group oncogene RING1 is over-expressed in non-small cell lung cancer.Pathol Oncol Res. 2014 Jul;20(3):549-56. doi: 10.1007/s12253-013-9727-9. Epub 2014 Jan 11.
2028 The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior.EBioMedicine. 2017 Jun;20:79-97. doi: 10.1016/j.ebiom.2017.04.015. Epub 2017 Apr 12.
2029 Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer.Mol Cancer Ther. 2007 Feb;6(2):542-51. doi: 10.1158/1535-7163.MCT-06-0659.
2030 Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.Lung Cancer. 2010 Aug;69(2):232-8. doi: 10.1016/j.lungcan.2009.10.010. Epub 2009 Nov 14.
2031 Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival.J Biol Chem. 2003 Jun 27;278(26):23630-8. doi: 10.1074/jbc.M300997200. Epub 2003 Apr 24.
2032 Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein.Cell Growth Differ. 2000 Apr;11(4):185-90.
2033 Arkadia regulates tumor metastasis by modulation of the TGF- pathway.Cancer Res. 2013 Mar 15;73(6):1800-10. doi: 10.1158/0008-5472.CAN-12-1916. Epub 2013 Mar 6.
2034 Overexpression of RNF146 in non-small cell lung cancer enhances proliferation and invasion of tumors through the Wnt/-catenin signaling pathway.PLoS One. 2014 Jan 14;9(1):e85377. doi: 10.1371/journal.pone.0085377. eCollection 2014.
2035 Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype.J Cancer. 2018 Feb 12;9(5):841-850. doi: 10.7150/jca.23138. eCollection 2018.
2036 Association of Perioperative Redox Balance on Long-Term Outcome in Patients Undergoing Lung Resection.Ann Thorac Cardiovasc Surg. 2018 Feb 20;24(1):13-18. doi: 10.5761/atcs.oa.17-00127. Epub 2017 Nov 10.
2037 Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study.Onco Targets Ther. 2019 Oct 9;12:8263-8273. doi: 10.2147/OTT.S217514. eCollection 2019.
2038 The changing face of cancer treatments.BMJ Case Rep. 2018 Sep 1;2018:bcr2018224784. doi: 10.1136/bcr-2018-224784.
2039 Down-regulation of ribosomal protein L22 in non-small cell lung cancer.Med Oncol. 2013;30(3):646. doi: 10.1007/s12032-013-0646-0. Epub 2013 Jun 25.
2040 Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors.BMC Cancer. 2004 Aug 4;4:43. doi: 10.1186/1471-2407-4-43.
2041 A novel platform to enable inhaled naked RNAi medicine for lung cancer.Sci Rep. 2013 Nov 25;3:3325. doi: 10.1038/srep03325.
2042 SOX9 dependent FOXA1 expression promotes tumorigenesis in lung carcinoma.Biochem Biophys Res Commun. 2019 Aug 13;516(1):236-244. doi: 10.1016/j.bbrc.2019.05.169. Epub 2019 Jun 17.
2043 Decreased expression of RPS15A suppresses proliferation of lung cancer cells.Tumour Biol. 2015 Sep;36(9):6733-40. doi: 10.1007/s13277-015-3371-9. Epub 2015 Apr 3.
2044 HPV 16 E6/E7 up-regulate the expression of both HIF-1 and GLUT1 by inhibition of RRAD and activation of NF-B in lung cancer cells.J Cancer. 2019 Nov 17;10(27):6903-6909. doi: 10.7150/jca.37070. eCollection 2019.
2045 Identification of a novel nucleus protein involved in the regulation of urokinase in 95D cells.Acta Biochim Biophys Sin (Shanghai). 2005 May;37(5):303-9. doi: 10.1111/j.1745-7270.2005.00041.x.
2046 Differences in survival according to malignancy type and degree of immunodeficiency in HIV-infected patients.Med Clin (Barc). 2020 Apr 24;154(8):295-300. doi: 10.1016/j.medcli.2019.06.019. Epub 2019 Aug 27.
2047 RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma.J Cancer. 2019 Oct 17;10(25):6278-6285. doi: 10.7150/jca.35072. eCollection 2019.
2048 The expression of RUNDC3B is associated with promoter methylation in lymphoid malignancies.Hematol Oncol. 2017 Mar;35(1):25-33. doi: 10.1002/hon.2238. Epub 2015 May 25.
2049 RUVBL1, a novel C-RAF-binding protein, activates the RAF/MEK/ERK pathway to promote lung cancer tumorigenesis.Biochem Biophys Res Commun. 2018 Apr 15;498(4):932-939. doi: 10.1016/j.bbrc.2018.03.084. Epub 2018 Mar 15.
2050 RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition.Transl Oncol. 2017 Apr;10(2):280-287. doi: 10.1016/j.tranon.2017.01.004. Epub 2017 Feb 28.
2051 Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells.Mol Cell Biochem. 2012 Jan;359(1-2):323-32. doi: 10.1007/s11010-011-1026-8. Epub 2011 Aug 23.
2052 S100A13 is a new angiogenic marker in human melanoma.Mod Pathol. 2010 Jun;23(6):804-13. doi: 10.1038/modpathol.2010.54. Epub 2010 Mar 5.
2053 Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity.Clin Chim Acta. 2017 Jan;464:118-122. doi: 10.1016/j.cca.2016.11.027. Epub 2016 Nov 19.
2054 S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.Oncotarget. 2017 Apr 11;8(15):24804-24814. doi: 10.18632/oncotarget.15063.
2055 Graphene Oxide-Facilitated Comprehensive Analysis of Cellular Nucleic Acid Binding Proteins for Lung Cancer.ACS Appl Mater Interfaces. 2018 May 30;10(21):17756-17770. doi: 10.1021/acsami.8b05428. Epub 2018 May 15.
2056 Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer.Genes Chromosomes Cancer. 2008 Sep;47(9):810-8. doi: 10.1002/gcc.20582.
2057 Effects of SASH1 on lung cancer cell proliferation, apoptosis, and invasion in vitro.Tumour Biol. 2012 Oct;33(5):1393-401. doi: 10.1007/s13277-012-0387-2. Epub 2012 Apr 10.
2058 Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell transformation.Mol Carcinog. 2018 Aug;57(8):968-977. doi: 10.1002/mc.22817. Epub 2018 Apr 17.
2059 Dose-dependent activation of putative oncogene SBSN by BORIS.PLoS One. 2012;7(7):e40389. doi: 10.1371/journal.pone.0040389. Epub 2012 Jul 5.
2060 Scavenger Receptor A1 Prevents Metastasis of Non-Small Cell Lung Cancer via Suppression of Macrophage Serum Amyloid A1.Cancer Res. 2017 Apr 1;77(7):1586-1598. doi: 10.1158/0008-5472.CAN-16-1569. Epub 2017 Feb 15.
2061 Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.BMC Cancer. 2010 Feb 12;10:41. doi: 10.1186/1471-2407-10-41.
2062 Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells.Cancer Res. 1989 Aug 1;49(15):4154-8.
2063 The Epithelial Sodium Channel (ENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors.Transl Oncol. 2018 Apr;11(2):292-299. doi: 10.1016/j.tranon.2018.01.004. Epub 2018 Feb 2.
2064 SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response.Theranostics. 2019 Aug 14;9(22):6380-6395. doi: 10.7150/thno.34443. eCollection 2019.
2065 Molecular characterization of defective antigen processing in human prostate cancer.J Natl Cancer Inst. 1995 Feb 15;87(4):280-5. doi: 10.1093/jnci/87.4.280.
2066 Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism.Eur J Nutr. 2008 Feb;47(1):47-54. doi: 10.1007/s00394-008-0696-9. Epub 2008 Jan 31.
2067 Impaired ligand-dependent MET activation caused by an extracellular SEMA domain missense mutation in lung cancer.Cancer Sci. 2019 Oct;110(10):3340-3349. doi: 10.1111/cas.14142. Epub 2019 Aug 13.
2068 Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion.Tumour Biol. 2014 May;35(5):4949-55. doi: 10.1007/s13277-014-1651-4. Epub 2014 Jan 29.
2069 The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.Tumour Biol. 2017 Jun;39(6):1010428317703819. doi: 10.1177/1010428317703819.
2070 Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer.Cancer Treat Rev. 2013 Feb;39(1):77-88. doi: 10.1016/j.ctrv.2012.06.001. Epub 2012 Jul 11.
2071 Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.BMC Cancer. 2010 May 31;10:245. doi: 10.1186/1471-2407-10-245.
2072 Sestrin-3 modulation is essential for therapeutic efficacy of cucurbitacin B in lung cancer cells.Carcinogenesis. 2017 Feb 1;38(2):184-195. doi: 10.1093/carcin/bgw124.
2073 Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer.Respir Res. 2019 Oct 17;20(1):222. doi: 10.1186/s12931-019-1192-x.
2074 H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis.Cancer Res. 2014 Dec 15;74(24):7333-43. doi: 10.1158/0008-5472.CAN-13-3572. Epub 2014 Dec 4.
2075 Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.Cancer Prev Res (Phila). 2010 May;3(5):664-9. doi: 10.1158/1940-6207.CAPR-09-0141. Epub 2010 Apr 27.
2076 Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.Am J Pathol. 2012 Apr;180(4):1653-62. doi: 10.1016/j.ajpath.2011.12.014. Epub 2012 Feb 4.
2077 Secreted frizzled-related protein 1 (SFRP1) gene methylation changes in the human lung adenocarcinoma cells treated with L-securinine.J Asian Nat Prod Res. 2018 Feb;20(2):163-171. doi: 10.1080/10286020.2017.1329828. Epub 2017 May 26.
2078 Epigallocatechin-3-gallate (EGCG) inhibits aggregation of pulmonary fibrosis associated mutant surfactant protein A2 via a proteasomal degradation pathway.Int J Biochem Cell Biol. 2019 Nov;116:105612. doi: 10.1016/j.biocel.2019.105612. Epub 2019 Sep 20.
2079 MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3286-3296. doi: 10.1080/21691401.2019.1648283.
2080 PLOD3 promotes lung metastasis via regulation of STAT3.Cell Death Dis. 2018 Nov 15;9(12):1138. doi: 10.1038/s41419-018-1186-5.
2081 New perspective on SH2B1: An accelerator of cancer progression.Biomed Pharmacother. 2020 Jan;121:109651. doi: 10.1016/j.biopha.2019.109651. Epub 2019 Nov 15.
2082 Imputation-based association analyses identify new lung cancer susceptibility variants in CDK6 and SH3RF1 and their interactions with smoking in Chinese populations.Carcinogenesis. 2013 Sep;34(9):2010-6. doi: 10.1093/carcin/bgt145. Epub 2013 May 3.
2083 Shank-associated RH domain-interacting protein expression is upregulated in entodermal and mesodermal cancer or downregulated in ectodermal malignancy.Oncol Lett. 2018 Dec;16(6):7180-7188. doi: 10.3892/ol.2018.9514. Epub 2018 Sep 27.
2084 DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers.Oncogene. 2008 Jul 31;27(33):4615-24. doi: 10.1038/onc.2008.98. Epub 2008 Apr 7.
2085 The Shisa3 knockout mouse exhibits normal bone phenotype.J Bone Miner Metab. 2019 Nov;37(6):967-975. doi: 10.1007/s00774-019-01014-y. Epub 2019 Jun 20.
2086 SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production.J Exp Clin Cancer Res. 2019 Feb 12;38(1):70. doi: 10.1186/s13046-019-1067-5.
2087 Variants in folate pathway genes as modulators of genetic instability and lung cancer risk.Genes Chromosomes Cancer. 2011 Jan;50(1):1-12. doi: 10.1002/gcc.20826.
2088 The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.Cell Rep. 2019 Mar 12;26(11):3037-3050.e4. doi: 10.1016/j.celrep.2019.02.052.
2089 The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.PLoS One. 2015 Nov 18;10(11):e0143376. doi: 10.1371/journal.pone.0143376. eCollection 2015.
2090 FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway.Biochem Biophys Res Commun. 2020 Jan 22;521(4):1003-1009. doi: 10.1016/j.bbrc.2019.11.029. Epub 2019 Nov 12.
2091 Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese.Mol Carcinog. 2013 Nov;52 Suppl 1:E110-7. doi: 10.1002/mc.22039. Epub 2013 May 9.
2092 SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway.Oncogene. 2017 May 11;36(19):2724-2736. doi: 10.1038/onc.2016.425. Epub 2016 Dec 12.
2093 MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.Biochem Biophys Res Commun. 2019 Jul 12;515(1):85-91. doi: 10.1016/j.bbrc.2019.05.111. Epub 2019 May 23.
2094 Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.Cell Prolif. 2019 Jul;52(4):e12617. doi: 10.1111/cpr.12617. Epub 2019 Apr 22.
2095 A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.Oncotarget. 2015 Sep 22;6(28):24895-903. doi: 10.18632/oncotarget.4366.
2096 Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5.Cancer Res. 1998 Sep 15;58(18):4155-9.
2097 Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity.Oncogene. 2015 Apr 9;34(15):1979-90. doi: 10.1038/onc.2014.123. Epub 2014 May 26.
2098 SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3/-catenin pathway.Cell Signal. 2019 Jul;59:1-12. doi: 10.1016/j.cellsig.2019.03.004. Epub 2019 Mar 4.
2099 Effects of Slit3 silencing on the invasive ability of lung carcinoma A549 cells.Oncol Rep. 2015 Aug;34(2):952-60. doi: 10.3892/or.2015.4031. Epub 2015 Jun 5.
2100 The Relationship between Nkx2.1 and DNA Oxidative Damage Repair in Nickel Smelting Workers: Jinchang Cohort Study.Int J Environ Res Public Health. 2019 Jan 4;16(1):120. doi: 10.3390/ijerph16010120.
2101 SMAGP, a new small trans-membrane glycoprotein altered in cancer.Oncogene. 2004 Apr 22;23(19):3395-403. doi: 10.1038/sj.onc.1207469.
2102 Author Correction: Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.Nat Med. 2018 Oct;24(10):1627. doi: 10.1038/s41591-018-0173-9.
2103 MicroRNA-7 Compromises p53 Protein-dependent Apoptosis by Controlling the Expression of the Chromatin Remodeling Factor SMARCD1.J Biol Chem. 2016 Jan 22;291(4):1877-1889. doi: 10.1074/jbc.M115.667568. Epub 2015 Nov 5.
2104 SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer.Cell Res. 2015 Apr;25(4):445-58. doi: 10.1038/cr.2015.16. Epub 2015 Feb 6.
2105 Downregulating PRL-3 inhibit migration and invasion of lung cancer cell via RhoA and mDia1.Tumori. 2012 May-Jun;98(3):370-6. doi: 10.1177/030089161209800315.
2106 Evaluation of the diagnostic efficacy of (18) F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country.Cancer Med. 2020 Feb;9(3):931-942. doi: 10.1002/cam4.2770. Epub 2019 Dec 13.
2107 Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKI.Oncogene. 2017 Oct 12;36(41):5668-5680. doi: 10.1038/onc.2017.166. Epub 2017 Jun 5.
2108 MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF- receptor I ubiquitination.Mol Oncol. 2019 Dec;13(12):2663-2678. doi: 10.1002/1878-0261.12581. Epub 2019 Nov 8.
2109 High expression of SNIP1 correlates with poor prognosis in non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro.Lung Cancer. 2013 Oct;82(1):24-30. doi: 10.1016/j.lungcan.2013.07.015. Epub 2013 Aug 9.
2110 Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung cancer cells in mice.J Drug Target. 2018 Mar;26(3):222-230. doi: 10.1080/1061186X.2017.1354003. Epub 2017 Jul 18.
2111 Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines.Int J Oncol. 2012 Oct;41(4):1520-30. doi: 10.3892/ijo.2012.1578. Epub 2012 Jul 31.
2112 Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugs.Cancer Sci. 2013 May;104(5):573-83. doi: 10.1111/cas.12117. Epub 2013 Mar 8.
2113 Epigenetic inactivation of SOX1 promotes cell migration in lung cancer.Tumour Biol. 2015 Jun;36(6):4603-10. doi: 10.1007/s13277-015-3107-x. Epub 2015 Jan 23.
2114 SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.Discov Med. 2012 Jul;14(74):33-40.
2115 Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.Oncol Rep. 2018 Jan;39(1):201-208. doi: 10.3892/or.2017.6077. Epub 2017 Nov 6.
2116 SOX30 Inhibits Tumor Metastasis through Attenuating Wnt-Signaling via Transcriptional and Posttranslational Regulation of -Catenin in Lung Cancer.EBioMedicine. 2018 May;31:253-266. doi: 10.1016/j.ebiom.2018.04.026. Epub 2018 May 5.
2117 SOX4, an epithelial-mesenchymal transition inducer, transactivates ADAM28 gene expression and co-localizes with ADAM28 at the invasive front of human breast and lung carcinomas.Pathol Int. 2018 Jun 7. doi: 10.1111/pin.12685. Online ahead of print.
2118 SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21(CIPI) , cyclin D1 and -catenin.FEBS Open Bio. 2020 Jan;10(1):135-146. doi: 10.1002/2211-5463.12762. Epub 2019 Dec 12.
2119 SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells.Oncogene. 2019 Aug;38(34):6196-6210. doi: 10.1038/s41388-019-0865-8. Epub 2019 Jul 22.
2120 The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.Mol Cell Biol. 2020 Jan 3;40(2):e00307-19. doi: 10.1128/MCB.00307-19. Print 2020 Jan 3.
2121 Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.J Cell Physiol. 2019 Aug;234(10):17589-17599. doi: 10.1002/jcp.28383. Epub 2019 Mar 1.
2122 The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer.Cell Stress Chaperones. 2017 Mar;22(2):237-244. doi: 10.1007/s12192-016-0758-5. Epub 2016 Dec 27.
2123 A potential prognostic biomarker SPC24 promotes tumorigenesis and metastasis in lung cancer.Oncotarget. 2017 Jul 4;8(39):65469-65480. doi: 10.18632/oncotarget.18971. eCollection 2017 Sep 12.
2124 Spindle pole body component 25 homolog expressed by ECM stiffening is required for lung cancer cell proliferation.Biochem Biophys Res Commun. 2018 Jun 12;500(4):937-943. doi: 10.1016/j.bbrc.2018.04.205. Epub 2018 May 2.
2125 ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration.Cancer Lett. 2010 Apr 1;290(1):87-95. doi: 10.1016/j.canlet.2009.09.001. Epub 2009 Sep 30.
2126 Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration.PLoS One. 2014 Oct 20;9(10):e110119. doi: 10.1371/journal.pone.0110119. eCollection 2014.
2127 Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display.Genomics. 1999 Oct 1;61(1):5-14. doi: 10.1006/geno.1999.5939.
2128 SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.Am J Cancer Res. 2019 Jul 1;9(7):1469-1483. eCollection 2019.
2129 A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer.Sci Rep. 2019 May 20;9(1):7618. doi: 10.1038/s41598-019-43100-1.
2130 Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.J Cell Biochem. 2019 Oct;120(10):17303-17311. doi: 10.1002/jcb.28992. Epub 2019 May 20.
2131 SRSF7 knockdown promotes apoptosis of colon and lung cancer cells.Oncol Lett. 2018 Apr;15(4):5545-5552. doi: 10.3892/ol.2018.8072. Epub 2018 Feb 16.
2132 The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.Mol Cancer Res. 2017 Jun;15(6):651-659. doi: 10.1158/1541-7786.MCR-16-0466. Epub 2017 Feb 23.
2133 Influences of two significant variants located in the ST6GAL1 3'-untranslated region on lung carcinoma susceptibility in the Chinese Han population.Eur J Cancer Prev. 2020 Jan;29(1):60-64. doi: 10.1097/CEJ.0000000000000512.
2134 Forensic evaluation of STR typing reliability in lung cancer.Leg Med (Tokyo). 2018 Jan;30:38-41. doi: 10.1016/j.legalmed.2017.11.004. Epub 2017 Nov 11.
2135 A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer.Clin Cancer Res. 2009 Dec 1;15(23):7309-15. doi: 10.1158/1078-0432.CCR-09-1572. Epub 2009 Nov 17.
2136 Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis.Oncogene. 2019 Jun;38(26):5191-5210. doi: 10.1038/s41388-019-0786-6. Epub 2019 Mar 27.
2137 HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.Respir Res. 2012 Aug 8;13(1):69. doi: 10.1186/1465-9921-13-69.
2138 SUMO1 promotes the proliferation and invasion of non-small cell lung cancer cells by regulating NF-B.Thorac Cancer. 2019 Jan;10(1):33-40. doi: 10.1111/1759-7714.12895. Epub 2018 Nov 4.
2139 SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.Tumour Biol. 2016 Jul;37(7):9919-30. doi: 10.1007/s13277-015-4734-y. Epub 2016 Jan 27.
2140 The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.J Cancer. 2019 Jan 1;10(3):721-729. doi: 10.7150/jca.28254. eCollection 2019.
2141 Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.J Transl Med. 2017 Jun 17;15(1):138. doi: 10.1186/s12967-017-1241-5.
2142 Synaptojanin 2 functions at an early step of clathrin-mediated endocytosis.Curr Biol. 2003 Apr 15;13(8):659-63. doi: 10.1016/s0960-9822(03)00241-0.
2143 Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo.Appl Biochem Biotechnol. 2019 Apr;187(4):1328-1343. doi: 10.1007/s12010-018-2869-1. Epub 2018 Sep 19.
2144 Synaptotagmin-7, a binding protein of P53, inhibits the senescence and promotes the tumorigenicity of lung cancer cells.Biosci Rep. 2019 Feb 8;39(2):BSR20181298. doi: 10.1042/BSR20181298. Print 2019 Feb 28.
2145 Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.Clin Cancer Res. 2008 Mar 1;14(5):1494-501. doi: 10.1158/1078-0432.CCR-07-1066.
2146 Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay.Mol Cell. 2019 Sep 5;75(5):967-981.e9. doi: 10.1016/j.molcel.2019.06.001. Epub 2019 Jul 9.
2147 TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis.Nat Cell Biol. 2019 Dec;21(12):1604-1614. doi: 10.1038/s41556-019-0429-8. Epub 2019 Dec 2.
2148 TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.Cell Death Differ. 2019 Jul;26(7):1235-1250. doi: 10.1038/s41418-018-0202-8. Epub 2018 Sep 25.
2149 Vitamin B12 and its binding proteins in patients with non-small cell lung cancer referred to fast-track diagnostic work-up for lung cancer.Scand J Clin Lab Invest. 2020 Feb;80(1):14-19. doi: 10.1080/00365513.2019.1692232. Epub 2019 Nov 18.
2150 Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma.Cancers (Basel). 2019 Jun 3;11(6):768. doi: 10.3390/cancers11060768.
2151 Testin is a tumor suppressor in non-small cell lung cancer.Oncol Rep. 2017 Feb;37(2):1027-1035. doi: 10.3892/or.2016.5316. Epub 2016 Dec 14.
2152 Tescalcin/c-Src/IGF1R-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.Sci Rep. 2018 Jul 16;8(1):10711. doi: 10.1038/s41598-018-29142-x.
2153 Expression of tesmin (MTL5) in nonsmall cell lung cancer: A preliminary study.Oncol Rep. 2019 Jul;42(1):253-262. doi: 10.3892/or.2019.7145. Epub 2019 May 2.
2154 Expression and methylation of mitochondrial transcription factor a in chronic obstructive pulmonary disease patients with lung cancer.PLoS One. 2013 Dec 18;8(12):e82739. doi: 10.1371/journal.pone.0082739. eCollection 2013.
2155 TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.Mol Cancer. 2014 Apr 26;13:89. doi: 10.1186/1476-4598-13-89.
2156 A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.BMC Genomics. 2013;14 Suppl 6(Suppl 6):S5. doi: 10.1186/1471-2164-14-S6-S5. Epub 2013 Oct 25.
2157 Possible Molecular Mechanisms for the Roles of MicroRNA-21 Played in Lung Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819875130. doi: 10.1177/1533033819875130.
2158 Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.Oncol Rep. 2012 Apr;27(4):1277-83. doi: 10.3892/or.2012.1627. Epub 2012 Jan 11.
2159 Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma.Cancer Sci. 2015 Jan;106(1):34-42. doi: 10.1111/cas.12569. Epub 2014 Dec 8.
2160 Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.IUBMB Life. 2018 Jun;70(6):536-546. doi: 10.1002/iub.1752. Epub 2018 Apr 29.
2161 Carboxyl-terminal modulator protein induces apoptosis by regulating mitochondrial function in lung cancer cells.Int J Oncol. 2012 May;40(5):1515-24. doi: 10.3892/ijo.2011.1319. Epub 2011 Dec 23.
2162 In Silico Selection Approach to Develop DNA Aptamers for a Stem-like Cell Subpopulation of Non-small Lung Cancer Adenocarcinoma Cell Line A549.Radiol Oncol. 2018 Mar 25;52(2):152-159. doi: 10.2478/raon-2018-0014. eCollection 2018 Jun.
2163 The Fibroblast TIAM2 Promotes Lung Cancer Cell Invasion and Metastasis.J Cancer. 2019 Apr 21;10(8):1879-1889. doi: 10.7150/jca.30477. eCollection 2019.
2164 Met is involved in TIGAR-regulated metastasis of non-small-cell lung cancer.Mol Cancer. 2018 May 12;17(1):88. doi: 10.1186/s12943-018-0839-4.
2165 TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner.Br J Cancer. 2015 Nov 17;113(10):1484-92. doi: 10.1038/bjc.2015.323. Epub 2015 Oct 29.
2166 Depletion of C3orf1/TIMMDC1 inhibits migration and proliferation in 95D lung carcinoma cells.Int J Mol Sci. 2014 Nov 10;15(11):20555-71. doi: 10.3390/ijms151120555.
2167 Silencing of CT120 by antisense oligonucleotides could inhibit the lung cancer cells growth.Ir J Med Sci. 2010 Jun;179(2):217-23. doi: 10.1007/s11845-009-0418-1. Epub 2009 Dec 20.
2168 Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.Respir Res. 2019 May 29;20(1):106. doi: 10.1186/s12931-019-1071-5.
2169 TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1.Oncotarget. 2014 Oct 30;5(20):9823-37. doi: 10.18632/oncotarget.2450.
2170 Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.Mol Cells. 2012 Aug;34(2):171-6. doi: 10.1007/s10059-012-0083-5. Epub 2012 Jul 18.
2171 Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue.Int J Cancer. 2012 Sep 1;131(5):E643-8. doi: 10.1002/ijc.27426. Epub 2012 Feb 28.
2172 TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.Nat Commun. 2018 Jul 16;9(1):2731. doi: 10.1038/s41467-018-05013-x.
2173 TMEM17 depresses invasion and metastasis in lung cancer cells via ERK signaling pathway.Oncotarget. 2017 Aug 7;8(41):70685-70694. doi: 10.18632/oncotarget.19977. eCollection 2017 Sep 19.
2174 Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology.Acta Histochem. 2012 Nov;114(7):705-12. doi: 10.1016/j.acthis.2011.12.006. Epub 2012 Jan 12.
2175 TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.Mol Carcinog. 2019 Apr;58(4):474-487. doi: 10.1002/mc.22942. Epub 2018 Dec 11.
2176 The Expression of TMEM74 in Liver Cancer and Lung Cancer Correlating With Survival Outcomes.Appl Immunohistochem Mol Morphol. 2019 Sep;27(8):618-625. doi: 10.1097/PAI.0000000000000659.
2177 Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers.Clin Cancer Res. 2012 Jul 1;18(13):3658-67. doi: 10.1158/1078-0432.CCR-11-2857. Epub 2012 May 9.
2178 Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.Cancer Lett. 2019 Jul 1;453:21-33. doi: 10.1016/j.canlet.2019.03.013. Epub 2019 Mar 21.
2179 TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-B Signaling Cascade.Biomolecules. 2019 Dec 6;9(12):836. doi: 10.3390/biom9120836.
2180 TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.BMC Cancer. 2018 Mar 6;18(1):260. doi: 10.1186/s12885-018-4177-0.
2181 The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression.Genome Biol. 2019 May 24;20(1):103. doi: 10.1186/s13059-019-1696-1.
2182 Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study.Carcinogenesis. 2011 Apr;32(4):507-15. doi: 10.1093/carcin/bgr014. Epub 2011 Feb 2.
2183 CD137 ligand feedback upregulates PD-L1 expression on lung cancer via T cell production of IFN-.Thorac Cancer. 2019 Dec;10(12):2225-2235. doi: 10.1111/1759-7714.13207. Epub 2019 Oct 17.
2184 Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells.Mol Med Rep. 2013 May;7(5):1678-82. doi: 10.3892/mmr.2013.1362. Epub 2013 Mar 6.
2185 Distribution bias and biochemical characterization of TOP1MT single nucleotide variants.Sci Rep. 2017 Aug 17;7(1):8614. doi: 10.1038/s41598-017-09258-2.
2186 TOX3 is a favorable prognostic indicator and potential immunomodulatory factor in lung adenocarcinoma.Oncol Lett. 2019 Oct;18(4):4144-4152. doi: 10.3892/ol.2019.10748. Epub 2019 Aug 16.
2187 Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer.J Exp Clin Cancer Res. 2009 Feb 19;28(1):22. doi: 10.1186/1756-9966-28-22.
2188 Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-B Signaling Pathway in Vitro and in Vivo.Cell Physiol Biochem. 2018;46(3):999-1008. doi: 10.1159/000488831. Epub 2018 Apr 13.
2189 Distinct prognostic value of circulating anti-telomerase CD4(+) Th1 immunity and exhausted PD-1(+)/TIM-3(+) T cells in lung cancer.Br J Cancer. 2019 Aug;121(5):405-416. doi: 10.1038/s41416-019-0531-5. Epub 2019 Jul 30.
2190 TPM4 promotes cell migration by modulating F-actin formation in lung cancer.Onco Targets Ther. 2019 May 31;12:4055-4063. doi: 10.2147/OTT.S198542. eCollection 2019.
2191 TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.Cancer Res. 2018 Jul 15;78(14):3982-3994. doi: 10.1158/0008-5472.CAN-18-0429. Epub 2018 May 10.
2192 TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts.Sci Rep. 2017 Aug 21;7(1):8923. doi: 10.1038/s41598-017-09447-z.
2193 TRAP1 regulates autophagy in lung cancer cells.Eur J Clin Invest. 2018 Apr;48(4). doi: 10.1111/eci.12900. Epub 2018 Feb 23.
2194 Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.Oncogene. 2003 Mar 27;22(12):1892-905. doi: 10.1038/sj.onc.1206304.
2195 An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy.J Mol Med (Berl). 2006 Mar;84(3):215-25. doi: 10.1007/s00109-005-0009-1. Epub 2005 Dec 31.
2196 TRIB3 promotes lung cancer progression by activating -catenin signaling.Eur J Pharmacol. 2019 Nov 15;863:172697. doi: 10.1016/j.ejphar.2019.172697. Epub 2019 Sep 25.
2197 Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.J Cancer. 2019 Jan 29;10(4):843-852. doi: 10.7150/jca.27856. eCollection 2019.
2198 SSA/RO52gene and expressed sequence tags in an 85 kb region of chromosome segment 11p15.5.Int J Cancer. 2000 Jul 1;87(1):61-7. doi: 10.1002/1097-0215(20000701)87:1<61::aid-ijc9>3.0.co;2-r.
2199 TRIM45 Suppresses the Development of Non-small Cell Lung Cancer.Curr Mol Med. 2020;20(4):299-306. doi: 10.2174/1566524019666191017143833.
2200 TRIM52 regulates the proliferation and invasiveness of lung cancer cells via the Wnt/catenin pathway.Oncol Rep. 2019 Jun;41(6):3325-3334. doi: 10.3892/or.2019.7110. Epub 2019 Apr 11.
2201 TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.Oncol Rep. 2018 Jul;40(1):206-216. doi: 10.3892/or.2018.6426. Epub 2018 May 8.
2202 Combinatory inhibition of TRIM65 and MDM2 in lung cancer cells.Biochem Biophys Res Commun. 2018 Nov 30;506(3):698-702. doi: 10.1016/j.bbrc.2018.10.130. Epub 2018 Oct 27.
2203 The human tRNA-modifying protein, TRIT1, forms amyloid fibers in vitro.Gene. 2017 May 15;612:19-24. doi: 10.1016/j.gene.2016.10.041. Epub 2016 Oct 29.
2204 Identification of trophinin as an enhancer for cell invasion and a prognostic factor for early stage lung cancer.Eur J Cancer. 2007 Mar;43(4):782-90. doi: 10.1016/j.ejca.2006.09.029. Epub 2007 Jan 24.
2205 Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma.J Thorac Dis. 2019 May;11(5):2043-2050. doi: 10.21037/jtd.2019.04.86.
2206 Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.Cancer Med. 2018 May;7(5):1921-1932. doi: 10.1002/cam4.1421. Epub 2018 Mar 30.
2207 Bone Marrow and Tumor Radiomics at (18)F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer.Radiology. 2019 Nov;293(2):451-459. doi: 10.1148/radiol.2019190357. Epub 2019 Sep 17.
2208 Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.Cancer Biother Radiopharm. 2016 Dec;31(10):353-359. doi: 10.1089/cbr.2016.2108.
2209 Differentially expressed nucleolar TGF-beta1 target (DENTT) shows tissue-specific nuclear and cytoplasmic localization and increases TGF-beta1-responsive transcription in primates.Biochim Biophys Acta. 2005 May 1;1728(3):163-80. doi: 10.1016/j.bbaexp.2005.02.010. Epub 2005 Mar 22.
2210 A novel adamantane thiadiazole derivative induces mitochondria-mediated apoptosis in lung carcinoma cell line.Bioorg Med Chem. 2017 Jan 1;25(1):241-253. doi: 10.1016/j.bmc.2016.10.040. Epub 2016 Nov 5.
2211 Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort.BMJ Open. 2019 Jan 17;9(1):e024719. doi: 10.1136/bmjopen-2018-024719.
2212 AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival.PLoS One. 2019 Feb 7;14(2):e0211745. doi: 10.1371/journal.pone.0211745. eCollection 2019.
2213 Overexpression of APC11 predicts worse survival in lung adenocarcinoma.Onco Targets Ther. 2018 Oct 17;11:7125-7132. doi: 10.2147/OTT.S177252. eCollection 2018.
2214 Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer.Sci Rep. 2018 Oct 5;8(1):14896. doi: 10.1038/s41598-018-33190-8.
2215 DNA methylation and associated gene expression in blood prior to lung cancer diagnosis in the Norwegian Women and Cancer cohort.Sci Rep. 2018 Nov 13;8(1):16714. doi: 10.1038/s41598-018-34334-6.
2216 BHLHB3: a candidate tumor suppressor in lung cancer.Oncogene. 2008 Jun 12;27(26):3761-4. doi: 10.1038/sj.onc.1211038. Epub 2008 Jan 28.
2217 GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population.Curr Med Sci. 2018 Aug;38(4):734-740. doi: 10.1007/s11596-018-1938-6. Epub 2018 Aug 20.
2218 CDP138 silencing inhibits TGF-/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer.Cell Death Dis. 2017 Sep 7;8(9):e3036. doi: 10.1038/cddis.2017.434.
2219 Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.PLoS One. 2018 Nov 19;13(11):e0207483. doi: 10.1371/journal.pone.0207483. eCollection 2018.
2220 Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.Cancer Manag Res. 2018 Dec 14;10:6971-6984. doi: 10.2147/CMAR.S182852. eCollection 2018.
2221 Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.Respir Med. 2015 Jan;109(1):131-6. doi: 10.1016/j.rmed.2014.11.004. Epub 2014 Nov 21.
2222 Decreased Lung Tumor Development in SwAPP Mice through the Downregulation of CHI3L1 and STAT 3 Activity via the Upregulation of miRNA342-3p.Mol Ther Nucleic Acids. 2019 Jun 7;16:63-72. doi: 10.1016/j.omtn.2019.02.007. Epub 2019 Feb 20.
2223 The red wine component ellagic acid induces autophagy and exhibits anti-lung cancer activity invitro and invivo.J Cell Mol Med. 2019 Jan;23(1):143-154. doi: 10.1111/jcmm.13899. Epub 2018 Oct 24.
2224 CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.Dis Markers. 2014;2014:619273. doi: 10.1155/2014/619273. Epub 2014 Dec 7.
2225 Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).J Oncol Pract. 2018 Oct;14(10):e631-e643. doi: 10.1200/JOP.18.00175. Epub 2018 Sep 12.
2226 Toll-like receptor agonist rMBP-NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer.Oncol Lett. 2018 Oct;16(4):4707-4712. doi: 10.3892/ol.2018.9182. Epub 2018 Jul 20.
2227 Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.Cancer Res. 2007 Jul 1;67(13):6293-303. doi: 10.1158/0008-5472.CAN-06-3884.
2228 Downregulation of TM7SF4 inhibits cell proliferation and metastasis of A549 cells through regulating the PI3K/AKT/mTOR signaling pathway.Mol Med Rep. 2017 Nov;16(5):6122-6127. doi: 10.3892/mmr.2017.7324. Epub 2017 Aug 22.
2229 DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.J Cell Mol Med. 2020 Jan;24(1):1141-1145. doi: 10.1111/jcmm.14734. Epub 2019 Nov 20.
2230 Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.Clin Lung Cancer. 2008 Nov;9(6):367-74. doi: 10.3816/CLC.2008.n.053.
2231 RNA sequencing identifies novel markers of non-small cell lung cancer.Lung Cancer. 2014 Jun;84(3):229-35. doi: 10.1016/j.lungcan.2014.03.018. Epub 2014 Mar 26.
2232 Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.J Clin Lab Anal. 2019 Jun;33(5):e22863. doi: 10.1002/jcla.22863. Epub 2019 Feb 19.
2233 Pivotal roles of protein 4.1B/DAL?, a FERMdomain containing protein, in tumor progression (Review).Int J Oncol. 2019 Nov;55(5):979-987. doi: 10.3892/ijo.2019.4877. Epub 2019 Sep 13.
2234 Effect of separase depletion on ionizing radiation-induced cell cycle checkpoints and survival in human lung cancer cell lines.Cell Prolif. 2008 Aug;41(4):660-70. doi: 10.1111/j.1365-2184.2008.00540.x. Epub 2008 Jun 19.
2235 Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer.Thorac Cancer. 2019 Apr;10(4):642-658. doi: 10.1111/1759-7714.12976. Epub 2019 Feb 18.
2236 FRMD3, a novel putative tumour suppressor in NSCLC.Oncogene. 2007 Jun 28;26(30):4464-8. doi: 10.1038/sj.onc.1210225. Epub 2007 Jan 29.
2237 Early detection of lung cancer by using an autoantibody panel in Chinese population.Oncoimmunology. 2017 Oct 16;7(2):e1384108. doi: 10.1080/2162402X.2017.1384108. eCollection 2018.
2238 Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.Br J Cancer. 2004 Jan 26;90(2):436-42. doi: 10.1038/sj.bjc.6601531.
2239 Induction of Human-Lung-Cancer-A549-Cell Apoptosis by 4-Hydroperoxy-2-decenoic Acid Ethyl Ester through Intracellular ROS Accumulation and the Induction of Proapoptotic CHOP Expression.J Agric Food Chem. 2018 Oct 17;66(41):10741-10747. doi: 10.1021/acs.jafc.8b04424. Epub 2018 Oct 8.
2240 HPIP silencing inhibits TGF-1-induced EMT in lung cancer cells.Int J Mol Med. 2017 Feb;39(2):479-483. doi: 10.3892/ijmm.2017.2851. Epub 2017 Jan 5.
2241 Deregulated ALG-2/HEBP2 axis alters microtubule dynamics and mitotic spindle behavior to stimulate cancer development.J Cell Physiol. 2017 Nov;232(11):3067-3076. doi: 10.1002/jcp.25754. Epub 2017 Mar 1.
2242 Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer.Biochem Biophys Res Commun. 2018 Nov 30;506(3):455-462. doi: 10.1016/j.bbrc.2018.10.087. Epub 2018 Oct 20.
2243 Lung cancer susceptibility genetic variants modulate HOXB2 expression in the lung.Int J Dev Biol. 2018;62(11-12):857-864. doi: 10.1387/ijdb.180210yb.
2244 Clinical translation of [(18)F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer.Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2285-2299. doi: 10.1007/s00259-018-4098-9. Epub 2018 Sep 27.
2245 Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling.Mol Ther. 2018 Sep 5;26(9):2255-2266. doi: 10.1016/j.ymthe.2018.06.016. Epub 2018 Jun 22.
2246 KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.Clin Cancer Res. 2007 Jun 1;13(11):3229-34. doi: 10.1158/1078-0432.CCR-07-0393.
2247 Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.Cell Physiol Biochem. 2018;51(1):1-10. doi: 10.1159/000495155. Epub 2018 Nov 15.
2248 Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer.Lung Cancer. 2018 Dec;126:55-63. doi: 10.1016/j.lungcan.2018.07.005. Epub 2018 Jul 5.
2249 Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning.Iran J Pharm Res. 2018 Winter;17(1):396-407.
2250 Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.Biochem Biophys Res Commun. 2014 Jan 24;443(4):1141-7. doi: 10.1016/j.bbrc.2013.12.106. Epub 2013 Dec 28.
2251 Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma.Onco Targets Ther. 2019 Jul 10;12:5537-5544. doi: 10.2147/OTT.S196925. eCollection 2019.
2252 Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells.Onco Targets Ther. 2018 May 25;11:3111-3117. doi: 10.2147/OTT.S156102. eCollection 2018.
2253 Human MOB1 expression in non-small-cell lung cancer.Clin Lung Cancer. 2007 Jan;8(4):273-6. doi: 10.3816/CLC.2007.n.006.
2254 MORC2 Enhances Tumor Growth by Promoting Angiogenesis and Tumor-Associated Macrophage Recruitment via Wnt/-Catenin in Lung Cancer.Cell Physiol Biochem. 2018;51(4):1679-1694. doi: 10.1159/000495673. Epub 2018 Nov 30.
2255 Prognostic significance of folate metabolism polymorphisms for lung cancer.Br J Cancer. 2007 Jul 16;97(2):247-52. doi: 10.1038/sj.bjc.6603830. Epub 2007 May 29.
2256 Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.Biochem Biophys Res Commun. 2018 Sep 5;503(2):856-862. doi: 10.1016/j.bbrc.2018.06.087. Epub 2018 Jun 23.
2257 Chemical identification of a sulfated glucan from Antrodia cinnamomea and its anti-cancer functions via inhibition of EGFR and mTOR activity.Carbohydr Polym. 2018 Dec 15;202:536-544. doi: 10.1016/j.carbpol.2018.09.009. Epub 2018 Sep 6.
2258 Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.Biomed Pharmacother. 2015 Jul;73:97-101. doi: 10.1016/j.biopha.2015.05.015. Epub 2015 Jun 1.
2259 Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis.Eur Respir J. 2012 May;39(5):1171-80. doi: 10.1183/09031936.00184410. Epub 2011 Sep 29.
2260 The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth.Cell Death Dis. 2018 May 22;9(6):603. doi: 10.1038/s41419-018-0580-3.
2261 Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.Clin Lung Cancer. 2013 Jan;14(1):45-9. doi: 10.1016/j.cllc.2012.04.004. Epub 2012 Jun 1.
2262 The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.Curr Mol Med. 2019;19(1):54-75. doi: 10.2174/1566524019666190308163315.
2263 Methylation status of the PPP1R13L promoter region among lung cancer patients and healthy controls. Analytical cross-sectional study.Sao Paulo Med J. 2019 Aug 29;137(3):255-261. doi: 10.1590/1516-3180.2018.0358230419.
2264 PRDX3 is associated with metastasis and poor survival in uveal melanoma.J Clin Pathol. 2020 Jul;73(7):408-412. doi: 10.1136/jclinpath-2019-206173. Epub 2019 Nov 26.
2265 Long Noncoding RNA PRRG4-4 Promotes Viability, Cell Cycle, Migration, and Invasion in Lung Cancer Cells.DNA Cell Biol. 2018 Dec;37(12):953-966. doi: 10.1089/dna.2018.4220. Epub 2018 Oct 26.
2266 Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis.Int J Mol Sci. 2018 Oct 17;19(10):3213. doi: 10.3390/ijms19103213.
2267 Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.Oncol Rep. 2006 May;15(5):1281-5.
2268 Role of RNA-binding protein 5 in the diagnosis and chemotherapeutic response of lung cancer.Oncol Lett. 2019 Feb;17(2):2013-2019. doi: 10.3892/ol.2018.9818. Epub 2018 Dec 10.
2269 Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis.Oncol Lett. 2018 Oct;16(4):4201-4210. doi: 10.3892/ol.2018.9221. Epub 2018 Jul 26.
2270 Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice.Int Immunopharmacol. 2018 Feb;55:306-311. doi: 10.1016/j.intimp.2017.12.029. Epub 2018 Jan 5.
2271 Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma.Cancer Sci. 2010 Jan;101(1):46-53. doi: 10.1111/j.1349-7006.2009.01351.x. Epub 2009 Sep 9.
2272 Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.Oncotarget. 2017 Jul 11;8(28):45710-45724. doi: 10.18632/oncotarget.17391.
2273 SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma.Oncol Lett. 2018 Nov;16(5):5916-5922. doi: 10.3892/ol.2018.9403. Epub 2018 Sep 5.
2274 Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis.Sci Rep. 2017 Sep 4;7(1):10407. doi: 10.1038/s41598-017-10891-0.
2275 Hydrogen gas inhibits lung cancer progression through targeting SMC3.Biomed Pharmacother. 2018 Aug;104:788-797. doi: 10.1016/j.biopha.2018.05.055. Epub 2018 May 29.
2276 SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation.Cancer Res. 2017 Dec 1;77(23):6729-6745. doi: 10.1158/0008-5472.CAN-17-0828. Epub 2017 Sep 26.
2277 Spermassociated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.Oncol Rep. 2018 Aug;40(2):783-792. doi: 10.3892/or.2018.6473. Epub 2018 Jun 4.
2278 Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes.Front Oncol. 2018 Oct 30;8:482. doi: 10.3389/fonc.2018.00482. eCollection 2018.
2279 A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population.BMC Cancer. 2011 Mar 23;11:104. doi: 10.1186/1471-2407-11-104.
2280 VAMP8, a vesicle-SNARE required for RAB37-mediated exocytosis, possesses a tumor metastasis suppressor function.Cancer Lett. 2018 Nov 28;437:79-88. doi: 10.1016/j.canlet.2018.08.023. Epub 2018 Aug 27.
2281 Antibacterial and anticancer potential of marine endophytic actinomycetes Streptomyces coeruleorubidus GRG 4 (KY457708) compound against colistin resistant uropathogens and A549 lung cancer cells.Microb Pathog. 2018 Dec;125:325-335. doi: 10.1016/j.micpath.2018.09.025. Epub 2018 Sep 19.
2282 Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism.Cell Rep. 2018 Nov 20;25(8):2223-2233.e6. doi: 10.1016/j.celrep.2018.10.100.
2283 LncRNA LCPAT1 Mediates Smoking/ Particulate Matter 2.5-Induced Cell Autophagy and Epithelial-Mesenchymal Transition in Lung Cancer Cells via RCC2.Cell Physiol Biochem. 2018;47(3):1244-1258. doi: 10.1159/000490220. Epub 2018 Jun 15.
2284 TRIM44 promotes proliferation and metastasis in nonsmall cell lung cancer via mTOR signaling pathway.Oncotarget. 2016 May 24;7(21):30479-91. doi: 10.18632/oncotarget.8586.
2285 Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.Pathol Res Pract. 2018 Aug;214(8):1130-1135. doi: 10.1016/j.prp.2018.06.008. Epub 2018 Jun 18.